Name,Category,CategoryID,GO,Description,PARENT_GO,LogP,Enrichment,Z-score,#TotalGeneInLibrary,#GeneInGO,#GeneInHitList,#GeneInGOAndHitList,%InGO,STDV %InGO,GeneID,Hits,Log(q-value)
CNet-SVM,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-11,1.1e+02,25,30198,119,14,6,43,13,2002|2246|2253|3725|7480|54361,ELK1|FGF1|FGF8|JUN|WNT10B|WNT4,-8.7
CNet-SVM,KEGG Pathway,24,hsa05224,Breast cancer,,-10,88,23,30198,147,14,6,43,13,2246|2253|3725|3845|7480|54361,FGF1|FGF8|JUN|KRAS|WNT10B|WNT4,-8.2
CNet-SVM,WikiPathways,27,WP4262,Breast cancer pathway,,-10,82,22,30198,157,14,6,43,13,2246|2253|3725|3845|7480|54361,FGF1|FGF8|JUN|KRAS|WNT10B|WNT4,-8.1
CNet-SVM,KEGG Pathway,24,hsa05200,Pathways in cancer,,-8.8,28,14,30198,531,14,7,50,13,2002|2246|2253|3725|3845|7480|54361,ELK1|FGF1|FGF8|JUN|KRAS|WNT10B|WNT4,-6.9
CNet-SVM,KEGG Pathway,24,hsa05226,Gastric cancer,,-8.3,72,19,30198,149,14,5,36,13,2246|2253|3845|7480|54361,FGF1|FGF8|KRAS|WNT10B|WNT4,-6.5
CNet-SVM,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-7.6,29,13,30198,447,14,6,43,13,2002|2246|2253|3725|7480|54361,ELK1|FGF1|FGF8|JUN|WNT10B|WNT4,-5.9
CNet-SVM,WikiPathways,27,WP4928,MAPK pathway in congenital thyroid cancer,,-7.4,4e+02,35,30198,16,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-5.7
CNet-SVM,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-7.3,26,12,30198,498,14,6,43,13,2002|2246|2253|3725|5179|54361,ELK1|FGF1|FGF8|JUN|PENK|WNT4,-5.7
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-7.2,3.6e+02,33,30198,18,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.6
CNet-SVM,WikiPathways,27,WP382,MAPK signaling pathway,,-7.2,43,14,30198,249,14,5,36,13,2002|2246|2253|3725|3845,ELK1|FGF1|FGF8|JUN|KRAS,-5.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-7,3.2e+02,31,30198,20,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-7,3.2e+02,31,30198,20,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-7,3.1e+02,30,30198,21,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-6.9,2.9e+02,30,30198,22,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-6.9,2.9e+02,30,30198,22,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-6.9,2.8e+02,29,30198,23,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.3
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-6.9,2.8e+02,29,30198,23,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.3
CNet-SVM,WikiPathways,27,WP399,Wnt signaling pathway and pluripotency,,-6.8,81,18,30198,107,14,4,29,12,3725|7480|10009|54361,JUN|WNT10B|ZBTB33|WNT4,-5.3
CNet-SVM,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-6.8,37,13,30198,294,14,5,36,13,2002|2246|2253|3725|3845,ELK1|FGF1|FGF8|JUN|KRAS,-5.3
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-6.7,2.6e+02,28,30198,25,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.3
CNet-SVM,GO Biological Processes,19,GO:0031128,developmental induction,19_GO:0032502 developmental process,-6.7,2.6e+02,28,30198,25,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-5.3
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-6.7,2.6e+02,28,30198,25,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.3
CNet-SVM,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-6.7,75,17,30198,115,14,4,29,12,3725|3845|7480|54361,JUN|KRAS|WNT10B|WNT4,-5.2
CNet-SVM,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-6.6,72,17,30198,120,14,4,29,12,2246|2253|7480|54361,FGF1|FGF8|WNT10B|WNT4,-5.2
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-6.6,2.4e+02,27,30198,27,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.2
CNet-SVM,GO Biological Processes,19,GO:0110110,positive regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-6.5,2.2e+02,25,30198,30,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-5.1
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-6.5,2.2e+02,25,30198,30,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5.1
CNet-SVM,Canonical Pathways,11,M5883,NABA SECRETED FACTORS,,-6.5,31,12,30198,343,14,5,36,13,2246|2253|2920|7480|54361,FGF1|FGF8|CXCL2|WNT10B|WNT4,-5
CNet-SVM,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-6.5,65,16,30198,133,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-5
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-6.5,2.1e+02,25,30198,31,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-5
CNet-SVM,WikiPathways,27,WP422,MAPK cascade,,-6.4,2e+02,24,30198,33,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-4.9
CNet-SVM,Canonical Pathways,11,M5885,NABA MATRISOME ASSOCIATED,,-6.2,17,9.7,30198,751,14,6,43,13,1472|2246|2253|2920|7480|54361,CST4|FGF1|FGF8|CXCL2|WNT10B|WNT4,-4.8
CNet-SVM,WikiPathways,27,WP4666,Hepatitis B infection,,-6.2,56,15,30198,154,14,4,29,12,1959|2002|3725|3845,EGR2|ELK1|JUN|KRAS,-4.8
CNet-SVM,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-6.2,1.7e+02,22,30198,38,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.8
CNet-SVM,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-6.1,53,14,30198,162,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-4.7
CNet-SVM,KEGG Pathway,24,hsa05161,Hepatitis B,,-6.1,53,14,30198,162,14,4,29,12,1959|2002|3725|3845,EGR2|ELK1|JUN|KRAS,-4.7
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-6.1,1.6e+02,22,30198,40,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM,WikiPathways,27,WP127,IL-5 signaling pathway,,-6.1,1.6e+02,22,30198,40,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-4.7
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-6.1,1.6e+02,22,30198,41,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-6.1,51,14,30198,168,14,4,29,12,2002|3845|7480|54361,ELK1|KRAS|WNT10B|WNT4,-4.7
CNet-SVM,GO Biological Processes,19,GO:0001658,branching involved in ureteric bud morphogenesis,19_GO:0032502 developmental process,-6,1.5e+02,21,30198,42,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.7
CNet-SVM,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-6,50,14,30198,171,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-4.7
CNet-SVM,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-6,1.5e+02,21,30198,43,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-6,50,14,30198,174,14,4,29,12,2002|2246|2253|3845,ELK1|FGF1|FGF8|KRAS,-4.6
CNet-SVM,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-6,48,14,30198,178,14,4,29,12,2002|2246|2253|3845,ELK1|FGF1|FGF8|KRAS,-4.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-5.9,1.3e+02,20,30198,48,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-5.8,1.3e+02,20,30198,50,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.5
CNet-SVM,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-5.8,23,10,30198,468,14,5,36,13,2246|2253|3725|5179|54361,FGF1|FGF8|JUN|PENK|WNT4,-4.5
CNet-SVM,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-5.8,44,13,30198,198,14,4,29,12,2002|2246|2253|3845,ELK1|FGF1|FGF8|KRAS,-4.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-5.8,1.2e+02,19,30198,52,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.5
CNet-SVM,GO Biological Processes,19,GO:0060675,ureteric bud morphogenesis,19_GO:0032502 developmental process,-5.8,1.2e+02,19,30198,52,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-5.7,1.2e+02,19,30198,53,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.4
CNet-SVM,GO Biological Processes,19,GO:0072171,mesonephric tubule morphogenesis,19_GO:0032502 developmental process,-5.7,1.2e+02,19,30198,53,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-5.7,1.2e+02,19,30198,54,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-5.7,1.2e+02,19,30198,54,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.4
CNet-SVM,KEGG Pathway,24,hsa05205,Proteoglycans in cancer,,-5.7,42,13,30198,205,14,4,29,12,2002|3845|7480|54361,ELK1|KRAS|WNT10B|WNT4,-4.4
CNet-SVM,Canonical Pathways,11,M276,PID FGF PATHWAY,,-5.7,1.2e+02,19,30198,55,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-4.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-5.6,21,9.8,30198,521,14,5,36,13,1959|2002|2246|2253|3845,EGR2|ELK1|FGF1|FGF8|KRAS,-4.3
CNet-SVM,KEGG Pathway,24,hsa05166,Human T-cell leukemia virus 1 infection,,-5.6,39,12,30198,222,14,4,29,12,1959|2002|3725|3845,EGR2|ELK1|JUN|KRAS,-4.3
CNet-SVM,GO Biological Processes,19,GO:0072078,nephron tubule morphogenesis,19_GO:0032502 developmental process,-5.5,1e+02,17,30198,63,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.2
CNet-SVM,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-5.5,1e+02,17,30198,63,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.2
CNet-SVM,WikiPathways,27,WP4155,Endometrial cancer,,-5.5,1e+02,17,30198,63,14,3,21,11,2002|2246|3845,ELK1|FGF1|KRAS,-4.2
CNet-SVM,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-5.5,37,12,30198,232,14,4,29,12,2002|2246|2253|3845,ELK1|FGF1|FGF8|KRAS,-4.2
CNet-SVM,Canonical Pathways,11,M272,PID CD8 TCR DOWNSTREAM PATHWAY,,-5.5,1e+02,17,30198,65,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-4.2
CNet-SVM,GO Biological Processes,19,GO:0072088,nephron epithelium morphogenesis,19_GO:0032502 developmental process,-5.5,1e+02,17,30198,65,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.2
CNet-SVM,GO Biological Processes,19,GO:0072028,nephron morphogenesis,19_GO:0032502 developmental process,-5.4,97,17,30198,67,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.2
CNet-SVM,GO Biological Processes,19,GO:0061333,renal tubule morphogenesis,19_GO:0032502 developmental process,-5.4,97,17,30198,67,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4.2
CNet-SVM,KEGG Pathway,24,hsa05218,Melanoma,,-5.3,90,16,30198,72,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-5.3,89,16,30198,73,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM,GO Biological Processes,19,GO:0072080,nephron tubule development,19_GO:0032502 developmental process,-5.3,85,16,30198,76,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4
CNet-SVM,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-5.2,83,16,30198,78,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-4
CNet-SVM,GO Biological Processes,19,GO:0061326,renal tubule development,19_GO:0032502 developmental process,-5.2,81,15,30198,80,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4
CNet-SVM,GO Biological Processes,19,GO:0001657,ureteric bud development,19_GO:0032502 developmental process,-5.2,79,15,30198,82,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-4
CNet-SVM,GO Biological Processes,19,GO:0072163,mesonephric epithelium development,19_GO:0032502 developmental process,-5.1,78,15,30198,83,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.9
CNet-SVM,GO Biological Processes,19,GO:0072164,mesonephric tubule development,19_GO:0032502 developmental process,-5.1,78,15,30198,83,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.9
CNet-SVM,GO Biological Processes,19,GO:0060993,kidney morphogenesis,19_GO:0032502 developmental process,-5.1,77,15,30198,84,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.9
CNet-SVM,GO Biological Processes,19,GO:0071774,response to fibroblast growth factor,19_GO:0050896 response to stimulus,-5.1,77,15,30198,84,14,3,21,11,2002|2246|2253,ELK1|FGF1|FGF8,-3.9
CNet-SVM,KEGG Pathway,24,hsa04012,ErbB signaling pathway,,-5.1,76,15,30198,85,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.9
CNet-SVM,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-5.1,74,15,30198,87,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-3.9
CNet-SVM,GO Biological Processes,19,GO:0001823,mesonephros development,19_GO:0032502 developmental process,-5.1,74,15,30198,87,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.9
CNet-SVM,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-5.1,16,8.6,30198,663,14,5,36,13,2246|2253|3725|3845|54361,FGF1|FGF8|JUN|KRAS|WNT4,-3.9
CNet-SVM,WikiPathways,27,WP673,ErbB signaling pathway,,-5,71,14,30198,91,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.8
CNet-SVM,WikiPathways,27,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,,-5,71,14,30198,91,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-3.8
CNet-SVM,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-5,28,10,30198,307,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-3.8
CNet-SVM,KEGG Pathway,24,hsa04912,GnRH signaling pathway,,-5,70,14,30198,93,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.8
CNet-SVM,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-5,27,10,30198,314,14,4,29,12,2002|2253|3725|3845,ELK1|FGF8|JUN|KRAS,-3.8
CNet-SVM,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-4.9,15,8.3,30198,708,14,5,36,13,2920|3845|5179|7480|54361,CXCL2|KRAS|PENK|WNT10B|WNT4,-3.8
CNet-SVM,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-4.9,27,10,30198,325,14,4,29,12,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-3.8
CNet-SVM,GO Biological Processes,19,GO:0072009,nephron epithelium development,19_GO:0032502 developmental process,-4.9,65,14,30198,99,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.8
CNet-SVM,KEGG Pathway,24,hsa04916,Melanogenesis,,-4.9,64,14,30198,101,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-3.7
CNet-SVM,KEGG Pathway,24,hsa04625,C-type lectin receptor signaling pathway,,-4.9,62,13,30198,104,14,3,21,11,1959|3725|3845,EGR2|JUN|KRAS,-3.7
CNet-SVM,WikiPathways,27,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,,-4.9,62,13,30198,104,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-3.7
CNet-SVM,Canonical Pathways,11,M164,PID ERBB1 DOWNSTREAM PATHWAY,,-4.8,62,13,30198,105,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.7
CNet-SVM,WikiPathways,27,WP4659,Gastrin signaling pathway,,-4.7,57,13,30198,114,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-187037,Signaling by NTRK1 (TRKA),,-4.7,56,13,30198,115,14,3,21,11,1959|2002|3845,EGR2|ELK1|KRAS,-3.6
CNet-SVM,WikiPathways,27,WP428,Wnt signaling,,-4.7,55,13,30198,118,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-3.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-5619507,Activation of HOX genes during differentiation,,-4.7,53,12,30198,121,14,3,21,11,1959|3725|10664,EGR2|JUN|CTCF,-3.5
CNet-SVM,GO Biological Processes,19,GO:0030278,regulation of ossification,19_GO:0032501 multicellular organismal process,-4.7,53,12,30198,121,14,3,21,11,1959|7480|54361,EGR2|WNT10B|WNT4,-3.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,,-4.7,53,12,30198,121,14,3,21,11,1959|3725|10664,EGR2|JUN|CTCF,-3.5
CNet-SVM,GO Biological Processes,19,GO:0001889,liver development,19_GO:0032502 developmental process,-4.6,53,12,30198,122,14,3,21,11,2002|3725|54361,ELK1|JUN|WNT4,-3.5
CNet-SVM,GO Biological Processes,19,GO:0061008,hepaticobiliary system development,19_GO:0032502 developmental process,-4.6,52,12,30198,125,14,3,21,11,2002|3725|54361,ELK1|JUN|WNT4,-3.5
CNet-SVM,GO Biological Processes,19,GO:2000027,regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-4.6,51,12,30198,126,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.5
CNet-SVM,GO Biological Processes,19,GO:0072073,kidney epithelium development,19_GO:0032502 developmental process,-4.6,51,12,30198,128,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.5
CNet-SVM,GO Biological Processes,19,GO:0072006,nephron development,19_GO:0032502 developmental process,-4.6,51,12,30198,128,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-3.5
CNet-SVM,Canonical Pathways,11,M186,PID PDGFRB PATHWAY,,-4.6,50,12,30198,129,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.5
CNet-SVM,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-4.6,21,8.9,30198,402,14,4,29,12,2002|2253|3725|54361,ELK1|FGF8|JUN|WNT4,-3.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-166520,Signaling by NTRKs,,-4.5,48,12,30198,134,14,3,21,11,1959|2002|3845,EGR2|ELK1|KRAS,-3.4
CNet-SVM,KEGG Pathway,24,hsa04550,Signaling pathways regulating pluripotency of stem cells,,-4.4,45,11,30198,143,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-3.3
CNet-SVM,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-4.4,45,11,30198,144,14,3,21,11,1959|2002|3725,EGR2|ELK1|JUN,-3.3
CNet-SVM,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-4.4,45,11,30198,145,14,3,21,11,2253|3725|3845,FGF8|JUN|KRAS,-3.3
CNet-SVM,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-4.4,43,11,30198,150,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-3.3
CNet-SVM,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-4.4,19,8.4,30198,447,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-3.3
CNet-SVM,GO Biological Processes,19,GO:0071560,cellular response to transforming growth factor beta stimulus,19_GO:0050896 response to stimulus,-4.4,43,11,30198,151,14,3,21,11,3725|5179|54361,JUN|PENK|WNT4,-3.3
CNet-SVM,KEGG Pathway,24,hsa04921,Oxytocin signaling pathway,,-4.3,42,11,30198,154,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.3
CNet-SVM,KEGG Pathway,24,hsa04150,mTOR signaling pathway,,-4.3,41,11,30198,156,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-3.2
CNet-SVM,KEGG Pathway,24,hsa04390,Hippo signaling pathway,,-4.3,41,11,30198,157,14,3,21,11,2246|7480|54361,FGF1|WNT10B|WNT4,-3.2
CNet-SVM,GO Biological Processes,19,GO:0071559,response to transforming growth factor beta,19_GO:0050896 response to stimulus,-4.3,41,11,30198,158,14,3,21,11,3725|5179|54361,JUN|PENK|WNT4,-3.2
CNet-SVM,Reactome Gene Sets,6,R-HSA-500792,GPCR ligand binding,,-4.3,18,8.2,30198,467,14,4,29,12,2920|5179|7480|54361,CXCL2|PENK|WNT10B|WNT4,-3.2
CNet-SVM,WikiPathways,27,WP437,EGF/EGFR signaling pathway,,-4.3,40,11,30198,163,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-3.2
CNet-SVM,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-4.3,39,11,30198,165,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-3.2
CNet-SVM,GO Biological Processes,19,GO:0061061,muscle structure development,19_GO:0032502 developmental process,-4.2,18,8,30198,484,14,4,29,12,1959|3845|7480|54361,EGR2|KRAS|WNT10B|WNT4,-3.2
CNet-SVM,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-4.2,39,11,30198,167,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-3.2
CNet-SVM,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-4.2,18,8,30198,492,14,4,29,12,2253|5179|7480|54361,FGF8|PENK|WNT10B|WNT4,-3.1
CNet-SVM,GO Biological Processes,19,GO:0071396,cellular response to lipid,19_GO:0050896 response to stimulus,-4.2,17,7.9,30198,503,14,4,29,12,2002|2920|5179|7480,ELK1|CXCL2|PENK|WNT10B,-3.1
CNet-SVM,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-4.2,17,7.9,30198,505,14,4,29,12,1959|2246|2253|3725,EGR2|FGF1|FGF8|JUN,-3.1
CNet-SVM,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-4.1,16,7.7,30198,526,14,4,29,12,1959|2246|2253|3725,EGR2|FGF1|FGF8|JUN,-3
CNet-SVM,KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-4,33,9.7,30198,194,14,3,21,11,2920|3725|3845,CXCL2|JUN|KRAS,-3
CNet-SVM,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-4,15,7.4,30198,557,14,4,29,12,2246|2253|3845|54361,FGF1|FGF8|KRAS|WNT4,-3
CNet-SVM,KEGG Pathway,24,hsa05203,Viral carcinogenesis,,-4,32,9.5,30198,204,14,3,21,11,1959|3725|3845,EGR2|JUN|KRAS,-2.9
CNet-SVM,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-4,31,9.4,30198,207,14,3,21,11,2253|3725|3845,FGF8|JUN|KRAS,-2.9
CNet-SVM,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-3.9,31,9.4,30198,209,14,3,21,11,2253|3725|3845,FGF8|JUN|KRAS,-2.9
CNet-SVM,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-3.9,31,9.3,30198,210,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.9
CNet-SVM,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-3.9,31,9.3,30198,212,14,3,21,11,2253|3725|3845,FGF8|JUN|KRAS,-2.9
CNet-SVM,GO Biological Processes,19,GO:0042063,gliogenesis,19_GO:0032502 developmental process,-3.9,30,9.3,30198,213,14,3,21,11,1959|3845|5179,EGR2|KRAS|PENK,-2.9
CNet-SVM,KEGG Pathway,24,hsa05417,Lipid and atherosclerosis,,-3.9,30,9.2,30198,215,14,3,21,11,2920|3725|3845,CXCL2|JUN|KRAS,-2.9
CNet-SVM,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-3.9,30,9.2,30198,218,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.9
CNet-SVM,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-3.9,29,9.1,30198,221,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.8
CNet-SVM,Reactome Gene Sets,6,R-HSA-8939211,ESR-mediated signaling,,-3.9,29,9,30198,223,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-2.8
CNet-SVM,GO Biological Processes,19,GO:0045165,cell fate commitment,19_GO:0032502 developmental process,-3.8,27,8.6,30198,244,14,3,21,11,2253|7480|54361,FGF8|WNT10B|WNT4,-2.7
CNet-SVM,GO Biological Processes,19,GO:0090068,positive regulation of cell cycle process,19_GO:0048518 positive regulation of biological process,-3.7,25,8.3,30198,259,14,3,21,11,2253|7480|54361,FGF8|WNT10B|WNT4,-2.7
CNet-SVM,GO Biological Processes,19,GO:0042692,muscle cell differentiation,19_GO:0032502 developmental process,-3.7,25,8.3,30198,261,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.6
CNet-SVM,GO Biological Processes,19,GO:0198738,cell-cell signaling by wnt,19_GO:0023052 signaling,-3.7,25,8.3,30198,262,14,3,21,11,7480|10009|54361,WNT10B|ZBTB33|WNT4,-2.6
CNet-SVM,GO Biological Processes,19,GO:0016055,Wnt signaling pathway,19_GO:0023052 signaling,-3.7,25,8.3,30198,262,14,3,21,11,7480|10009|54361,WNT10B|ZBTB33|WNT4,-2.6
CNet-SVM,WikiPathways,27,WP5124,Alzheimer's disease,,-3.6,24,8.2,30198,267,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-3.6,24,8.2,30198,267,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-1280215,Cytokine Signaling in Immune system,,-3.6,12,6.5,30198,715,14,4,29,12,2002|2920|3725|3845,ELK1|CXCL2|JUN|KRAS,-2.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-3.6,23,8,30198,280,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.6
CNet-SVM,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-3.5,23,7.9,30198,286,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.5
CNet-SVM,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-3.5,12,6.4,30198,734,14,4,29,12,2253|7480|10664|54361,FGF8|WNT10B|CTCF|WNT4,-2.5
CNet-SVM,GO Biological Processes,19,GO:0001822,kidney development,19_GO:0032502 developmental process,-3.5,23,7.9,30198,287,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-2.5
CNet-SVM,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-3.5,12,6.3,30198,744,14,4,29,12,1959|2253|3845|54361,EGR2|FGF8|KRAS|WNT4,-2.5
CNet-SVM,GO Biological Processes,19,GO:0072001,renal system development,19_GO:0032502 developmental process,-3.5,22,7.8,30198,296,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-2.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-9006931,Signaling by Nuclear Receptors,,-3.5,22,7.7,30198,299,14,3,21,11,2002|3725|3845,ELK1|JUN|KRAS,-2.5
CNet-SVM,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-3.4,21,7.6,30198,309,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.4
CNet-SVM,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-3.4,21,7.6,30198,309,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.4
CNet-SVM,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-3.4,21,7.5,30198,312,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.4
CNet-SVM,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-3.4,11,6.1,30198,789,14,4,29,12,1959|2253|3845|54361,EGR2|FGF8|KRAS|WNT4,-2.4
CNet-SVM,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-3.4,20,7.4,30198,323,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.4
CNet-SVM,GO Biological Processes,19,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,19_GO:0023052 signaling,-3.4,20,7.4,30198,326,14,3,21,11,7480|10009|54361,WNT10B|ZBTB33|WNT4,-2.4
CNet-SVM,KEGG Pathway,24,hsa05165,Human papillomavirus infection,,-3.4,20,7.3,30198,331,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.4
CNet-SVM,Reactome Gene Sets,6,R-HSA-195721,Signaling by WNT,,-3.4,19,7.3,30198,332,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.4
CNet-SVM,GO Biological Processes,19,GO:0001655,urogenital system development,19_GO:0032502 developmental process,-3.4,19,7.3,30198,334,14,3,21,11,2246|2253|54361,FGF1|FGF8|WNT4,-2.4
CNet-SVM,WikiPathways,27,WP2059,Alzheimer's disease and miRNA effects,,-3.3,19,7.2,30198,337,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.4
CNet-SVM,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-3.3,19,7.1,30198,345,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.3
CNet-SVM,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-3.3,18,7,30198,354,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.3
CNet-SVM,GO Biological Processes,19,GO:0045787,positive regulation of cell cycle,19_GO:0048518 positive regulation of biological process,-3.3,18,7,30198,358,14,3,21,11,2253|7480|54361,FGF8|WNT10B|WNT4,-2.3
CNet-SVM,GO Biological Processes,19,GO:0030900,forebrain development,19_GO:0032502 developmental process,-3.2,17,6.8,30198,374,14,3,21,11,2253|3845|54361,FGF8|KRAS|WNT4,-2.2
CNet-SVM,GO Biological Processes,19,GO:0050678,regulation of epithelial cell proliferation,19_GO:0050789 regulation of biological process,-3.2,17,6.8,30198,382,14,3,21,11,2246|3725|7480,FGF1|JUN|WNT10B,-2.2
CNet-SVM,KEGG Pathway,24,hsa05010,Alzheimer disease,,-3.2,17,6.7,30198,384,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-2.2
CNet-SVM,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-3.1,15,6.4,30198,421,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-2.1
CNet-SVM,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-3,15,6.3,30198,433,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-2.1
CNet-SVM,GO Biological Processes,19,GO:0009314,response to radiation,19_GO:0050896 response to stimulus,-3,15,6.3,30198,435,14,3,21,11,2002|3845|5179,ELK1|KRAS|PENK,-2.1
CNet-SVM,Reactome Gene Sets,6,R-HSA-449147,Signaling by Interleukins,,-2.9,14,6.1,30198,462,14,3,21,11,2002|2920|3725,ELK1|CXCL2|JUN,-2
CNet-SVM,KEGG Pathway,24,hsa05022,Pathways of neurodegeneration - multiple diseases,,-2.9,14,6,30198,476,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-1.9
CNet-SVM,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-2.9,13,5.9,30198,492,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-1.9
CNet-SVM,GO Biological Processes,19,GO:0071407,cellular response to organic cyclic compound,19_GO:0050896 response to stimulus,-2.8,13,5.8,30198,505,14,3,21,11,2002|5179|7480,ELK1|PENK|WNT10B,-1.9
CNet-SVM,GO Biological Processes,19,GO:0007423,sensory organ development,19_GO:0032502 developmental process,-2.7,12,5.5,30198,555,14,3,21,11,2253|3725|7480,FGF8|JUN|WNT10B,-1.8
CNet-SVM,GO Biological Processes,19,GO:0007610,behavior,19_GO:0032501 multicellular organismal process,-2.7,11,5.4,30198,572,14,3,21,11,1959|3845|5179,EGR2|KRAS|PENK,-1.7
CNet-SVM,GO Biological Processes,19,GO:0030855,epithelial cell differentiation,19_GO:0032502 developmental process,-2.7,11,5.3,30198,576,14,3,21,11,2253|3725|54361,FGF8|JUN|WNT4,-1.7
CNet-SVM,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-2.7,11,5.3,30198,580,14,3,21,11,3725|5179|7480,JUN|PENK|WNT10B,-1.7
CNet-SVM,GO Biological Processes,19,GO:0010942,positive regulation of cell death,19_GO:0048518 positive regulation of biological process,-2.6,11,5.2,30198,605,14,3,21,11,2002|3725|7480,ELK1|JUN|WNT10B,-1.7
CNet-SVM,GO Biological Processes,19,GO:0030097,hemopoiesis,19_GO:0002376 immune system process,-2.6,11,5.2,30198,606,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-1.7
CNet-SVM,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-2.6,11,5.2,30198,606,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-1.7
CNet-SVM,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-2.6,10,5.1,30198,633,14,3,21,11,2920|3845|5179,CXCL2|KRAS|PENK,-1.6
CNet-SVM,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-2.5,10,5,30198,640,14,3,21,11,3725|5179|7480,JUN|PENK|WNT10B,-1.6
CNet-SVM,GO Biological Processes,19,GO:0048534,hematopoietic or lymphoid organ development,19_GO:0002376 immune system process,-2.5,9.9,4.9,30198,655,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-1.6
CNet-SVM,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-2.4,9.4,4.8,30198,688,14,3,21,11,2246|2253|3725,FGF1|FGF8|JUN,-1.5
CNet-SVM,GO Biological Processes,19,GO:0002520,immune system development,19_GO:0002376 immune system process,-2.4,9.3,4.8,30198,699,14,3,21,11,3725|7480|54361,JUN|WNT10B|WNT4,-1.5
CNet-SVM,GO Biological Processes,19,GO:0045596,negative regulation of cell differentiation,19_GO:0032502 developmental process,-2.4,9.3,4.8,30198,699,14,3,21,11,3845|7480|54361,KRAS|WNT10B|WNT4,-1.5
CNet-SVM,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-2.4,8.7,4.6,30198,741,14,3,21,11,2246|2253|3845,FGF1|FGF8|KRAS,-1.4
CNet-SVM,GO Biological Processes,19,GO:0008285,negative regulation of cell population proliferation,19_GO:0048519 negative regulation of biological process,-2.3,8.2,4.4,30198,786,14,3,21,11,3725|7480|10664,JUN|WNT10B|CTCF,-1.4
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa05224,Breast cancer,,-9.3,2.1e+02,29,30198,147,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-7.2
CNet-SVM_MCODE_ALL,WikiPathways,27,WP4262,Breast cancer pathway,,-9.2,1.9e+02,28,30198,157,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-7.2
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-9.1,1.3e+03,61,30198,18,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7.2
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-9,1.1e+03,58,30198,20,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-9,1.1e+03,58,30198,20,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-8.9,1.1e+03,57,30198,21,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-8.9,1e+03,56,30198,22,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-8.9,1e+03,56,30198,22,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-8.8,9.8e+02,54,30198,23,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.9
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-8.8,9.8e+02,54,30198,23,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.9
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-8.7,9.1e+02,52,30198,25,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.8
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-8.7,9.1e+02,52,30198,25,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.8
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-8.6,8.4e+02,50,30198,27,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-8.5,7.5e+02,48,30198,30,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-8.4,7.3e+02,47,30198,31,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.6
CNet-SVM_MCODE_ALL,WikiPathways,27,WP382,MAPK signaling pathway,,-8.3,1.2e+02,22,30198,249,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.5
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-8.1,6e+02,42,30198,38,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.4
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-8.1,5.7e+02,41,30198,40,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.3
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-8.1,1e+02,20,30198,294,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.3
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-8,5.5e+02,41,30198,41,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.3
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-8,5.3e+02,40,30198,43,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.2
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-7.9,93,19,30198,325,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.2
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-7.8,4.7e+02,38,30198,48,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.1
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-7.8,4.5e+02,37,30198,50,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.1
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-7.7,4.4e+02,36,30198,52,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-7.7,4.3e+02,36,30198,53,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-7.7,4.2e+02,35,30198,54,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-7.7,4.2e+02,35,30198,54,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_MCODE_ALL,Canonical Pathways,11,M276,PID FGF PATHWAY,,-7.6,4.1e+02,35,30198,55,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-7.5,3.6e+02,33,30198,63,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.8
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa05218,Melanoma,,-7.3,3.1e+02,31,30198,72,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-7.3,3.1e+02,30,30198,73,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.7
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-7.2,2.9e+02,29,30198,78,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-7,2.6e+02,28,30198,87,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.5
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa05200,Pathways in cancer,,-7,57,15,30198,531,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-5.5
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-6.6,46,13,30198,663,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-5.2
CNet-SVM_MCODE_ALL,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-6.6,1.9e+02,24,30198,119,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-5.2
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-6.5,1.7e+02,23,30198,133,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-6.4,1.6e+02,22,30198,145,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.9
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa05226,Gastric cancer,,-6.3,1.5e+02,21,30198,149,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.9
CNet-SVM_MCODE_ALL,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-6.3,1.5e+02,21,30198,150,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.9
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-6.2,1.4e+02,20,30198,162,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.8
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-6.1,1.3e+02,20,30198,171,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.8
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-6.1,1.3e+02,20,30198,174,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-6.1,1.3e+02,19,30198,178,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-6,1.1e+02,18,30198,198,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-5.9,1.1e+02,18,30198,207,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-5.9,1.1e+02,18,30198,209,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.6
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-5.9,1.1e+02,18,30198,210,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.6
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-5.9,1.1e+02,18,30198,212,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.5
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-5.8,1e+02,18,30198,218,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.5
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.8,1e+02,17,30198,221,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.5
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-5.7,98,17,30198,232,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.4
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-5.6,85,16,30198,267,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.3
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-5.5,81,15,30198,280,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.2
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-5.5,79,15,30198,286,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.2
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-5.4,74,15,30198,307,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-5.4,73,15,30198,309,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_MCODE_ALL,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-5.4,73,15,30198,309,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.4,73,15,30198,312,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-5.4,72,15,30198,314,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.1
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-5.3,70,14,30198,323,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_MCODE_ALL,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-5.2,66,14,30198,345,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4
CNet-SVM_MCODE_ALL,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-5.2,64,14,30198,354,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-5,54,13,30198,421,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.8
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-4.9,52,12,30198,433,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.8
CNet-SVM_MCODE_ALL,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-4.9,51,12,30198,447,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.7
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-4.9,51,12,30198,447,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.7
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-4.8,48,12,30198,468,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.7
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-4.8,46,12,30198,492,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-4.8,45,12,30198,498,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-4.7,45,11,30198,505,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-4.7,43,11,30198,521,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-4.7,43,11,30198,526,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-4.6,41,11,30198,557,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.5
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-4.5,37,10,30198,606,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.4
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-4.3,33,9.7,30198,688,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.2
CNet-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-4.2,31,9.4,30198,741,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.2
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05224,Breast cancer,,-9.3,2.1e+02,29,30198,147,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-7.2
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP4262,Breast cancer pathway,,-9.2,1.9e+02,28,30198,157,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-7.2
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-9.1,1.3e+03,61,30198,18,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7.2
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-9,1.1e+03,58,30198,20,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-9,1.1e+03,58,30198,20,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-8.9,1.1e+03,57,30198,21,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-8.9,1e+03,56,30198,22,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-8.9,1e+03,56,30198,22,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-8.8,9.8e+02,54,30198,23,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.9
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-8.8,9.8e+02,54,30198,23,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.9
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-8.7,9.1e+02,52,30198,25,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.8
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-8.7,9.1e+02,52,30198,25,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.8
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-8.6,8.4e+02,50,30198,27,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-8.5,7.5e+02,48,30198,30,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-8.4,7.3e+02,47,30198,31,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.6
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP382,MAPK signaling pathway,,-8.3,1.2e+02,22,30198,249,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.5
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-8.1,6e+02,42,30198,38,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.4
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-8.1,5.7e+02,41,30198,40,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.3
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-8.1,1e+02,20,30198,294,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.3
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-8,5.5e+02,41,30198,41,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.3
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-8,5.3e+02,40,30198,43,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.2
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-7.9,93,19,30198,325,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-6.2
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-7.8,4.7e+02,38,30198,48,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.1
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-7.8,4.5e+02,37,30198,50,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6.1
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-7.7,4.4e+02,36,30198,52,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-7.7,4.3e+02,36,30198,53,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-7.7,4.2e+02,35,30198,54,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-7.7,4.2e+02,35,30198,54,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-6
CNet-SVM_SUB1_MCODE_1,Canonical Pathways,11,M276,PID FGF PATHWAY,,-7.6,4.1e+02,35,30198,55,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-7.5,3.6e+02,33,30198,63,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.8
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05218,Melanoma,,-7.3,3.1e+02,31,30198,72,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-7.3,3.1e+02,30,30198,73,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.7
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-7.2,2.9e+02,29,30198,78,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-7,2.6e+02,28,30198,87,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5.5
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05200,Pathways in cancer,,-7,57,15,30198,531,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-5.5
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-6.6,46,13,30198,663,4,4,1e+02,22,2246|2253|3725|3845,FGF1|FGF8|JUN|KRAS,-5.2
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-6.6,1.9e+02,24,30198,119,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-5.2
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-6.5,1.7e+02,23,30198,133,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-5
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-6.4,1.6e+02,22,30198,145,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.9
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05226,Gastric cancer,,-6.3,1.5e+02,21,30198,149,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.9
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-6.3,1.5e+02,21,30198,150,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.9
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-6.2,1.4e+02,20,30198,162,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.8
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-6.1,1.3e+02,20,30198,171,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.8
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-6.1,1.3e+02,20,30198,174,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-6.1,1.3e+02,19,30198,178,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.7
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-6,1.1e+02,18,30198,198,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-5.9,1.1e+02,18,30198,207,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-5.9,1.1e+02,18,30198,209,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.6
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-5.9,1.1e+02,18,30198,210,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.6
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-5.9,1.1e+02,18,30198,212,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.5
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-5.8,1e+02,18,30198,218,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.5
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.8,1e+02,17,30198,221,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.5
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-5.7,98,17,30198,232,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.4
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-5.6,85,16,30198,267,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.3
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-5.5,81,15,30198,280,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.2
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-5.5,79,15,30198,286,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.2
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-5.4,74,15,30198,307,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-5.4,73,15,30198,309,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-5.4,73,15,30198,309,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.4,73,15,30198,312,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-5.4,72,15,30198,314,4,3,75,22,2253|3725|3845,FGF8|JUN|KRAS,-4.1
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-5.3,70,14,30198,323,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-4.1
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-5.2,66,14,30198,345,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4
CNet-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-5.2,64,14,30198,354,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-4
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-5,54,13,30198,421,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.8
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-4.9,52,12,30198,433,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.8
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-4.9,51,12,30198,447,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.7
CNet-SVM_SUB1_MCODE_1,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-4.9,51,12,30198,447,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.7
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-4.8,48,12,30198,468,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.7
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-4.8,46,12,30198,492,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-4.8,45,12,30198,498,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-4.7,45,11,30198,505,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-4.7,43,11,30198,521,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-4.7,43,11,30198,526,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.6
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-4.6,41,11,30198,557,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.5
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-4.5,37,10,30198,606,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.4
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-4.3,33,9.7,30198,688,4,3,75,22,2246|2253|3725,FGF1|FGF8|JUN,-3.2
CNet-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-4.2,31,9.4,30198,741,4,3,75,22,2246|2253|3845,FGF1|FGF8|KRAS,-3.2
SCAD-SVM,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-4.4,36,10,30198,633,4,3,75,22,2920|3845|5179,CXCL2|KRAS|PENK,-3.3
SCAD-SVM,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-4.3,32,9.6,30198,708,4,3,75,22,2920|3845|5179,CXCL2|KRAS|PENK,-3.2
SGLasso-SVM,GO Biological Processes,19,GO:0007088,regulation of mitotic nuclear division,19_GO:0050789 regulation of biological process,-9,2e+02,29,30198,118,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-7
SGLasso-SVM,GO Biological Processes,19,GO:0051301,cell division,19_GO:0009987 cellular process,-8.9,60,17,30198,503,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-7
SGLasso-SVM,GO Biological Processes,19,GO:1903047,mitotic cell cycle process,19_GO:0009987 cellular process,-8.9,59,17,30198,514,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-6.9
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-69278,"Cell Cycle, Mitotic",,-8.7,54,16,30198,561,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-6.8
SGLasso-SVM,GO Biological Processes,19,GO:0051783,regulation of nuclear division,19_GO:0050789 regulation of biological process,-8.6,1.7e+02,26,30198,145,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-6.7
SGLasso-SVM,GO Biological Processes,19,GO:0000278,mitotic cell cycle,19_GO:0009987 cellular process,-8.5,50,16,30198,605,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-6.7
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-1640170,Cell Cycle,,-8.2,44,15,30198,692,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-6.4
SGLasso-SVM,GO Biological Processes,19,GO:0007094,mitotic spindle assembly checkpoint signaling,19_GO:0023052 signaling,-8.1,6.2e+02,43,30198,29,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:0071173,spindle assembly checkpoint signaling,19_GO:0023052 signaling,-8.1,6.2e+02,43,30198,29,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:0071174,mitotic spindle checkpoint signaling,19_GO:0023052 signaling,-8.1,6.2e+02,43,30198,29,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-8.1,41,14,30198,734,5,5,1e+02,18,699|1063|4751|22974|83540,BUB1|CENPF|NEK2|TPX2|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:0031577,spindle checkpoint signaling,19_GO:0023052 signaling,-8.1,6e+02,43,30198,30,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,19_GO:0048519 negative regulation of biological process,-8,5.8e+02,42,30198,31,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.3
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-68877,Mitotic Prometaphase,,-8,1.2e+02,22,30198,204,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-6.3
SGLasso-SVM,GO Biological Processes,19,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,19_GO:0048519 negative regulation of biological process,-7.9,5.5e+02,41,30198,33,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.2
SGLasso-SVM,GO Biological Processes,19,GO:0033046,negative regulation of sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-7.9,5.3e+02,40,30198,34,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.2
SGLasso-SVM,GO Biological Processes,19,GO:2000816,negative regulation of mitotic sister chromatid separation,19_GO:0048519 negative regulation of biological process,-7.9,5.3e+02,40,30198,34,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.2
SGLasso-SVM,GO Biological Processes,19,GO:0033048,negative regulation of mitotic sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-7.9,5.3e+02,40,30198,34,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.2
SGLasso-SVM,GO Biological Processes,19,GO:1905819,negative regulation of chromosome separation,19_GO:0048519 negative regulation of biological process,-7.8,5e+02,39,30198,36,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.1
SGLasso-SVM,GO Biological Processes,19,GO:0051985,negative regulation of chromosome segregation,19_GO:0048519 negative regulation of biological process,-7.8,5e+02,39,30198,36,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6.1
SGLasso-SVM,GO Biological Processes,19,GO:0098813,nuclear chromosome segregation,19_GO:0009987 cellular process,-7.8,1.1e+02,20,30198,228,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-6.1
SGLasso-SVM,GO Biological Processes,19,GO:0045839,negative regulation of mitotic nuclear division,19_GO:0048519 negative regulation of biological process,-7.7,4.6e+02,37,30198,39,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-6
SGLasso-SVM,GO Biological Processes,19,GO:0033044,regulation of chromosome organization,19_GO:0050789 regulation of biological process,-7.6,97,20,30198,250,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-6
SGLasso-SVM,GO Biological Processes,19,GO:0051784,negative regulation of nuclear division,19_GO:0048519 negative regulation of biological process,-7.5,3.9e+02,34,30198,46,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM,GO Biological Processes,19,GO:0007059,chromosome segregation,19_GO:0009987 cellular process,-7.4,85,18,30198,285,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-5.8
SGLasso-SVM,GO Biological Processes,19,GO:0010948,negative regulation of cell cycle process,19_GO:0048519 negative regulation of biological process,-7.4,84,18,30198,287,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-5.8
SGLasso-SVM,GO Biological Processes,19,GO:0000280,nuclear division,19_GO:0009987 cellular process,-7.3,78,18,30198,310,5,4,80,18,699|4751|22974|83540,BUB1|NEK2|TPX2|NUF2,-5.7
SGLasso-SVM,GO Biological Processes,19,GO:0033047,regulation of mitotic sister chromatid segregation,19_GO:0050789 regulation of biological process,-7.2,3.3e+02,31,30198,55,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM,GO Biological Processes,19,GO:0048285,organelle fission,19_GO:0009987 cellular process,-7.1,72,17,30198,335,5,4,80,18,699|4751|22974|83540,BUB1|NEK2|TPX2|NUF2,-5.6
SGLasso-SVM,GO Biological Processes,19,GO:0010639,negative regulation of organelle organization,19_GO:0048519 negative regulation of biological process,-7.1,71,17,30198,342,5,4,80,18,699|1063|22974|83540,BUB1|CENPF|TPX2|NUF2,-5.5
SGLasso-SVM,GO Biological Processes,19,GO:0045786,negative regulation of cell cycle,19_GO:0048519 negative regulation of biological process,-6.9,64,16,30198,375,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-5.4
SGLasso-SVM,GO Biological Processes,19,GO:2001251,negative regulation of chromosome organization,19_GO:0048519 negative regulation of biological process,-6.7,2.3e+02,26,30198,80,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.3
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-68886,M Phase,,-6.7,58,15,30198,418,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-5.3
SGLasso-SVM,GO Biological Processes,19,GO:0030071,regulation of mitotic metaphase/anaphase transition,19_GO:0050789 regulation of biological process,-6.6,2e+02,24,30198,91,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM,GO Biological Processes,19,GO:0007052,mitotic spindle organization,19_GO:0009987 cellular process,-6.5,1.9e+02,24,30198,94,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-5.1
SGLasso-SVM,GO Biological Processes,19,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,19_GO:0050789 regulation of biological process,-6.5,1.9e+02,24,30198,94,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-141424,Amplification of signal from the kinetochores,,-6.5,1.9e+02,24,30198,96,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,-6.5,1.9e+02,24,30198,96,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM,GO Biological Processes,19,GO:0010965,regulation of mitotic sister chromatid separation,19_GO:0050789 regulation of biological process,-6.5,1.9e+02,24,30198,96,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM,GO Biological Processes,19,GO:0033045,regulation of sister chromatid segregation,19_GO:0050789 regulation of biological process,-6.4,1.7e+02,23,30198,105,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-5
SGLasso-SVM,GO Biological Processes,19,GO:0007346,regulation of mitotic cell cycle,19_GO:0050789 regulation of biological process,-6.4,47,13,30198,517,5,4,80,18,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-5
SGLasso-SVM,GO Biological Processes,19,GO:1905818,regulation of chromosome separation,19_GO:0050789 regulation of biological process,-6.3,1.7e+02,22,30198,109,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-69618,Mitotic Spindle Checkpoint,,-6.3,1.6e+02,22,30198,113,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,,-6.2,1.5e+02,21,30198,117,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.8
SGLasso-SVM,GO Biological Processes,19,GO:0007093,mitotic cell cycle checkpoint signaling,19_GO:0023052 signaling,-6.2,1.5e+02,21,30198,123,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.8
SGLasso-SVM,GO Biological Processes,19,GO:1902850,microtubule cytoskeleton organization involved in mitosis,19_GO:0009987 cellular process,-6.2,1.4e+02,21,30198,125,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-4.8
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,,-6.2,1.4e+02,21,30198,126,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.8
SGLasso-SVM,GO Biological Processes,19,GO:0051983,regulation of chromosome segregation,19_GO:0050789 regulation of biological process,-6.1,1.4e+02,20,30198,130,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-5663220,RHO GTPases Activate Formins,,-6,1.3e+02,20,30198,140,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM,GO Biological Processes,19,GO:0000819,sister chromatid segregation,19_GO:0009987 cellular process,-6,1.2e+02,19,30198,146,5,3,60,22,699|4751|83540,BUB1|NEK2|NUF2,-4.6
SGLasso-SVM,GO Biological Processes,19,GO:0000075,cell cycle checkpoint signaling,19_GO:0023052 signaling,-5.9,1.2e+02,19,30198,153,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.6
SGLasso-SVM,GO Biological Processes,19,GO:0007051,spindle organization,19_GO:0009987 cellular process,-5.9,1.2e+02,19,30198,155,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-4.6
SGLasso-SVM,GO Biological Processes,19,GO:0051129,negative regulation of cellular component organization,19_GO:0048519 negative regulation of biological process,-5.9,35,12,30198,693,5,4,80,18,699|1063|22974|83540,BUB1|CENPF|TPX2|NUF2,-4.5
SGLasso-SVM,GO Biological Processes,19,GO:0140014,mitotic nuclear division,19_GO:0009987 cellular process,-5.8,1.1e+02,18,30198,169,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-4.5
SGLasso-SVM,GO Biological Processes,19,GO:1901991,negative regulation of mitotic cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-5.7,1e+02,17,30198,178,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.4
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-2467813,Separation of Sister Chromatids,,-5.6,95,17,30198,191,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.3
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-69275,G2/M Transition,,-5.6,92,17,30198,196,5,3,60,22,1063|4751|22974,CENPF|NEK2|TPX2,-4.3
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-453274,Mitotic G2-G2/M phases,,-5.6,92,16,30198,198,5,3,60,22,1063|4751|22974,CENPF|NEK2|TPX2,-4.3
SGLasso-SVM,GO Biological Processes,19,GO:0045930,negative regulation of mitotic cell cycle,19_GO:0048519 negative regulation of biological process,-5.4,80,15,30198,227,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-68882,Mitotic Anaphase,,-5.3,77,15,30198,236,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-2555396,Mitotic Metaphase and Anaphase,,-5.3,76,15,30198,237,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM,GO Biological Processes,19,GO:1901988,negative regulation of cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-5.3,76,15,30198,238,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM,GO Biological Processes,19,GO:0051321,meiotic cell cycle,19_GO:0022414 reproductive process,-5.3,75,15,30198,241,5,3,60,22,699|4751|83540,BUB1|NEK2|NUF2,-4.1
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-69620,Cell Cycle Checkpoints,,-5.1,62,13,30198,293,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-3.9
SGLasso-SVM,GO Biological Processes,19,GO:0140694,non-membrane-bounded organelle assembly,19_GO:0009987 cellular process,-5,58,13,30198,312,5,3,60,22,1063|4751|22974,CENPF|NEK2|TPX2,-3.8
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-195258,RHO GTPase Effectors,,-4.9,55,13,30198,327,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM,GO Biological Processes,19,GO:1901990,regulation of mitotic cell cycle phase transition,19_GO:0050789 regulation of biological process,-4.8,51,12,30198,355,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM,GO Biological Processes,19,GO:1901987,regulation of cell cycle phase transition,19_GO:0050789 regulation of biological process,-4.5,40,11,30198,454,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-3.4
SGLasso-SVM,GO Biological Processes,19,GO:0000226,microtubule cytoskeleton organization,19_GO:0009987 cellular process,-4.3,34,10,30198,526,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-3.2
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-194315,Signaling by Rho GTPases,,-3.9,26,8.5,30198,707,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-2.9
SGLasso-SVM,Reactome Gene Sets,6,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",,-3.9,25,8.4,30198,723,5,3,60,22,699|1063|83540,BUB1|CENPF|NUF2,-2.8
SGLasso-SVM,GO Biological Processes,19,GO:0070925,organelle assembly,19_GO:0009987 cellular process,-3.8,23,8.1,30198,783,5,3,60,22,1063|4751|22974,CENPF|NEK2|TPX2,-2.7
SGLasso-SVM,GO Biological Processes,19,GO:0007017,microtubule-based process,19_GO:0009987 cellular process,-3.8,23,8.1,30198,786,5,3,60,22,4751|22974|83540,NEK2|TPX2|NUF2,-2.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071174,mitotic spindle checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071173,spindle assembly checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007094,mitotic spindle assembly checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0031577,spindle checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,55,30198,30,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,19_GO:0048519 negative regulation of biological process,-9,9.7e+02,54,30198,31,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,19_GO:0048519 negative regulation of biological process,-8.9,9.2e+02,52,30198,33,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0033048,negative regulation of mitotic sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0033046,negative regulation of sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:2000816,negative regulation of mitotic sister chromatid separation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1905819,negative regulation of chromosome separation,19_GO:0048519 negative regulation of biological process,-8.8,8.4e+02,50,30198,36,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051985,negative regulation of chromosome segregation,19_GO:0048519 negative regulation of biological process,-8.8,8.4e+02,50,30198,36,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0045839,negative regulation of mitotic nuclear division,19_GO:0048519 negative regulation of biological process,-8.7,7.7e+02,48,30198,39,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.8
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051784,negative regulation of nuclear division,19_GO:0048519 negative regulation of biological process,-8.5,6.6e+02,44,30198,46,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0033047,regulation of mitotic sister chromatid segregation,19_GO:0050789 regulation of biological process,-8.2,5.5e+02,41,30198,55,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.5
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:2001251,negative regulation of chromosome organization,19_GO:0048519 negative regulation of biological process,-7.7,3.8e+02,34,30198,80,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0030071,regulation of mitotic metaphase/anaphase transition,19_GO:0050789 regulation of biological process,-7.6,3.3e+02,32,30198,91,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,19_GO:0050789 regulation of biological process,-7.5,3.2e+02,31,30198,94,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-141424,Amplification of signal from the kinetochores,,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0010965,regulation of mitotic sister chromatid separation,19_GO:0050789 regulation of biological process,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0033045,regulation of sister chromatid segregation,19_GO:0050789 regulation of biological process,-7.4,2.9e+02,29,30198,105,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.8
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1905818,regulation of chromosome separation,19_GO:0050789 regulation of biological process,-7.3,2.8e+02,29,30198,109,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-69618,Mitotic Spindle Checkpoint,,-7.3,2.7e+02,28,30198,113,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,,-7.2,2.6e+02,28,30198,117,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007088,regulation of mitotic nuclear division,19_GO:0050789 regulation of biological process,-7.2,2.6e+02,28,30198,118,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007093,mitotic cell cycle checkpoint signaling,19_GO:0023052 signaling,-7.2,2.5e+02,27,30198,123,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,,-7.1,2.4e+02,27,30198,126,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051983,regulation of chromosome segregation,19_GO:0050789 regulation of biological process,-7.1,2.3e+02,26,30198,130,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5663220,RHO GTPases Activate Formins,,-7,2.2e+02,25,30198,140,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.5
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051783,regulation of nuclear division,19_GO:0050789 regulation of biological process,-7,2.1e+02,25,30198,145,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.4
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0000075,cell cycle checkpoint signaling,19_GO:0023052 signaling,-6.9,2e+02,24,30198,153,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.4
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901991,negative regulation of mitotic cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-6.7,1.7e+02,22,30198,178,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.2
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2467813,Separation of Sister Chromatids,,-6.6,1.6e+02,22,30198,191,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-68877,Mitotic Prometaphase,,-6.5,1.5e+02,21,30198,204,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0045930,negative regulation of mitotic cell cycle,19_GO:0048519 negative regulation of biological process,-6.4,1.3e+02,20,30198,227,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0098813,nuclear chromosome segregation,19_GO:0009987 cellular process,-6.4,1.3e+02,20,30198,228,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-68882,Mitotic Anaphase,,-6.3,1.3e+02,20,30198,236,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2555396,Mitotic Metaphase and Anaphase,,-6.3,1.3e+02,19,30198,237,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901988,negative regulation of cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-6.3,1.3e+02,19,30198,238,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0033044,regulation of chromosome organization,19_GO:0050789 regulation of biological process,-6.3,1.2e+02,19,30198,250,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.8
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007059,chromosome segregation,19_GO:0009987 cellular process,-6.1,1.1e+02,18,30198,285,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0010948,negative regulation of cell cycle process,19_GO:0048519 negative regulation of biological process,-6.1,1.1e+02,18,30198,287,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-69620,Cell Cycle Checkpoints,,-6,1e+02,17,30198,293,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-195258,RHO GTPase Effectors,,-5.9,92,17,30198,327,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.6
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0010639,negative regulation of organelle organization,19_GO:0048519 negative regulation of biological process,-5.8,88,16,30198,342,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.5
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901990,regulation of mitotic cell cycle phase transition,19_GO:0050789 regulation of biological process,-5.8,85,16,30198,355,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.5
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0045786,negative regulation of cell cycle,19_GO:0048519 negative regulation of biological process,-5.7,81,15,30198,375,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.4
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-68886,M Phase,,-5.6,72,15,30198,418,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.3
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901987,regulation of cell cycle phase transition,19_GO:0050789 regulation of biological process,-5.5,67,14,30198,454,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.2
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051301,cell division,19_GO:0009987 cellular process,-5.3,60,13,30198,503,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:1903047,mitotic cell cycle process,19_GO:0009987 cellular process,-5.3,59,13,30198,514,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007346,regulation of mitotic cell cycle,19_GO:0050789 regulation of biological process,-5.3,58,13,30198,517,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-69278,"Cell Cycle, Mitotic",,-5.2,54,13,30198,561,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0000278,mitotic cell cycle,19_GO:0009987 cellular process,-5.1,50,12,30198,605,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.9
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1640170,Cell Cycle,,-4.9,44,11,30198,692,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.8
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051129,negative regulation of cellular component organization,19_GO:0048519 negative regulation of biological process,-4.9,44,11,30198,693,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.8
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-194315,Signaling by Rho GTPases,,-4.9,43,11,30198,707,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",,-4.9,42,11,30198,723,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM_MCODE_ALL,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-4.8,41,11,30198,734,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007094,mitotic spindle assembly checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0071174,mitotic spindle checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0071173,spindle assembly checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,56,30198,29,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0031577,spindle checkpoint signaling,19_GO:0023052 signaling,-9.1,1e+03,55,30198,30,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,19_GO:0048519 negative regulation of biological process,-9,9.7e+02,54,30198,31,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,19_GO:0048519 negative regulation of biological process,-8.9,9.2e+02,52,30198,33,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:2000816,negative regulation of mitotic sister chromatid separation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0033048,negative regulation of mitotic sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0033046,negative regulation of sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-8.9,8.9e+02,52,30198,34,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1905819,negative regulation of chromosome separation,19_GO:0048519 negative regulation of biological process,-8.8,8.4e+02,50,30198,36,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051985,negative regulation of chromosome segregation,19_GO:0048519 negative regulation of biological process,-8.8,8.4e+02,50,30198,36,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0045839,negative regulation of mitotic nuclear division,19_GO:0048519 negative regulation of biological process,-8.7,7.7e+02,48,30198,39,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.8
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051784,negative regulation of nuclear division,19_GO:0048519 negative regulation of biological process,-8.5,6.6e+02,44,30198,46,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0033047,regulation of mitotic sister chromatid segregation,19_GO:0050789 regulation of biological process,-8.2,5.5e+02,41,30198,55,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.5
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:2001251,negative regulation of chromosome organization,19_GO:0048519 negative regulation of biological process,-7.7,3.8e+02,34,30198,80,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-6.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0030071,regulation of mitotic metaphase/anaphase transition,19_GO:0050789 regulation of biological process,-7.6,3.3e+02,32,30198,91,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,19_GO:0050789 regulation of biological process,-7.5,3.2e+02,31,30198,94,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-141424,Amplification of signal from the kinetochores,,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0010965,regulation of mitotic sister chromatid separation,19_GO:0050789 regulation of biological process,-7.5,3.1e+02,31,30198,96,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0033045,regulation of sister chromatid segregation,19_GO:0050789 regulation of biological process,-7.4,2.9e+02,29,30198,105,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.8
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1905818,regulation of chromosome separation,19_GO:0050789 regulation of biological process,-7.3,2.8e+02,29,30198,109,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-69618,Mitotic Spindle Checkpoint,,-7.3,2.7e+02,28,30198,113,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,,-7.2,2.6e+02,28,30198,117,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007088,regulation of mitotic nuclear division,19_GO:0050789 regulation of biological process,-7.2,2.6e+02,28,30198,118,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007093,mitotic cell cycle checkpoint signaling,19_GO:0023052 signaling,-7.2,2.5e+02,27,30198,123,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,,-7.1,2.4e+02,27,30198,126,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051983,regulation of chromosome segregation,19_GO:0050789 regulation of biological process,-7.1,2.3e+02,26,30198,130,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.6
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5663220,RHO GTPases Activate Formins,,-7,2.2e+02,25,30198,140,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.5
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051783,regulation of nuclear division,19_GO:0050789 regulation of biological process,-7,2.1e+02,25,30198,145,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.4
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0000075,cell cycle checkpoint signaling,19_GO:0023052 signaling,-6.9,2e+02,24,30198,153,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.4
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901991,negative regulation of mitotic cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-6.7,1.7e+02,22,30198,178,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.2
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2467813,Separation of Sister Chromatids,,-6.6,1.6e+02,22,30198,191,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-68877,Mitotic Prometaphase,,-6.5,1.5e+02,21,30198,204,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0045930,negative regulation of mitotic cell cycle,19_GO:0048519 negative regulation of biological process,-6.4,1.3e+02,20,30198,227,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-5
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0098813,nuclear chromosome segregation,19_GO:0009987 cellular process,-6.4,1.3e+02,20,30198,228,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-68882,Mitotic Anaphase,,-6.3,1.3e+02,20,30198,236,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2555396,Mitotic Metaphase and Anaphase,,-6.3,1.3e+02,19,30198,237,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901988,negative regulation of cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-6.3,1.3e+02,19,30198,238,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.9
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0033044,regulation of chromosome organization,19_GO:0050789 regulation of biological process,-6.3,1.2e+02,19,30198,250,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.8
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007059,chromosome segregation,19_GO:0009987 cellular process,-6.1,1.1e+02,18,30198,285,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0010948,negative regulation of cell cycle process,19_GO:0048519 negative regulation of biological process,-6.1,1.1e+02,18,30198,287,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-69620,Cell Cycle Checkpoints,,-6,1e+02,17,30198,293,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.7
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-195258,RHO GTPase Effectors,,-5.9,92,17,30198,327,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.6
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0010639,negative regulation of organelle organization,19_GO:0048519 negative regulation of biological process,-5.8,88,16,30198,342,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.5
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901990,regulation of mitotic cell cycle phase transition,19_GO:0050789 regulation of biological process,-5.8,85,16,30198,355,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.5
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0045786,negative regulation of cell cycle,19_GO:0048519 negative regulation of biological process,-5.7,81,15,30198,375,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.4
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-68886,M Phase,,-5.6,72,15,30198,418,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.3
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1901987,regulation of cell cycle phase transition,19_GO:0050789 regulation of biological process,-5.5,67,14,30198,454,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.2
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051301,cell division,19_GO:0009987 cellular process,-5.3,60,13,30198,503,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:1903047,mitotic cell cycle process,19_GO:0009987 cellular process,-5.3,59,13,30198,514,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007346,regulation of mitotic cell cycle,19_GO:0050789 regulation of biological process,-5.3,58,13,30198,517,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4.1
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-69278,"Cell Cycle, Mitotic",,-5.2,54,13,30198,561,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-4
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0000278,mitotic cell cycle,19_GO:0009987 cellular process,-5.1,50,12,30198,605,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.9
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1640170,Cell Cycle,,-4.9,44,11,30198,692,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.8
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0051129,negative regulation of cellular component organization,19_GO:0048519 negative regulation of biological process,-4.9,44,11,30198,693,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.8
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-194315,Signaling by Rho GTPases,,-4.9,43,11,30198,707,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",,-4.9,42,11,30198,723,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SGLasso-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-4.8,41,11,30198,734,3,3,1e+02,27,699|1063|83540,BUB1|CENPF|NUF2,-3.7
SVM-RFE,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-4.4,42,11,30198,309,7,3,43,19,2253|3845|7148,FGF8|KRAS|TNXB,-3.3
SVM-RFE,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-4.3,38,10,30198,345,7,3,43,19,2253|3845|7148,FGF8|KRAS|TNXB,-3.2
SVM-RFE,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-4.3,37,10,30198,354,7,3,43,19,2253|3845|7148,FGF8|KRAS|TNXB,-3.2
SVM-RFE,GO Biological Processes,19,GO:0030900,forebrain development,19_GO:0032502 developmental process,-4.2,35,10,30198,374,7,3,43,19,2253|3845|5307,FGF8|KRAS|PITX1,-3.1
SVM-RFE,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-3.5,20,7.5,30198,633,7,3,43,19,2920|3845|5179,CXCL2|KRAS|PENK,-2.5
SVM-RFE,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-3.4,18,7.1,30198,708,7,3,43,19,2920|3845|5179,CXCL2|KRAS|PENK,-2.4
SVM-RFE,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-3.3,17,6.9,30198,744,7,3,43,19,2253|3845|5307,FGF8|KRAS|PITX1,-2.3
SVM-RFE,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-3.2,16,6.7,30198,789,7,3,43,19,2253|3845|5307,FGF8|KRAS|PITX1,-2.3
_FINAL,KEGG Pathway,24,hsa05224,Breast cancer,,-24,53,30,30198,147,66,17,26,5.4,208|1499|2246|2253|3725|3815|3845|4040|5595|6464|7480|8817|23493|26508|28514|51176|54361,AKT2|CTNNB1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|MAPK3|SHC1|WNT10B|FGF18|HEY2|HEYL|DLL1|LEF1|WNT4,-21
_FINAL,WikiPathways,27,WP4262,Breast cancer pathway,,-24,50,29,30198,157,66,17,26,5.4,208|1499|2246|2253|3725|3815|3845|4040|5595|6464|7480|8817|23493|26508|28514|51176|54361,AKT2|CTNNB1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|MAPK3|SHC1|WNT10B|FGF18|HEY2|HEYL|DLL1|LEF1|WNT4,-20
_FINAL,KEGG Pathway,24,hsa05200,Pathways in cancer,,-19,17,18,30198,531,66,20,30,5.7,208|1284|1499|2002|2246|2253|3725|3815|3845|4040|4089|4436|5595|7480|8817|23493|26508|28514|51176|54361,AKT2|COL4A2|CTNNB1|ELK1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|SMAD4|MSH2|MAPK3|WNT10B|FGF18|HEY2|HEYL|DLL1|LEF1|WNT4,-15
_FINAL,KEGG Pathway,24,hsa05226,Gastric cancer,,-17,40,22,30198,149,66,13,20,4.9,208|1499|2246|2253|3845|4040|4089|5595|6464|7480|8817|51176|54361,AKT2|CTNNB1|FGF1|FGF8|KRAS|LRP6|SMAD4|MAPK3|SHC1|WNT10B|FGF18|LEF1|WNT4,-14
_FINAL,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-16,46,23,30198,119,66,12,18,4.7,208|1499|2002|2246|2253|3725|4040|4089|6927|7480|8817|54361,AKT2|CTNNB1|ELK1|FGF1|FGF8|JUN|LRP6|SMAD4|HNF1A|WNT10B|FGF18|WNT4,-13
_FINAL,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-15,16,15,30198,498,66,17,26,5.4,1284|1311|1385|1499|2002|2246|2253|3381|3725|4089|5179|5595|6464|8817|26508|51176|54361,COL4A2|COMP|CREB1|CTNNB1|ELK1|FGF1|FGF8|IBSP|JUN|SMAD4|PENK|MAPK3|SHC1|FGF18|HEYL|LEF1|WNT4,-12
_FINAL,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-15,17,16,30198,433,66,16,24,5.3,208|1385|1499|1523|2246|2253|3815|3845|4040|4089|5595|6464|8817|23493|26508|28514,AKT2|CREB1|CTNNB1|CUX1|FGF1|FGF8|KIT|KRAS|LRP6|SMAD4|MAPK3|SHC1|FGF18|HEY2|HEYL|DLL1,-12
_FINAL,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-15,16,15,30198,447,66,16,24,5.3,208|1284|1385|1499|2002|2246|2253|3725|3815|4040|5595|6464|7480|8817|51176|54361,AKT2|COL4A2|CREB1|CTNNB1|ELK1|FGF1|FGF8|JUN|KIT|LRP6|MAPK3|SHC1|WNT10B|FGF18|LEF1|WNT4,-12
_FINAL,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-15,42,21,30198,120,66,11,17,4.6,1499|2246|2253|4040|4089|5595|7480|8817|23493|28514|54361,CTNNB1|FGF1|FGF8|LRP6|SMAD4|MAPK3|WNT10B|FGF18|HEY2|DLL1|WNT4,-12
_FINAL,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-15,33,19,30198,168,66,12,18,4.7,208|1499|2002|3845|4040|4089|5595|6464|6599|7480|51176|54361,AKT2|CTNNB1|ELK1|KRAS|LRP6|SMAD4|MAPK3|SHC1|SMARCC1|WNT10B|LEF1|WNT4,-12
_FINAL,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-14,16,15,30198,468,66,16,24,5.3,1284|1311|1385|1499|2246|2253|3381|3725|4089|5179|5595|6464|8817|26508|51176|54361,COL4A2|COMP|CREB1|CTNNB1|FGF1|FGF8|IBSP|JUN|SMAD4|PENK|MAPK3|SHC1|FGF18|HEYL|LEF1|WNT4,-12
_FINAL,GO Biological Processes,19,GO:0061061,muscle structure development,19_GO:0032502 developmental process,-14,15,15,30198,484,66,16,24,5.3,148|905|1063|1311|1499|1959|3131|3845|4089|5307|6722|7480|23493|26508|28514|54361,ADRA1A|CCNT2|CENPF|COMP|CTNNB1|EGR2|HLF|KRAS|SMAD4|PITX1|SRF|WNT10B|HEY2|HEYL|DLL1|WNT4,-11
_FINAL,WikiPathways,27,WP4216,Chromosomal and microsatellite instability in colorectal cancer,,-13,56,22,30198,74,66,9,14,4.2,208|1499|3725|3845|4089|4436|5595|5966|51176,AKT2|CTNNB1|JUN|KRAS|SMAD4|MSH2|MAPK3|REL|LEF1,-11
_FINAL,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-13,31,18,30198,165,66,11,17,4.6,208|1284|1499|3845|4040|4089|5595|6464|7480|28514|54361,AKT2|COL4A2|CTNNB1|KRAS|LRP6|SMAD4|MAPK3|SHC1|WNT10B|DLL1|WNT4,-10
_FINAL,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-13,16,14,30198,402,66,14,21,5,208|1385|1499|2002|2253|3725|4089|5021|5307|5595|6722|6927|51176|54361,AKT2|CREB1|CTNNB1|ELK1|FGF8|JUN|SMAD4|OXTR|PITX1|MAPK3|SRF|HNF1A|LEF1|WNT4,-10
_FINAL,KEGG Pathway,24,hsa05165,Human papillomavirus infection,,-12,18,15,30198,331,66,13,20,4.9,208|1284|1311|1385|1499|3381|3845|5595|7148|7480|23493|26508|54361,AKT2|COL4A2|COMP|CREB1|CTNNB1|IBSP|KRAS|MAPK3|TNXB|WNT10B|HEY2|HEYL|WNT4,-9.9
_FINAL,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-11,18,14,30198,309,66,12,18,4.7,208|1284|1311|1385|2246|2253|3381|3815|3845|5595|7148|8817,AKT2|COL4A2|COMP|CREB1|FGF1|FGF8|IBSP|KIT|KRAS|MAPK3|TNXB|FGF18,-9.1
_FINAL,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-11,36,18,30198,115,66,9,14,4.2,208|1499|3725|3845|4089|6464|7480|51176|54361,AKT2|CTNNB1|JUN|KRAS|SMAD4|SHC1|WNT10B|LEF1|WNT4,-9
_FINAL,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-11,12,12,30198,521,66,14,21,5,208|1284|1385|1499|1959|2002|2246|2253|3815|3845|5595|6464|6722|8817,AKT2|COL4A2|CREB1|CTNNB1|EGR2|ELK1|FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|SRF|FGF18,-8.9
_FINAL,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-11,47,19,30198,78,66,8,12,4,1499|2253|4040|4089|23493|26508|51176|54361,CTNNB1|FGF8|LRP6|SMAD4|HEY2|HEYL|LEF1|WNT4,-8.8
_FINAL,GO Biological Processes,19,GO:1901861,regulation of muscle tissue development,19_GO:0032502 developmental process,-11,70,22,30198,46,66,7,11,3.8,1063|1385|1499|2253|7480|28514|51176,CENPF|CREB1|CTNNB1|FGF8|WNT10B|DLL1|LEF1,-8.7
_FINAL,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-11,9.3,11,30198,789,66,16,24,5.3,1063|1385|1499|1959|2253|3624|3845|4040|5021|5307|5595|6532|6722|28514|51176|54361,CENPF|CREB1|CTNNB1|EGR2|FGF8|INHBA|KRAS|LRP6|OXTR|PITX1|MAPK3|SLC6A4|SRF|DLL1|LEF1|WNT4,-8.7
_FINAL,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-11,10,11,30198,663,66,15,23,5.2,1284|1311|1499|2246|2253|3725|3845|4089|6464|6722|8817|23493|28514|51176|54361,COL4A2|COMP|CTNNB1|FGF1|FGF8|JUN|KRAS|SMAD4|SHC1|SRF|FGF18|HEY2|DLL1|LEF1|WNT4,-8.7
_FINAL,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-11,16,13,30198,345,66,12,18,4.7,208|1284|1311|1385|2246|2253|3381|3815|3845|5595|7148|8817,AKT2|COL4A2|COMP|CREB1|FGF1|FGF8|IBSP|KIT|KRAS|MAPK3|TNXB|FGF18,-8.6
_FINAL,KEGG Pathway,24,hsa05210,Colorectal cancer,,-11,43,18,30198,86,66,8,12,4,208|1499|3725|3845|4089|4436|5595|51176,AKT2|CTNNB1|JUN|KRAS|SMAD4|MSH2|MAPK3|LEF1,-8.5
_FINAL,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-11,16,13,30198,354,66,12,18,4.7,208|1284|1311|1385|2246|2253|3381|3815|3845|5595|7148|8817,AKT2|COL4A2|COMP|CREB1|FGF1|FGF8|IBSP|KIT|KRAS|MAPK3|TNXB|FGF18,-8.5
_FINAL,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-11,23,15,30198,198,66,10,15,4.4,1385|1499|2002|2246|2253|3845|5595|6722|8817|51176,CREB1|CTNNB1|ELK1|FGF1|FGF8|KRAS|MAPK3|SRF|FGF18|LEF1,-8.5
_FINAL,KEGG Pathway,24,hsa04510,Focal adhesion,,-11,23,14,30198,201,66,10,15,4.4,208|1284|1311|1499|2002|3381|3725|5595|6464|7148,AKT2|COL4A2|COMP|CTNNB1|ELK1|IBSP|JUN|MAPK3|SHC1|TNXB,-8.4
_FINAL,WikiPathways,27,WP306,Focal adhesion,,-11,23,14,30198,202,66,10,15,4.4,208|1284|1311|1499|2002|3381|3725|5595|6464|7148,AKT2|COL4A2|COMP|CTNNB1|ELK1|IBSP|JUN|MAPK3|SHC1|TNXB,-8.4
_FINAL,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-11,59,20,30198,54,66,7,11,3.8,208|2246|2253|3845|5595|6464|8817,AKT2|FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-8.3
_FINAL,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-10,11,11,30198,606,66,14,21,5,208|1284|1311|2246|2253|3624|3725|3815|4089|5595|6464|6599|8817|51176,AKT2|COL4A2|COMP|FGF1|FGF8|INHBA|JUN|KIT|SMAD4|MAPK3|SHC1|SMARCC1|FGF18|LEF1,-8.2
_FINAL,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-10,9.2,11,30198,744,66,15,23,5.2,1063|1385|1499|1959|2253|3624|3845|4040|5021|5307|6532|6722|28514|51176|54361,CENPF|CREB1|CTNNB1|EGR2|FGF8|INHBA|KRAS|LRP6|OXTR|PITX1|SLC6A4|SRF|DLL1|LEF1|WNT4,-8.1
_FINAL,KEGG Pathway,24,hsa04916,Melanogenesis,,-10,36,17,30198,101,66,8,12,4,1385|1499|3815|3845|5595|7480|51176|54361,CREB1|CTNNB1|KIT|KRAS|MAPK3|WNT10B|LEF1|WNT4,-8.1
_FINAL,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-10,12,11,30198,505,66,13,20,4.9,1284|1311|1499|1959|2246|2253|3725|6464|6722|8817|23493|28514|51176,COL4A2|COMP|CTNNB1|EGR2|FGF1|FGF8|JUN|SHC1|SRF|FGF18|HEY2|DLL1|LEF1,-8
_FINAL,GO Biological Processes,19,GO:0060537,muscle tissue development,19_GO:0032502 developmental process,-10,16,13,30198,309,66,11,17,4.6,148|905|1959|3131|4089|5307|6722|7480|23493|26508|28514,ADRA1A|CCNT2|EGR2|HLF|SMAD4|PITX1|SRF|WNT10B|HEY2|HEYL|DLL1,-8
_FINAL,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-10,20,13,30198,232,66,10,15,4.4,208|2002|2246|2253|3815|3845|5595|5966|6464|8817,AKT2|ELK1|FGF1|FGF8|KIT|KRAS|MAPK3|REL|SHC1|FGF18,-7.9
_FINAL,WikiPathways,27,WP4155,Endometrial cancer,,-10,51,19,30198,63,66,7,11,3.8,208|1499|2002|2246|3845|5595|51176,AKT2|CTNNB1|ELK1|FGF1|KRAS|MAPK3|LEF1,-7.9
_FINAL,WikiPathways,27,WP399,Wnt signaling pathway and pluripotency,,-10,34,16,30198,107,66,8,12,4,1499|3725|4040|4800|7480|10009|51176|54361,CTNNB1|JUN|LRP6|NFYA|WNT10B|ZBTB33|LEF1|WNT4,-7.9
_FINAL,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-10,11,11,30198,526,66,13,20,4.9,1284|1311|1499|1959|2246|2253|3725|6464|6722|8817|23493|28514|51176,COL4A2|COMP|CTNNB1|EGR2|FGF1|FGF8|JUN|SHC1|SRF|FGF18|HEY2|DLL1|LEF1,-7.9
_FINAL,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-9.9,13,12,30198,421,66,12,18,4.7,1284|1311|1499|2246|2253|3725|6464|6722|8817|23493|28514|51176,COL4A2|COMP|CTNNB1|FGF1|FGF8|JUN|SHC1|SRF|FGF18|HEY2|DLL1|LEF1,-7.8
_FINAL,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-9.9,25,14,30198,168,66,9,14,4.2,1499|2253|4040|4089|5595|23493|26508|51176|54361,CTNNB1|FGF8|LRP6|SMAD4|MAPK3|HEY2|HEYL|LEF1|WNT4,-7.8
_FINAL,WikiPathways,27,WP4659,Gastrin signaling pathway,,-9.8,32,16,30198,114,66,8,12,4,1385|1499|2002|3725|3815|3845|5595|6464,CREB1|CTNNB1|ELK1|JUN|KIT|KRAS|MAPK3|SHC1,-7.7
_FINAL,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-9.8,24,14,30198,174,66,9,14,4.2,1385|1499|2002|2246|2253|3845|5595|6722|8817,CREB1|CTNNB1|ELK1|FGF1|FGF8|KRAS|MAPK3|SRF|FGF18,-7.7
_FINAL,WikiPathways,27,WP4928,MAPK pathway in congenital thyroid cancer,,-9.7,1.4e+02,27,30198,16,66,5,7.6,3.3,2002|3725|3845|5595|6464,ELK1|JUN|KRAS|MAPK3|SHC1,-7.6
_FINAL,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-9.7,23,14,30198,178,66,9,14,4.2,1385|1499|2002|2246|2253|3845|5595|6722|8817,CREB1|CTNNB1|ELK1|FGF1|FGF8|KRAS|MAPK3|SRF|FGF18,-7.6
_FINAL,GO Biological Processes,19,GO:0035270,endocrine system development,19_GO:0032502 developmental process,-9.5,30,15,30198,124,66,8,12,4,1385|2253|4089|5307|5595|6722|28514|54361,CREB1|FGF8|SMAD4|PITX1|MAPK3|SRF|DLL1|WNT4,-7.4
_FINAL,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-9.5,69,20,30198,40,66,6,9.1,3.5,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-7.4
_FINAL,GO Biological Processes,19,GO:0072080,nephron tubule development,19_GO:0032502 developmental process,-9.5,42,17,30198,76,66,7,11,3.8,1499|2246|2253|4089|26508|28514|54361,CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4,-7.4
_FINAL,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-9.4,1.3e+02,25,30198,18,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-7.4
_FINAL,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-9.4,67,20,30198,41,66,6,9.1,3.5,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-7.4
_FINAL,Reactome Gene Sets,6,R-HSA-9009391,Extra-nuclear estrogen signaling,,-9.4,42,17,30198,77,66,7,11,3.8,208|1385|2002|3845|5595|6464|6722,AKT2|CREB1|ELK1|KRAS|MAPK3|SHC1|SRF,-7.4
_FINAL,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-9.4,41,17,30198,78,66,7,11,3.8,208|2246|2253|3845|5595|6464|8817,AKT2|FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-7.4
_FINAL,GO Biological Processes,19,GO:0061326,renal tubule development,19_GO:0032502 developmental process,-9.3,40,16,30198,80,66,7,11,3.8,1499|2246|2253|4089|26508|28514|54361,CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4,-7.3
_FINAL,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-9.3,28,14,30198,133,66,8,12,4,1499|2246|2253|3845|4089|6722|51176|54361,CTNNB1|FGF1|FGF8|KRAS|SMAD4|SRF|LEF1|WNT4,-7.2
_FINAL,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-9.2,1.1e+02,24,30198,20,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-7.2
_FINAL,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-9.2,11,11,30198,492,66,12,18,4.7,699|1311|1499|2253|3815|4040|4089|5179|7480|9833|51176|54361,BUB1|COMP|CTNNB1|FGF8|KIT|LRP6|SMAD4|PENK|WNT10B|MELK|LEF1|WNT4,-7.2
_FINAL,Canonical Pathways,11,M70,PID PS1 PATHWAY,,-9.1,60,19,30198,46,66,6,9.1,3.5,1499|3725|4040|5595|6927|28514,CTNNB1|JUN|LRP6|MAPK3|HNF1A|DLL1,-7.1
_FINAL,GO Biological Processes,19,GO:0007517,muscle organ development,19_GO:0032502 developmental process,-9.1,16,12,30198,293,66,10,15,4.4,905|1063|1959|3131|4089|5307|7480|23493|26508|28514,CCNT2|CENPF|EGR2|HLF|SMAD4|PITX1|WNT10B|HEY2|HEYL|DLL1,-7.1
_FINAL,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-9.1,20,13,30198,210,66,9,14,4.2,1499|2253|4040|4089|6722|23493|26508|28514|51176,CTNNB1|FGF8|LRP6|SMAD4|SRF|HEY2|HEYL|DLL1|LEF1,-7.1
_FINAL,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-9.1,16,12,30198,294,66,10,15,4.4,208|2002|2246|2253|3725|3815|3845|5595|6722|8817,AKT2|ELK1|FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SRF|FGF18,-7.1
_FINAL,KEGG Pathway,24,hsa04550,Signaling pathways regulating pluripotency of stem cells,,-9,26,14,30198,143,66,8,12,4,208|1499|3624|3845|4089|5595|7480|54361,AKT2|CTNNB1|INHBA|KRAS|SMAD4|MAPK3|WNT10B|WNT4,-7.1
_FINAL,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-8.9,55,18,30198,50,66,6,9.1,3.5,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-7
_FINAL,WikiPathways,27,WP3646,Hepatitis C and hepatocellular carcinoma,,-8.9,55,18,30198,50,66,6,9.1,3.5,1284|3725|4089|5595|6927|51176,COL4A2|JUN|SMAD4|MAPK3|HNF1A|LEF1,-7
_FINAL,KEGG Pathway,24,hsa05166,Human T-cell leukemia virus 1 infection,,-8.9,19,12,30198,222,66,9,14,4.2,208|1385|1959|2002|3725|3845|4089|5595|6722,AKT2|CREB1|EGR2|ELK1|JUN|KRAS|SMAD4|MAPK3|SRF,-7
_FINAL,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-8.9,99,22,30198,23,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-6.9
_FINAL,GO Biological Processes,19,GO:0048534,hematopoietic or lymphoid organ development,19_GO:0002376 immune system process,-8.8,9.1,9.8,30198,655,66,13,20,4.9,1499|3624|3725|3815|4436|5595|6722|7480|9833|28514|51176|54361|168002,CTNNB1|INHBA|JUN|KIT|MSH2|MAPK3|SRF|WNT10B|MELK|DLL1|LEF1|WNT4|DACT2,-6.9
_FINAL,WikiPathways,27,WP4666,Hepatitis B infection,,-8.8,24,13,30198,154,66,8,12,4,208|1385|1959|2002|3725|3845|4089|5595,AKT2|CREB1|EGR2|ELK1|JUN|KRAS|SMAD4|MAPK3,-6.9
_FINAL,Reactome Gene Sets,6,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,,-8.8,95,22,30198,24,66,5,7.6,3.3,208|1385|2002|5595|6722,AKT2|CREB1|ELK1|MAPK3|SRF,-6.9
_FINAL,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-8.7,52,17,30198,53,66,6,9.1,3.5,208|2246|2253|3845|6464|8817,AKT2|FGF1|FGF8|KRAS|SHC1|FGF18,-6.9
_FINAL,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-8.7,18,12,30198,231,66,9,14,4.2,1499|2253|4040|4089|5595|23493|26508|51176|54361,CTNNB1|FGF8|LRP6|SMAD4|MAPK3|HEY2|HEYL|LEF1|WNT4,-6.8
_FINAL,GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-8.7,10,10,30198,541,66,12,18,4.7,148|1499|2253|3725|4089|5021|5595|6464|6722|23493|26508|28514,ADRA1A|CTNNB1|FGF8|JUN|SMAD4|OXTR|MAPK3|SHC1|SRF|HEY2|HEYL|DLL1,-6.8
_FINAL,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-8.7,51,17,30198,54,66,6,9.1,3.5,208|2246|2253|3845|6464|8817,AKT2|FGF1|FGF8|KRAS|SHC1|FGF18,-6.8
_FINAL,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-8.7,14,11,30198,323,66,10,15,4.4,1284|1499|2246|2253|3725|6464|6722|8817|28514|51176,COL4A2|CTNNB1|FGF1|FGF8|JUN|SHC1|SRF|FGF18|DLL1|LEF1,-6.8
_FINAL,GO Biological Processes,19,GO:0072009,nephron epithelium development,19_GO:0032502 developmental process,-8.7,32,15,30198,99,66,7,11,3.8,1499|2246|2253|4089|26508|28514|54361,CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4,-6.8
_FINAL,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-8.7,92,21,30198,25,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-6.8
_FINAL,Canonical Pathways,11,M276,PID FGF PATHWAY,,-8.6,50,17,30198,55,66,6,9.1,3.5,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-6.8
_FINAL,KEGG Pathway,24,hsa05161,Hepatitis B,,-8.6,23,13,30198,162,66,8,12,4,208|1385|1959|2002|3725|3845|4089|5595,AKT2|CREB1|EGR2|ELK1|JUN|KRAS|SMAD4|MAPK3,-6.7
_FINAL,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-8.6,23,13,30198,162,66,8,12,4,1499|2246|2253|3845|4089|6722|51176|54361,CTNNB1|FGF1|FGF8|KRAS|SMAD4|SRF|LEF1|WNT4,-6.7
_FINAL,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-8.6,9.9,9.9,30198,557,66,12,18,4.7,1499|2246|2253|3624|3845|4089|6722|23493|26508|28514|51176|54361,CTNNB1|FGF1|FGF8|INHBA|KRAS|SMAD4|SRF|HEY2|HEYL|DLL1|LEF1|WNT4,-6.7
_FINAL,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-8.5,14,11,30198,335,66,10,15,4.4,1499|1959|2253|4040|4089|6722|23493|26508|28514|51176,CTNNB1|EGR2|FGF8|LRP6|SMAD4|SRF|HEY2|HEYL|DLL1|LEF1,-6.7
_FINAL,KEGG Pathway,24,hsa05213,Endometrial cancer,,-8.5,47,17,30198,58,66,6,9.1,3.5,208|1499|2002|3845|5595|51176,AKT2|CTNNB1|ELK1|KRAS|MAPK3|LEF1,-6.7
_FINAL,WikiPathways,27,WP560,TGF-beta receptor signaling,,-8.5,47,17,30198,58,66,6,9.1,3.5,1499|3624|3725|4089|5595|51176,CTNNB1|INHBA|JUN|SMAD4|MAPK3|LEF1,-6.7
_FINAL,GO Biological Processes,19,GO:0002520,immune system development,19_GO:0002376 immune system process,-8.5,8.5,9.4,30198,699,66,13,20,4.9,1499|3624|3725|3815|4436|5595|6722|7480|9833|28514|51176|54361|168002,CTNNB1|INHBA|JUN|KIT|MSH2|MAPK3|SRF|WNT10B|MELK|DLL1|LEF1|WNT4|DACT2,-6.7
_FINAL,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-8.5,85,20,30198,27,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-6.7
_FINAL,WikiPathways,27,WP382,MAPK signaling pathway,,-8.4,17,12,30198,249,66,9,14,4.2,208|2002|2246|2253|3725|3845|5595|6722|8817,AKT2|ELK1|FGF1|FGF8|JUN|KRAS|MAPK3|SRF|FGF18,-6.6
_FINAL,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-8.4,21,13,30198,171,66,8,12,4,1499|2246|2253|3845|4089|6722|51176|54361,CTNNB1|FGF1|FGF8|KRAS|SMAD4|SRF|LEF1|WNT4,-6.6
_FINAL,WikiPathways,27,WP4816,TGF-beta receptor signaling in skeletal dysplasias,,-8.3,44,16,30198,62,66,6,9.1,3.5,1499|3624|3725|4089|5595|51176,CTNNB1|INHBA|JUN|SMAD4|MAPK3|LEF1,-6.5
_FINAL,WikiPathways,27,WP3972,PDGFR-beta pathway,,-8.3,79,20,30198,29,66,5,7.6,3.3,2002|3725|5595|6464|6722,ELK1|JUN|MAPK3|SHC1|SRF,-6.5
_FINAL,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-8.2,8.1,9.1,30198,734,66,13,20,4.9,699|1063|1499|2253|3624|4436|4751|6599|7480|10664|22974|54361|83540,BUB1|CENPF|CTNNB1|FGF8|INHBA|MSH2|NEK2|SMARCC1|WNT10B|CTCF|TPX2|WNT4|NUF2,-6.5
_FINAL,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-8.2,76,19,30198,30,66,5,7.6,3.3,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-6.5
_FINAL,Reactome Gene Sets,6,R-HSA-187037,Signaling by NTRK1 (TRKA),,-8.2,28,14,30198,115,66,7,11,3.8,1385|1959|2002|3845|5595|6464|6722,CREB1|EGR2|ELK1|KRAS|MAPK3|SHC1|SRF,-6.4
_FINAL,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-8.2,8,9.1,30198,741,66,13,20,4.9,148|208|905|2246|2253|3624|3815|3845|4089|5595|8817|22974|128239,ADRA1A|AKT2|CCNT2|FGF1|FGF8|INHBA|KIT|KRAS|SMAD4|MAPK3|FGF18|TPX2|IQGAP3,-6.4
_FINAL,GO Biological Processes,19,GO:0030097,hemopoiesis,19_GO:0002376 immune system process,-8.2,9.1,9.4,30198,606,66,12,18,4.7,1499|3624|3725|3815|4436|6722|7480|9833|28514|51176|54361|168002,CTNNB1|INHBA|JUN|KIT|MSH2|SRF|WNT10B|MELK|DLL1|LEF1|WNT4|DACT2,-6.4
_FINAL,WikiPathways,27,WP4685,Melanoma,,-8.1,40,15,30198,68,66,6,9.1,3.5,208|1385|2002|3815|3845|5595,AKT2|CREB1|ELK1|KIT|KRAS|MAPK3,-6.3
_FINAL,GO Biological Processes,19,GO:0030900,forebrain development,19_GO:0032502 developmental process,-8.1,12,10,30198,374,66,10,15,4.4,1385|1499|2253|3624|3845|5021|5307|6722|51176|54361,CREB1|CTNNB1|FGF8|INHBA|KRAS|OXTR|PITX1|SRF|LEF1|WNT4,-6.3
_FINAL,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-8,10,9.7,30198,492,66,11,17,4.6,148|1499|2246|2253|3489|3725|3815|5595|6464|8817|128239,ADRA1A|CTNNB1|FGF1|FGF8|IGFBP6|JUN|KIT|MAPK3|SHC1|FGF18|IQGAP3,-6.3
_FINAL,GO Biological Processes,19,GO:0007519,skeletal muscle tissue development,19_GO:0032502 developmental process,-8,26,13,30198,122,66,7,11,3.8,905|1959|3131|5307|7480|26508|28514,CCNT2|EGR2|HLF|PITX1|WNT10B|HEYL|DLL1,-6.3
_FINAL,GO Biological Processes,19,GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,19_GO:0032502 developmental process,-8,1.5e+02,25,30198,12,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-6.3
_FINAL,KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-8,19,12,30198,194,66,8,12,4,208|1385|1499|2920|3725|3845|5595|51176,AKT2|CREB1|CTNNB1|CXCL2|JUN|KRAS|MAPK3|LEF1,-6.2
_FINAL,Canonical Pathways,11,M270,PID MAPK TRK PATHWAY,,-7.9,67,18,30198,34,66,5,7.6,3.3,1385|2002|3845|5595|6722,CREB1|ELK1|KRAS|MAPK3|SRF,-6.2
_FINAL,KEGG Pathway,24,hsa05218,Melanoma,,-7.9,38,15,30198,72,66,6,9.1,3.5,208|2246|2253|3845|5595|8817,AKT2|FGF1|FGF8|KRAS|MAPK3|FGF18,-6.2
_FINAL,GO Biological Processes,19,GO:0001822,kidney development,19_GO:0032502 developmental process,-7.9,14,11,30198,287,66,9,14,4.2,1063|1499|2246|2253|4089|26508|28514|54361|168002,CENPF|CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4|DACT2,-6.2
_FINAL,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-7.9,38,15,30198,73,66,6,9.1,3.5,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-6.2
_FINAL,GO Biological Processes,19,GO:0072073,kidney epithelium development,19_GO:0032502 developmental process,-7.9,25,13,30198,128,66,7,11,3.8,1499|2246|2253|4089|26508|28514|54361,CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4,-6.2
_FINAL,GO Biological Processes,19,GO:0072006,nephron development,19_GO:0032502 developmental process,-7.9,25,13,30198,128,66,7,11,3.8,1499|2246|2253|4089|26508|28514|54361,CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4,-6.2
_FINAL,KEGG Pathway,24,hsa04926,Relaxin signaling pathway,,-7.9,25,13,30198,129,66,7,11,3.8,208|1284|1385|3725|3845|5595|6464,AKT2|COL4A2|CREB1|JUN|KRAS|MAPK3|SHC1,-6.2
_FINAL,GO Biological Processes,19,GO:1903047,mitotic cell cycle process,19_GO:0009987 cellular process,-7.8,9.8,9.4,30198,514,66,11,17,4.6,571|699|1063|1876|4436|4751|7480|9833|22974|83540|128239,BACH1|BUB1|CENPF|E2F6|MSH2|NEK2|WNT10B|MELK|TPX2|NUF2|IQGAP3,-6.1
_FINAL,KEGG Pathway,24,hsa05205,Proteoglycans in cancer,,-7.8,18,11,30198,205,66,8,12,4,208|1499|2002|3845|5595|7480|54361|60495,AKT2|CTNNB1|ELK1|KRAS|MAPK3|WNT10B|WNT4|HPSE2,-6.1
_FINAL,GO Biological Processes,19,GO:0072001,renal system development,19_GO:0032502 developmental process,-7.8,14,10,30198,296,66,9,14,4.2,1063|1499|2246|2253|4089|26508|28514|54361|168002,CENPF|CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4|DACT2,-6.1
_FINAL,GO Biological Processes,19,GO:0060538,skeletal muscle organ development,19_GO:0032502 developmental process,-7.7,24,12,30198,134,66,7,11,3.8,905|1959|3131|5307|7480|26508|28514,CCNT2|EGR2|HLF|PITX1|WNT10B|HEYL|DLL1,-6.1
_FINAL,Reactome Gene Sets,6,R-HSA-166520,Signaling by NTRKs,,-7.7,24,12,30198,134,66,7,11,3.8,1385|1959|2002|3845|5595|6464|6722,CREB1|EGR2|ELK1|KRAS|MAPK3|SHC1|SRF,-6.1
_FINAL,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-7.7,17,11,30198,210,66,8,12,4,208|1499|2246|2253|3815|3845|5595|8817,AKT2|CTNNB1|FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-6
_FINAL,GO Biological Processes,19,GO:0051145,smooth muscle cell differentiation,19_GO:0032502 developmental process,-7.7,60,17,30198,38,66,5,7.6,3.3,1311|1499|6722|23493|54361,COMP|CTNNB1|SRF|HEY2|WNT4,-6
_FINAL,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-7.7,17,11,30198,212,66,8,12,4,208|1385|2253|3725|3845|5595|8817|28514,AKT2|CREB1|FGF8|JUN|KRAS|MAPK3|FGF18|DLL1,-6
_FINAL,GO Biological Processes,19,GO:0042063,gliogenesis,19_GO:0032502 developmental process,-7.7,17,11,30198,213,66,8,12,4,208|1499|1959|3845|5179|5595|28514|51176,AKT2|CTNNB1|EGR2|KRAS|PENK|MAPK3|DLL1|LEF1,-6
_FINAL,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-7.6,13,10,30198,307,66,9,14,4.2,1499|2246|2253|3845|4089|6722|28514|51176|54361,CTNNB1|FGF1|FGF8|KRAS|SMAD4|SRF|DLL1|LEF1|WNT4,-6
_FINAL,WikiPathways,27,WP2526,PDGF pathway,,-7.6,57,17,30198,40,66,5,7.6,3.3,2002|3725|5595|6464|6722,ELK1|JUN|MAPK3|SHC1|SRF,-5.9
_FINAL,WikiPathways,27,WP127,IL-5 signaling pathway,,-7.6,57,17,30198,40,66,5,7.6,3.3,2002|3725|3845|5595|6464,ELK1|JUN|KRAS|MAPK3|SHC1,-5.9
_FINAL,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-7.5,8,8.7,30198,688,66,12,18,4.7,148|1499|2246|2253|3489|3725|3815|4089|5595|6464|8817|128239,ADRA1A|CTNNB1|FGF1|FGF8|IGFBP6|JUN|KIT|SMAD4|MAPK3|SHC1|FGF18|IQGAP3,-5.9
_FINAL,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-7.5,22,12,30198,144,66,7,11,3.8,1385|1499|1959|2002|3725|5595|6464,CREB1|CTNNB1|EGR2|ELK1|JUN|MAPK3|SHC1,-5.9
_FINAL,Reactome Gene Sets,6,R-HSA-8939211,ESR-mediated signaling,,-7.5,16,11,30198,223,66,8,12,4,208|1385|2002|3725|3845|5595|6464|6722,AKT2|CREB1|ELK1|JUN|KRAS|MAPK3|SHC1|SRF,-5.9
_FINAL,GO Biological Processes,19,GO:0007423,sensory organ development,19_GO:0032502 developmental process,-7.5,9.1,9,30198,555,66,11,17,4.6,1499|2253|3624|3725|3815|5595|6722|7480|23493|28514|51176,CTNNB1|FGF8|INHBA|JUN|KIT|MAPK3|SRF|WNT10B|HEY2|DLL1|LEF1,-5.9
_FINAL,KEGG Pathway,24,hsa04012,ErbB signaling pathway,,-7.5,32,14,30198,85,66,6,9.1,3.5,208|2002|3725|3845|5595|6464,AKT2|ELK1|JUN|KRAS|MAPK3|SHC1,-5.9
_FINAL,GO Biological Processes,19,GO:0001658,branching involved in ureteric bud morphogenesis,19_GO:0032502 developmental process,-7.5,54,16,30198,42,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5.8
_FINAL,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-7.4,32,13,30198,87,66,6,9.1,3.5,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-5.8
_FINAL,GO Biological Processes,19,GO:0060425,lung morphogenesis,19_GO:0032502 developmental process,-7.4,53,16,30198,43,66,5,7.6,3.3,1499|2253|3845|5595|6722,CTNNB1|FGF8|KRAS|MAPK3|SRF,-5.8
_FINAL,GO Biological Processes,19,GO:0051960,regulation of nervous system development,19_GO:0032502 developmental process,-7.4,10,9.3,30198,443,66,10,15,4.4,1499|1523|1959|3815|5021|6722|23493|26508|28514|51176,CTNNB1|CUX1|EGR2|KIT|OXTR|SRF|HEY2|HEYL|DLL1|LEF1,-5.8
_FINAL,WikiPathways,27,WP2840,Hair follicle development: cytodifferentiation - part 3 of 3,,-7.4,31,13,30198,89,66,6,9.1,3.5,1499|1523|1959|3725|4089|51176,CTNNB1|CUX1|EGR2|JUN|SMAD4|LEF1,-5.8
_FINAL,GO Biological Processes,19,GO:0048598,embryonic morphogenesis,19_GO:0032502 developmental process,-7.3,8.7,8.8,30198,576,66,11,17,4.6,1284|1499|2253|3624|4089|5307|5595|6722|28514|51176|54361,COL4A2|CTNNB1|FGF8|INHBA|SMAD4|PITX1|MAPK3|SRF|DLL1|LEF1|WNT4,-5.7
_FINAL,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-7.3,10,9.2,30198,447,66,10,15,4.4,1499|1959|2253|4040|4089|6722|23493|26508|28514|51176,CTNNB1|EGR2|FGF8|LRP6|SMAD4|SRF|HEY2|HEYL|DLL1|LEF1,-5.7
_FINAL,GO Biological Processes,19,GO:0001655,urogenital system development,19_GO:0032502 developmental process,-7.3,12,9.7,30198,334,66,9,14,4.2,1063|1499|2246|2253|4089|26508|28514|54361|168002,CENPF|CTNNB1|FGF1|FGF8|SMAD4|HEYL|DLL1|WNT4|DACT2,-5.7
_FINAL,GO Biological Processes,19,GO:0016202,regulation of striated muscle tissue development,19_GO:0032502 developmental process,-7.3,1.1e+02,21,30198,17,66,4,6.1,2.9,1063|1385|2253|51176,CENPF|CREB1|FGF8|LEF1,-5.7
_FINAL,WikiPathways,27,WP673,ErbB signaling pathway,,-7.3,30,13,30198,91,66,6,9.1,3.5,208|2002|3725|3845|5595|6464,AKT2|ELK1|JUN|KRAS|MAPK3|SHC1,-5.7
_FINAL,WikiPathways,27,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,,-7.3,30,13,30198,91,66,6,9.1,3.5,1499|3725|4040|7480|51176|54361,CTNNB1|JUN|LRP6|WNT10B|LEF1|WNT4,-5.7
_FINAL,WikiPathways,27,WP1591,Heart development,,-7.3,50,15,30198,46,66,5,7.6,3.3,1499|2253|4089|6722|23493,CTNNB1|FGF8|SMAD4|SRF|HEY2,-5.7
_FINAL,GO Biological Processes,19,GO:0046661,male sex differentiation,19_GO:0022414 reproductive process,-7.2,20,11,30198,160,66,7,11,3.8,1499|2253|3624|3815|4089|4436|54361,CTNNB1|FGF8|INHBA|KIT|SMAD4|MSH2|WNT4,-5.6
_FINAL,GO Biological Processes,19,GO:0045165,cell fate commitment,19_GO:0032502 developmental process,-7.2,15,10,30198,244,66,8,12,4,1499|2253|4089|5307|7480|23493|28514|54361,CTNNB1|FGF8|SMAD4|PITX1|WNT10B|HEY2|DLL1|WNT4,-5.6
_FINAL,GO Biological Processes,19,GO:0060438,trachea development,19_GO:0032502 developmental process,-7.2,1e+02,20,30198,18,66,4,6.1,2.9,1499|5595|6722|51176,CTNNB1|MAPK3|SRF|LEF1,-5.6
_FINAL,GO Biological Processes,19,GO:0007369,gastrulation,19_GO:0032502 developmental process,-7.2,20,11,30198,161,66,7,11,3.8,1284|1499|2253|3624|4089|6722|51176,COL4A2|CTNNB1|FGF8|INHBA|SMAD4|SRF|LEF1,-5.6
_FINAL,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-7.2,48,15,30198,48,66,5,7.6,3.3,208|2246|2253|3845|8817,AKT2|FGF1|FGF8|KRAS|FGF18,-5.6
_FINAL,KEGG Pathway,24,hsa05215,Prostate cancer,,-7.1,28,13,30198,97,66,6,9.1,3.5,208|1385|1499|3845|5595|51176,AKT2|CREB1|CTNNB1|KRAS|MAPK3|LEF1,-5.6
_FINAL,GO Biological Processes,19,GO:0033044,regulation of chromosome organization,19_GO:0050789 regulation of biological process,-7.1,15,10,30198,250,66,8,12,4,699|1063|1499|4751|5595|6599|10664|83540,BUB1|CENPF|CTNNB1|NEK2|MAPK3|SMARCC1|CTCF|NUF2,-5.6
_FINAL,GO Biological Processes,19,GO:0000278,mitotic cell cycle,19_GO:0009987 cellular process,-7.1,8.3,8.5,30198,605,66,11,17,4.6,571|699|1063|1876|4436|4751|7480|9833|22974|83540|128239,BACH1|BUB1|CENPF|E2F6|MSH2|NEK2|WNT10B|MELK|TPX2|NUF2|IQGAP3,-5.6
_FINAL,GO Biological Processes,19,GO:0009725,response to hormone,19_GO:0050896 response to stimulus,-7.1,7.3,8.2,30198,753,66,12,18,4.7,148|208|1385|1959|3624|3815|4040|5021|6464|6599|6722|7480,ADRA1A|AKT2|CREB1|EGR2|INHBA|KIT|LRP6|OXTR|SHC1|SMARCC1|SRF|WNT10B,-5.6
_FINAL,KEGG Pathway,24,hsa01522,Endocrine resistance,,-7.1,28,13,30198,98,66,6,9.1,3.5,208|3725|3845|5595|6464|28514,AKT2|JUN|KRAS|MAPK3|SHC1|DLL1,-5.6
_FINAL,WikiPathways,27,WP734,Serotonin receptor 4/6/7 and NR3C signaling,,-7.1,96,19,30198,19,66,4,6.1,2.9,1385|2002|5595|6722,CREB1|ELK1|MAPK3|SRF,-5.6
_FINAL,GO Biological Processes,19,GO:0010001,glial cell differentiation,19_GO:0032502 developmental process,-7.1,19,11,30198,167,66,7,11,3.8,208|1499|1959|3845|5595|28514|51176,AKT2|CTNNB1|EGR2|KRAS|MAPK3|DLL1|LEF1,-5.5
_FINAL,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-7.1,19,11,30198,167,66,7,11,3.8,1499|3725|4040|4089|7480|51176|54361,CTNNB1|JUN|LRP6|SMAD4|WNT10B|LEF1|WNT4,-5.5
_FINAL,KEGG Pathway,24,hsa04933,AGE-RAGE signaling pathway in diabetic complications,,-7.1,27,12,30198,100,66,6,9.1,3.5,208|1284|3725|3845|4089|5595,AKT2|COL4A2|JUN|KRAS|SMAD4|MAPK3,-5.5
_FINAL,GO Biological Processes,19,GO:0072132,mesenchyme morphogenesis,19_GO:0032502 developmental process,-7,45,15,30198,51,66,5,7.6,3.3,2253|4089|23493|26508|51176,FGF8|SMAD4|HEY2|HEYL|LEF1,-5.5
_FINAL,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-7,92,19,30198,20,66,4,6.1,2.9,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-5.5
_FINAL,WikiPathways,27,WP732,Serotonin receptor 2 and ELK-SRF/GATA4 signaling,,-7,92,19,30198,20,66,4,6.1,2.9,2002|3845|5595|6722,ELK1|KRAS|MAPK3|SRF,-5.5
_FINAL,GO Biological Processes,19,GO:0043586,tongue development,19_GO:0032502 developmental process,-7,92,19,30198,20,66,4,6.1,2.9,1499|3815|7480|51176,CTNNB1|KIT|WNT10B|LEF1,-5.5
_FINAL,GO Biological Processes,19,GO:0050767,regulation of neurogenesis,19_GO:0032502 developmental process,-7,11,9.3,30198,364,66,9,14,4.2,1499|1523|1959|3815|6722|23493|26508|28514|51176,CTNNB1|CUX1|EGR2|KIT|SRF|HEY2|HEYL|DLL1|LEF1,-5.5
_FINAL,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-7,44,15,30198,52,66,5,7.6,3.3,208|2246|2253|3845|8817,AKT2|FGF1|FGF8|KRAS|FGF18,-5.5
_FINAL,GO Biological Processes,19,GO:0060675,ureteric bud morphogenesis,19_GO:0032502 developmental process,-7,44,15,30198,52,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5.5
_FINAL,GO Biological Processes,19,GO:0042692,muscle cell differentiation,19_GO:0032502 developmental process,-7,14,9.9,30198,261,66,8,12,4,148|1311|1499|3845|6722|7480|23493|54361,ADRA1A|COMP|CTNNB1|KRAS|SRF|WNT10B|HEY2|WNT4,-5.5
_FINAL,Reactome Gene Sets,6,R-HSA-2219528,PI3K/AKT Signaling in Cancer,,-7,26,12,30198,104,66,6,9.1,3.5,208|1385|2246|2253|3815|8817,AKT2|CREB1|FGF1|FGF8|KIT|FGF18,-5.4
_FINAL,WikiPathways,27,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,,-7,26,12,30198,104,66,6,9.1,3.5,1499|3725|4040|7480|51176|54361,CTNNB1|JUN|LRP6|WNT10B|LEF1|WNT4,-5.4
_FINAL,GO Biological Processes,19,GO:0072171,mesonephric tubule morphogenesis,19_GO:0032502 developmental process,-6.9,43,14,30198,53,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5.4
_FINAL,Canonical Pathways,11,M164,PID ERBB1 DOWNSTREAM PATHWAY,,-6.9,26,12,30198,105,66,6,9.1,3.5,1385|2002|3725|3845|5595|6722,CREB1|ELK1|JUN|KRAS|MAPK3|SRF,-5.4
_FINAL,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-6.9,87,18,30198,21,66,4,6.1,2.9,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-5.4
_FINAL,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-6.9,14,9.8,30198,267,66,8,12,4,208|1385|2246|2253|3725|3815|5595|8817,AKT2|CREB1|FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-5.4
_FINAL,GO Biological Processes,19,GO:0060284,regulation of cell development,19_GO:0032502 developmental process,-6.9,9.1,8.6,30198,501,66,10,15,4.4,1499|1523|1959|3815|4089|6722|23493|26508|28514|51176,CTNNB1|CUX1|EGR2|KIT|SMAD4|SRF|HEY2|HEYL|DLL1|LEF1,-5.4
_FINAL,GO Biological Processes,19,GO:0001501,skeletal system development,19_GO:0032502 developmental process,-6.8,9.1,8.5,30198,505,66,10,15,4.4,1300|1311|1499|2253|3815|5307|5595|6722|7480|8817,COL10A1|COMP|CTNNB1|FGF8|KIT|PITX1|MAPK3|SRF|WNT10B|FGF18,-5.3
_FINAL,Canonical Pathways,11,M206,PID PDGFRA PATHWAY,,-6.8,83,18,30198,22,66,4,6.1,2.9,2002|3725|6464|6722,ELK1|JUN|SHC1|SRF,-5.3
_FINAL,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-6.8,83,18,30198,22,66,4,6.1,2.9,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-5.3
_FINAL,GO Biological Processes,19,GO:0048634,regulation of muscle organ development,19_GO:0032502 developmental process,-6.8,83,18,30198,22,66,4,6.1,2.9,1063|1385|2253|51176,CENPF|CREB1|FGF8|LEF1,-5.3
_FINAL,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-6.8,83,18,30198,22,66,4,6.1,2.9,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-5.3
_FINAL,GO Biological Processes,19,GO:0001775,cell activation,19_GO:0009987 cellular process,-6.8,7.8,8.2,30198,647,66,11,17,4.6,1311|1499|3043|3725|3815|4089|4436|6722|28514|51176|54361,COMP|CTNNB1|HBB|JUN|KIT|SMAD4|MSH2|SRF|DLL1|LEF1|WNT4,-5.3
_FINAL,WikiPathways,27,WP4223,Ras signaling,,-6.8,17,10,30198,185,66,7,11,3.8,208|2002|3815|3845|5595|5966|6464,AKT2|ELK1|KIT|KRAS|MAPK3|REL|SHC1,-5.3
_FINAL,GO Biological Processes,19,GO:0007346,regulation of mitotic cell cycle,19_GO:0050789 regulation of biological process,-6.8,8.9,8.4,30198,517,66,10,15,4.4,699|1063|1499|2253|3624|4436|4751|6599|7480|83540,BUB1|CENPF|CTNNB1|FGF8|INHBA|MSH2|NEK2|SMARCC1|WNT10B|NUF2,-5.3
_FINAL,GO Biological Processes,19,GO:0003272,endocardial cushion formation,19_GO:0032502 developmental process,-6.7,80,18,30198,23,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-5.3
_FINAL,Reactome Gene Sets,6,R-HSA-199418,Negative regulation of the PI3K/AKT network,,-6.7,24,12,30198,113,66,6,9.1,3.5,208|2246|2253|3815|5595|8817,AKT2|FGF1|FGF8|KIT|MAPK3|FGF18,-5.3
_FINAL,Canonical Pathways,11,M17200,SA B CELL RECEPTOR COMPLEXES,,-6.7,76,17,30198,24,66,4,6.1,2.9,2002|3725|5595|6464,ELK1|JUN|MAPK3|SHC1,-5.2
_FINAL,Reactome Gene Sets,6,R-HSA-198725,Nuclear Events (kinase and transcription factor activation),,-6.6,38,13,30198,61,66,5,7.6,3.3,1385|1959|2002|5595|6722,CREB1|EGR2|ELK1|MAPK3|SRF,-5.2
_FINAL,WikiPathways,27,WP428,Wnt signaling,,-6.6,23,11,30198,118,66,6,9.1,3.5,1499|3725|4040|7480|51176|54361,CTNNB1|JUN|LRP6|WNT10B|LEF1|WNT4,-5.2
_FINAL,GO Biological Processes,19,GO:0098609,cell-cell adhesion,19_GO:0009987 cellular process,-6.6,8.5,8.2,30198,537,66,10,15,4.4,1311|1499|3043|3815|4040|4680|6464|6722|7148|51176,COMP|CTNNB1|HBB|KIT|LRP6|CEACAM6|SHC1|SRF|TNXB|LEF1,-5.1
_FINAL,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-6.6,73,17,30198,25,66,4,6.1,2.9,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-5.1
_FINAL,GO Biological Processes,19,GO:0031128,developmental induction,19_GO:0032502 developmental process,-6.6,73,17,30198,25,66,4,6.1,2.9,1499|2246|2253|54361,CTNNB1|FGF1|FGF8|WNT4,-5.1
_FINAL,GO Biological Processes,19,GO:1903131,mononuclear cell differentiation,19_GO:0002376 immune system process,-6.6,12,9.2,30198,295,66,8,12,4,1499|3725|3815|4436|6722|28514|51176|54361,CTNNB1|JUN|KIT|MSH2|SRF|DLL1|LEF1|WNT4,-5.1
_FINAL,GO Biological Processes,19,GO:0072078,nephron tubule morphogenesis,19_GO:0032502 developmental process,-6.6,36,13,30198,63,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5.1
_FINAL,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-6.6,36,13,30198,63,66,5,7.6,3.3,1523|2246|2253|3845|8817,CUX1|FGF1|FGF8|KRAS|FGF18,-5.1
_FINAL,Reactome Gene Sets,6,R-HSA-9006931,Signaling by Nuclear Receptors,,-6.5,12,9.1,30198,299,66,8,12,4,208|1385|2002|3725|3845|5595|6464|6722,AKT2|CREB1|ELK1|JUN|KRAS|MAPK3|SHC1|SRF,-5.1
_FINAL,GO Biological Processes,19,GO:0072088,nephron epithelium morphogenesis,19_GO:0032502 developmental process,-6.5,35,13,30198,65,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5.1
_FINAL,KEGG Pathway,24,hsa05203,Viral carcinogenesis,,-6.5,16,9.9,30198,204,66,7,11,3.8,1385|1959|3725|3845|5595|5966|6722,CREB1|EGR2|JUN|KRAS|MAPK3|REL|SRF,-5
_FINAL,Reactome Gene Sets,6,R-HSA-190371,FGFR3b ligand binding and activation,,-6.5,2e+02,24,30198,7,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-5
_FINAL,GO Biological Processes,19,GO:0048608,reproductive structure development,19_GO:0022414 reproductive process,-6.5,9.7,8.5,30198,423,66,9,14,4.2,1499|2253|3624|3815|4089|4436|23493|51176|54361,CTNNB1|FGF8|INHBA|KIT|SMAD4|MSH2|HEY2|LEF1|WNT4,-5
_FINAL,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-6.4,7.1,7.7,30198,708,66,11,17,4.6,148|208|1385|2920|3845|5021|5179|5595|6464|7480|54361,ADRA1A|AKT2|CREB1|CXCL2|KRAS|OXTR|PENK|MAPK3|SHC1|WNT10B|WNT4,-5
_FINAL,GO Biological Processes,19,GO:0061458,reproductive system development,19_GO:0032502 developmental process,-6.4,9.7,8.4,30198,426,66,9,14,4.2,1499|2253|3624|3815|4089|4436|23493|51176|54361,CTNNB1|FGF8|INHBA|KIT|SMAD4|MSH2|HEY2|LEF1|WNT4,-5
_FINAL,GO Biological Processes,19,GO:0072028,nephron morphogenesis,19_GO:0032502 developmental process,-6.4,34,13,30198,67,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5
_FINAL,KEGG Pathway,24,hsa05221,Acute myeloid leukemia,,-6.4,34,13,30198,67,66,5,7.6,3.3,208|3815|3845|5595|51176,AKT2|KIT|KRAS|MAPK3|LEF1,-5
_FINAL,GO Biological Processes,19,GO:0061333,renal tubule morphogenesis,19_GO:0032502 developmental process,-6.4,34,13,30198,67,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-5
_FINAL,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-6.4,12,9,30198,309,66,8,12,4,208|1385|2246|2253|3725|3815|5595|8817,AKT2|CREB1|FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-5
_FINAL,Canonical Pathways,11,M186,PID PDGFRB PATHWAY,,-6.4,21,11,30198,129,66,6,9.1,3.5,2002|3725|3845|5595|6464|6722,ELK1|JUN|KRAS|MAPK3|SHC1|SRF,-5
_FINAL,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-6.4,12,8.9,30198,312,66,8,12,4,148|2246|2253|3725|4089|5595|6464|8817,ADRA1A|FGF1|FGF8|JUN|SMAD4|MAPK3|SHC1|FGF18,-5
_FINAL,GO Biological Processes,19,GO:0060317,cardiac epithelial to mesenchymal transition,19_GO:0032502 developmental process,-6.4,65,16,30198,28,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-5
_FINAL,Reactome Gene Sets,6,R-HSA-5654732,Negative regulation of FGFR3 signaling,,-6.3,63,16,30198,29,66,4,6.1,2.9,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-4.9
_FINAL,GO Biological Processes,19,GO:0030855,epithelial cell differentiation,19_GO:0032502 developmental process,-6.3,7.9,7.9,30198,576,66,10,15,4.4,208|1385|1499|2253|3725|4089|23493|28514|54361|168002,AKT2|CREB1|CTNNB1|FGF8|JUN|SMAD4|HEY2|DLL1|WNT4|DACT2,-4.9
_FINAL,GO Biological Processes,19,GO:0110110,positive regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-6.3,61,15,30198,30,66,4,6.1,2.9,1499|2246|2253|54361,CTNNB1|FGF1|FGF8|WNT4,-4.9
_FINAL,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-6.3,11,8.7,30198,325,66,8,12,4,2246|2253|3725|3815|3845|5595|6464|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SHC1|FGF18,-4.9
_FINAL,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-6.3,14,9.4,30198,221,66,7,11,3.8,148|2246|2253|3725|5595|6464|8817,ADRA1A|FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-4.9
_FINAL,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-6.3,9.2,8.2,30198,447,66,9,14,4.2,1499|2246|2253|3845|4089|6722|28514|51176|54361,CTNNB1|FGF1|FGF8|KRAS|SMAD4|SRF|DLL1|LEF1|WNT4,-4.9
_FINAL,KEGG Pathway,24,hsa04915,Estrogen signaling pathway,,-6.2,20,10,30198,138,66,6,9.1,3.5,208|1385|3725|3845|5595|6464,AKT2|CREB1|JUN|KRAS|MAPK3|SHC1,-4.8
_FINAL,GO Biological Processes,19,GO:0007492,endoderm development,19_GO:0032502 developmental process,-6.2,31,12,30198,74,66,5,7.6,3.3,1284|1499|2253|3624|4089,COL4A2|CTNNB1|FGF8|INHBA|SMAD4,-4.8
_FINAL,GO Biological Processes,19,GO:0001569,branching involved in blood vessel morphogenesis,19_GO:0032502 developmental process,-6.2,59,15,30198,31,66,4,6.1,2.9,1499|2253|6722|51176,CTNNB1|FGF8|SRF|LEF1,-4.8
_FINAL,Reactome Gene Sets,6,R-HSA-5654733,Negative regulation of FGFR4 signaling,,-6.2,59,15,30198,31,66,4,6.1,2.9,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-4.8
_FINAL,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-6.2,59,15,30198,31,66,4,6.1,2.9,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-4.8
_FINAL,GO Biological Processes,19,GO:0045987,positive regulation of smooth muscle contraction,19_GO:0048518 positive regulation of biological process,-6.2,59,15,30198,31,66,4,6.1,2.9,148|3815|5021|6722,ADRA1A|KIT|OXTR|SRF,-4.8
_FINAL,Reactome Gene Sets,6,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,,-6.2,59,15,30198,31,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-4.8
_FINAL,GO Biological Processes,19,GO:2000142,"regulation of DNA-templated transcription, initiation",19_GO:0008152 metabolic process,-6.2,30,12,30198,76,66,5,7.6,3.3,3725|6722|6927|7480|23493,JUN|SRF|HNF1A|WNT10B|HEY2,-4.8
_FINAL,KEGG Pathway,24,hsa05220,Chronic myeloid leukemia,,-6.2,30,12,30198,76,66,5,7.6,3.3,208|3845|4089|5595|6464,AKT2|KRAS|SMAD4|MAPK3|SHC1,-4.8
_FINAL,WikiPathways,27,WP2034,Leptin signaling pathway,,-6.2,30,12,30198,76,66,5,7.6,3.3,1385|2002|5595|5966|6464,CREB1|ELK1|MAPK3|REL|SHC1,-4.8
_FINAL,WikiPathways,27,WP4674,Head and neck squamous cell carcinoma,,-6.2,30,12,30198,76,66,5,7.6,3.3,208|1499|3845|4089|5966,AKT2|CTNNB1|KRAS|SMAD4|REL,-4.8
_FINAL,GO Biological Processes,19,GO:0003151,outflow tract morphogenesis,19_GO:0032502 developmental process,-6.2,30,12,30198,76,66,5,7.6,3.3,2253|3725|4089|23493|26508,FGF8|JUN|SMAD4|HEY2|HEYL,-4.8
_FINAL,Reactome Gene Sets,6,R-HSA-2871796,FCERI mediated MAPK activation,,-6.1,57,15,30198,32,66,4,6.1,2.9,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4.8
_FINAL,GO Biological Processes,19,GO:0051783,regulation of nuclear division,19_GO:0050789 regulation of biological process,-6.1,19,10,30198,145,66,6,9.1,3.5,699|1063|2253|4751|54361|83540,BUB1|CENPF|FGF8|NEK2|WNT4|NUF2,-4.7
_FINAL,WikiPathways,27,WP422,MAPK cascade,,-6.1,55,15,30198,33,66,4,6.1,2.9,2002|3725|3845|5595,ELK1|JUN|KRAS|MAPK3,-4.7
_FINAL,WikiPathways,27,WP2839,Hair follicle development: organogenesis - part 2 of 3,,-6.1,55,15,30198,33,66,4,6.1,2.9,1499|2246|3624|51176,CTNNB1|FGF1|INHBA|LEF1,-4.7
_FINAL,Canonical Pathways,11,M5883,NABA SECRETED FACTORS,,-6.1,11,8.4,30198,343,66,8,12,4,2246|2253|2920|3624|7480|8817|27190|54361,FGF1|FGF8|CXCL2|INHBA|WNT10B|FGF18|IL17B|WNT4,-4.7
_FINAL,Canonical Pathways,11,M48,PID MET PATHWAY,,-6.1,29,12,30198,79,66,5,7.6,3.3,208|1499|3725|5595|6464,AKT2|CTNNB1|JUN|MAPK3|SHC1,-4.7
_FINAL,WikiPathways,27,WP722,Serotonin HTR1 group and FOS pathway,,-6,54,14,30198,34,66,4,6.1,2.9,1385|2002|5595|6722,CREB1|ELK1|MAPK3|SRF,-4.7
_FINAL,Reactome Gene Sets,6,R-HSA-5654727,Negative regulation of FGFR2 signaling,,-6,54,14,30198,34,66,4,6.1,2.9,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-4.7
_FINAL,GO Biological Processes,19,GO:0008285,negative regulation of cell population proliferation,19_GO:0048519 negative regulation of biological process,-6,6.4,7.2,30198,786,66,11,17,4.6,148|1499|3489|3624|3725|4089|6532|6722|7480|10664|28514,ADRA1A|CTNNB1|IGFBP6|INHBA|JUN|SMAD4|SLC6A4|SRF|WNT10B|CTCF|DLL1,-4.6
_FINAL,GO Biological Processes,19,GO:0001657,ureteric bud development,19_GO:0032502 developmental process,-6,28,11,30198,82,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0072163,mesonephric epithelium development,19_GO:0032502 developmental process,-6,28,11,30198,83,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0072164,mesonephric tubule development,19_GO:0032502 developmental process,-6,28,11,30198,83,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-6,7.2,7.4,30198,632,66,10,15,4.4,1499|2253|4040|4089|4436|4751|6722|23493|28514|51176,CTNNB1|FGF8|LRP6|SMAD4|MSH2|NEK2|SRF|HEY2|DLL1|LEF1,-4.6
_FINAL,GO Biological Processes,19,GO:0002521,leukocyte differentiation,19_GO:0002376 immune system process,-5.9,10,8.2,30198,358,66,8,12,4,1499|3725|3815|4436|6722|28514|51176|54361,CTNNB1|JUN|KIT|MSH2|SRF|DLL1|LEF1|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0060993,kidney morphogenesis,19_GO:0032502 developmental process,-5.9,27,11,30198,84,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0060070,canonical Wnt signaling pathway,19_GO:0023052 signaling,-5.9,27,11,30198,84,66,5,7.6,3.3,1499|4040|7480|51176|54361,CTNNB1|LRP6|WNT10B|LEF1|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0003203,endocardial cushion morphogenesis,19_GO:0032502 developmental process,-5.9,51,14,30198,36,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-4.6
_FINAL,KEGG Pathway,24,hsa04934,Cushing syndrome,,-5.9,18,9.8,30198,155,66,6,9.1,3.5,1385|1499|5595|7480|51176|54361,CREB1|CTNNB1|MAPK3|WNT10B|LEF1|WNT4,-4.6
_FINAL,KEGG Pathway,24,hsa04150,mTOR signaling pathway,,-5.9,18,9.7,30198,156,66,6,9.1,3.5,208|3845|4040|5595|7480|54361,AKT2|KRAS|LRP6|MAPK3|WNT10B|WNT4,-4.6
_FINAL,WikiPathways,27,WP2857,Mesodermal commitment pathway,,-5.9,18,9.7,30198,156,66,6,9.1,3.5,2253|3624|4089|6722|28514|51176,FGF8|INHBA|SMAD4|SRF|DLL1|LEF1,-4.6
_FINAL,GO Biological Processes,19,GO:0003007,heart morphogenesis,19_GO:0032502 developmental process,-5.9,13,8.8,30198,250,66,7,11,3.8,2253|3725|4089|6722|23493|26508|28514,FGF8|JUN|SMAD4|SRF|HEY2|HEYL|DLL1,-4.6
_FINAL,KEGG Pathway,24,hsa04390,Hippo signaling pathway,,-5.9,17,9.7,30198,157,66,6,9.1,3.5,1499|2246|4089|7480|51176|54361,CTNNB1|FGF1|SMAD4|WNT10B|LEF1|WNT4,-4.6
_FINAL,GO Biological Processes,19,GO:0051216,cartilage development,19_GO:0032502 developmental process,-5.9,17,9.7,30198,157,66,6,9.1,3.5,1311|5307|5595|6722|7480|8817,COMP|PITX1|MAPK3|SRF|WNT10B|FGF18,-4.6
_FINAL,KEGG Pathway,24,hsa05216,Thyroid cancer,,-5.9,49,14,30198,37,66,4,6.1,2.9,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-4.6
_FINAL,WikiPathways,27,WP3995,Prion disease pathway,,-5.9,49,14,30198,37,66,4,6.1,2.9,1385|2002|5595|10664,CREB1|ELK1|MAPK3|CTCF,-4.6
_FINAL,GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-5.9,17,9.7,30198,158,66,6,9.1,3.5,1499|3815|4040|4089|5595|6722,CTNNB1|KIT|LRP6|SMAD4|MAPK3|SRF,-4.6
_FINAL,GO Biological Processes,19,GO:0001823,mesonephros development,19_GO:0032502 developmental process,-5.9,26,11,30198,87,66,5,7.6,3.3,1499|2246|2253|4089|54361,CTNNB1|FGF1|FGF8|SMAD4|WNT4,-4.5
_FINAL,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-5.8,48,14,30198,38,66,4,6.1,2.9,1523|2246|2253|3845,CUX1|FGF1|FGF8|KRAS,-4.5
_FINAL,GO Biological Processes,19,GO:0070371,ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.8,48,14,30198,38,66,4,6.1,2.9,4089|5021|5595|128239,SMAD4|OXTR|MAPK3|IQGAP3,-4.5
_FINAL,WikiPathways,27,WP481,Insulin signaling,,-5.8,17,9.6,30198,161,66,6,9.1,3.5,208|2002|3725|5595|6464|6722,AKT2|ELK1|JUN|MAPK3|SHC1|SRF,-4.5
_FINAL,GO Biological Processes,19,GO:0071396,cellular response to lipid,19_GO:0050896 response to stimulus,-5.8,8.2,7.6,30198,503,66,9,14,4.2,1385|2002|2920|3624|4040|5179|5595|6532|7480,CREB1|ELK1|CXCL2|INHBA|LRP6|PENK|MAPK3|SLC6A4|WNT10B,-4.5
_FINAL,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-5.8,7,7.3,30198,653,66,10,15,4.4,1499|2253|4040|4089|4436|4751|6722|23493|28514|51176,CTNNB1|FGF8|LRP6|SMAD4|MSH2|NEK2|SRF|HEY2|DLL1|LEF1,-4.5
_FINAL,WikiPathways,27,WP706,Sudden infant death syndrome (SIDS) susceptibility pathways,,-5.8,17,9.5,30198,162,66,6,9.1,3.5,1385|1499|3725|4800|6532|10664,CREB1|CTNNB1|JUN|NFYA|SLC6A4|CTCF,-4.5
_FINAL,GO Biological Processes,19,GO:0030098,lymphocyte differentiation,19_GO:0002376 immune system process,-5.8,12,8.6,30198,257,66,7,11,3.8,1499|3815|4436|6722|28514|51176|54361,CTNNB1|KIT|MSH2|SRF|DLL1|LEF1|WNT4,-4.5
_FINAL,GO Biological Processes,19,GO:0071407,cellular response to organic cyclic compound,19_GO:0050896 response to stimulus,-5.8,8.2,7.6,30198,505,66,9,14,4.2,1385|1499|2002|3624|4040|5179|5595|6532|7480,CREB1|CTNNB1|ELK1|INHBA|LRP6|PENK|MAPK3|SLC6A4|WNT10B,-4.5
_FINAL,Canonical Pathways,11,M5493,WNT SIGNALING,,-5.8,26,11,30198,89,66,5,7.6,3.3,1499|3725|4040|51176|54361,CTNNB1|JUN|LRP6|LEF1|WNT4,-4.5
_FINAL,GO Biological Processes,19,GO:0040007,growth,19_GO:0040007 growth,-5.8,9.8,8,30198,373,66,8,12,4,148|1311|1499|2246|4089|6722|7480|28514,ADRA1A|COMP|CTNNB1|FGF1|SMAD4|SRF|WNT10B|DLL1,-4.5
_FINAL,GO Biological Processes,19,GO:0048589,developmental growth,19_GO:0040007 growth,-5.8,9.8,8,30198,373,66,8,12,4,148|1311|1499|2246|4089|6722|7480|28514,ADRA1A|COMP|CTNNB1|FGF1|SMAD4|SRF|WNT10B|DLL1,-4.5
_FINAL,GO Biological Processes,19,GO:0043588,skin development,19_GO:0032502 developmental process,-5.8,12,8.6,30198,259,66,7,11,3.8,1311|1499|3624|4089|6722|28514|168002,COMP|CTNNB1|INHBA|SMAD4|SRF|DLL1|DACT2,-4.5
_FINAL,Canonical Pathways,11,M82,PID RET PATHWAY,,-5.8,47,13,30198,39,66,4,6.1,2.9,1385|3725|5595|6464,CREB1|JUN|MAPK3|SHC1,-4.5
_FINAL,WikiPathways,27,WP4150,Wnt signaling in kidney disease,,-5.8,47,13,30198,39,66,4,6.1,2.9,1499|4040|7480|54361,CTNNB1|LRP6|WNT10B|WNT4,-4.5
_FINAL,Reactome Gene Sets,6,R-HSA-9031628,NGF-stimulated transcription,,-5.8,47,13,30198,39,66,4,6.1,2.9,1385|1959|2002|6722,CREB1|EGR2|ELK1|SRF,-4.5
_FINAL,WikiPathways,27,WP69,T-cell receptor signaling pathway,,-5.8,25,11,30198,91,66,5,7.6,3.3,1385|3725|5595|5966|6464,CREB1|JUN|MAPK3|REL|SHC1,-4.5
_FINAL,GO Biological Processes,19,GO:0007611,learning or memory,19_GO:0032501 multicellular organismal process,-5.7,12,8.5,30198,265,66,7,11,3.8,1385|1959|3815|3845|5021|6532|6722,CREB1|EGR2|KIT|KRAS|OXTR|SLC6A4|SRF,-4.4
_FINAL,WikiPathways,27,WP5124,Alzheimer's disease,,-5.7,12,8.4,30198,267,66,7,11,3.8,208|1499|3845|4040|5595|7480|54361,AKT2|CTNNB1|KRAS|LRP6|MAPK3|WNT10B|WNT4,-4.4
_FINAL,GO Biological Processes,19,GO:0021983,pituitary gland development,19_GO:0032502 developmental process,-5.7,45,13,30198,41,66,4,6.1,2.9,1385|2253|5307|54361,CREB1|FGF8|PITX1|WNT4,-4.4
_FINAL,GO Biological Processes,19,GO:0009798,axis specification,19_GO:0032502 developmental process,-5.7,24,11,30198,94,66,5,7.6,3.3,1499|4089|6722|23493|28514,CTNNB1|SMAD4|SRF|HEY2|DLL1,-4.4
_FINAL,Reactome Gene Sets,6,R-HSA-1839130,Signaling by activated point mutants of FGFR3,,-5.7,1.1e+02,18,30198,12,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.4
_FINAL,Reactome Gene Sets,6,R-HSA-2033514,FGFR3 mutant receptor activation,,-5.7,1.1e+02,18,30198,12,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.4
_FINAL,WikiPathways,27,WP2036,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,,-5.7,44,13,30198,42,66,4,6.1,2.9,208|1499|3725|5595,AKT2|CTNNB1|JUN|MAPK3,-4.4
_FINAL,GO Biological Processes,19,GO:0001503,ossification,19_GO:0032501 multicellular organismal process,-5.6,12,8.3,30198,273,66,7,11,3.8,1311|1499|3381|4089|5179|8817|51176,COMP|CTNNB1|IBSP|SMAD4|PENK|FGF18|LEF1,-4.4
_FINAL,GO Biological Processes,19,GO:0071772,response to BMP,19_GO:0050896 response to stimulus,-5.6,24,10,30198,97,66,5,7.6,3.3,1311|4089|5595|26508|51176,COMP|SMAD4|MAPK3|HEYL|LEF1,-4.3
_FINAL,GO Biological Processes,19,GO:0071773,cellular response to BMP stimulus,19_GO:0050896 response to stimulus,-5.6,24,10,30198,97,66,5,7.6,3.3,1311|4089|5595|26508|51176,COMP|SMAD4|MAPK3|HEYL|LEF1,-4.3
_FINAL,GO Biological Processes,19,GO:0060840,artery development,19_GO:0032502 developmental process,-5.6,24,10,30198,97,66,5,7.6,3.3,1311|1959|2253|6722|23493,COMP|EGR2|FGF8|SRF|HEY2,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-5.6,43,13,30198,43,66,4,6.1,2.9,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-4.3
_FINAL,GO Biological Processes,19,GO:0007548,sex differentiation,19_GO:0022414 reproductive process,-5.6,12,8.3,30198,276,66,7,11,3.8,1499|2253|3624|3815|4089|4436|54361,CTNNB1|FGF8|INHBA|KIT|SMAD4|MSH2|WNT4,-4.3
_FINAL,WikiPathways,27,WP23,B cell receptor signaling pathway,,-5.6,23,10,30198,98,66,5,7.6,3.3,1385|2002|3725|5966|6464,CREB1|ELK1|JUN|REL|SHC1,-4.3
_FINAL,GO Biological Processes,19,GO:0060173,limb development,19_GO:0032502 developmental process,-5.6,16,9.1,30198,177,66,6,9.1,3.5,1311|1499|2253|4089|5307|51176,COMP|CTNNB1|FGF8|SMAD4|PITX1|LEF1,-4.3
_FINAL,GO Biological Processes,19,GO:0048736,appendage development,19_GO:0032502 developmental process,-5.6,16,9.1,30198,177,66,6,9.1,3.5,1311|1499|2253|4089|5307|51176,COMP|CTNNB1|FGF8|SMAD4|PITX1|LEF1,-4.3
_FINAL,GO Biological Processes,19,GO:0035282,segmentation,19_GO:0032502 developmental process,-5.6,23,10,30198,99,66,5,7.6,3.3,1959|4040|4089|28514|51176,EGR2|LRP6|SMAD4|DLL1|LEF1,-4.3
_FINAL,GO Biological Processes,19,GO:0009410,response to xenobiotic stimulus,19_GO:0050896 response to stimulus,-5.6,9.1,7.7,30198,401,66,8,12,4,148|1063|1385|1499|3624|3725|5021|6532,ADRA1A|CENPF|CREB1|CTNNB1|INHBA|JUN|OXTR|SLC6A4,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-109704,PI3K Cascade,,-5.6,42,13,30198,44,66,4,6.1,2.9,208|2246|2253|8817,AKT2|FGF1|FGF8|FGF18,-4.3
_FINAL,Canonical Pathways,11,M175,PID ERBB2 ERBB3 PATHWAY,,-5.6,42,13,30198,44,66,4,6.1,2.9,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-5.6,11,8.2,30198,280,66,7,11,3.8,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-4.3
_FINAL,GO Biological Processes,19,GO:0045596,negative regulation of cell differentiation,19_GO:0032502 developmental process,-5.6,6.5,6.9,30198,699,66,10,15,4.4,1499|3624|3845|4089|6532|6599|7480|23493|28514|54361,CTNNB1|INHBA|KRAS|SMAD4|SLC6A4|SMARCC1|WNT10B|HEY2|DLL1|WNT4,-4.3
_FINAL,GO Biological Processes,19,GO:0000165,MAPK cascade,19_GO:0023052 signaling,-5.6,15,9,30198,180,66,6,9.1,3.5,2253|3845|4089|5021|5595|128239,FGF8|KRAS|SMAD4|OXTR|MAPK3|IQGAP3,-4.3
_FINAL,GO Biological Processes,19,GO:0061029,eyelid development in camera-type eye,19_GO:0032502 developmental process,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,3624|3725|6722,INHBA|JUN|SRF,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-190372,FGFR3c ligand binding and activation,,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.3
_FINAL,WikiPathways,27,WP3301,MFAP5-mediated ovarian cancer cell motility and invasiveness,,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,1385|3725|5595,CREB1|JUN|MAPK3,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-190239,FGFR3 ligand binding and activation,,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-190375,FGFR2c ligand binding and activation,,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,,-5.6,1.1e+02,18,30198,13,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.3
_FINAL,GO Biological Processes,19,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,19_GO:0023052 signaling,-5.5,9,7.6,30198,405,66,8,12,4,208|1284|2246|2253|3815|6464|6599|8817,AKT2|COL4A2|FGF1|FGF8|KIT|SHC1|SMARCC1|FGF18,-4.3
_FINAL,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-5.5,11,8.1,30198,286,66,7,11,3.8,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-4.2
_FINAL,WikiPathways,27,WP4535,Envelope proteins and their potential roles in EDMD physiopathology,,-5.5,40,12,30198,46,66,4,6.1,2.9,3845|4089|5595|6722,KRAS|SMAD4|MAPK3|SRF,-4.2
_FINAL,GO Biological Processes,19,GO:0003197,endocardial cushion development,19_GO:0032502 developmental process,-5.5,40,12,30198,46,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-4.2
_FINAL,KEGG Pathway,24,hsa04625,C-type lectin receptor signaling pathway,,-5.5,22,10,30198,104,66,5,7.6,3.3,208|1959|3725|3845|5595,AKT2|EGR2|JUN|KRAS|MAPK3,-4.2
_FINAL,GO Biological Processes,19,GO:0030335,positive regulation of cell migration,19_GO:0040011 locomotion,-5.5,7.4,7.1,30198,560,66,9,14,4.2,208|2246|3725|3815|4680|5595|8817|51176|131578,AKT2|FGF1|JUN|KIT|CEACAM6|MAPK3|FGF18|LEF1|LRRC15,-4.2
_FINAL,Reactome Gene Sets,6,R-HSA-190322,FGFR4 ligand binding and activation,,-5.4,98,17,30198,14,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.2
_FINAL,GO Biological Processes,19,GO:1905208,negative regulation of cardiocyte differentiation,19_GO:0032502 developmental process,-5.4,98,17,30198,14,66,3,4.5,2.6,4089|23493|28514,SMAD4|HEY2|DLL1,-4.2
_FINAL,Canonical Pathways,11,M134,PID TCR RAS PATHWAY,,-5.4,98,17,30198,14,66,3,4.5,2.6,2002|3845|5595,ELK1|KRAS|MAPK3,-4.2
_FINAL,Reactome Gene Sets,6,R-HSA-69278,"Cell Cycle, Mitotic",,-5.4,7.3,7.1,30198,561,66,9,14,4.2,208|699|1063|1876|4751|5595|22974|83540|286826,AKT2|BUB1|CENPF|E2F6|NEK2|MAPK3|TPX2|NUF2|LIN9,-4.2
_FINAL,Reactome Gene Sets,6,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",,-5.4,22,9.9,30198,106,66,5,7.6,3.3,2246|2253|3815|5595|8817,FGF1|FGF8|KIT|MAPK3|FGF18,-4.2
_FINAL,GO Biological Processes,19,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,19_GO:0023052 signaling,-5.4,15,8.7,30198,189,66,6,9.1,3.5,1311|3624|3725|4089|5595|51176,COMP|INHBA|JUN|SMAD4|MAPK3|LEF1,-4.2
_FINAL,GO Biological Processes,19,GO:0045933,positive regulation of muscle contraction,19_GO:0048518 positive regulation of biological process,-5.4,38,12,30198,48,66,4,6.1,2.9,148|3815|5021|6722,ADRA1A|KIT|OXTR|SRF,-4.2
_FINAL,WikiPathways,27,WP2848,Pluripotent stem cell differentiation pathway,,-5.4,38,12,30198,48,66,4,6.1,2.9,2246|2253|3624|3815,FGF1|FGF8|INHBA|KIT,-4.2
_FINAL,GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-5.4,7.2,7,30198,575,66,9,14,4.2,148|905|1499|2246|3815|4751|5595|8817|22974,ADRA1A|CCNT2|CTNNB1|FGF1|KIT|NEK2|MAPK3|FGF18|TPX2,-4.1
_FINAL,Reactome Gene Sets,6,R-HSA-1502540,Signaling by Activin,,-5.4,92,16,30198,15,66,3,4.5,2.6,3624|4089|5595,INHBA|SMAD4|MAPK3,-4.1
_FINAL,GO Biological Processes,19,GO:0001759,organ induction,19_GO:0032502 developmental process,-5.4,92,16,30198,15,66,3,4.5,2.6,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.1
_FINAL,Reactome Gene Sets,6,R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,,-5.4,92,16,30198,15,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4.1
_FINAL,GO Biological Processes,19,GO:0035051,cardiocyte differentiation,19_GO:0032502 developmental process,-5.3,21,9.7,30198,111,66,5,7.6,3.3,148|4089|5595|6722|23493,ADRA1A|SMAD4|MAPK3|SRF|HEY2,-4.1
_FINAL,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-5.3,7.1,6.9,30198,580,66,9,14,4.2,208|1499|3725|5179|5595|6464|6532|6599|7480,AKT2|CTNNB1|JUN|PENK|MAPK3|SHC1|SLC6A4|SMARCC1|WNT10B,-4.1
_FINAL,KEGG Pathway,24,hsa04668,TNF signaling pathway,,-5.3,20,9.6,30198,112,66,5,7.6,3.3,208|1385|2920|3725|5595,AKT2|CREB1|CXCL2|JUN|MAPK3,-4.1
_FINAL,GO Biological Processes,19,GO:0050890,cognition,19_GO:0032501 multicellular organismal process,-5.3,10,7.8,30198,307,66,7,11,3.8,1385|1959|3815|3845|5021|6532|6722,CREB1|EGR2|KIT|KRAS|OXTR|SLC6A4|SRF,-4.1
_FINAL,GO Biological Processes,19,GO:2000147,positive regulation of cell motility,19_GO:0040011 locomotion,-5.3,7.1,6.9,30198,584,66,9,14,4.2,208|2246|3725|3815|4680|5595|8817|51176|131578,AKT2|FGF1|JUN|KIT|CEACAM6|MAPK3|FGF18|LEF1|LRRC15,-4.1
_FINAL,Canonical Pathways,11,M5885,NABA MATRISOME ASSOCIATED,,-5.3,6.1,6.6,30198,751,66,10,15,4.4,1472|2246|2253|2920|3624|7480|8817|27190|54361|60495,CST4|FGF1|FGF8|CXCL2|INHBA|WNT10B|FGF18|IL17B|WNT4|HPSE2,-4.1
_FINAL,WikiPathways,27,WP3888,VEGFA-VEGFR2 signaling pathway,,-5.3,8.3,7.2,30198,439,66,8,12,4,1385|1499|2002|3725|5595|6464|6722|7148,CREB1|CTNNB1|ELK1|JUN|MAPK3|SHC1|SRF|TNXB,-4.1
_FINAL,GO Biological Processes,19,GO:0043392,negative regulation of DNA binding,19_GO:0065007 biological regulation,-5.3,35,12,30198,52,66,4,6.1,2.9,3725|4751|23493|51176,JUN|NEK2|HEY2|LEF1,-4.1
_FINAL,GO Biological Processes,19,GO:0001704,formation of primary germ layer,19_GO:0032502 developmental process,-5.3,20,9.5,30198,114,66,5,7.6,3.3,1284|1499|3624|6722|51176,COL4A2|CTNNB1|INHBA|SRF|LEF1,-4.1
_FINAL,GO Biological Processes,19,GO:0048568,embryonic organ development,19_GO:0032502 developmental process,-5.2,8.2,7.2,30198,445,66,8,12,4,1499|2253|3815|5595|6722|23493|28514|51176,CTNNB1|FGF8|KIT|MAPK3|SRF|HEY2|DLL1|LEF1,-4
_FINAL,GO Biological Processes,19,GO:0051272,positive regulation of cellular component movement,19_GO:0051179 localization,-5.2,6.9,6.8,30198,597,66,9,14,4.2,208|2246|3725|3815|4680|5595|8817|51176|131578,AKT2|FGF1|JUN|KIT|CEACAM6|MAPK3|FGF18|LEF1|LRRC15,-4
_FINAL,GO Biological Processes,19,GO:0040017,positive regulation of locomotion,19_GO:0040011 locomotion,-5.2,6.9,6.8,30198,599,66,9,14,4.2,208|2246|3725|3815|4680|5595|8817|51176|131578,AKT2|FGF1|JUN|KIT|CEACAM6|MAPK3|FGF18|LEF1|LRRC15,-4
_FINAL,Canonical Pathways,11,M286,PID TGFBR PATHWAY,,-5.2,34,11,30198,54,66,4,6.1,2.9,1499|4089|6464|168002,CTNNB1|SMAD4|SHC1|DACT2,-4
_FINAL,GO Biological Processes,19,GO:0007088,regulation of mitotic nuclear division,19_GO:0050789 regulation of biological process,-5.2,19,9.4,30198,118,66,5,7.6,3.3,699|1063|2253|4751|83540,BUB1|CENPF|FGF8|NEK2|NUF2,-4
_FINAL,KEGG Pathway,24,hsa04935,"Growth hormone synthesis, secretion and action",,-5.2,19,9.3,30198,119,66,5,7.6,3.3,208|1385|3845|5595|6464,AKT2|CREB1|KRAS|MAPK3|SHC1,-4
_FINAL,KEGG Pathway,24,hsa04722,Neurotrophin signaling pathway,,-5.2,19,9.3,30198,119,66,5,7.6,3.3,208|3725|3845|5595|6464,AKT2|JUN|KRAS|MAPK3|SHC1,-4
_FINAL,GO Biological Processes,19,GO:0035113,embryonic appendage morphogenesis,19_GO:0032502 developmental process,-5.2,19,9.3,30198,119,66,5,7.6,3.3,1499|2253|4089|5307|51176,CTNNB1|FGF8|SMAD4|PITX1|LEF1,-4
_FINAL,GO Biological Processes,19,GO:0030326,embryonic limb morphogenesis,19_GO:0032502 developmental process,-5.2,19,9.3,30198,119,66,5,7.6,3.3,1499|2253|4089|5307|51176,CTNNB1|FGF8|SMAD4|PITX1|LEF1,-4
_FINAL,Canonical Pathways,11,M122,PID IL2 1PATHWAY,,-5.2,33,11,30198,55,66,4,6.1,2.9,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4
_FINAL,WikiPathways,27,WP5144,NRP1-triggered signaling pathways in pancreatic cancer,,-5.2,33,11,30198,55,66,4,6.1,2.9,208|4089|5595|5966,AKT2|SMAD4|MAPK3|REL,-4
_FINAL,Canonical Pathways,11,M18895,SA TRKA RECEPTOR,,-5.2,81,15,30198,17,66,3,4.5,2.6,208|2002|6464,AKT2|ELK1|SHC1,-4
_FINAL,GO Biological Processes,19,GO:0035886,vascular associated smooth muscle cell differentiation,19_GO:0032502 developmental process,-5.2,81,15,30198,17,66,3,4.5,2.6,1311|6722|23493,COMP|SRF|HEY2,-4
_FINAL,Canonical Pathways,11,M12771,SA PTEN PATHWAY,,-5.2,81,15,30198,17,66,3,4.5,2.6,208|5595|6464,AKT2|MAPK3|SHC1,-4
_FINAL,Reactome Gene Sets,6,R-HSA-2033519,Activated point mutants of FGFR2,,-5.2,81,15,30198,17,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-4
_FINAL,GO Biological Processes,19,GO:0061448,connective tissue development,19_GO:0032502 developmental process,-5.2,13,8.2,30198,211,66,6,9.1,3.5,1311|5307|5595|6722|7480|8817,COMP|PITX1|MAPK3|SRF|WNT10B|FGF18,-4
_FINAL,GO Biological Processes,19,GO:0030278,regulation of ossification,19_GO:0032501 multicellular organismal process,-5.2,19,9.2,30198,121,66,5,7.6,3.3,1311|1959|5595|7480|54361,COMP|EGR2|MAPK3|WNT10B|WNT4,-4
_FINAL,GO Biological Processes,19,GO:0051101,regulation of DNA binding,19_GO:0065007 biological regulation,-5.2,19,9.2,30198,121,66,5,7.6,3.3,1499|3725|4751|23493|51176,CTNNB1|JUN|NEK2|HEY2|LEF1,-4
_FINAL,KEGG Pathway,24,hsa04919,Thyroid hormone signaling pathway,,-5.2,19,9.2,30198,121,66,5,7.6,3.3,208|1499|3845|5595|54361,AKT2|CTNNB1|KRAS|MAPK3|WNT4,-4
_FINAL,GO Biological Processes,19,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,19_GO:0023052 signaling,-5.1,9.8,7.5,30198,326,66,7,11,3.8,1499|4040|7480|9127|10009|51176|54361,CTNNB1|LRP6|WNT10B|P2RX6|ZBTB33|LEF1|WNT4,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-195258,RHO GTPase Effectors,,-5.1,9.8,7.5,30198,327,66,7,11,3.8,699|1063|1499|5595|6722|83540|128239,BUB1|CENPF|CTNNB1|MAPK3|SRF|NUF2|IQGAP3,-3.9
_FINAL,GO Biological Processes,19,GO:0009948,anterior/posterior axis specification,19_GO:0032502 developmental process,-5.1,32,11,30198,57,66,4,6.1,2.9,1499|4089|6722|23493,CTNNB1|SMAD4|SRF|HEY2,-3.9
_FINAL,GO Biological Processes,19,GO:0030879,mammary gland development,19_GO:0032502 developmental process,-5.1,19,9.2,30198,123,66,5,7.6,3.3,208|1385|5021|51176|54361,AKT2|CREB1|OXTR|LEF1|WNT4,-3.9
_FINAL,GO Biological Processes,19,GO:0007498,mesoderm development,19_GO:0032502 developmental process,-5.1,18,9.1,30198,124,66,5,7.6,3.3,2253|3624|4089|6722|51176,FGF8|INHBA|SMAD4|SRF|LEF1,-3.9
_FINAL,WikiPathways,27,WP4560,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,,-5.1,76,15,30198,18,66,3,4.5,2.6,1385|3725|5595,CREB1|JUN|MAPK3,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,,-5.1,76,15,30198,18,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,,-5.1,76,15,30198,18,66,3,4.5,2.6,1385|3845|5595,CREB1|KRAS|MAPK3,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-5654710,PI-3K cascade:FGFR3,,-5.1,76,15,30198,18,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.9
_FINAL,GO Biological Processes,19,GO:0035904,aorta development,19_GO:0032502 developmental process,-5.1,32,11,30198,58,66,4,6.1,2.9,1959|2253|6722|23493,EGR2|FGF8|SRF|HEY2,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-195721,Signaling by WNT,,-5.1,9.6,7.4,30198,332,66,7,11,3.8,208|1499|3845|4040|7480|51176|54361,AKT2|CTNNB1|KRAS|LRP6|WNT10B|LEF1|WNT4,-3.9
_FINAL,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-5.1,13,8,30198,218,66,6,9.1,3.5,2246|2253|3845|5595|8817|128239,FGF1|FGF8|KRAS|MAPK3|FGF18|IQGAP3,-3.9
_FINAL,GO Biological Processes,19,GO:0003206,cardiac chamber morphogenesis,19_GO:0032502 developmental process,-5.1,18,9,30198,126,66,5,7.6,3.3,2253|4089|6722|23493|26508,FGF8|SMAD4|SRF|HEY2|HEYL,-3.9
_FINAL,WikiPathways,27,WP4205,MET in type 1 papillary renal cell carcinoma,,-5.1,31,11,30198,59,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3.9
_FINAL,GO Biological Processes,19,GO:0008406,gonad development,19_GO:0022414 reproductive process,-5.1,12,8,30198,220,66,6,9.1,3.5,2253|3624|3815|4089|4436|54361,FGF8|INHBA|KIT|SMAD4|MSH2|WNT4,-3.9
_FINAL,WikiPathways,27,WP2059,Alzheimer's disease and miRNA effects,,-5,9.5,7.3,30198,337,66,7,11,3.8,208|1499|3845|4040|5595|7480|54361,AKT2|CTNNB1|KRAS|LRP6|MAPK3|WNT10B|WNT4,-3.9
_FINAL,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-5,6.5,6.6,30198,633,66,9,14,4.2,148|208|1385|2920|3845|5021|5179|5595|6464,ADRA1A|AKT2|CREB1|CXCL2|KRAS|OXTR|PENK|MAPK3|SHC1,-3.8
_FINAL,GO Biological Processes,19,GO:0001756,somitogenesis,19_GO:0032502 developmental process,-5,30,11,30198,61,66,4,6.1,2.9,4040|4089|28514|51176,LRP6|SMAD4|DLL1|LEF1,-3.8
_FINAL,KEGG Pathway,24,hsa05163,Human cytomegalovirus infection,,-5,12,7.9,30198,225,66,6,9.1,3.5,208|1385|1499|2002|3845|5595,AKT2|CREB1|CTNNB1|ELK1|KRAS|MAPK3,-3.8
_FINAL,GO Biological Processes,19,GO:0045137,development of primary sexual characteristics,19_GO:0022414 reproductive process,-5,12,7.9,30198,225,66,6,9.1,3.5,2253|3624|3815|4089|4436|54361,FGF8|INHBA|KIT|SMAD4|MSH2|WNT4,-3.8
_FINAL,WikiPathways,27,WP236,Adipogenesis,,-5,17,8.8,30198,131,66,5,7.6,3.3,1385|1499|1959|6927|7480,CREB1|CTNNB1|EGR2|HNF1A|WNT10B,-3.8
_FINAL,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-5,6.4,6.5,30198,640,66,9,14,4.2,208|1499|3725|5179|5595|6464|6532|6599|7480,AKT2|CTNNB1|JUN|PENK|MAPK3|SHC1|SLC6A4|SMARCC1|WNT10B,-3.8
_FINAL,GO Biological Processes,19,GO:0045930,negative regulation of mitotic cell cycle,19_GO:0048519 negative regulation of biological process,-5,12,7.9,30198,227,66,6,9.1,3.5,699|1063|1499|3624|4436|83540,BUB1|CENPF|CTNNB1|INHBA|MSH2|NUF2,-3.8
_FINAL,GO Biological Processes,19,GO:0001649,osteoblast differentiation,19_GO:0032502 developmental process,-5,17,8.8,30198,132,66,5,7.6,3.3,1499|3381|4089|5179|51176,CTNNB1|IBSP|SMAD4|PENK|LEF1,-3.8
_FINAL,WikiPathways,27,WP3927,BMP signaling in eyelid development,,-5,69,14,30198,20,66,3,4.5,2.6,3725|4089|5595,JUN|SMAD4|MAPK3,-3.8
_FINAL,Reactome Gene Sets,6,R-HSA-190241,FGFR2 ligand binding and activation,,-5,69,14,30198,20,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.8
_FINAL,Reactome Gene Sets,6,R-HSA-5654720,PI-3K cascade:FGFR4,,-5,69,14,30198,20,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.8
_FINAL,Reactome Gene Sets,6,R-HSA-375165,NCAM signaling for neurite out-growth,,-4.9,29,10,30198,63,66,4,6.1,2.9,1284|1385|3845|5595,COL4A2|CREB1|KRAS|MAPK3,-3.8
_FINAL,Canonical Pathways,11,M10,PID BCR 5PATHWAY,,-4.9,29,10,30198,63,66,4,6.1,2.9,2002|3725|5595|6464,ELK1|JUN|MAPK3|SHC1,-3.8
_FINAL,KEGG Pathway,24,hsa05217,Basal cell carcinoma,,-4.9,29,10,30198,63,66,4,6.1,2.9,1499|7480|51176|54361,CTNNB1|WNT10B|LEF1|WNT4,-3.8
_FINAL,Reactome Gene Sets,6,R-HSA-450294,MAP kinase activation,,-4.9,29,10,30198,64,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.8
_FINAL,GO Biological Processes,19,GO:0043434,response to peptide hormone,19_GO:0050896 response to stimulus,-4.9,9,7.1,30198,354,66,7,11,3.8,208|1385|1959|4040|5021|6464|6599,AKT2|CREB1|EGR2|LRP6|OXTR|SHC1|SMARCC1,-3.7
_FINAL,GO Biological Processes,19,GO:0008584,male gonad development,19_GO:0022414 reproductive process,-4.9,17,8.7,30198,136,66,5,7.6,3.3,3624|3815|4089|4436|54361,INHBA|KIT|SMAD4|MSH2|WNT4,-3.7
_FINAL,GO Biological Processes,19,GO:0006940,regulation of smooth muscle contraction,19_GO:0032501 multicellular organismal process,-4.9,28,10,30198,65,66,4,6.1,2.9,148|3815|5021|6722,ADRA1A|KIT|OXTR|SRF,-3.7
_FINAL,Canonical Pathways,11,M272,PID CD8 TCR DOWNSTREAM PATHWAY,,-4.9,28,10,30198,65,66,4,6.1,2.9,2002|3725|3845|5595,ELK1|JUN|KRAS|MAPK3,-3.7
_FINAL,GO Biological Processes,19,GO:2000144,"positive regulation of DNA-templated transcription, initiation",19_GO:0048518 positive regulation of biological process,-4.9,28,10,30198,65,66,4,6.1,2.9,3725|6722|6927|7480,JUN|SRF|HNF1A|WNT10B,-3.7
_FINAL,KEGG Pathway,24,hsa04910,Insulin signaling pathway,,-4.9,17,8.6,30198,137,66,5,7.6,3.3,208|2002|3845|5595|6464,AKT2|ELK1|KRAS|MAPK3|SHC1,-3.7
_FINAL,GO Biological Processes,19,GO:0046546,development of primary male sexual characteristics,19_GO:0022414 reproductive process,-4.9,17,8.6,30198,137,66,5,7.6,3.3,3624|3815|4089|4436|54361,INHBA|KIT|SMAD4|MSH2|WNT4,-3.7
_FINAL,GO Biological Processes,19,GO:0007063,regulation of sister chromatid cohesion,19_GO:0050789 regulation of biological process,-4.9,65,14,30198,21,66,3,4.5,2.6,699|1499|10664,BUB1|CTNNB1|CTCF,-3.7
_FINAL,GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-4.9,6.2,6.4,30198,660,66,9,14,4.2,148|905|2246|3815|4040|6464|7148|8817|22974,ADRA1A|CCNT2|FGF1|KIT|LRP6|SHC1|TNXB|FGF18|TPX2,-3.7
_FINAL,WikiPathways,27,WP2374,Oncostatin M signaling pathway,,-4.9,28,10,30198,66,66,4,6.1,2.9,1385|3845|5595|6464,CREB1|KRAS|MAPK3|SHC1,-3.7
_FINAL,GO Biological Processes,19,GO:0030099,myeloid cell differentiation,19_GO:0002376 immune system process,-4.9,12,7.6,30198,238,66,6,9.1,3.5,1499|3624|3725|3815|6722|51176,CTNNB1|INHBA|JUN|KIT|SRF|LEF1,-3.7
_FINAL,GO Biological Processes,19,GO:0040008,regulation of growth,19_GO:0040007 growth,-4.9,6.2,6.3,30198,664,66,9,14,4.2,1385|2253|3624|4089|6464|6532|6722|23493|28514,CREB1|FGF8|INHBA|SMAD4|SHC1|SLC6A4|SRF|HEY2|DLL1,-3.7
_FINAL,GO Biological Processes,19,GO:0051301,cell division,19_GO:0009987 cellular process,-4.9,7.3,6.6,30198,503,66,8,12,4,699|905|1063|3815|4751|22974|51176|83540,BUB1|CCNT2|CENPF|KIT|NEK2|TPX2|LEF1|NUF2,-3.7
_FINAL,GO Biological Processes,19,GO:0014074,response to purine-containing compound,19_GO:0050896 response to stimulus,-4.8,16,8.5,30198,140,66,5,7.6,3.3,1385|5179|6532|7480|9127,CREB1|PENK|SLC6A4|WNT10B|P2RX6,-3.7
_FINAL,GO Biological Processes,19,GO:0060260,regulation of transcription initiation from RNA polymerase II promoter,19_GO:0008152 metabolic process,-4.8,27,10,30198,67,66,4,6.1,2.9,6722|6927|7480|23493,SRF|HNF1A|WNT10B|HEY2,-3.7
_FINAL,KEGG Pathway,24,hsa04020,Calcium signaling pathway,,-4.8,11,7.6,30198,240,66,6,9.1,3.5,148|2246|2253|5021|8817|9127,ADRA1A|FGF1|FGF8|OXTR|FGF18|P2RX6,-3.7
_FINAL,GO Biological Processes,19,GO:0035107,appendage morphogenesis,19_GO:0032502 developmental process,-4.8,16,8.4,30198,142,66,5,7.6,3.3,1499|2253|4089|5307|51176,CTNNB1|FGF8|SMAD4|PITX1|LEF1,-3.7
_FINAL,GO Biological Processes,19,GO:0035108,limb morphogenesis,19_GO:0032502 developmental process,-4.8,16,8.4,30198,142,66,5,7.6,3.3,1499|2253|4089|5307|51176,CTNNB1|FGF8|SMAD4|PITX1|LEF1,-3.7
_FINAL,GO Biological Processes,19,GO:0035065,regulation of histone acetylation,19_GO:0008152 metabolic process,-4.8,27,10,30198,68,66,4,6.1,2.9,4089|4800|5595|10664,SMAD4|NFYA|MAPK3|CTCF,-3.7
_FINAL,WikiPathways,27,WP3680,Physico-chemical features and toxicity-associated pathways,,-4.8,27,10,30198,68,66,4,6.1,2.9,1499|2002|3725|6464,CTNNB1|ELK1|JUN|SHC1,-3.7
_FINAL,GO Biological Processes,19,GO:0051098,regulation of binding,19_GO:0065007 biological regulation,-4.8,8.7,7,30198,367,66,7,11,3.8,1499|3725|4089|4751|5595|23493|51176,CTNNB1|JUN|SMAD4|NEK2|MAPK3|HEY2|LEF1,-3.7
_FINAL,WikiPathways,27,WP3303,RAC1/PAK1/p38/MMP2 pathway,,-4.8,27,9.9,30198,69,66,4,6.1,2.9,1499|3845|4436|5595,CTNNB1|KRAS|MSH2|MAPK3,-3.6
_FINAL,GO Biological Processes,19,GO:0048844,artery morphogenesis,19_GO:0032502 developmental process,-4.8,27,9.9,30198,69,66,4,6.1,2.9,1311|2253|6722|23493,COMP|FGF8|SRF|HEY2,-3.6
_FINAL,KEGG Pathway,24,hsa05211,Renal cell carcinoma,,-4.8,27,9.9,30198,69,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3.6
_FINAL,GO Biological Processes,19,GO:0021537,telencephalon development,19_GO:0032502 developmental process,-4.8,11,7.5,30198,246,66,6,9.1,3.5,1499|2253|3624|5021|6722|51176,CTNNB1|FGF8|INHBA|OXTR|SRF|LEF1,-3.6
_FINAL,GO Biological Processes,19,GO:0061311,cell surface receptor signaling pathway involved in heart development,19_GO:0023052 signaling,-4.8,60,13,30198,23,66,3,4.5,2.6,1499|23493|26508,CTNNB1|HEY2|HEYL,-3.6
_FINAL,GO Biological Processes,19,GO:0060343,trabecula formation,19_GO:0032502 developmental process,-4.8,60,13,30198,23,66,3,4.5,2.6,6722|7480|23493,SRF|WNT10B|HEY2,-3.6
_FINAL,Reactome Gene Sets,6,R-HSA-5654695,PI-3K cascade:FGFR2,,-4.8,60,13,30198,23,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.6
_FINAL,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-4.8,60,13,30198,23,66,3,4.5,2.6,2246|2253|3845,FGF1|FGF8|KRAS,-3.6
_FINAL,WikiPathways,27,WP712,Estrogen signaling pathway,,-4.8,60,13,30198,23,66,3,4.5,2.6,1385|2002|3725,CREB1|ELK1|JUN,-3.6
_FINAL,Canonical Pathways,11,M81,PID CDC42 PATHWAY,,-4.8,26,9.9,30198,70,66,4,6.1,2.9,1499|3725|5595|128239,CTNNB1|JUN|MAPK3|IQGAP3,-3.6
_FINAL,Canonical Pathways,11,M167,PID AP1 PATHWAY,,-4.8,26,9.9,30198,70,66,4,6.1,2.9,1385|1499|3725|5179,CREB1|CTNNB1|JUN|PENK,-3.6
_FINAL,KEGG Pathway,24,hsa05230,Central carbon metabolism in cancer,,-4.8,26,9.9,30198,70,66,4,6.1,2.9,208|3815|3845|5595,AKT2|KIT|KRAS|MAPK3,-3.6
_FINAL,KEGG Pathway,24,hsa04917,Prolactin signaling pathway,,-4.8,26,9.9,30198,70,66,4,6.1,2.9,208|3845|5595|6464,AKT2|KRAS|MAPK3|SHC1,-3.6
_FINAL,GO Biological Processes,19,GO:0045786,negative regulation of cell cycle,19_GO:0048519 negative regulation of biological process,-4.7,8.5,6.9,30198,375,66,7,11,3.8,699|1063|1499|3624|4436|4751|83540,BUB1|CENPF|CTNNB1|INHBA|MSH2|NEK2|NUF2,-3.6
_FINAL,GO Biological Processes,19,GO:0060411,cardiac septum morphogenesis,19_GO:0032502 developmental process,-4.7,26,9.8,30198,71,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-3.6
_FINAL,KEGG Pathway,24,hsa04520,Adherens junction,,-4.7,26,9.8,30198,71,66,4,6.1,2.9,1499|4089|5595|51176,CTNNB1|SMAD4|MAPK3|LEF1,-3.6
_FINAL,KEGG Pathway,24,hsa04072,Phospholipase D signaling pathway,,-4.7,15,8.3,30198,148,66,5,7.6,3.3,208|3815|3845|5595|6464,AKT2|KIT|KRAS|MAPK3|SHC1,-3.6
_FINAL,GO Biological Processes,19,GO:0045321,leukocyte activation,19_GO:0002376 immune system process,-4.7,7,6.5,30198,526,66,8,12,4,1499|3725|3815|4436|6722|28514|51176|54361,CTNNB1|JUN|KIT|MSH2|SRF|DLL1|LEF1|WNT4,-3.6
_FINAL,Reactome Gene Sets,6,R-HSA-1640170,Cell Cycle,,-4.7,6,6.2,30198,692,66,9,14,4.2,208|699|1063|1876|4751|5595|22974|83540|286826,AKT2|BUB1|CENPF|E2F6|NEK2|MAPK3|TPX2|NUF2|LIN9,-3.6
_FINAL,Reactome Gene Sets,6,R-HSA-448424,Interleukin-17 signaling,,-4.7,25,9.7,30198,72,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.6
_FINAL,Canonical Pathways,11,M268,PID S1P S1P2 PATHWAY,,-4.7,57,13,30198,24,66,3,4.5,2.6,2002|3725|5595,ELK1|JUN|MAPK3,-3.6
_FINAL,GO Biological Processes,19,GO:1901863,positive regulation of muscle tissue development,19_GO:0032502 developmental process,-4.7,57,13,30198,24,66,3,4.5,2.6,1385|1499|28514,CREB1|CTNNB1|DLL1,-3.6
_FINAL,GO Biological Processes,19,GO:0003181,atrioventricular valve morphogenesis,19_GO:0032502 developmental process,-4.7,57,13,30198,24,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-3.6
_FINAL,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-4.7,15,8.2,30198,150,66,5,7.6,3.3,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-3.6
_FINAL,GO Biological Processes,19,GO:0001701,in utero embryonic development,19_GO:0032502 developmental process,-4.7,8.4,6.8,30198,382,66,7,11,3.8,1499|4089|4436|4751|6722|23493|51176,CTNNB1|SMAD4|MSH2|NEK2|SRF|HEY2|LEF1,-3.6
_FINAL,GO Biological Processes,19,GO:0071560,cellular response to transforming growth factor beta stimulus,19_GO:0050896 response to stimulus,-4.7,15,8.2,30198,151,66,5,7.6,3.3,1284|3725|4089|5179|54361,COL4A2|JUN|SMAD4|PENK|WNT4,-3.6
_FINAL,KEGG Pathway,24,hsa05010,Alzheimer disease,,-4.7,8.3,6.8,30198,384,66,7,11,3.8,208|1499|3845|4040|5595|7480|54361,AKT2|CTNNB1|KRAS|LRP6|MAPK3|WNT10B|WNT4,-3.6
_FINAL,GO Biological Processes,19,GO:0021536,diencephalon development,19_GO:0032502 developmental process,-4.7,25,9.6,30198,74,66,4,6.1,2.9,1385|2253|5307|54361,CREB1|FGF8|PITX1|WNT4,-3.5
_FINAL,GO Biological Processes,19,GO:0030217,T cell differentiation,19_GO:0002376 immune system process,-4.7,15,8.1,30198,153,66,5,7.6,3.3,1499|3815|6722|51176|54361,CTNNB1|KIT|SRF|LEF1|WNT4,-3.5
_FINAL,GO Biological Processes,19,GO:0030878,thyroid gland development,19_GO:0032502 developmental process,-4.7,55,13,30198,25,66,3,4.5,2.6,2253|5595|6722,FGF8|MAPK3|SRF,-3.5
_FINAL,Canonical Pathways,11,M274,PID LYMPH ANGIOGENESIS PATHWAY,,-4.7,55,13,30198,25,66,3,4.5,2.6,1385|5595|6464,CREB1|MAPK3|SHC1,-3.5
_FINAL,WikiPathways,27,WP4483,"Relationship between inflammation, COX-2 and EGFR",,-4.7,55,13,30198,25,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-3.5
_FINAL,WikiPathways,27,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,,-4.7,55,13,30198,25,66,3,4.5,2.6,4089|5595|6464,SMAD4|MAPK3|SHC1,-3.5
_FINAL,KEGG Pathway,24,hsa04921,Oxytocin signaling pathway,,-4.6,15,8.1,30198,154,66,5,7.6,3.3,2002|3725|3845|5021|5595,ELK1|JUN|KRAS|OXTR|MAPK3,-3.5
_FINAL,KEGG Pathway,24,hsa05214,Glioma,,-4.6,24,9.5,30198,75,66,4,6.1,2.9,208|3845|5595|6464,AKT2|KRAS|MAPK3|SHC1,-3.5
_FINAL,GO Biological Processes,19,GO:0016055,Wnt signaling pathway,19_GO:0023052 signaling,-4.6,10,7.2,30198,262,66,6,9.1,3.5,1499|4040|7480|10009|51176|54361,CTNNB1|LRP6|WNT10B|ZBTB33|LEF1|WNT4,-3.5
_FINAL,GO Biological Processes,19,GO:0198738,cell-cell signaling by wnt,19_GO:0023052 signaling,-4.6,10,7.2,30198,262,66,6,9.1,3.5,1499|4040|7480|10009|51176|54361,CTNNB1|LRP6|WNT10B|ZBTB33|LEF1|WNT4,-3.5
_FINAL,KEGG Pathway,24,hsa05212,Pancreatic cancer,,-4.6,24,9.4,30198,76,66,4,6.1,2.9,208|3845|4089|5595,AKT2|KRAS|SMAD4|MAPK3,-3.5
_FINAL,WikiPathways,27,WP2037,Prolactin signaling pathway,,-4.6,24,9.4,30198,76,66,4,6.1,2.9,2002|3725|5595|6464,ELK1|JUN|MAPK3|SHC1,-3.5
_FINAL,Reactome Gene Sets,6,R-HSA-3000178,ECM proteoglycans,,-4.6,24,9.4,30198,76,66,4,6.1,2.9,1284|1311|3381|7148,COL4A2|COMP|IBSP|TNXB,-3.5
_FINAL,GO Biological Processes,19,GO:0045834,positive regulation of lipid metabolic process,19_GO:0048518 positive regulation of biological process,-4.6,15,8,30198,156,66,5,7.6,3.3,208|1385|2246|3815|54361,AKT2|CREB1|FGF1|KIT|WNT4,-3.5
_FINAL,GO Biological Processes,19,GO:2000756,regulation of peptidyl-lysine acetylation,19_GO:0008152 metabolic process,-4.6,24,9.4,30198,77,66,4,6.1,2.9,4089|4800|5595|10664,SMAD4|NFYA|MAPK3|CTCF,-3.5
_FINAL,WikiPathways,27,WP3658,Wnt/beta-catenin signaling pathway in leukemia,,-4.6,53,12,30198,26,66,3,4.5,2.6,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.5
_FINAL,Canonical Pathways,11,M185,PID ALK1 PATHWAY,,-4.6,53,12,30198,26,66,3,4.5,2.6,3624|4089|5595,INHBA|SMAD4|MAPK3,-3.5
_FINAL,GO Biological Processes,19,GO:0001702,gastrulation with mouth forming second,19_GO:0032502 developmental process,-4.6,53,12,30198,26,66,3,4.5,2.6,1499|4089|6722,CTNNB1|SMAD4|SRF,-3.5
_FINAL,GO Biological Processes,19,GO:0003156,regulation of animal organ formation,19_GO:0032502 developmental process,-4.6,53,12,30198,26,66,3,4.5,2.6,1499|2246|2253,CTNNB1|FGF1|FGF8,-3.5
_FINAL,GO Biological Processes,19,GO:0048641,regulation of skeletal muscle tissue development,19_GO:0032502 developmental process,-4.6,53,12,30198,26,66,3,4.5,2.6,1499|7480|28514,CTNNB1|WNT10B|DLL1,-3.5
_FINAL,GO Biological Processes,19,GO:0071559,response to transforming growth factor beta,19_GO:0050896 response to stimulus,-4.6,14,8,30198,158,66,5,7.6,3.3,1284|3725|4089|5179|54361,COL4A2|JUN|SMAD4|PENK|WNT4,-3.5
_FINAL,GO Biological Processes,19,GO:0048511,rhythmic process,19_GO:0048511 rhythmic process,-4.6,10,7.1,30198,266,66,6,9.1,3.5,1385|3131|3624|4800|5021|6532,CREB1|HLF|INHBA|NFYA|OXTR|SLC6A4,-3.5
_FINAL,GO Biological Processes,19,GO:0055001,muscle cell development,19_GO:0032502 developmental process,-4.6,14,7.9,30198,159,66,5,7.6,3.3,148|1311|6722|7480|23493,ADRA1A|COMP|SRF|WNT10B|HEY2,-3.5
_FINAL,GO Biological Processes,19,GO:0051147,regulation of muscle cell differentiation,19_GO:0032502 developmental process,-4.6,14,7.9,30198,159,66,5,7.6,3.3,3815|4089|6722|23493|28514,KIT|SMAD4|SRF|HEY2|DLL1,-3.5
_FINAL,Reactome Gene Sets,6,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,,-4.6,23,9.3,30198,78,66,4,6.1,2.9,2246|2253|3815|8817,FGF1|FGF8|KIT|FGF18,-3.5
_FINAL,KEGG Pathway,24,hsa01521,EGFR tyrosine kinase inhibitor resistance,,-4.6,23,9.2,30198,79,66,4,6.1,2.9,208|3845|5595|6464,AKT2|KRAS|MAPK3|SHC1,-3.4
_FINAL,GO Biological Processes,19,GO:0061053,somite development,19_GO:0032502 developmental process,-4.6,23,9.2,30198,79,66,4,6.1,2.9,4040|4089|28514|51176,LRP6|SMAD4|DLL1|LEF1,-3.4
_FINAL,GO Biological Processes,19,GO:0051962,positive regulation of nervous system development,19_GO:0032502 developmental process,-4.6,10,7.1,30198,270,66,6,9.1,3.5,1499|1523|1959|3815|5021|6722,CTNNB1|CUX1|EGR2|KIT|OXTR|SRF,-3.4
_FINAL,Canonical Pathways,11,M1718,SIG IL4RECEPTOR IN B LYPHOCYTES,,-4.6,51,12,30198,27,66,3,4.5,2.6,208|5595|6464,AKT2|MAPK3|SHC1,-3.4
_FINAL,GO Biological Processes,19,GO:0003171,atrioventricular valve development,19_GO:0032502 developmental process,-4.6,51,12,30198,27,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-3.4
_FINAL,GO Biological Processes,19,GO:0006351,"transcription, DNA-templated",19_GO:0008152 metabolic process,-4.5,7.9,6.6,30198,403,66,7,11,3.8,905|1284|1385|4089|4800|5595|286826,CCNT2|COL4A2|CREB1|SMAD4|NFYA|MAPK3|LIN9,-3.4
_FINAL,GO Biological Processes,19,GO:0030198,extracellular matrix organization,19_GO:0009987 cellular process,-4.5,10,7.1,30198,271,66,6,9.1,3.5,1284|1300|1311|3381|7148|60495,COL4A2|COL10A1|COMP|IBSP|TNXB|HPSE2,-3.4
_FINAL,GO Biological Processes,19,GO:0044772,mitotic cell cycle phase transition,19_GO:0009987 cellular process,-4.5,14,7.8,30198,162,66,5,7.6,3.3,571|1876|7480|9833|128239,BACH1|E2F6|WNT10B|MELK|IQGAP3,-3.4
_FINAL,GO Biological Processes,19,GO:0043062,extracellular structure organization,19_GO:0009987 cellular process,-4.5,10,7.1,30198,272,66,6,9.1,3.5,1284|1300|1311|3381|7148|60495,COL4A2|COL10A1|COMP|IBSP|TNXB|HPSE2,-3.4
_FINAL,GO Biological Processes,19,GO:0097659,nucleic acid-templated transcription,19_GO:0008152 metabolic process,-4.5,7.9,6.6,30198,405,66,7,11,3.8,905|1284|1385|4089|4800|5595|286826,CCNT2|COL4A2|CREB1|SMAD4|NFYA|MAPK3|LIN9,-3.4
_FINAL,WikiPathways,27,WP437,EGF/EGFR signaling pathway,,-4.5,14,7.8,30198,163,66,5,7.6,3.3,1385|2002|3725|3845|6464,CREB1|ELK1|JUN|KRAS|SHC1,-3.4
_FINAL,GO Biological Processes,19,GO:0045229,external encapsulating structure organization,19_GO:0009987 cellular process,-4.5,10,7,30198,274,66,6,9.1,3.5,1284|1300|1311|3381|7148|60495,COL4A2|COL10A1|COMP|IBSP|TNXB|HPSE2,-3.4
_FINAL,GO Biological Processes,19,GO:0001656,metanephros development,19_GO:0032502 developmental process,-4.5,23,9.1,30198,81,66,4,6.1,2.9,1499|2253|4089|54361,CTNNB1|FGF8|SMAD4|WNT4,-3.4
_FINAL,Canonical Pathways,11,M5884,NABA CORE MATRISOME,,-4.5,10,7,30198,275,66,6,9.1,3.5,1284|1300|1311|3381|3489|7148,COL4A2|COL10A1|COMP|IBSP|IGFBP6|TNXB,-3.4
_FINAL,GO Biological Processes,19,GO:0007568,aging,19_GO:0032502 developmental process,-4.5,14,7.8,30198,165,66,5,7.6,3.3,148|1284|1311|4089|5179,ADRA1A|COL4A2|COMP|SMAD4|PENK,-3.4
_FINAL,GO Biological Processes,19,GO:0051100,negative regulation of binding,19_GO:0065007 biological regulation,-4.5,14,7.8,30198,165,66,5,7.6,3.3,3725|4751|5595|23493|51176,JUN|NEK2|MAPK3|HEY2|LEF1,-3.4
_FINAL,GO Biological Processes,19,GO:0035116,embryonic hindlimb morphogenesis,19_GO:0032502 developmental process,-4.5,49,12,30198,28,66,3,4.5,2.6,1499|2253|5307,CTNNB1|FGF8|PITX1,-3.4
_FINAL,Canonical Pathways,11,M115,PID REG GR PATHWAY,,-4.5,22,9,30198,82,66,4,6.1,2.9,1385|3725|5595|6599,CREB1|JUN|MAPK3|SMARCC1,-3.4
_FINAL,KEGG Pathway,24,hsa04662,B cell receptor signaling pathway,,-4.5,22,9,30198,82,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3.4
_FINAL,GO Biological Processes,19,GO:0030509,BMP signaling pathway,19_GO:0023052 signaling,-4.5,22,9,30198,82,66,4,6.1,2.9,1311|4089|5595|51176,COMP|SMAD4|MAPK3|LEF1,-3.4
_FINAL,KEGG Pathway,24,hsa04022,cGMP-PKG signaling pathway,,-4.5,14,7.7,30198,167,66,5,7.6,3.3,148|208|1385|5595|6722,ADRA1A|AKT2|CREB1|MAPK3|SRF,-3.4
_FINAL,GO Biological Processes,19,GO:0003205,cardiac chamber development,19_GO:0032502 developmental process,-4.5,14,7.7,30198,167,66,5,7.6,3.3,2253|4089|6722|23493|26508,FGF8|SMAD4|SRF|HEY2|HEYL,-3.4
_FINAL,GO Biological Processes,19,GO:0035050,embryonic heart tube development,19_GO:0032502 developmental process,-4.5,22,9,30198,83,66,4,6.1,2.9,1499|2253|6722|28514,CTNNB1|FGF8|SRF|DLL1,-3.4
_FINAL,GO Biological Processes,19,GO:0032774,RNA biosynthetic process,19_GO:0008152 metabolic process,-4.5,7.7,6.4,30198,415,66,7,11,3.8,905|1284|1385|4089|4800|5595|286826,CCNT2|COL4A2|CREB1|SMAD4|NFYA|MAPK3|LIN9,-3.4
_FINAL,GO Biological Processes,19,GO:0007610,behavior,19_GO:0032501 multicellular organismal process,-4.5,6.4,6.1,30198,572,66,8,12,4,1385|1959|3815|3845|5021|5179|6532|6722,CREB1|EGR2|KIT|KRAS|OXTR|PENK|SLC6A4|SRF,-3.4
_FINAL,WikiPathways,27,WP2361,Gastric cancer network 1,,-4.5,47,12,30198,29,66,3,4.5,2.6,1063|22974|286826,CENPF|TPX2|LIN9,-3.4
_FINAL,GO Biological Processes,19,GO:0071174,mitotic spindle checkpoint signaling,19_GO:0023052 signaling,-4.5,47,12,30198,29,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.4
_FINAL,GO Biological Processes,19,GO:0071173,spindle assembly checkpoint signaling,19_GO:0023052 signaling,-4.5,47,12,30198,29,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.4
_FINAL,Reactome Gene Sets,6,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,,-4.5,47,12,30198,29,66,3,4.5,2.6,1385|3845|5595,CREB1|KRAS|MAPK3,-3.4
_FINAL,GO Biological Processes,19,GO:0007094,mitotic spindle assembly checkpoint signaling,19_GO:0023052 signaling,-4.5,47,12,30198,29,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.4
_FINAL,GO Biological Processes,19,GO:0048639,positive regulation of developmental growth,19_GO:0040007 growth,-4.5,14,7.6,30198,169,66,5,7.6,3.3,1385|2253|6722|23493|28514,CREB1|FGF8|SRF|HEY2|DLL1,-3.4
_FINAL,GO Biological Processes,19,GO:0046649,lymphocyte activation,19_GO:0002376 immune system process,-4.5,7.7,6.4,30198,417,66,7,11,3.8,1499|3815|4436|6722|28514|51176|54361,CTNNB1|KIT|MSH2|SRF|DLL1|LEF1|WNT4,-3.4
_FINAL,GO Biological Processes,19,GO:0071774,response to fibroblast growth factor,19_GO:0050896 response to stimulus,-4.5,22,8.9,30198,84,66,4,6.1,2.9,2002|2246|2253|8817,ELK1|FGF1|FGF8|FGF18,-3.4
_FINAL,WikiPathways,27,WP4806,EGFR tyrosine kinase inhibitor resistance,,-4.5,22,8.9,30198,84,66,4,6.1,2.9,208|3845|5595|6464,AKT2|KRAS|MAPK3|SHC1,-3.4
_FINAL,Reactome Gene Sets,6,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,,-4.4,22,8.9,30198,85,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.3
_FINAL,GO Biological Processes,19,GO:2000243,positive regulation of reproductive process,19_GO:0022414 reproductive process,-4.4,22,8.9,30198,85,66,4,6.1,2.9,1499|3624|5021|54361,CTNNB1|INHBA|OXTR|WNT4,-3.3
_FINAL,Reactome Gene Sets,6,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,,-4.4,22,8.9,30198,85,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.3
_FINAL,Reactome Gene Sets,6,R-HSA-975871,MyD88 cascade initiated on plasma membrane,,-4.4,22,8.9,30198,85,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.3
_FINAL,Reactome Gene Sets,6,R-HSA-216083,Integrin cell surface interactions,,-4.4,22,8.9,30198,85,66,4,6.1,2.9,1284|1300|1311|3381,COL4A2|COL10A1|COMP|IBSP,-3.3
_FINAL,GO Biological Processes,19,GO:0044770,cell cycle phase transition,19_GO:0009987 cellular process,-4.4,13,7.6,30198,171,66,5,7.6,3.3,571|1876|7480|9833|128239,BACH1|E2F6|WNT10B|MELK|IQGAP3,-3.3
_FINAL,GO Biological Processes,19,GO:0031577,spindle checkpoint signaling,19_GO:0023052 signaling,-4.4,46,11,30198,30,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.3
_FINAL,WikiPathways,27,WP2870,Extracellular vesicle-mediated signaling in recipient cells,,-4.4,46,11,30198,30,66,3,4.5,2.6,1499|3845|4089,CTNNB1|KRAS|SMAD4,-3.3
_FINAL,GO Biological Processes,19,GO:0071542,dopaminergic neuron differentiation,19_GO:0032502 developmental process,-4.4,46,11,30198,30,66,3,4.5,2.6,1499|2253|4040,CTNNB1|FGF8|LRP6,-3.3
_FINAL,GO Biological Processes,19,GO:0010948,negative regulation of cell cycle process,19_GO:0048519 negative regulation of biological process,-4.4,9.6,6.8,30198,287,66,6,9.1,3.5,699|1063|3624|4436|4751|83540,BUB1|CENPF|INHBA|MSH2|NEK2|NUF2,-3.3
_FINAL,GO Biological Processes,19,GO:0044057,regulation of system process,19_GO:0032501 multicellular organismal process,-4.4,6.3,6,30198,583,66,8,12,4,148|1959|3624|3815|4089|5021|6722|23493,ADRA1A|EGR2|INHBA|KIT|SMAD4|OXTR|SRF|HEY2,-3.3
_FINAL,GO Biological Processes,19,GO:0036293,response to decreased oxygen levels,19_GO:0050896 response to stimulus,-4.4,9.5,6.8,30198,290,66,6,9.1,3.5,571|4089|5021|5179|6532|6722,BACH1|SMAD4|OXTR|PENK|SLC6A4|SRF,-3.3
_FINAL,KEGG Pathway,24,hsa04512,ECM-receptor interaction,,-4.4,21,8.7,30198,88,66,4,6.1,2.9,1284|1311|3381|7148,COL4A2|COMP|IBSP|TNXB,-3.3
_FINAL,Reactome Gene Sets,6,R-HSA-1839124,FGFR1 mutant receptor activation,,-4.4,44,11,30198,31,66,3,4.5,2.6,1523|2246|2253,CUX1|FGF1|FGF8,-3.3
_FINAL,GO Biological Processes,19,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,19_GO:0048519 negative regulation of biological process,-4.4,44,11,30198,31,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.3
_FINAL,KEGG Pathway,24,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,,-4.4,21,8.7,30198,89,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3.3
_FINAL,WikiPathways,27,WP4263,Pancreatic adenocarcinoma pathway,,-4.4,21,8.7,30198,89,66,4,6.1,2.9,208|3845|4089|5595,AKT2|KRAS|SMAD4|MAPK3,-3.3
_FINAL,GO Biological Processes,19,GO:0050804,modulation of chemical synaptic transmission,19_GO:0023052 signaling,-4.3,7.4,6.3,30198,435,66,7,11,3.8,148|1959|3815|3845|5021|6532|6722,ADRA1A|EGR2|KIT|KRAS|OXTR|SLC6A4|SRF,-3.2
_FINAL,GO Biological Processes,19,GO:0099177,regulation of trans-synaptic signaling,19_GO:0023052 signaling,-4.3,7.3,6.2,30198,436,66,7,11,3.8,148|1959|3815|3845|5021|6532|6722,ADRA1A|EGR2|KIT|KRAS|OXTR|SLC6A4|SRF,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-8941326,RUNX2 regulates bone development,,-4.3,43,11,30198,32,66,3,4.5,2.6,4089|5595|23493,SMAD4|MAPK3|HEY2,-3.2
_FINAL,GO Biological Processes,19,GO:0042310,vasoconstriction,19_GO:0032501 multicellular organismal process,-4.3,43,11,30198,32,66,3,4.5,2.6,148|1311|6532,ADRA1A|COMP|SLC6A4,-3.2
_FINAL,GO Biological Processes,19,GO:0035909,aorta morphogenesis,19_GO:0032502 developmental process,-4.3,43,11,30198,32,66,3,4.5,2.6,2253|6722|23493,FGF8|SRF|HEY2,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,,-4.3,43,11,30198,32,66,3,4.5,2.6,905|4089|5595,CCNT2|SMAD4|MAPK3,-3.2
_FINAL,GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-4.3,5.3,5.7,30198,778,66,9,14,4.2,148|905|2246|3815|4040|6464|7148|8817|22974,ADRA1A|CCNT2|FGF1|KIT|LRP6|SHC1|TNXB|FGF18|TPX2,-3.2
_FINAL,GO Biological Processes,19,GO:0030071,regulation of mitotic metaphase/anaphase transition,19_GO:0050789 regulation of biological process,-4.3,20,8.5,30198,91,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-3.2
_FINAL,WikiPathways,27,WP138,Androgen receptor signaling pathway,,-4.3,20,8.5,30198,91,66,4,6.1,2.9,1385|1499|3725|4089,CREB1|CTNNB1|JUN|SMAD4,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,,-4.3,20,8.5,30198,91,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.2
_FINAL,GO Biological Processes,19,GO:1901983,regulation of protein acetylation,19_GO:0008152 metabolic process,-4.3,20,8.5,30198,91,66,4,6.1,2.9,4089|4800|5595|10664,SMAD4|NFYA|MAPK3|CTCF,-3.2
_FINAL,GO Biological Processes,19,GO:1901652,response to peptide,19_GO:0050896 response to stimulus,-4.3,7.3,6.2,30198,441,66,7,11,3.8,208|1385|1959|4040|5021|6464|6599,AKT2|CREB1|EGR2|LRP6|OXTR|SHC1|SMARCC1,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-975155,MyD88 dependent cascade initiated on endosome,,-4.3,20,8.5,30198,92,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.2
_FINAL,GO Biological Processes,19,GO:0010942,positive regulation of cell death,19_GO:0048518 positive regulation of biological process,-4.3,6.1,5.9,30198,605,66,8,12,4,1499|2002|3043|3624|3725|4089|7480|9833,CTNNB1|ELK1|HBB|INHBA|JUN|SMAD4|WNT10B|MELK,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-1474244,Extracellular matrix organization,,-4.3,9.1,6.6,30198,301,66,6,9.1,3.5,1284|1300|1311|3381|4680|7148,COL4A2|COL10A1|COMP|IBSP|CEACAM6|TNXB,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-1839126,FGFR2 mutant receptor activation,,-4.3,42,11,30198,33,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-5654726,Negative regulation of FGFR1 signaling,,-4.3,42,11,30198,33,66,3,4.5,2.6,2246|2253|5595,FGF1|FGF8|MAPK3,-3.2
_FINAL,WikiPathways,27,WP4149,White fat cell differentiation,,-4.3,42,11,30198,33,66,3,4.5,2.6,1385|1959|7480,CREB1|EGR2|WNT10B,-3.2
_FINAL,WikiPathways,27,WP3676,BDNF-TrkB signaling,,-4.3,42,11,30198,33,66,3,4.5,2.6,1385|3845|6464,CREB1|KRAS|SHC1,-3.2
_FINAL,GO Biological Processes,19,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,19_GO:0048519 negative regulation of biological process,-4.3,42,11,30198,33,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:0002244,hematopoietic progenitor cell differentiation,19_GO:0002376 immune system process,-4.3,20,8.4,30198,93,66,4,6.1,2.9,3624|3815|6722|168002,INHBA|KIT|SRF|DACT2,-3.2
_FINAL,KEGG Pathway,24,hsa04912,GnRH signaling pathway,,-4.3,20,8.4,30198,93,66,4,6.1,2.9,2002|3725|3845|5595,ELK1|JUN|KRAS|MAPK3,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,,-4.3,20,8.4,30198,93,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.2
_FINAL,WikiPathways,27,WP2355,Corticotropin-releasing hormone signaling pathway,,-4.3,20,8.4,30198,93,66,4,6.1,2.9,1385|1499|2002|5595,CREB1|CTNNB1|ELK1|MAPK3,-3.2
_FINAL,GO Biological Processes,19,GO:0031056,regulation of histone modification,19_GO:0008152 metabolic process,-4.3,12,7.3,30198,185,66,5,7.6,3.3,1499|4089|4800|5595|10664,CTNNB1|SMAD4|NFYA|MAPK3|CTCF,-3.2
_FINAL,KEGG Pathway,24,hsa04657,IL-17 signaling pathway,,-4.3,19,8.4,30198,94,66,4,6.1,2.9,2920|3725|5595|27190,CXCL2|JUN|MAPK3|IL17B,-3.2
_FINAL,WikiPathways,27,WP231,TNF-alpha signaling pathway,,-4.3,19,8.4,30198,94,66,4,6.1,2.9,3725|3845|5595|5966,JUN|KRAS|MAPK3|REL,-3.2
_FINAL,GO Biological Processes,19,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,19_GO:0050789 regulation of biological process,-4.3,19,8.4,30198,94,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:0003158,endothelium development,19_GO:0032502 developmental process,-4.3,19,8.4,30198,94,66,4,6.1,2.9,1499|4089|23493|28514,CTNNB1|SMAD4|HEY2|DLL1,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,,-4.3,19,8.4,30198,94,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.2
_FINAL,WikiPathways,27,WP400,p38 MAPK signaling pathway,,-4.2,40,11,30198,34,66,3,4.5,2.6,1385|2002|6464,CREB1|ELK1|SHC1,-3.2
_FINAL,GO Biological Processes,19,GO:0032228,"regulation of synaptic transmission, GABAergic",19_GO:0023052 signaling,-4.2,40,11,30198,34,66,3,4.5,2.6,148|3845|5021,ADRA1A|KRAS|OXTR,-3.2
_FINAL,GO Biological Processes,19,GO:0032212,positive regulation of telomere maintenance via telomerase,19_GO:0048518 positive regulation of biological process,-4.2,40,11,30198,34,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-3.2
_FINAL,GO Biological Processes,19,GO:0033048,negative regulation of mitotic sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-4.2,40,11,30198,34,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:2000816,negative regulation of mitotic sister chromatid separation,19_GO:0048519 negative regulation of biological process,-4.2,40,11,30198,34,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:0033046,negative regulation of sister chromatid segregation,19_GO:0048519 negative regulation of biological process,-4.2,40,11,30198,34,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:0051973,positive regulation of telomerase activity,19_GO:0048518 positive regulation of biological process,-4.2,40,11,30198,34,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-3.2
_FINAL,WikiPathways,27,WP313,Hepatocyte growth factor receptor signaling,,-4.2,40,11,30198,34,66,3,4.5,2.6,2002|3725|5595,ELK1|JUN|MAPK3,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-187687,Signalling to ERKs,,-4.2,40,11,30198,34,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-3.2
_FINAL,GO Biological Processes,19,GO:0097306,cellular response to alcohol,19_GO:0050896 response to stimulus,-4.2,19,8.3,30198,95,66,4,6.1,2.9,1385|1499|3624|4040,CREB1|CTNNB1|INHBA|LRP6,-3.2
_FINAL,GO Biological Processes,19,GO:0051090,regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-4.2,7.1,6.1,30198,452,66,7,11,3.8,1499|3815|4040|5595|6722|7480|26508,CTNNB1|KIT|LRP6|MAPK3|SRF|WNT10B|HEYL,-3.2
_FINAL,GO Biological Processes,19,GO:0010965,regulation of mitotic sister chromatid separation,19_GO:0050789 regulation of biological process,-4.2,19,8.3,30198,96,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,,-4.2,19,8.3,30198,96,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.2
_FINAL,Reactome Gene Sets,6,R-HSA-8878159,Transcriptional regulation by RUNX3,,-4.2,19,8.3,30198,96,66,4,6.1,2.9,1499|3845|4089|51176,CTNNB1|KRAS|SMAD4|LEF1,-3.2
_FINAL,GO Biological Processes,19,GO:1901987,regulation of cell cycle phase transition,19_GO:0050789 regulation of biological process,-4.2,7.1,6.1,30198,454,66,7,11,3.8,699|1063|3624|4436|6599|7480|83540,BUB1|CENPF|INHBA|MSH2|SMARCC1|WNT10B|NUF2,-3.2
_FINAL,GO Biological Processes,19,GO:1905207,regulation of cardiocyte differentiation,19_GO:0032502 developmental process,-4.2,39,11,30198,35,66,3,4.5,2.6,4089|23493|28514,SMAD4|HEY2|DLL1,-3.1
_FINAL,Canonical Pathways,11,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,,-4.2,39,11,30198,35,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-3.1
_FINAL,GO Biological Processes,19,GO:0035137,hindlimb morphogenesis,19_GO:0032502 developmental process,-4.2,39,11,30198,35,66,3,4.5,2.6,1499|2253|5307,CTNNB1|FGF8|PITX1,-3.1
_FINAL,KEGG Pathway,24,hsa04062,Chemokine signaling pathway,,-4.2,12,7.1,30198,192,66,5,7.6,3.3,208|2920|3845|5595|6464,AKT2|CXCL2|KRAS|MAPK3|SHC1,-3.1
_FINAL,KEGG Pathway,24,hsa05231,Choline metabolism in cancer,,-4.2,19,8.2,30198,98,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3.1
_FINAL,GO Biological Processes,19,GO:0008585,female gonad development,19_GO:0022414 reproductive process,-4.2,19,8.2,30198,98,66,4,6.1,2.9,3624|3815|4089|54361,INHBA|KIT|SMAD4|WNT4,-3.1
_FINAL,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-4.2,8.7,6.5,30198,314,66,6,9.1,3.5,1499|2002|2253|3725|3845|4436,CTNNB1|ELK1|FGF8|JUN|KRAS|MSH2,-3.1
_FINAL,Reactome Gene Sets,6,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling,,-4.2,18,8.2,30198,99,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.1
_FINAL,Reactome Gene Sets,6,R-HSA-166166,MyD88-independent TLR4 cascade,,-4.2,18,8.2,30198,99,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.1
_FINAL,GO Biological Processes,19,GO:0070482,response to oxygen levels,19_GO:0050896 response to stimulus,-4.2,8.7,6.4,30198,316,66,6,9.1,3.5,571|4089|5021|5179|6532|6722,BACH1|SMAD4|OXTR|PENK|SLC6A4|SRF,-3.1
_FINAL,GO Biological Processes,19,GO:0051985,negative regulation of chromosome segregation,19_GO:0048519 negative regulation of biological process,-4.2,38,10,30198,36,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.1
_FINAL,Canonical Pathways,11,M22,PID GMCSF PATHWAY,,-4.2,38,10,30198,36,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-3.1
_FINAL,Canonical Pathways,11,M271,PID PI3K PLC TRK PATHWAY,,-4.2,38,10,30198,36,66,3,4.5,2.6,1385|3845|6464,CREB1|KRAS|SHC1,-3.1
_FINAL,GO Biological Processes,19,GO:1905819,negative regulation of chromosome separation,19_GO:0048519 negative regulation of biological process,-4.2,38,10,30198,36,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3.1
_FINAL,Reactome Gene Sets,6,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,,-4.1,18,8.1,30198,101,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.1
_FINAL,Reactome Gene Sets,6,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,,-4.1,18,8.1,30198,101,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3.1
_FINAL,WikiPathways,27,WP1544,MicroRNAs in cardiomyocyte hypertrophy,,-4.1,18,8.1,30198,101,66,4,6.1,2.9,208|1499|4040|5595,AKT2|CTNNB1|LRP6|MAPK3,-3.1
_FINAL,GO Biological Processes,19,GO:0051146,striated muscle cell differentiation,19_GO:0032502 developmental process,-4.1,12,7,30198,197,66,5,7.6,3.3,148|3845|6722|7480|23493,ADRA1A|KRAS|SRF|WNT10B|HEY2,-3.1
_FINAL,WikiPathways,27,WP4331,Neovascularisation processes,,-4.1,37,10,30198,37,66,3,4.5,2.6,3815|5595|5966,KIT|MAPK3|REL,-3.1
_FINAL,GO Biological Processes,19,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,19_GO:0048518 positive regulation of biological process,-4.1,37,10,30198,37,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-3.1
_FINAL,KEGG Pathway,24,hsa04914,Progesterone-mediated oocyte maturation,,-4.1,18,8,30198,102,66,4,6.1,2.9,208|699|3845|5595,AKT2|BUB1|KRAS|MAPK3,-3.1
_FINAL,WikiPathways,27,WP2064,Neural crest differentiation,,-4.1,18,8,30198,102,66,4,6.1,2.9,1499|2253|23493|28514,CTNNB1|FGF8|HEY2|DLL1,-3.1
_FINAL,GO Biological Processes,19,GO:0046545,development of primary female sexual characteristics,19_GO:0022414 reproductive process,-4.1,18,8,30198,102,66,4,6.1,2.9,3624|3815|4089|54361,INHBA|KIT|SMAD4|WNT4,-3.1
_FINAL,KEGG Pathway,24,hsa04660,T cell receptor signaling pathway,,-4.1,18,7.9,30198,104,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-3
_FINAL,Reactome Gene Sets,6,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,,-4.1,18,7.9,30198,104,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3
_FINAL,GO Biological Processes,19,GO:0070167,regulation of biomineral tissue development,19_GO:0110148 biomineralization,-4.1,18,7.9,30198,104,66,4,6.1,2.9,1311|7480|23493|54361,COMP|WNT10B|HEY2|WNT4,-3
_FINAL,Reactome Gene Sets,6,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,,-4.1,18,7.9,30198,104,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-3
_FINAL,GO Biological Processes,19,GO:0048638,regulation of developmental growth,19_GO:0040007 growth,-4.1,8.3,6.3,30198,329,66,6,9.1,3.5,1385|2253|6532|6722|23493|28514,CREB1|FGF8|SLC6A4|SRF|HEY2|DLL1,-3
_FINAL,GO Biological Processes,19,GO:0033045,regulation of sister chromatid segregation,19_GO:0050789 regulation of biological process,-4.1,17,7.9,30198,105,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-3
_FINAL,GO Biological Processes,19,GO:0045839,negative regulation of mitotic nuclear division,19_GO:0048519 negative regulation of biological process,-4.1,35,10,30198,39,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-3
_FINAL,GO Biological Processes,19,GO:0090287,regulation of cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-4.1,8.3,6.2,30198,331,66,6,9.1,3.5,1499|2246|4089|8817|28514|54361,CTNNB1|FGF1|SMAD4|FGF18|DLL1|WNT4,-3
_FINAL,GO Biological Processes,19,GO:0110149,regulation of biomineralization,19_GO:0110148 biomineralization,-4.1,17,7.9,30198,106,66,4,6.1,2.9,1311|7480|23493|54361,COMP|WNT10B|HEY2|WNT4,-3
_FINAL,GO Biological Processes,19,GO:0003279,cardiac septum development,19_GO:0032502 developmental process,-4.1,17,7.9,30198,106,66,4,6.1,2.9,2253|4089|23493|26508,FGF8|SMAD4|HEY2|HEYL,-3
_FINAL,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-4,11,6.8,30198,207,66,5,7.6,3.3,1499|2253|3725|3845|4436,CTNNB1|FGF8|JUN|KRAS|MSH2,-3
_FINAL,Canonical Pathways,11,M62,PID EPHB FWD PATHWAY,,-4,34,9.9,30198,40,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-3
_FINAL,WikiPathways,27,WP4871,Kisspeptin/kisspeptin receptor system in the ovary,,-4,34,9.9,30198,40,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-3
_FINAL,WikiPathways,27,WP4844,Influence of laminopathies on Wnt signaling,,-4,34,9.9,30198,40,66,3,4.5,2.6,1499|7480|51176,CTNNB1|WNT10B|LEF1,-3
_FINAL,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-4,11,6.8,30198,209,66,5,7.6,3.3,1499|2253|3725|3845|4436,CTNNB1|FGF8|JUN|KRAS|MSH2,-3
_FINAL,GO Biological Processes,19,GO:0060348,bone development,19_GO:0032502 developmental process,-4,11,6.8,30198,209,66,5,7.6,3.3,1311|2253|3815|6722|8817,COMP|FGF8|KIT|SRF|FGF18,-3
_FINAL,GO Biological Processes,19,GO:1905818,regulation of chromosome separation,19_GO:0050789 regulation of biological process,-4,17,7.7,30198,109,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-3
_FINAL,GO Biological Processes,19,GO:0045637,regulation of myeloid cell differentiation,19_GO:0002376 immune system process,-4,11,6.7,30198,210,66,5,7.6,3.3,1385|1499|3624|28514|51176,CREB1|CTNNB1|INHBA|DLL1|LEF1,-3
_FINAL,GO Biological Processes,19,GO:0035987,endodermal cell differentiation,19_GO:0032502 developmental process,-4,33,9.7,30198,41,66,3,4.5,2.6,1284|1499|3624,COL4A2|CTNNB1|INHBA,-2.9
_FINAL,GO Biological Processes,19,GO:0090066,regulation of anatomical structure size,19_GO:0065007 biological regulation,-4,6.5,5.7,30198,495,66,7,11,3.8,148|1311|1385|5021|6532|6722|128239,ADRA1A|COMP|CREB1|OXTR|SLC6A4|SRF|IQGAP3,-2.9
_FINAL,WikiPathways,27,WP49,IL-2 signaling pathway,,-4,33,9.6,30198,42,66,3,4.5,2.6,3725|5595|6464,JUN|MAPK3|SHC1,-2.9
_FINAL,GO Biological Processes,19,GO:0060412,ventricular septum morphogenesis,19_GO:0032502 developmental process,-4,33,9.6,30198,42,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-2.9
_FINAL,Reactome Gene Sets,6,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,,-4,33,9.6,30198,42,66,3,4.5,2.6,208|1499|51176,AKT2|CTNNB1|LEF1,-2.9
_FINAL,KEGG Pathway,24,hsa05417,Lipid and atherosclerosis,,-4,11,6.6,30198,215,66,5,7.6,3.3,208|2920|3725|3845|5595,AKT2|CXCL2|JUN|KRAS|MAPK3,-2.9
_FINAL,KEGG Pathway,24,hsa04725,Cholinergic synapse,,-4,16,7.6,30198,113,66,4,6.1,2.9,208|1385|3845|5595,AKT2|CREB1|KRAS|MAPK3,-2.9
_FINAL,Reactome Gene Sets,6,R-HSA-416476,G alpha (q) signalling events,,-4,11,6.6,30198,216,66,5,7.6,3.3,148|1385|3845|5021|5595,ADRA1A|CREB1|KRAS|OXTR|MAPK3,-2.9
_FINAL,GO Biological Processes,19,GO:0051150,regulation of smooth muscle cell differentiation,19_GO:0032502 developmental process,-3.9,32,9.5,30198,43,66,3,4.5,2.6,3815|6722|23493,KIT|SRF|HEY2,-2.9
_FINAL,GO Biological Processes,19,GO:1901342,regulation of vasculature development,19_GO:0032502 developmental process,-3.9,7.8,6,30198,353,66,6,9.1,3.5,1284|1499|2246|8817|28514|54361,COL4A2|CTNNB1|FGF1|FGF18|DLL1|WNT4,-2.9
_FINAL,WikiPathways,27,WP2332,Interleukin-11 signaling pathway,,-3.9,31,9.4,30198,44,66,3,4.5,2.6,1385|3381|5595,CREB1|IBSP|MAPK3,-2.9
_FINAL,GO Biological Processes,19,GO:0061383,trabecula morphogenesis,19_GO:0032502 developmental process,-3.9,31,9.4,30198,44,66,3,4.5,2.6,6722|7480|23493,SRF|WNT10B|HEY2,-2.9
_FINAL,WikiPathways,27,WP4823,Genes controlling nephrogenesis,,-3.9,31,9.4,30198,44,66,3,4.5,2.6,1499|2253|54361,CTNNB1|FGF8|WNT4,-2.9
_FINAL,GO Biological Processes,19,GO:0002573,myeloid leukocyte differentiation,19_GO:0002376 immune system process,-3.9,16,7.5,30198,116,66,4,6.1,2.9,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-2.9
_FINAL,KEGG Pathway,24,hsa04024,cAMP signaling pathway,,-3.9,10,6.5,30198,221,66,5,7.6,3.3,208|1385|3725|5021|5595,AKT2|CREB1|JUN|OXTR|MAPK3,-2.9
_FINAL,GO Biological Processes,19,GO:1901990,regulation of mitotic cell cycle phase transition,19_GO:0050789 regulation of biological process,-3.9,7.7,6,30198,355,66,6,9.1,3.5,699|1063|3624|6599|7480|83540,BUB1|CENPF|INHBA|SMARCC1|WNT10B|NUF2,-2.9
_FINAL,GO Biological Processes,19,GO:0050769,positive regulation of neurogenesis,19_GO:0032502 developmental process,-3.9,10,6.5,30198,222,66,5,7.6,3.3,1499|1523|1959|3815|6722,CTNNB1|CUX1|EGR2|KIT|SRF,-2.9
_FINAL,GO Biological Processes,19,GO:0046660,female sex differentiation,19_GO:0022414 reproductive process,-3.9,16,7.4,30198,117,66,4,6.1,2.9,3624|3815|4089|54361,INHBA|KIT|SMAD4|WNT4,-2.9
_FINAL,Reactome Gene Sets,6,R-HSA-9006936,Signaling by TGFB family members,,-3.9,16,7.4,30198,118,66,4,6.1,2.9,905|3624|4089|5595,CCNT2|INHBA|SMAD4|MAPK3,-2.8
_FINAL,Canonical Pathways,11,M71,PID ILK PATHWAY,,-3.9,31,9.3,30198,45,66,3,4.5,2.6,1385|1499|3725,CREB1|CTNNB1|JUN,-2.8
_FINAL,GO Biological Processes,19,GO:0048538,thymus development,19_GO:0002376 immune system process,-3.9,31,9.3,30198,45,66,3,4.5,2.6,1499|5595|6722,CTNNB1|MAPK3|SRF,-2.8
_FINAL,GO Biological Processes,19,GO:0045787,positive regulation of cell cycle,19_GO:0048518 positive regulation of biological process,-3.9,7.7,5.9,30198,358,66,6,9.1,3.5,905|2253|4040|6532|7480|54361,CCNT2|FGF8|LRP6|SLC6A4|WNT10B|WNT4,-2.8
_FINAL,GO Biological Processes,19,GO:0048705,skeletal system morphogenesis,19_GO:0032502 developmental process,-3.9,10,6.5,30198,225,66,5,7.6,3.3,1311|1499|2253|7480|8817,COMP|CTNNB1|FGF8|WNT10B|FGF18,-2.8
_FINAL,GO Biological Processes,19,GO:0002761,regulation of myeloid leukocyte differentiation,19_GO:0002376 immune system process,-3.9,15,7.4,30198,119,66,4,6.1,2.9,1385|1499|3624|51176,CREB1|CTNNB1|INHBA|LEF1,-2.8
_FINAL,Reactome Gene Sets,6,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,,-3.8,30,9.2,30198,46,66,3,4.5,2.6,905|4089|5595,CCNT2|SMAD4|MAPK3,-2.8
_FINAL,Canonical Pathways,11,M8626,SIG BCR SIGNALING PATHWAY,,-3.8,30,9.2,30198,46,66,3,4.5,2.6,208|5595|6464,AKT2|MAPK3|SHC1,-2.8
_FINAL,GO Biological Processes,19,GO:0002067,glandular epithelial cell differentiation,19_GO:0032502 developmental process,-3.8,30,9.2,30198,46,66,3,4.5,2.6,2253|28514|54361,FGF8|DLL1|WNT4,-2.8
_FINAL,GO Biological Processes,19,GO:1902895,positive regulation of miRNA transcription,19_GO:0048518 positive regulation of biological process,-3.8,30,9.2,30198,46,66,3,4.5,2.6,3725|4089|6722,JUN|SMAD4|SRF,-2.8
_FINAL,GO Biological Processes,19,GO:0051784,negative regulation of nuclear division,19_GO:0048519 negative regulation of biological process,-3.8,30,9.2,30198,46,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-2.8
_FINAL,GO Biological Processes,19,GO:0000904,cell morphogenesis involved in differentiation,19_GO:0032502 developmental process,-3.8,6.1,5.5,30198,522,66,7,11,3.8,1385|1499|1959|4089|6722|51176|168002,CREB1|CTNNB1|EGR2|SMAD4|SRF|LEF1|DACT2,-2.8
_FINAL,GO Biological Processes,19,GO:0048871,multicellular organismal homeostasis,19_GO:0032501 multicellular organismal process,-3.8,7.6,5.9,30198,363,66,6,9.1,3.5,1311|1472|1499|3845|6722|28514,COMP|CST4|CTNNB1|KRAS|SRF|DLL1,-2.8
_FINAL,GO Biological Processes,19,GO:0007613,memory,19_GO:0032501 multicellular organismal process,-3.8,15,7.3,30198,121,66,4,6.1,2.9,1385|5021|6532|6722,CREB1|OXTR|SLC6A4|SRF,-2.8
_FINAL,Reactome Gene Sets,6,R-HSA-8878166,Transcriptional regulation by RUNX2,,-3.8,15,7.3,30198,121,66,4,6.1,2.9,208|4089|5595|23493,AKT2|SMAD4|MAPK3|HEY2,-2.8
_FINAL,GO Biological Processes,19,GO:0042476,odontogenesis,19_GO:0032502 developmental process,-3.8,15,7.3,30198,121,66,4,6.1,2.9,1499|2253|3624|51176,CTNNB1|FGF8|INHBA|LEF1,-2.8
_FINAL,GO Biological Processes,19,GO:0001889,liver development,19_GO:0032502 developmental process,-3.8,15,7.3,30198,122,66,4,6.1,2.9,2002|3725|6927|54361,ELK1|JUN|HNF1A|WNT4,-2.8
_FINAL,GO Biological Processes,19,GO:0051972,regulation of telomerase activity,19_GO:0008152 metabolic process,-3.8,29,9.1,30198,47,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-2.8
_FINAL,GO Biological Processes,19,GO:0035914,skeletal muscle cell differentiation,19_GO:0032502 developmental process,-3.8,29,9.1,30198,47,66,3,4.5,2.6,1959|3131|26508,EGR2|HLF|HEYL,-2.8
_FINAL,Reactome Gene Sets,6,R-HSA-9707616,Heme signaling,,-3.8,29,9.1,30198,47,66,3,4.5,2.6,571|1385|3043,BACH1|CREB1|HBB,-2.8
_FINAL,GO Biological Processes,19,GO:0007093,mitotic cell cycle checkpoint signaling,19_GO:0023052 signaling,-3.8,15,7.2,30198,123,66,4,6.1,2.9,699|1063|4436|83540,BUB1|CENPF|MSH2|NUF2,-2.8
_FINAL,GO Biological Processes,19,GO:0032355,response to estradiol,19_GO:0050896 response to stimulus,-3.8,15,7.2,30198,123,66,4,6.1,2.9,1499|5021|5179|6532,CTNNB1|OXTR|PENK|SLC6A4,-2.8
_FINAL,Reactome Gene Sets,6,R-HSA-201681,TCF dependent signaling in response to WNT,,-3.8,9.8,6.3,30198,233,66,5,7.6,3.3,208|1499|4040|51176|54361,AKT2|CTNNB1|LRP6|LEF1|WNT4,-2.8
_FINAL,GO Biological Processes,19,GO:0060324,face development,19_GO:0032502 developmental process,-3.8,29,9,30198,48,66,3,4.5,2.6,5595|6722|51176,MAPK3|SRF|LEF1,-2.8
_FINAL,Reactome Gene Sets,6,R-HSA-1280215,Cytokine Signaling in Immune system,,-3.8,5.1,5.2,30198,715,66,8,12,4,208|1385|2002|2920|3725|3845|5595|6464,AKT2|CREB1|ELK1|CXCL2|JUN|KRAS|MAPK3|SHC1,-2.8
_FINAL,GO Biological Processes,19,GO:0061008,hepaticobiliary system development,19_GO:0032502 developmental process,-3.8,15,7.2,30198,125,66,4,6.1,2.9,2002|3725|6927|54361,ELK1|JUN|HNF1A|WNT4,-2.7
_FINAL,GO Biological Processes,19,GO:0001894,tissue homeostasis,19_GO:0032501 multicellular organismal process,-3.8,9.7,6.3,30198,235,66,5,7.6,3.3,1311|1472|1499|3845|6722,COMP|CST4|CTNNB1|KRAS|SRF,-2.7
_FINAL,Reactome Gene Sets,6,R-HSA-157118,Signaling by NOTCH,,-3.8,9.7,6.3,30198,236,66,5,7.6,3.3,1385|3725|23493|26508|28514,CREB1|JUN|HEY2|HEYL|DLL1,-2.7
_FINAL,GO Biological Processes,19,GO:2000027,regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-3.8,15,7.1,30198,126,66,4,6.1,2.9,1499|2246|2253|54361,CTNNB1|FGF1|FGF8|WNT4,-2.7
_FINAL,GO Biological Processes,19,GO:0046683,response to organophosphorus,19_GO:0050896 response to stimulus,-3.8,15,7.1,30198,126,66,4,6.1,2.9,5179|6532|7480|9127,PENK|SLC6A4|WNT10B|P2RX6,-2.7
_FINAL,GO Biological Processes,19,GO:0008543,fibroblast growth factor receptor signaling pathway,19_GO:0023052 signaling,-3.8,28,8.9,30198,49,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-2.7
_FINAL,WikiPathways,27,WP286,IL-3 signaling pathway,,-3.8,28,8.9,30198,49,66,3,4.5,2.6,3725|5595|6464,JUN|MAPK3|SHC1,-2.7
_FINAL,Canonical Pathways,11,M92,PID ANGIOPOIETIN RECEPTOR PATHWAY,,-3.8,28,8.9,30198,49,66,3,4.5,2.6,2002|5595|6464,ELK1|MAPK3|SHC1,-2.7
_FINAL,GO Biological Processes,19,GO:0050886,endocrine process,19_GO:0032501 multicellular organismal process,-3.8,28,8.9,30198,49,66,3,4.5,2.6,3624|3845|5021,INHBA|KRAS|OXTR,-2.7
_FINAL,Reactome Gene Sets,6,R-HSA-9012852,Signaling by NOTCH3,,-3.8,28,8.9,30198,49,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.7
_FINAL,GO Biological Processes,19,GO:1901988,negative regulation of cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-3.8,9.6,6.2,30198,238,66,5,7.6,3.3,699|1063|3624|4436|83540,BUB1|CENPF|INHBA|MSH2|NUF2,-2.7
_FINAL,GO Biological Processes,19,GO:0097305,response to alcohol,19_GO:0050896 response to stimulus,-3.7,9.6,6.2,30198,239,66,5,7.6,3.3,1385|1499|3624|4040|5179,CREB1|CTNNB1|INHBA|LRP6|PENK,-2.7
_FINAL,KEGG Pathway,24,hsa04380,Osteoclast differentiation,,-3.7,14,7.1,30198,128,66,4,6.1,2.9,208|1385|3725|5595,AKT2|CREB1|JUN|MAPK3,-2.7
_FINAL,Reactome Gene Sets,6,R-HSA-1227986,Signaling by ERBB2,,-3.7,27,8.8,30198,50,66,3,4.5,2.6,208|3845|6464,AKT2|KRAS|SHC1,-2.7
_FINAL,GO Biological Processes,19,GO:0051983,regulation of chromosome segregation,19_GO:0050789 regulation of biological process,-3.7,14,7,30198,130,66,4,6.1,2.9,699|1063|6599|83540,BUB1|CENPF|SMARCC1|NUF2,-2.7
_FINAL,GO Biological Processes,19,GO:0001706,endoderm formation,19_GO:0032502 developmental process,-3.7,27,8.7,30198,51,66,3,4.5,2.6,1284|1499|3624,COL4A2|CTNNB1|INHBA,-2.7
_FINAL,WikiPathways,27,WP4539,Synaptic signaling pathways associated with autism spectrum disorder,,-3.7,27,8.7,30198,51,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.7
_FINAL,Canonical Pathways,11,M7955,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,,-3.7,27,8.7,30198,51,66,3,4.5,2.6,208|5595|6464,AKT2|MAPK3|SHC1,-2.7
_FINAL,KEGG Pathway,24,hsa04068,FoxO signaling pathway,,-3.7,14,7,30198,131,66,4,6.1,2.9,208|3845|4089|5595,AKT2|KRAS|SMAD4|MAPK3,-2.7
_FINAL,WikiPathways,27,WP4657,22q11.2 copy number variation syndrome,,-3.7,14,6.9,30198,132,66,4,6.1,2.9,2253|6722|8659|9127,FGF8|SRF|ALDH4A1|P2RX6,-2.7
_FINAL,GO Biological Processes,19,GO:0048708,astrocyte differentiation,19_GO:0032502 developmental process,-3.7,26,8.6,30198,52,66,3,4.5,2.6,3845|5595|28514,KRAS|MAPK3|DLL1,-2.7
_FINAL,Canonical Pathways,11,M231,PID KIT PATHWAY,,-3.7,26,8.6,30198,52,66,3,4.5,2.6,3815|5595|6464,KIT|MAPK3|SHC1,-2.7
_FINAL,GO Biological Processes,19,GO:0071900,regulation of protein serine/threonine kinase activity,19_GO:0008152 metabolic process,-3.7,7.1,5.6,30198,388,66,6,9.1,3.5,905|2246|3815|4040|7148|8817,CCNT2|FGF1|KIT|LRP6|TNXB|FGF18,-2.7
_FINAL,Reactome Gene Sets,6,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,,-3.7,14,6.9,30198,134,66,4,6.1,2.9,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-2.6
_FINAL,Canonical Pathways,11,M151,PID AR TF PATHWAY,,-3.7,26,8.5,30198,53,66,3,4.5,2.6,3725|5966|6599,JUN|REL|SMARCC1,-2.6
_FINAL,WikiPathways,27,WP363,Wnt signaling pathway,,-3.7,26,8.5,30198,53,66,3,4.5,2.6,1499|4040|51176,CTNNB1|LRP6|LEF1,-2.6
_FINAL,GO Biological Processes,19,GO:0032210,regulation of telomere maintenance via telomerase,19_GO:0008152 metabolic process,-3.7,26,8.5,30198,53,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-2.6
_FINAL,GO Biological Processes,19,GO:0033077,T cell differentiation in thymus,19_GO:0002376 immune system process,-3.7,26,8.5,30198,53,66,3,4.5,2.6,1499|6722|54361,CTNNB1|SRF|WNT4,-2.6
_FINAL,GO Biological Processes,19,GO:0000086,G2/M transition of mitotic cell cycle,19_GO:0009987 cellular process,-3.7,26,8.5,30198,53,66,3,4.5,2.6,571|7480|9833,BACH1|WNT10B|MELK,-2.6
_FINAL,KEGG Pathway,24,hsa05132,Salmonella infection,,-3.7,9.2,6.1,30198,249,66,5,7.6,3.3,208|1499|3725|5595|51176,AKT2|CTNNB1|JUN|MAPK3|LEF1,-2.6
_FINAL,Reactome Gene Sets,6,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,,-3.7,14,6.8,30198,135,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-2.6
_FINAL,Canonical Pathways,11,M278,PID RAC1 PATHWAY,,-3.6,25,8.4,30198,54,66,3,4.5,2.6,1499|3725|128239,CTNNB1|JUN|IQGAP3,-2.6
_FINAL,GO Biological Processes,19,GO:0010718,positive regulation of epithelial to mesenchymal transition,19_GO:0032502 developmental process,-3.6,25,8.4,30198,54,66,3,4.5,2.6,1499|4089|51176,CTNNB1|SMAD4|LEF1,-2.6
_FINAL,KEGG Pathway,24,hsa04210,Apoptosis,,-3.6,13,6.8,30198,136,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-2.6
_FINAL,GO Biological Processes,19,GO:0090257,regulation of muscle system process,19_GO:0032501 multicellular organismal process,-3.6,9,6,30198,253,66,5,7.6,3.3,148|3815|4089|5021|6722,ADRA1A|KIT|SMAD4|OXTR|SRF,-2.6
_FINAL,GO Biological Processes,19,GO:0001541,ovarian follicle development,19_GO:0022414 reproductive process,-3.6,25,8.3,30198,55,66,3,4.5,2.6,3624|3815|4089,INHBA|KIT|SMAD4,-2.6
_FINAL,WikiPathways,27,WP2018,RANKL/RANK signaling pathway,,-3.6,25,8.3,30198,55,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-2.6
_FINAL,GO Biological Processes,19,GO:0033047,regulation of mitotic sister chromatid segregation,19_GO:0050789 regulation of biological process,-3.6,25,8.3,30198,55,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-2.6
_FINAL,WikiPathways,27,WP395,IL-4 signaling pathway,,-3.6,25,8.3,30198,55,66,3,4.5,2.6,2002|5595|6464,ELK1|MAPK3|SHC1,-2.6
_FINAL,GO Biological Processes,19,GO:0003179,heart valve morphogenesis,19_GO:0032502 developmental process,-3.6,25,8.3,30198,55,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-2.6
_FINAL,GO Biological Processes,19,GO:1903706,regulation of hemopoiesis,19_GO:0002376 immune system process,-3.6,6.9,5.5,30198,400,66,6,9.1,3.5,1385|1499|3624|6599|28514|51176,CREB1|CTNNB1|INHBA|SMARCC1|DLL1|LEF1,-2.6
_FINAL,KEGG Pathway,24,hsa04371,Apelin signaling pathway,,-3.6,13,6.7,30198,139,66,4,6.1,2.9,208|3845|4089|5595,AKT2|KRAS|SMAD4|MAPK3,-2.6
_FINAL,GO Biological Processes,19,GO:0048168,regulation of neuronal synaptic plasticity,19_GO:0023052 signaling,-3.6,25,8.2,30198,56,66,3,4.5,2.6,1959|3815|3845,EGR2|KIT|KRAS,-2.6
_FINAL,Reactome Gene Sets,6,R-HSA-5663220,RHO GTPases Activate Formins,,-3.6,13,6.7,30198,140,66,4,6.1,2.9,699|1063|6722|83540,BUB1|CENPF|SRF|NUF2,-2.6
_FINAL,GO Biological Processes,19,GO:0008015,blood circulation,19_GO:0032501 multicellular organismal process,-3.6,6.8,5.5,30198,406,66,6,9.1,3.5,148|1311|3043|5021|6532|28514,ADRA1A|COMP|HBB|OXTR|SLC6A4|DLL1,-2.6
_FINAL,GO Biological Processes,19,GO:0097746,blood vessel diameter maintenance,19_GO:0032501 multicellular organismal process,-3.6,13,6.7,30198,141,66,4,6.1,2.9,148|1311|5021|6532,ADRA1A|COMP|OXTR|SLC6A4,-2.6
_FINAL,GO Biological Processes,19,GO:0035296,regulation of tube diameter,19_GO:0065007 biological regulation,-3.6,13,6.7,30198,141,66,4,6.1,2.9,148|1311|5021|6532,ADRA1A|COMP|OXTR|SLC6A4,-2.6
_FINAL,GO Biological Processes,19,GO:0044839,cell cycle G2/M phase transition,19_GO:0009987 cellular process,-3.6,24,8.2,30198,57,66,3,4.5,2.6,571|7480|9833,BACH1|WNT10B|MELK,-2.6
_FINAL,WikiPathways,27,WP195,IL-1 signaling pathway,,-3.6,24,8.2,30198,57,66,3,4.5,2.6,3725|5595|5966,JUN|MAPK3|REL,-2.6
_FINAL,GO Biological Processes,19,GO:0035150,regulation of tube size,19_GO:0065007 biological regulation,-3.6,13,6.6,30198,142,66,4,6.1,2.9,148|1311|5021|6532,ADRA1A|COMP|OXTR|SLC6A4,-2.6
_FINAL,KEGG Pathway,24,hsa04936,Alcoholic liver disease,,-3.6,13,6.6,30198,142,66,4,6.1,2.9,208|1499|2920|51176,AKT2|CTNNB1|CXCL2|LEF1,-2.6
_FINAL,GO Biological Processes,19,GO:0045927,positive regulation of growth,19_GO:0040007 growth,-3.6,8.8,5.9,30198,261,66,5,7.6,3.3,1385|2253|6722|23493|28514,CREB1|FGF8|SRF|HEY2|DLL1,-2.6
_FINAL,GO Biological Processes,19,GO:0045860,positive regulation of protein kinase activity,19_GO:0048518 positive regulation of biological process,-3.6,6.7,5.4,30198,409,66,6,9.1,3.5,148|905|2246|3815|8817|22974,ADRA1A|CCNT2|FGF1|KIT|FGF18|TPX2,-2.6
_FINAL,Reactome Gene Sets,6,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,,-3.5,24,8.1,30198,58,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,,-3.5,24,8.1,30198,58,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-2644603,Signaling by NOTCH1 in Cancer,,-3.5,24,8.1,30198,58,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,,-3.5,24,8.1,30198,58,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,,-3.5,24,8.1,30198,58,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,GO Biological Processes,19,GO:0051091,positive regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-3.5,8.6,5.8,30198,265,66,5,7.6,3.3,1499|3815|4040|6722|7480,CTNNB1|KIT|LRP6|SRF|WNT10B,-2.5
_FINAL,GO Biological Processes,19,GO:0042110,T cell activation,19_GO:0002376 immune system process,-3.5,8.6,5.8,30198,265,66,5,7.6,3.3,1499|3815|6722|51176|54361,CTNNB1|KIT|SRF|LEF1|WNT4,-2.5
_FINAL,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-3.5,13,6.6,30198,145,66,4,6.1,2.9,2253|3725|3845|4436,FGF8|JUN|KRAS|MSH2,-2.5
_FINAL,Canonical Pathways,11,M166,PID ATF2 PATHWAY,,-3.5,23,8,30198,59,66,3,4.5,2.6,1385|3725|5595,CREB1|JUN|MAPK3,-2.5
_FINAL,GO Biological Processes,19,GO:0060261,positive regulation of transcription initiation from RNA polymerase II promoter,19_GO:0048518 positive regulation of biological process,-3.5,23,8,30198,59,66,3,4.5,2.6,6722|6927|7480,SRF|HNF1A|WNT10B,-2.5
_FINAL,KEGG Pathway,24,hsa04330,Notch signaling pathway,,-3.5,23,8,30198,59,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.5
_FINAL,KEGG Pathway,24,hsa04370,VEGF signaling pathway,,-3.5,23,8,30198,59,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.5
_FINAL,GO Biological Processes,19,GO:0002040,sprouting angiogenesis,19_GO:0032502 developmental process,-3.5,23,8,30198,59,66,3,4.5,2.6,6722|28514|51176,SRF|DLL1|LEF1,-2.5
_FINAL,GO Biological Processes,19,GO:0046686,response to cadmium ion,19_GO:0050896 response to stimulus,-3.5,23,8,30198,59,66,3,4.5,2.6,3725|3815|5595,JUN|KIT|MAPK3,-2.5
_FINAL,GO Biological Processes,19,GO:0030902,hindbrain development,19_GO:0032502 developmental process,-3.5,13,6.5,30198,146,66,4,6.1,2.9,1499|1959|28514|51176,CTNNB1|EGR2|DLL1|LEF1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-3858494,Beta-catenin independent WNT signaling,,-3.5,13,6.5,30198,146,66,4,6.1,2.9,1499|3845|51176|54361,CTNNB1|KRAS|LEF1|WNT4,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-2262752,Cellular responses to stress,,-3.5,4.7,4.9,30198,784,66,8,12,4,208|571|1385|3043|3725|4800|5595|6464,AKT2|BACH1|CREB1|HBB|JUN|NFYA|MAPK3|SHC1,-2.5
_FINAL,GO Biological Processes,19,GO:0030155,regulation of cell adhesion,19_GO:0050789 regulation of biological process,-3.5,4.7,4.9,30198,786,66,8,12,4,3381|4680|6599|6722|28514|51176|54361|168002,IBSP|CEACAM6|SMARCC1|SRF|DLL1|LEF1|WNT4|DACT2,-2.5
_FINAL,GO Biological Processes,19,GO:0034654,nucleobase-containing compound biosynthetic process,19_GO:0008152 metabolic process,-3.5,4.7,4.9,30198,787,66,8,12,4,905|1063|1284|1385|4089|4800|5595|286826,CCNT2|CENPF|COL4A2|CREB1|SMAD4|NFYA|MAPK3|LIN9,-2.5
_FINAL,WikiPathways,27,WP304,Kit receptor signaling pathway,,-3.5,23,7.9,30198,60,66,3,4.5,2.6,3815|5595|6464,KIT|MAPK3|SHC1,-2.5
_FINAL,GO Biological Processes,19,GO:1902893,regulation of miRNA transcription,19_GO:0008152 metabolic process,-3.5,23,7.9,30198,60,66,3,4.5,2.6,3725|4089|6722,JUN|SMAD4|SRF,-2.5
_FINAL,Canonical Pathways,11,M7,PID FCER1 PATHWAY,,-3.5,23,7.9,30198,60,66,3,4.5,2.6,3725|5595|6464,JUN|MAPK3|SHC1,-2.5
_FINAL,GO Biological Processes,19,GO:0008286,insulin receptor signaling pathway,19_GO:0023052 signaling,-3.5,23,7.9,30198,60,66,3,4.5,2.6,208|6464|6599,AKT2|SHC1|SMARCC1,-2.5
_FINAL,WikiPathways,27,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,,-3.5,23,7.9,30198,60,66,3,4.5,2.6,1499|7480|51176,CTNNB1|WNT10B|LEF1,-2.5
_FINAL,Canonical Pathways,11,M187,PID TRKR PATHWAY,,-3.5,23,7.9,30198,61,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-2.5
_FINAL,GO Biological Processes,19,GO:1904356,regulation of telomere maintenance via telomere lengthening,19_GO:0008152 metabolic process,-3.5,23,7.9,30198,61,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-2.5
_FINAL,GO Biological Processes,19,GO:0060395,SMAD protein signal transduction,19_GO:0023052 signaling,-3.5,23,7.9,30198,61,66,3,4.5,2.6,3624|3725|4089,INHBA|JUN|SMAD4,-2.5
_FINAL,GO Biological Processes,19,GO:0055013,cardiac muscle cell development,19_GO:0032502 developmental process,-3.5,23,7.9,30198,61,66,3,4.5,2.6,148|6722|23493,ADRA1A|SRF|HEY2,-2.5
_FINAL,KEGG Pathway,24,hsa04261,Adrenergic signaling in cardiomyocytes,,-3.5,12,6.4,30198,150,66,4,6.1,2.9,148|208|1385|5595,ADRA1A|AKT2|CREB1|MAPK3,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-8953897,Cellular responses to stimuli,,-3.5,4.6,4.8,30198,798,66,8,12,4,208|571|1385|3043|3725|4800|5595|6464,AKT2|BACH1|CREB1|HBB|JUN|NFYA|MAPK3|SHC1,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-4086398,Ca2+ pathway,,-3.5,22,7.8,30198,62,66,3,4.5,2.6,1499|3845|51176,CTNNB1|KRAS|LEF1,-2.5
_FINAL,WikiPathways,27,WP5180,DYRK1A,,-3.5,22,7.8,30198,62,66,3,4.5,2.6,1385|28514|286826,CREB1|DLL1|LIN9,-2.5
_FINAL,Reactome Gene Sets,6,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,,-3.5,22,7.8,30198,62,66,3,4.5,2.6,905|3725|4436,CCNT2|JUN|MSH2,-2.5
_FINAL,GO Biological Processes,19,GO:1903532,positive regulation of secretion by cell,19_GO:0051179 localization,-3.5,8.3,5.7,30198,276,66,5,7.6,3.3,1385|3624|4089|5021|6532,CREB1|INHBA|SMAD4|OXTR|SLC6A4,-2.5
_FINAL,GO Biological Processes,19,GO:0001666,response to hypoxia,19_GO:0050896 response to stimulus,-3.5,8.3,5.7,30198,277,66,5,7.6,3.3,571|4089|5179|6532|6722,BACH1|SMAD4|PENK|SLC6A4|SRF,-2.5
_FINAL,GO Biological Processes,19,GO:0000075,cell cycle checkpoint signaling,19_GO:0023052 signaling,-3.4,12,6.4,30198,153,66,4,6.1,2.9,699|1063|4436|83540,BUB1|CENPF|MSH2|NUF2,-2.4
_FINAL,GO Biological Processes,19,GO:0001947,heart looping,19_GO:0032502 developmental process,-3.4,22,7.7,30198,63,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-2.4
_FINAL,Canonical Pathways,11,M254,PID MYC REPRESS PATHWAY,,-3.4,22,7.7,30198,63,66,3,4.5,2.6,1385|4089|4800,CREB1|SMAD4|NFYA,-2.4
_FINAL,GO Biological Processes,19,GO:0060249,anatomical structure homeostasis,19_GO:0065007 biological regulation,-3.4,8.2,5.7,30198,279,66,5,7.6,3.3,1311|1472|1499|3845|6722,COMP|CST4|CTNNB1|KRAS|SRF,-2.4
_FINAL,WikiPathways,27,WP4754,IL-18 signaling pathway,,-3.4,8.2,5.7,30198,279,66,5,7.6,3.3,1499|2920|3725|5595|5966,CTNNB1|CXCL2|JUN|MAPK3|REL,-2.4
_FINAL,WikiPathways,27,WP5094,Orexin receptor pathway,,-3.4,12,6.3,30198,155,66,4,6.1,2.9,1959|2920|5595|6722,EGR2|CXCL2|MAPK3|SRF,-2.4
_FINAL,KEGG Pathway,24,hsa04929,GnRH secretion,,-3.4,21,7.7,30198,64,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.4
_FINAL,GO Biological Processes,19,GO:0009314,response to radiation,19_GO:0050896 response to stimulus,-3.4,6.3,5.2,30198,435,66,6,9.1,3.5,208|2002|3815|3845|4436|5179,AKT2|ELK1|KIT|KRAS|MSH2|PENK,-2.4
_FINAL,GO Biological Processes,19,GO:0009611,response to wounding,19_GO:0050896 response to stimulus,-3.4,6.3,5.2,30198,435,66,6,9.1,3.5,1311|2246|3043|3725|4089|6722,COMP|FGF1|HBB|JUN|SMAD4|SRF,-2.4
_FINAL,GO Biological Processes,19,GO:0003012,muscle system process,19_GO:0032501 multicellular organismal process,-3.4,8.1,5.6,30198,282,66,5,7.6,3.3,148|1311|5021|9127|23493,ADRA1A|COMP|OXTR|P2RX6|HEY2,-2.4
_FINAL,KEGG Pathway,24,hsa04218,Cellular senescence,,-3.4,12,6.3,30198,156,66,4,6.1,2.9,208|3845|5595|286826,AKT2|KRAS|MAPK3|LIN9,-2.4
_FINAL,GO Biological Processes,19,GO:0030856,regulation of epithelial cell differentiation,19_GO:0032502 developmental process,-3.4,12,6.3,30198,157,66,4,6.1,2.9,1499|7480|23493|28514,CTNNB1|WNT10B|HEY2|DLL1,-2.4
_FINAL,KEGG Pathway,24,hsa05160,Hepatitis C,,-3.4,12,6.3,30198,157,66,4,6.1,2.9,208|1499|3845|5595,AKT2|CTNNB1|KRAS|MAPK3,-2.4
_FINAL,Reactome Gene Sets,6,R-HSA-168898,Toll-like Receptor Cascades,,-3.4,12,6.3,30198,157,66,4,6.1,2.9,1385|2002|3725|5595,CREB1|ELK1|JUN|MAPK3,-2.4
_FINAL,Reactome Gene Sets,6,R-HSA-9614085,FOXO-mediated transcription,,-3.4,21,7.6,30198,65,66,3,4.5,2.6,208|4089|4800,AKT2|SMAD4|NFYA,-2.4
_FINAL,GO Biological Processes,19,GO:1905330,regulation of morphogenesis of an epithelium,19_GO:0032502 developmental process,-3.4,21,7.6,30198,65,66,3,4.5,2.6,1499|2246|54361,CTNNB1|FGF1|WNT4,-2.4
_FINAL,GO Biological Processes,19,GO:0003170,heart valve development,19_GO:0032502 developmental process,-3.4,21,7.6,30198,65,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-2.4
_FINAL,GO Biological Processes,19,GO:0007059,chromosome segregation,19_GO:0009987 cellular process,-3.4,8,5.6,30198,285,66,5,7.6,3.3,699|1063|4751|10664|83540,BUB1|CENPF|NEK2|CTCF|NUF2,-2.4
_FINAL,WikiPathways,27,WP289,Myometrial relaxation and contraction pathways,,-3.4,12,6.2,30198,158,66,4,6.1,2.9,1385|3489|3725|5021,CREB1|IGFBP6|JUN|OXTR,-2.4
_FINAL,Canonical Pathways,11,M255,PID HIF1 TFPATHWAY,,-3.4,21,7.5,30198,66,66,3,4.5,2.6,1385|3725|4089,CREB1|JUN|SMAD4,-2.4
_FINAL,WikiPathways,27,WP2324,AGE/RAGE pathway,,-3.4,21,7.5,30198,66,66,3,4.5,2.6,3725|5595|6464,JUN|MAPK3|SHC1,-2.4
_FINAL,GO Biological Processes,19,GO:0032206,positive regulation of telomere maintenance,19_GO:0048518 positive regulation of biological process,-3.4,21,7.5,30198,66,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-2.4
_FINAL,Canonical Pathways,11,M295,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,,-3.4,20,7.5,30198,67,66,3,4.5,2.6,208|1385|6464,AKT2|CREB1|SHC1,-2.4
_FINAL,GO Biological Processes,19,GO:0055006,cardiac cell development,19_GO:0032502 developmental process,-3.4,20,7.5,30198,67,66,3,4.5,2.6,148|6722|23493,ADRA1A|SRF|HEY2,-2.4
_FINAL,GO Biological Processes,19,GO:0061371,determination of heart left/right asymmetry,19_GO:0032502 developmental process,-3.4,20,7.5,30198,67,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-2.4
_FINAL,GO Biological Processes,19,GO:0071300,cellular response to retinoic acid,19_GO:0050896 response to stimulus,-3.4,20,7.5,30198,67,66,3,4.5,2.6,1385|6532|7480,CREB1|SLC6A4|WNT10B,-2.4
_FINAL,GO Biological Processes,19,GO:0050909,sensory perception of taste,19_GO:0032501 multicellular organismal process,-3.4,20,7.5,30198,67,66,3,4.5,2.6,1472|7480|51176,CST4|WNT10B|LEF1,-2.4
_FINAL,GO Biological Processes,19,GO:0048562,embryonic organ morphogenesis,19_GO:0032502 developmental process,-3.3,7.8,5.5,30198,292,66,5,7.6,3.3,1499|2253|5595|6722|28514,CTNNB1|FGF8|MAPK3|SRF|DLL1,-2.4
_FINAL,WikiPathways,27,WP2032,Thyroid stimulating hormone (TSH) signaling pathway,,-3.3,20,7.4,30198,68,66,3,4.5,2.6,1385|3725|5595,CREB1|JUN|MAPK3,-2.4
_FINAL,GO Biological Processes,19,GO:0001707,mesoderm formation,19_GO:0032502 developmental process,-3.3,20,7.4,30198,68,66,3,4.5,2.6,3624|6722|51176,INHBA|SRF|LEF1,-2.4
_FINAL,GO Biological Processes,19,GO:0061351,neural precursor cell proliferation,19_GO:0009987 cellular process,-3.3,20,7.4,30198,68,66,3,4.5,2.6,2253|9833|51176,FGF8|MELK|LEF1,-2.4
_FINAL,GO Biological Processes,19,GO:0051148,negative regulation of muscle cell differentiation,19_GO:0032502 developmental process,-3.3,20,7.4,30198,68,66,3,4.5,2.6,4089|23493|28514,SMAD4|HEY2|DLL1,-2.4
_FINAL,KEGG Pathway,24,hsa04664,Fc epsilon RI signaling pathway,,-3.3,20,7.4,30198,68,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.4
_FINAL,GO Biological Processes,19,GO:0003143,embryonic heart tube morphogenesis,19_GO:0032502 developmental process,-3.3,20,7.4,30198,69,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-2.3
_FINAL,WikiPathways,27,WP3929,Chemokine signaling pathway,,-3.3,11,6.1,30198,165,66,4,6.1,2.9,208|3845|5595|6464,AKT2|KRAS|MAPK3|SHC1,-2.3
_FINAL,GO Biological Processes,19,GO:0010720,positive regulation of cell development,19_GO:0032502 developmental process,-3.3,7.7,5.4,30198,297,66,5,7.6,3.3,1499|1523|1959|3815|6722,CTNNB1|CUX1|EGR2|KIT|SRF,-2.3
_FINAL,GO Biological Processes,19,GO:0048332,mesoderm morphogenesis,19_GO:0032502 developmental process,-3.3,20,7.3,30198,70,66,3,4.5,2.6,3624|6722|51176,INHBA|SRF|LEF1,-2.3
_FINAL,GO Biological Processes,19,GO:0051054,positive regulation of DNA metabolic process,19_GO:0048518 positive regulation of biological process,-3.3,7.7,5.4,30198,298,66,5,7.6,3.3,1499|4436|4751|5595|6599,CTNNB1|MSH2|NEK2|MAPK3|SMARCC1,-2.3
_FINAL,GO Biological Processes,19,GO:0021543,pallium development,19_GO:0032502 developmental process,-3.3,11,6,30198,168,66,4,6.1,2.9,1499|2253|6722|51176,CTNNB1|FGF8|SRF|LEF1,-2.3
_FINAL,WikiPathways,27,WP4341,"Non-genomic actions of 1,25 dihydroxyvitamin D3",,-3.3,19,7.2,30198,71,66,3,4.5,2.6,3725|3845|5595,JUN|KRAS|MAPK3,-2.3
_FINAL,Reactome Gene Sets,6,R-HSA-449147,Signaling by Interleukins,,-3.3,5.9,5,30198,462,66,6,9.1,3.5,1385|2002|2920|3725|5595|6464,CREB1|ELK1|CXCL2|JUN|MAPK3|SHC1,-2.3
_FINAL,GO Biological Processes,19,GO:0042113,B cell activation,19_GO:0002376 immune system process,-3.3,11,6,30198,170,66,4,6.1,2.9,3815|4436|28514|51176,KIT|MSH2|DLL1|LEF1,-2.3
_FINAL,GO Biological Processes,19,GO:0051047,positive regulation of secretion,19_GO:0051179 localization,-3.3,7.6,5.4,30198,303,66,5,7.6,3.3,1385|3624|4089|5021|6532,CREB1|INHBA|SMAD4|OXTR|SLC6A4,-2.3
_FINAL,KEGG Pathway,24,hsa05223,Non-small cell lung cancer,,-3.3,19,7.2,30198,72,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.3
_FINAL,GO Biological Processes,19,GO:0003208,cardiac ventricle morphogenesis,19_GO:0032502 developmental process,-3.3,19,7.2,30198,72,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-2.3
_FINAL,WikiPathways,27,WP4255,Non-small cell lung cancer,,-3.3,19,7.2,30198,72,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.3
_FINAL,GO Biological Processes,19,GO:0002062,chondrocyte differentiation,19_GO:0032502 developmental process,-3.3,19,7.2,30198,72,66,3,4.5,2.6,1311|7480|8817,COMP|WNT10B|FGF18,-2.3
_FINAL,Reactome Gene Sets,6,R-HSA-500792,GPCR ligand binding,,-3.3,5.9,5,30198,467,66,6,9.1,3.5,148|2920|5021|5179|7480|54361,ADRA1A|CXCL2|OXTR|PENK|WNT10B|WNT4,-2.3
_FINAL,GO Biological Processes,19,GO:2000573,positive regulation of DNA biosynthetic process,19_GO:0048518 positive regulation of biological process,-3.3,19,7.1,30198,73,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-2.3
_FINAL,KEGG Pathway,24,hsa01524,Platinum drug resistance,,-3.3,19,7.1,30198,73,66,3,4.5,2.6,208|4436|5595,AKT2|MSH2|MAPK3,-2.3
_FINAL,GO Biological Processes,19,GO:0003281,ventricular septum development,19_GO:0032502 developmental process,-3.3,19,7.1,30198,73,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-2.3
_FINAL,GO Biological Processes,19,GO:1902105,regulation of leukocyte differentiation,19_GO:0002376 immune system process,-3.3,7.5,5.3,30198,306,66,5,7.6,3.3,1385|1499|3624|6599|51176,CREB1|CTNNB1|INHBA|SMARCC1|LEF1,-2.3
_FINAL,GO Biological Processes,19,GO:0006937,regulation of muscle contraction,19_GO:0032501 multicellular organismal process,-3.2,11,5.9,30198,173,66,4,6.1,2.9,148|3815|5021|6722,ADRA1A|KIT|OXTR|SRF,-2.3
_FINAL,GO Biological Processes,19,GO:0009416,response to light stimulus,19_GO:0050896 response to stimulus,-3.2,7.4,5.3,30198,308,66,5,7.6,3.3,208|2002|3815|3845|4436,AKT2|ELK1|KIT|KRAS|MSH2,-2.3
_FINAL,Reactome Gene Sets,6,R-HSA-1980143,Signaling by NOTCH1,,-3.2,19,7.1,30198,74,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-2.3
_FINAL,GO Biological Processes,19,GO:0031016,pancreas development,19_GO:0032502 developmental process,-3.2,19,7.1,30198,74,66,3,4.5,2.6,1499|6927|28514,CTNNB1|HNF1A|DLL1,-2.3
_FINAL,GO Biological Processes,19,GO:0048738,cardiac muscle tissue development,19_GO:0032502 developmental process,-3.2,11,5.9,30198,174,66,4,6.1,2.9,148|4089|6722|23493,ADRA1A|SMAD4|SRF|HEY2,-2.3
_FINAL,GO Biological Processes,19,GO:0045669,positive regulation of osteoblast differentiation,19_GO:0032502 developmental process,-3.2,18,7,30198,75,66,3,4.5,2.6,1499|7480|54361,CTNNB1|WNT10B|WNT4,-2.2
_FINAL,GO Biological Processes,19,GO:0009880,embryonic pattern specification,19_GO:0032502 developmental process,-3.2,18,7,30198,75,66,3,4.5,2.6,1499|4089|28514,CTNNB1|SMAD4|DLL1,-2.2
_FINAL,KEGG Pathway,24,hsa05022,Pathways of neurodegeneration - multiple diseases,,-3.2,5.8,4.9,30198,476,66,6,9.1,3.5,1499|3845|4040|5595|7480|54361,CTNNB1|KRAS|LRP6|MAPK3|WNT10B|WNT4,-2.2
_FINAL,GO Biological Processes,19,GO:1901991,negative regulation of mitotic cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-3.2,10,5.8,30198,178,66,4,6.1,2.9,699|1063|3624|83540,BUB1|CENPF|INHBA|NUF2,-2.2
_FINAL,GO Biological Processes,19,GO:0032870,cellular response to hormone stimulus,19_GO:0050896 response to stimulus,-3.2,5.7,4.9,30198,481,66,6,9.1,3.5,208|3624|3815|6464|6599|7480,AKT2|INHBA|KIT|SHC1|SMARCC1|WNT10B,-2.2
_FINAL,GO Biological Processes,19,GO:0000902,cell morphogenesis,19_GO:0032502 developmental process,-3.2,4.8,4.6,30198,670,66,7,11,3.8,1385|1499|1959|4089|6722|51176|168002,CREB1|CTNNB1|EGR2|SMAD4|SRF|LEF1|DACT2,-2.2
_FINAL,GO Biological Processes,19,GO:0014706,striated muscle tissue development,19_GO:0032502 developmental process,-3.2,10,5.8,30198,179,66,4,6.1,2.9,148|4089|6722|23493,ADRA1A|SMAD4|SRF|HEY2,-2.2
_FINAL,KEGG Pathway,24,hsa05140,Leishmaniasis,,-3.2,18,6.9,30198,77,66,3,4.5,2.6,2002|3725|5595,ELK1|JUN|MAPK3,-2.2
_FINAL,KEGG Pathway,24,hsa05152,Tuberculosis,,-3.2,10,5.8,30198,180,66,4,6.1,2.9,208|1385|4800|5595,AKT2|CREB1|NFYA|MAPK3,-2.2
_FINAL,GO Biological Processes,19,GO:0002366,leukocyte activation involved in immune response,19_GO:0002376 immune system process,-3.2,10,5.8,30198,180,66,4,6.1,2.9,3815|4436|28514|51176,KIT|MSH2|DLL1|LEF1,-2.2
_FINAL,GO Biological Processes,19,GO:0045446,endothelial cell differentiation,19_GO:0032502 developmental process,-3.2,18,6.9,30198,78,66,3,4.5,2.6,4089|23493|28514,SMAD4|HEY2|DLL1,-2.2
_FINAL,GO Biological Processes,19,GO:0044344,cellular response to fibroblast growth factor stimulus,19_GO:0050896 response to stimulus,-3.2,18,6.9,30198,78,66,3,4.5,2.6,2246|2253|8817,FGF1|FGF8|FGF18,-2.2
_FINAL,GO Biological Processes,19,GO:0043010,camera-type eye development,19_GO:0032502 developmental process,-3.2,7.1,5.2,30198,320,66,5,7.6,3.3,1499|3624|3725|6722|28514,CTNNB1|INHBA|JUN|SRF|DLL1,-2.2
_FINAL,GO Biological Processes,19,GO:0033674,positive regulation of kinase activity,19_GO:0048518 positive regulation of biological process,-3.2,5.6,4.8,30198,489,66,6,9.1,3.5,148|905|2246|3815|8817|22974,ADRA1A|CCNT2|FGF1|KIT|FGF18|TPX2,-2.2
_FINAL,GO Biological Processes,19,GO:0043405,regulation of MAP kinase activity,19_GO:0008152 metabolic process,-3.2,10,5.7,30198,183,66,4,6.1,2.9,2246|3815|7148|8817,FGF1|KIT|TNXB|FGF18,-2.2
_FINAL,GO Biological Processes,19,GO:0046903,secretion,19_GO:0051179 localization,-3.2,5.6,4.8,30198,490,66,6,9.1,3.5,1311|1385|3624|3815|5021|6927,COMP|CREB1|INHBA|KIT|OXTR|HNF1A,-2.2
_FINAL,GO Biological Processes,19,GO:0002263,cell activation involved in immune response,19_GO:0002376 immune system process,-3.1,9.9,5.7,30198,184,66,4,6.1,2.9,3815|4436|28514|51176,KIT|MSH2|DLL1|LEF1,-2.2
_FINAL,GO Biological Processes,19,GO:0031060,regulation of histone methylation,19_GO:0008152 metabolic process,-3.1,17,6.8,30198,80,66,3,4.5,2.6,1499|4089|10664,CTNNB1|SMAD4|CTCF,-2.2
_FINAL,Reactome Gene Sets,6,R-HSA-438064,Post NMDA receptor activation events,,-3.1,17,6.8,30198,80,66,3,4.5,2.6,1385|3845|5595,CREB1|KRAS|MAPK3,-2.2
_FINAL,GO Biological Processes,19,GO:0002065,columnar/cuboidal epithelial cell differentiation,19_GO:0032502 developmental process,-3.1,17,6.8,30198,80,66,3,4.5,2.6,2253|28514|54361,FGF8|DLL1|WNT4,-2.2
_FINAL,Canonical Pathways,11,M223,PID BETA CATENIN NUC PATHWAY,,-3.1,17,6.8,30198,80,66,3,4.5,2.6,1499|3725|51176,CTNNB1|JUN|LEF1,-2.2
_FINAL,GO Biological Processes,19,GO:2001251,negative regulation of chromosome organization,19_GO:0048519 negative regulation of biological process,-3.1,17,6.8,30198,80,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-2.2
_FINAL,GO Biological Processes,19,GO:0010660,regulation of muscle cell apoptotic process,19_GO:0050789 regulation of biological process,-3.1,17,6.7,30198,81,66,3,4.5,2.6,4040|4089|23493,LRP6|SMAD4|HEY2,-2.1
_FINAL,GO Biological Processes,19,GO:0098773,skin epidermis development,19_GO:0032502 developmental process,-3.1,17,6.7,30198,81,66,3,4.5,2.6,1499|3624|28514,CTNNB1|INHBA|DLL1,-2.1
_FINAL,GO Biological Processes,19,GO:0003013,circulatory system process,19_GO:0032501 multicellular organismal process,-3.1,5.5,4.8,30198,497,66,6,9.1,3.5,148|1311|3043|5021|6532|28514,ADRA1A|COMP|HBB|OXTR|SLC6A4|DLL1,-2.1
_FINAL,KEGG Pathway,24,hsa05034,Alcoholism,,-3.1,9.8,5.6,30198,187,66,4,6.1,2.9,1385|3845|5595|6464,CREB1|KRAS|MAPK3|SHC1,-2.1
_FINAL,GO Biological Processes,19,GO:0046777,protein autophosphorylation,19_GO:0008152 metabolic process,-3.1,9.8,5.6,30198,187,66,4,6.1,2.9,3815|4751|5595|9833,KIT|NEK2|MAPK3|MELK,-2.1
_FINAL,GO Biological Processes,19,GO:0000082,G1/S transition of mitotic cell cycle,19_GO:0009987 cellular process,-3.1,17,6.7,30198,82,66,3,4.5,2.6,571|1876|128239,BACH1|E2F6|IQGAP3,-2.1
_FINAL,Canonical Pathways,11,M2,PID SMAD2 3NUCLEAR PATHWAY,,-3.1,17,6.7,30198,82,66,3,4.5,2.6,1385|3725|4089,CREB1|JUN|SMAD4,-2.1
_FINAL,GO Biological Processes,19,GO:0008306,associative learning,19_GO:0032501 multicellular organismal process,-3.1,17,6.7,30198,82,66,3,4.5,2.6,3815|3845|6722,KIT|KRAS|SRF,-2.1
_FINAL,GO Biological Processes,19,GO:0042060,wound healing,19_GO:0050896 response to stimulus,-3.1,6.9,5.1,30198,330,66,5,7.6,3.3,1311|2246|3043|4089|6722,COMP|FGF1|HBB|SMAD4|SRF,-2.1
_FINAL,GO Biological Processes,19,GO:0008217,regulation of blood pressure,19_GO:0032501 multicellular organismal process,-3.1,9.6,5.6,30198,190,66,4,6.1,2.9,148|3043|5021|28514,ADRA1A|HBB|OXTR|DLL1,-2.1
_FINAL,WikiPathways,27,WP2261,Glioblastoma signaling pathways,,-3.1,17,6.6,30198,83,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-2.1
_FINAL,GO Biological Processes,19,GO:0010638,positive regulation of organelle organization,19_GO:0048518 positive regulation of biological process,-3.1,5.5,4.7,30198,503,66,6,9.1,3.5,208|1499|2253|4751|5595|54361,AKT2|CTNNB1|FGF8|NEK2|MAPK3|WNT4,-2.1
_FINAL,GO Biological Processes,19,GO:2000241,regulation of reproductive process,19_GO:0022414 reproductive process,-3.1,9.6,5.6,30198,191,66,4,6.1,2.9,1499|3624|5021|54361,CTNNB1|INHBA|OXTR|WNT4,-2.1
_FINAL,GO Biological Processes,19,GO:0044843,cell cycle G1/S phase transition,19_GO:0009987 cellular process,-3.1,16,6.6,30198,84,66,3,4.5,2.6,571|1876|128239,BACH1|E2F6|IQGAP3,-2.1
_FINAL,GO Biological Processes,19,GO:0030500,regulation of bone mineralization,19_GO:0110148 biomineralization,-3.1,16,6.6,30198,84,66,3,4.5,2.6,1311|7480|54361,COMP|WNT10B|WNT4,-2.1
_FINAL,Canonical Pathways,11,M195,PID CMYB PATHWAY,,-3.1,16,6.6,30198,84,66,3,4.5,2.6,3815|3845|51176,KIT|KRAS|LEF1,-2.1
_FINAL,GO Biological Processes,19,GO:0035265,organ growth,19_GO:0040007 growth,-3.1,16,6.6,30198,84,66,3,4.5,2.6,148|1311|28514,ADRA1A|COMP|DLL1,-2.1
_FINAL,GO Biological Processes,19,GO:0045664,regulation of neuron differentiation,19_GO:0032502 developmental process,-3.1,9.5,5.6,30198,192,66,4,6.1,2.9,6532|23493|26508|28514,SLC6A4|HEY2|HEYL|DLL1,-2.1
_FINAL,GO Biological Processes,19,GO:0006468,protein phosphorylation,19_GO:0008152 metabolic process,-3.1,4.5,4.5,30198,704,66,7,11,3.8,208|699|1385|3815|4751|5595|9833,AKT2|BUB1|CREB1|KIT|NEK2|MAPK3|MELK,-2.1
_FINAL,GO Biological Processes,19,GO:0055007,cardiac muscle cell differentiation,19_GO:0032502 developmental process,-3.1,16,6.5,30198,85,66,3,4.5,2.6,148|6722|23493,ADRA1A|SRF|HEY2,-2.1
_FINAL,Reactome Gene Sets,6,R-HSA-194315,Signaling by Rho GTPases,,-3.1,4.5,4.4,30198,707,66,7,11,3.8,699|1063|1499|5595|6722|83540|128239,BUB1|CENPF|CTNNB1|MAPK3|SRF|NUF2|IQGAP3,-2.1
_FINAL,Reactome Gene Sets,6,R-HSA-69275,G2/M Transition,,-3,9.3,5.5,30198,196,66,4,6.1,2.9,1063|4751|22974|286826,CENPF|NEK2|TPX2|LIN9,-2.1
_FINAL,Canonical Pathways,11,M3008,NABA ECM GLYCOPROTEINS,,-3,9.3,5.5,30198,196,66,4,6.1,2.9,1311|3381|3489|7148,COMP|IBSP|IGFBP6|TNXB,-2.1
_FINAL,GO Biological Processes,19,GO:0019216,regulation of lipid metabolic process,19_GO:0008152 metabolic process,-3,6.7,5,30198,341,66,5,7.6,3.3,208|1385|2246|3815|54361,AKT2|CREB1|FGF1|KIT|WNT4,-2.1
_FINAL,GO Biological Processes,19,GO:0010639,negative regulation of organelle organization,19_GO:0048519 negative regulation of biological process,-3,6.7,5,30198,342,66,5,7.6,3.3,699|1063|4089|22974|83540,BUB1|CENPF|SMAD4|TPX2|NUF2,-2.1
_FINAL,Reactome Gene Sets,6,R-HSA-453274,Mitotic G2-G2/M phases,,-3,9.2,5.4,30198,198,66,4,6.1,2.9,1063|4751|22974|286826,CENPF|NEK2|TPX2|LIN9,-2.1
_FINAL,GO Biological Processes,19,GO:0046889,positive regulation of lipid biosynthetic process,19_GO:0048518 positive regulation of biological process,-3,16,6.4,30198,88,66,3,4.5,2.6,1385|2246|54361,CREB1|FGF1|WNT4,-2.1
_FINAL,GO Biological Processes,19,GO:0010035,response to inorganic substance,19_GO:0050896 response to stimulus,-3,5.3,4.6,30198,521,66,6,9.1,3.5,1385|3043|3725|3815|5179|5595,CREB1|HBB|JUN|KIT|PENK|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0045765,regulation of angiogenesis,19_GO:0032502 developmental process,-3,6.6,4.9,30198,347,66,5,7.6,3.3,1284|1499|2246|8817|28514,COL4A2|CTNNB1|FGF1|FGF18|DLL1,-2
_FINAL,Reactome Gene Sets,6,R-HSA-170834,Signaling by TGF-beta Receptor Complex,,-3,15,6.4,30198,89,66,3,4.5,2.6,905|4089|5595,CCNT2|SMAD4|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0030218,erythrocyte differentiation,19_GO:0002376 immune system process,-3,15,6.4,30198,89,66,3,4.5,2.6,3624|3815|6722,INHBA|KIT|SRF,-2
_FINAL,KEGG Pathway,24,hsa04211,Longevity regulating pathway,,-3,15,6.4,30198,89,66,3,4.5,2.6,208|1385|3845,AKT2|CREB1|KRAS,-2
_FINAL,Reactome Gene Sets,6,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",,-3,4.4,4.4,30198,723,66,7,11,3.8,699|1063|1499|5595|6722|83540|128239,BUB1|CENPF|CTNNB1|MAPK3|SRF|NUF2|IQGAP3,-2
_FINAL,GO Biological Processes,19,GO:0010038,response to metal ion,19_GO:0050896 response to stimulus,-3,6.5,4.9,30198,351,66,5,7.6,3.3,1385|3725|3815|5179|5595,CREB1|JUN|KIT|PENK|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0009612,response to mechanical stimulus,19_GO:0050896 response to stimulus,-3,9,5.4,30198,203,66,4,6.1,2.9,1499|3725|3815|5595,CTNNB1|JUN|KIT|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0043065,positive regulation of apoptotic process,19_GO:0048518 positive regulation of biological process,-3,5.2,4.5,30198,529,66,6,9.1,3.5,1499|3624|3725|4089|7480|9833,CTNNB1|INHBA|JUN|SMAD4|WNT10B|MELK,-2
_FINAL,GO Biological Processes,19,GO:0048167,regulation of synaptic plasticity,19_GO:0023052 signaling,-3,9,5.3,30198,204,66,4,6.1,2.9,1959|3815|3845|6722,EGR2|KIT|KRAS|SRF,-2
_FINAL,Reactome Gene Sets,6,R-HSA-68877,Mitotic Prometaphase,,-3,9,5.3,30198,204,66,4,6.1,2.9,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-2
_FINAL,GO Biological Processes,19,GO:0060021,roof of mouth development,19_GO:0032502 developmental process,-3,15,6.3,30198,91,66,3,4.5,2.6,3624|4089|51176,INHBA|SMAD4|LEF1,-2
_FINAL,KEGG Pathway,24,hsa04658,Th1 and Th2 cell differentiation,,-3,15,6.3,30198,92,66,3,4.5,2.6,3725|5595|28514,JUN|MAPK3|DLL1,-2
_FINAL,GO Biological Processes,19,GO:0090132,epithelium migration,19_GO:0032501 multicellular organismal process,-3,15,6.3,30198,92,66,3,4.5,2.6,2253|3815|6722,FGF8|KIT|SRF,-2
_FINAL,GO Biological Processes,19,GO:0045638,negative regulation of myeloid cell differentiation,19_GO:0002376 immune system process,-3,15,6.3,30198,92,66,3,4.5,2.6,1499|3624|28514,CTNNB1|INHBA|DLL1,-2
_FINAL,GO Biological Processes,19,GO:0032868,response to insulin,19_GO:0050896 response to stimulus,-3,8.8,5.3,30198,207,66,4,6.1,2.9,208|1959|6464|6599,AKT2|EGR2|SHC1|SMARCC1,-2
_FINAL,GO Biological Processes,19,GO:0014033,neural crest cell differentiation,19_GO:0032502 developmental process,-2.9,15,6.2,30198,93,66,3,4.5,2.6,4040|4089|5595,LRP6|SMAD4|MAPK3,-2
_FINAL,Reactome Gene Sets,6,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,,-2.9,15,6.2,30198,93,66,3,4.5,2.6,1385|3845|5595,CREB1|KRAS|MAPK3,-2
_FINAL,KEGG Pathway,24,hsa04350,TGF-beta signaling pathway,,-2.9,15,6.2,30198,94,66,3,4.5,2.6,3624|4089|5595,INHBA|SMAD4|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0007052,mitotic spindle organization,19_GO:0009987 cellular process,-2.9,15,6.2,30198,94,66,3,4.5,2.6,4751|22974|83540,NEK2|TPX2|NUF2,-2
_FINAL,GO Biological Processes,19,GO:0050679,positive regulation of epithelial cell proliferation,19_GO:0048518 positive regulation of biological process,-2.9,8.7,5.3,30198,210,66,4,6.1,2.9,1499|2246|3725|128239,CTNNB1|FGF1|JUN|IQGAP3,-2
_FINAL,Reactome Gene Sets,6,R-HSA-3700989,Transcriptional Regulation by TP53,,-2.9,6.3,4.8,30198,362,66,5,7.6,3.3,208|905|3725|4436|22974,AKT2|CCNT2|JUN|MSH2|TPX2,-2
_FINAL,GO Biological Processes,19,GO:0043068,positive regulation of programmed cell death,19_GO:0048518 positive regulation of biological process,-2.9,5.1,4.5,30198,543,66,6,9.1,3.5,1499|3624|3725|4089|7480|9833,CTNNB1|INHBA|JUN|SMAD4|WNT10B|MELK,-2
_FINAL,KEGG Pathway,24,hsa05170,Human immunodeficiency virus 1 infection,,-2.9,8.6,5.2,30198,212,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-2
_FINAL,GO Biological Processes,19,GO:0031669,cellular response to nutrient levels,19_GO:0050896 response to stimulus,-2.9,8.6,5.2,30198,212,66,4,6.1,2.9,5179|5595|6722|54361,PENK|MAPK3|SRF|WNT4,-2
_FINAL,GO Biological Processes,19,GO:0006979,response to oxidative stress,19_GO:0050896 response to stimulus,-2.9,6.3,4.7,30198,365,66,5,7.6,3.3,3043|3725|5179|5595|9833,HBB|JUN|PENK|MAPK3|MELK,-2
_FINAL,GO Biological Processes,19,GO:0030168,platelet activation,19_GO:0032501 multicellular organismal process,-2.9,14,6.1,30198,96,66,3,4.5,2.6,1311|3043|6722,COMP|HBB|SRF,-1.9
_FINAL,Reactome Gene Sets,6,R-HSA-141424,Amplification of signal from the kinetochores,,-2.9,14,6.1,30198,96,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.9
_FINAL,Reactome Gene Sets,6,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,,-2.9,14,6.1,30198,96,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.9
_FINAL,GO Biological Processes,19,GO:0008593,regulation of Notch signaling pathway,19_GO:0023052 signaling,-2.9,14,6.1,30198,97,66,3,4.5,2.6,3815|23493|28514,KIT|HEY2|DLL1,-1.9
_FINAL,GO Biological Processes,19,GO:0070661,leukocyte proliferation,19_GO:0009987 cellular process,-2.9,14,6.1,30198,97,66,3,4.5,2.6,3815|51176|54361,KIT|LEF1|WNT4,-1.9
_FINAL,GO Biological Processes,19,GO:0001654,eye development,19_GO:0032502 developmental process,-2.9,6.2,4.7,30198,368,66,5,7.6,3.3,1499|3624|3725|6722|28514,CTNNB1|INHBA|JUN|SRF|DLL1,-1.9
_FINAL,GO Biological Processes,19,GO:0090130,tissue migration,19_GO:0032501 multicellular organismal process,-2.9,14,6,30198,98,66,3,4.5,2.6,2253|3815|6722,FGF8|KIT|SRF,-1.9
_FINAL,GO Biological Processes,19,GO:0034101,erythrocyte homeostasis,19_GO:0002376 immune system process,-2.9,14,6,30198,98,66,3,4.5,2.6,3624|3815|6722,INHBA|KIT|SRF,-1.9
_FINAL,GO Biological Processes,19,GO:0050878,regulation of body fluid levels,19_GO:0065007 biological regulation,-2.9,6.2,4.7,30198,371,66,5,7.6,3.3,1311|1385|3043|5021|6722,COMP|CREB1|HBB|OXTR|SRF,-1.9
_FINAL,GO Biological Processes,19,GO:0043583,ear development,19_GO:0032502 developmental process,-2.9,8.4,5.1,30198,217,66,4,6.1,2.9,2253|5595|23493|28514,FGF8|MAPK3|HEY2|DLL1,-1.9
_FINAL,GO Biological Processes,19,GO:1903530,regulation of secretion by cell,19_GO:0051179 localization,-2.9,5,4.4,30198,554,66,6,9.1,3.5,148|1385|3624|4089|5021|6532,ADRA1A|CREB1|INHBA|SMAD4|OXTR|SLC6A4,-1.9
_FINAL,GO Biological Processes,19,GO:0150063,visual system development,19_GO:0032502 developmental process,-2.9,6.1,4.7,30198,372,66,5,7.6,3.3,1499|3624|3725|6722|28514,CTNNB1|INHBA|JUN|SRF|DLL1,-1.9
_FINAL,WikiPathways,27,WP4540,Hippo signaling regulation pathways,,-2.9,14,6,30198,99,66,3,4.5,2.6,1499|3815|51176,CTNNB1|KIT|LEF1,-1.9
_FINAL,Reactome Gene Sets,6,R-HSA-4420097,VEGFA-VEGFR2 Pathway,,-2.9,14,6,30198,99,66,3,4.5,2.6,208|1499|3845,AKT2|CTNNB1|KRAS,-1.9
_FINAL,GO Biological Processes,19,GO:0034599,cellular response to oxidative stress,19_GO:0050896 response to stimulus,-2.9,8.4,5.1,30198,219,66,4,6.1,2.9,3725|5179|5595|9833,JUN|PENK|MAPK3|MELK,-1.9
_FINAL,GO Biological Processes,19,GO:0045639,positive regulation of myeloid cell differentiation,19_GO:0002376 immune system process,-2.9,14,6,30198,100,66,3,4.5,2.6,1385|3624|51176,CREB1|INHBA|LEF1,-1.9
_FINAL,GO Biological Processes,19,GO:0032204,regulation of telomere maintenance,19_GO:0008152 metabolic process,-2.9,14,6,30198,100,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-1.9
_FINAL,GO Biological Processes,19,GO:0046620,regulation of organ growth,19_GO:0040007 growth,-2.8,14,5.9,30198,101,66,3,4.5,2.6,2253|6532|23493,FGF8|SLC6A4|HEY2,-1.9
_FINAL,GO Biological Processes,19,GO:0048880,sensory system development,19_GO:0032502 developmental process,-2.8,6.1,4.6,30198,378,66,5,7.6,3.3,1499|3624|3725|6722|28514,CTNNB1|INHBA|JUN|SRF|DLL1,-1.9
_FINAL,KEGG Pathway,24,hsa05208,Chemical carcinogenesis - reactive oxygen species,,-2.8,8.2,5.1,30198,223,66,4,6.1,2.9,208|3725|3845|5595,AKT2|JUN|KRAS|MAPK3,-1.9
_FINAL,KEGG Pathway,24,hsa05142,Chagas disease,,-2.8,13,5.9,30198,102,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-1.9
_FINAL,GO Biological Processes,19,GO:0071902,positive regulation of protein serine/threonine kinase activity,19_GO:0048518 positive regulation of biological process,-2.8,8.2,5,30198,224,66,4,6.1,2.9,905|2246|3815|8817,CCNT2|FGF1|KIT|FGF18,-1.9
_FINAL,GO Biological Processes,19,GO:0050678,regulation of epithelial cell proliferation,19_GO:0050789 regulation of biological process,-2.8,6,4.6,30198,382,66,5,7.6,3.3,1499|2246|3725|7480|128239,CTNNB1|FGF1|JUN|WNT10B|IQGAP3,-1.9
_FINAL,GO Biological Processes,19,GO:0019218,regulation of steroid metabolic process,19_GO:0008152 metabolic process,-2.8,13,5.9,30198,103,66,3,4.5,2.6,2246|3815|54361,FGF1|KIT|WNT4,-1.9
_FINAL,GO Biological Processes,19,GO:0010717,regulation of epithelial to mesenchymal transition,19_GO:0032502 developmental process,-2.8,13,5.9,30198,103,66,3,4.5,2.6,1499|4089|51176,CTNNB1|SMAD4|LEF1,-1.9
_FINAL,WikiPathways,27,WP75,Toll-like receptor signaling pathway,,-2.8,13,5.8,30198,104,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-1.9
_FINAL,KEGG Pathway,24,hsa04620,Toll-like receptor signaling pathway,,-2.8,13,5.8,30198,104,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-1.9
_FINAL,GO Biological Processes,19,GO:0098813,nuclear chromosome segregation,19_GO:0009987 cellular process,-2.8,8,5,30198,228,66,4,6.1,2.9,699|1063|4751|83540,BUB1|CENPF|NEK2|NUF2,-1.8
_FINAL,GO Biological Processes,19,GO:0006936,muscle contraction,19_GO:0032501 multicellular organismal process,-2.8,8,5,30198,228,66,4,6.1,2.9,148|1311|5021|9127,ADRA1A|COMP|OXTR|P2RX6,-1.8
_FINAL,GO Biological Processes,19,GO:2001252,positive regulation of chromosome organization,19_GO:0048518 positive regulation of biological process,-2.8,13,5.8,30198,105,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-1.8
_FINAL,GO Biological Processes,19,GO:0009636,response to toxic substance,19_GO:0050896 response to stimulus,-2.8,8,5,30198,229,66,4,6.1,2.9,3043|5179|6532|6722,HBB|PENK|SLC6A4|SRF,-1.8
_FINAL,Reactome Gene Sets,6,R-HSA-9675108,Nervous system development,,-2.8,4.8,4.3,30198,577,66,6,9.1,3.5,1284|1385|1959|3845|5595|6464,COL4A2|CREB1|EGR2|KRAS|MAPK3|SHC1,-1.8
_FINAL,KEGG Pathway,24,hsa04928,"Parathyroid hormone synthesis, secretion and action",,-2.8,13,5.8,30198,106,66,3,4.5,2.6,1385|4040|5595,CREB1|LRP6|MAPK3,-1.8
_FINAL,Reactome Gene Sets,6,R-HSA-194138,Signaling by VEGF,,-2.8,13,5.7,30198,108,66,3,4.5,2.6,208|1499|3845,AKT2|CTNNB1|KRAS,-1.8
_FINAL,GO Biological Processes,19,GO:0021782,glial cell development,19_GO:0032502 developmental process,-2.8,13,5.7,30198,108,66,3,4.5,2.6,208|3845|28514,AKT2|KRAS|DLL1,-1.8
_FINAL,WikiPathways,27,WP4321,Thermogenesis,,-2.8,13,5.7,30198,108,66,3,4.5,2.6,1385|3845|6599,CREB1|KRAS|SMARCC1,-1.8
_FINAL,KEGG Pathway,24,hsa04659,Th17 cell differentiation,,-2.8,13,5.7,30198,108,66,3,4.5,2.6,3725|4089|5595,JUN|SMAD4|MAPK3,-1.8
_FINAL,GO Biological Processes,19,GO:0032526,response to retinoic acid,19_GO:0050896 response to stimulus,-2.8,13,5.7,30198,109,66,3,4.5,2.6,1385|6532|7480,CREB1|SLC6A4|WNT10B,-1.8
_FINAL,GO Biological Processes,19,GO:0019827,stem cell population maintenance,19_GO:0032502 developmental process,-2.7,12,5.6,30198,110,66,3,4.5,2.6,1499|3815|28514,CTNNB1|KIT|DLL1,-1.8
_FINAL,GO Biological Processes,19,GO:0031058,positive regulation of histone modification,19_GO:0048518 positive regulation of biological process,-2.7,12,5.6,30198,110,66,3,4.5,2.6,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-1.8
_FINAL,GO Biological Processes,19,GO:0048872,homeostasis of number of cells,19_GO:0065007 biological regulation,-2.7,7.7,4.8,30198,238,66,4,6.1,2.9,3624|3815|3845|6722,INHBA|KIT|KRAS|SRF,-1.8
_FINAL,GO Biological Processes,19,GO:0007219,Notch signaling pathway,19_GO:0023052 signaling,-2.7,12,5.6,30198,111,66,3,4.5,2.6,23493|26508|28514,HEY2|HEYL|DLL1,-1.8
_FINAL,GO Biological Processes,19,GO:0022412,cellular process involved in reproduction in multicellular organism,19_GO:0022414 reproductive process,-2.7,5.7,4.4,30198,402,66,5,7.6,3.3,1499|3624|3815|4436|54361,CTNNB1|INHBA|KIT|MSH2|WNT4,-1.8
_FINAL,GO Biological Processes,19,GO:0003014,renal system process,19_GO:0032501 multicellular organismal process,-2.7,12,5.6,30198,112,66,3,4.5,2.6,148|3043|6927,ADRA1A|HBB|HNF1A,-1.8
_FINAL,GO Biological Processes,19,GO:0098727,maintenance of cell number,19_GO:0032502 developmental process,-2.7,12,5.6,30198,112,66,3,4.5,2.6,1499|3815|28514,CTNNB1|KIT|DLL1,-1.8
_FINAL,Reactome Gene Sets,6,R-HSA-69618,Mitotic Spindle Checkpoint,,-2.7,12,5.6,30198,113,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.8
_FINAL,GO Biological Processes,19,GO:0031668,cellular response to extracellular stimulus,19_GO:0050896 response to stimulus,-2.7,7.5,4.8,30198,244,66,4,6.1,2.9,5179|5595|6722|54361,PENK|MAPK3|SRF|WNT4,-1.7
_FINAL,KEGG Pathway,24,hsa04726,Serotonergic synapse,,-2.7,12,5.5,30198,115,66,3,4.5,2.6,3845|5595|6532,KRAS|MAPK3|SLC6A4,-1.7
_FINAL,GO Biological Processes,19,GO:0043406,positive regulation of MAP kinase activity,19_GO:0023052 signaling,-2.7,12,5.5,30198,116,66,3,4.5,2.6,2246|3815|8817,FGF1|KIT|FGF18,-1.7
_FINAL,GO Biological Processes,19,GO:0051046,regulation of secretion,19_GO:0051179 localization,-2.7,4.5,4.1,30198,610,66,6,9.1,3.5,148|1385|3624|4089|5021|6532,ADRA1A|CREB1|INHBA|SMAD4|OXTR|SLC6A4,-1.7
_FINAL,Reactome Gene Sets,6,R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,,-2.7,12,5.4,30198,117,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.7
_FINAL,Reactome Gene Sets,6,R-HSA-68886,M Phase,,-2.7,5.5,4.3,30198,418,66,5,7.6,3.3,699|1063|4751|5595|83540,BUB1|CENPF|NEK2|MAPK3|NUF2,-1.7
_FINAL,KEGG Pathway,24,hsa04071,Sphingolipid signaling pathway,,-2.6,12,5.4,30198,119,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-1.7
_FINAL,GO Biological Processes,19,GO:2000278,regulation of DNA biosynthetic process,19_GO:0008152 metabolic process,-2.6,12,5.4,30198,119,66,3,4.5,2.6,1499|4751|5595,CTNNB1|NEK2|MAPK3,-1.7
_FINAL,KEGG Pathway,24,hsa04152,AMPK signaling pathway,,-2.6,11,5.4,30198,120,66,3,4.5,2.6,148|208|1385,ADRA1A|AKT2|CREB1,-1.7
_FINAL,GO Biological Processes,19,GO:0002262,myeloid cell homeostasis,19_GO:0002376 immune system process,-2.6,11,5.4,30198,120,66,3,4.5,2.6,3624|3815|6722,INHBA|KIT|SRF,-1.7
_FINAL,GO Biological Processes,19,GO:0030183,B cell differentiation,19_GO:0002376 immune system process,-2.6,11,5.4,30198,120,66,3,4.5,2.6,3815|4436|28514,KIT|MSH2|DLL1,-1.7
_FINAL,Reactome Gene Sets,6,R-HSA-109582,Hemostasis,,-2.6,4.4,4,30198,621,66,6,9.1,3.5,3043|3845|4680|5595|6464|9127,HBB|KRAS|CEACAM6|MAPK3|SHC1|P2RX6,-1.7
_FINAL,Reactome Gene Sets,6,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,,-2.6,11,5.3,30198,121,66,3,4.5,2.6,1959|3725|10664,EGR2|JUN|CTCF,-1.7
_FINAL,Reactome Gene Sets,6,R-HSA-5619507,Activation of HOX genes during differentiation,,-2.6,11,5.3,30198,121,66,3,4.5,2.6,1959|3725|10664,EGR2|JUN|CTCF,-1.7
_FINAL,GO Biological Processes,19,GO:0046887,positive regulation of hormone secretion,19_GO:0023052 signaling,-2.6,11,5.3,30198,122,66,3,4.5,2.6,1385|3624|4089,CREB1|INHBA|SMAD4,-1.7
_FINAL,GO Biological Processes,19,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,19_GO:0008152 metabolic process,-2.6,7.1,4.6,30198,258,66,4,6.1,2.9,148|2253|3815|6464,ADRA1A|FGF8|KIT|SHC1,-1.7
_FINAL,WikiPathways,27,WP4541,Hippo-Merlin signaling dysregulation,,-2.6,11,5.3,30198,123,66,3,4.5,2.6,1499|3815|3845,CTNNB1|KIT|KRAS,-1.7
_FINAL,WikiPathways,27,WP4549,Fragile X syndrome,,-2.6,11,5.3,30198,123,66,3,4.5,2.6,1385|3845|6464,CREB1|KRAS|SHC1,-1.7
_FINAL,GO Biological Processes,19,GO:0002285,lymphocyte activation involved in immune response,19_GO:0002376 immune system process,-2.6,11,5.3,30198,124,66,3,4.5,2.6,4436|28514|51176,MSH2|DLL1|LEF1,-1.6
_FINAL,GO Biological Processes,19,GO:0090596,sensory organ morphogenesis,19_GO:0032502 developmental process,-2.6,7,4.6,30198,262,66,4,6.1,2.9,1499|2253|5595|28514,CTNNB1|FGF8|MAPK3|DLL1,-1.6
_FINAL,GO Biological Processes,19,GO:1902850,microtubule cytoskeleton organization involved in mitosis,19_GO:0009987 cellular process,-2.6,11,5.2,30198,125,66,3,4.5,2.6,4751|22974|83540,NEK2|TPX2|NUF2,-1.6
_FINAL,GO Biological Processes,19,GO:0003018,vascular process in circulatory system,19_GO:0032501 multicellular organismal process,-2.6,7,4.5,30198,263,66,4,6.1,2.9,148|1311|5021|6532,ADRA1A|COMP|OXTR|SLC6A4,-1.6
_FINAL,GO Biological Processes,19,GO:0003231,cardiac ventricle development,19_GO:0032502 developmental process,-2.6,11,5.2,30198,126,66,3,4.5,2.6,4089|23493|26508,SMAD4|HEY2|HEYL,-1.6
_FINAL,Reactome Gene Sets,6,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,,-2.6,11,5.2,30198,126,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.6
_FINAL,GO Biological Processes,19,GO:0007368,determination of left/right symmetry,19_GO:0032502 developmental process,-2.6,11,5.2,30198,126,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-1.6
_FINAL,GO Biological Processes,19,GO:0048565,digestive tract development,19_GO:0032502 developmental process,-2.6,11,5.2,30198,127,66,3,4.5,2.6,1499|3815|5021,CTNNB1|KIT|OXTR,-1.6
_FINAL,GO Biological Processes,19,GO:0031175,neuron projection development,19_GO:0032502 developmental process,-2.6,4.3,3.9,30198,641,66,6,9.1,3.5,1385|1499|1959|3725|4089|6722,CREB1|CTNNB1|EGR2|JUN|SMAD4|SRF,-1.6
_FINAL,GO Biological Processes,19,GO:0062197,cellular response to chemical stress,19_GO:0050896 response to stimulus,-2.6,6.9,4.5,30198,267,66,4,6.1,2.9,3725|5179|5595|9833,JUN|PENK|MAPK3|MELK,-1.6
_FINAL,Reactome Gene Sets,6,R-HSA-112315,Transmission across Chemical Synapses,,-2.5,6.8,4.5,30198,270,66,4,6.1,2.9,1385|3845|5595|6532,CREB1|KRAS|MAPK3|SLC6A4,-1.6
_FINAL,GO Biological Processes,19,GO:0072175,epithelial tube formation,19_GO:0032502 developmental process,-2.5,11,5.1,30198,130,66,3,4.5,2.6,1499|2253|54361,CTNNB1|FGF8|WNT4,-1.6
_FINAL,GO Biological Processes,19,GO:0031667,response to nutrient levels,19_GO:0050896 response to stimulus,-2.5,5.1,4.1,30198,446,66,5,7.6,3.3,5179|5595|6532|6722|54361,PENK|MAPK3|SLC6A4|SRF|WNT4,-1.6
_FINAL,Reactome Gene Sets,6,R-HSA-69206,G1/S Transition,,-2.5,10,5.1,30198,131,66,3,4.5,2.6,208|1876|286826,AKT2|E2F6|LIN9,-1.6
_FINAL,KEGG Pathway,24,hsa04650,Natural killer cell mediated cytotoxicity,,-2.5,10,5.1,30198,131,66,3,4.5,2.6,3845|5595|6464,KRAS|MAPK3|SHC1,-1.6
_FINAL,WikiPathways,27,WP3915,Angiopoietin-like protein 8 regulatory pathway,,-2.5,10,5.1,30198,132,66,3,4.5,2.6,208|5595|6464,AKT2|MAPK3|SHC1,-1.6
_FINAL,GO Biological Processes,19,GO:0007160,cell-matrix adhesion,19_GO:0009987 cellular process,-2.5,10,5,30198,133,66,3,4.5,2.6,1499|6722|7148,CTNNB1|SRF|TNXB,-1.6
_FINAL,WikiPathways,27,WP366,TGF-beta signaling pathway,,-2.5,10,5,30198,133,66,3,4.5,2.6,3725|4089|6464,JUN|SMAD4|SHC1,-1.6
_FINAL,GO Biological Processes,19,GO:0009855,determination of bilateral symmetry,19_GO:0032502 developmental process,-2.5,10,5,30198,133,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-1.6
_FINAL,GO Biological Processes,19,GO:0009799,specification of symmetry,19_GO:0032502 developmental process,-2.5,10,5,30198,134,66,3,4.5,2.6,2253|6722|28514,FGF8|SRF|DLL1,-1.6
_FINAL,Reactome Gene Sets,6,R-HSA-202733,Cell surface interactions at the vascular wall,,-2.5,10,5,30198,137,66,3,4.5,2.6,3845|4680|6464,KRAS|CEACAM6|SHC1,-1.5
_FINAL,GO Biological Processes,19,GO:0045667,regulation of osteoblast differentiation,19_GO:0032502 developmental process,-2.5,10,5,30198,137,66,3,4.5,2.6,1499|7480|54361,CTNNB1|WNT10B|WNT4,-1.5
_FINAL,Canonical Pathways,11,M145,PID P53 DOWNSTREAM PATHWAY,,-2.5,10,5,30198,137,66,3,4.5,2.6,3725|4436|4800,JUN|MSH2|NFYA,-1.5
_FINAL,KEGG Pathway,24,hsa05135,Yersinia infection,,-2.5,10,5,30198,137,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-1.5
_FINAL,KEGG Pathway,24,hsa05418,Fluid shear stress and atherosclerosis,,-2.5,9.9,4.9,30198,139,66,3,4.5,2.6,208|1499|3725,AKT2|CTNNB1|JUN,-1.5
_FINAL,GO Biological Processes,19,GO:0055123,digestive system development,19_GO:0032502 developmental process,-2.5,9.9,4.9,30198,139,66,3,4.5,2.6,1499|3815|5021,CTNNB1|KIT|OXTR,-1.5
_FINAL,Reactome Gene Sets,6,R-HSA-6807070,PTEN Regulation,,-2.4,9.8,4.9,30198,140,66,3,4.5,2.6,208|3725|5595,AKT2|JUN|MAPK3,-1.5
_FINAL,KEGG Pathway,24,hsa04140,Autophagy - animal,,-2.4,9.7,4.9,30198,141,66,3,4.5,2.6,208|3845|5595,AKT2|KRAS|MAPK3,-1.5
_FINAL,GO Biological Processes,19,GO:0045785,positive regulation of cell adhesion,19_GO:0048518 positive regulation of biological process,-2.4,4.9,3.9,30198,471,66,5,7.6,3.3,3381|4680|6599|51176|54361,IBSP|CEACAM6|SMARCC1|LEF1|WNT4,-1.5
_FINAL,GO Biological Processes,19,GO:0016331,morphogenesis of embryonic epithelium,19_GO:0032502 developmental process,-2.4,9.6,4.8,30198,143,66,3,4.5,2.6,1499|2253|54361,CTNNB1|FGF8|WNT4,-1.5
_FINAL,GO Biological Processes,19,GO:0007584,response to nutrient,19_GO:0050896 response to stimulus,-2.4,9.5,4.8,30198,144,66,3,4.5,2.6,5179|6532|6722,PENK|SLC6A4|SRF,-1.5
_FINAL,WikiPathways,27,WP5083,Neuroinflammation and glutamatergic signaling,,-2.4,9.5,4.8,30198,144,66,3,4.5,2.6,1385|4089|5595,CREB1|SMAD4|MAPK3,-1.5
_FINAL,GO Biological Processes,19,GO:0009991,response to extracellular stimulus,19_GO:0050896 response to stimulus,-2.4,4.8,3.9,30198,479,66,5,7.6,3.3,5179|5595|6532|6722|54361,PENK|MAPK3|SLC6A4|SRF|WNT4,-1.5
_FINAL,GO Biological Processes,19,GO:0007281,germ cell development,19_GO:0022414 reproductive process,-2.4,6.2,4.2,30198,296,66,4,6.1,2.9,1499|3815|4436|54361,CTNNB1|KIT|MSH2|WNT4,-1.5
_FINAL,WikiPathways,27,WP2853,Endoderm differentiation,,-2.4,9.4,4.8,30198,146,66,3,4.5,2.6,1499|4089|51176,CTNNB1|SMAD4|LEF1,-1.5
_FINAL,GO Biological Processes,19,GO:0018108,peptidyl-tyrosine phosphorylation,19_GO:0008152 metabolic process,-2.4,9.4,4.8,30198,146,66,3,4.5,2.6,3815|5595|9833,KIT|MAPK3|MELK,-1.5
_FINAL,GO Biological Processes,19,GO:0035148,tube formation,19_GO:0032502 developmental process,-2.4,9.4,4.8,30198,146,66,3,4.5,2.6,1499|2253|54361,CTNNB1|FGF8|WNT4,-1.5
_FINAL,GO Biological Processes,19,GO:0000819,sister chromatid segregation,19_GO:0009987 cellular process,-2.4,9.4,4.8,30198,146,66,3,4.5,2.6,699|4751|83540,BUB1|NEK2|NUF2,-1.5
_FINAL,GO Biological Processes,19,GO:0007612,learning,19_GO:0032501 multicellular organismal process,-2.4,9.3,4.7,30198,147,66,3,4.5,2.6,3815|3845|6722,KIT|KRAS|SRF,-1.4
_FINAL,Reactome Gene Sets,6,R-HSA-453279,Mitotic G1 phase and G1/S transition,,-2.4,9.2,4.7,30198,149,66,3,4.5,2.6,208|1876|286826,AKT2|E2F6|LIN9,-1.4
_FINAL,GO Biological Processes,19,GO:0032869,cellular response to insulin stimulus,19_GO:0050896 response to stimulus,-2.4,9.2,4.7,30198,149,66,3,4.5,2.6,208|6464|6599,AKT2|SHC1|SMARCC1,-1.4
_FINAL,GO Biological Processes,19,GO:0062013,positive regulation of small molecule metabolic process,19_GO:0048518 positive regulation of biological process,-2.4,9.2,4.7,30198,149,66,3,4.5,2.6,208|2246|54361,AKT2|FGF1|WNT4,-1.4
_FINAL,GO Biological Processes,19,GO:0018212,peptidyl-tyrosine modification,19_GO:0008152 metabolic process,-2.4,9.2,4.7,30198,149,66,3,4.5,2.6,3815|5595|9833,KIT|MAPK3|MELK,-1.4
_FINAL,GO Biological Processes,19,GO:0044089,positive regulation of cellular component biogenesis,19_GO:0048518 positive regulation of biological process,-2.4,4.6,3.8,30198,492,66,5,7.6,3.3,3815|5021|6722|7480|54361,KIT|OXTR|SRF|WNT10B|WNT4,-1.4
_FINAL,GO Biological Processes,19,GO:2000181,negative regulation of blood vessel morphogenesis,19_GO:0032502 developmental process,-2.4,9.1,4.7,30198,151,66,3,4.5,2.6,1284|1499|54361,COL4A2|CTNNB1|WNT4,-1.4
_FINAL,GO Biological Processes,19,GO:1901343,negative regulation of vasculature development,19_GO:0032502 developmental process,-2.3,9,4.6,30198,152,66,3,4.5,2.6,1284|1499|54361,COL4A2|CTNNB1|WNT4,-1.4
_FINAL,GO Biological Processes,19,GO:0071345,cellular response to cytokine stimulus,19_GO:0050896 response to stimulus,-2.3,3.9,3.6,30198,710,66,6,9.1,3.5,1385|2920|3815|4089|5595|51176,CREB1|CXCL2|KIT|SMAD4|MAPK3|LEF1,-1.4
_FINAL,GO Biological Processes,19,GO:0071496,cellular response to external stimulus,19_GO:0050896 response to stimulus,-2.3,5.9,4.1,30198,308,66,4,6.1,2.9,5179|5595|6722|54361,PENK|MAPK3|SRF|WNT4,-1.4
_FINAL,GO Biological Processes,19,GO:0010817,regulation of hormone levels,19_GO:0065007 biological regulation,-2.3,4.6,3.8,30198,498,66,5,7.6,3.3,1385|3624|4089|6927|54361,CREB1|INHBA|SMAD4|HNF1A|WNT4,-1.4
_FINAL,KEGG Pathway,24,hsa05206,MicroRNAs in cancer,,-2.3,5.9,4.1,30198,310,66,4,6.1,2.9,3845|5595|6464|7148,KRAS|MAPK3|SHC1|TNXB,-1.4
_FINAL,GO Biological Processes,19,GO:0000280,nuclear division,19_GO:0009987 cellular process,-2.3,5.9,4.1,30198,310,66,4,6.1,2.9,699|4751|22974|83540,BUB1|NEK2|TPX2|NUF2,-1.4
_FINAL,GO Biological Processes,19,GO:0007051,spindle organization,19_GO:0009987 cellular process,-2.3,8.9,4.6,30198,155,66,3,4.5,2.6,4751|22974|83540,NEK2|TPX2|NUF2,-1.4
_FINAL,GO Biological Processes,19,GO:0140694,non-membrane-bounded organelle assembly,19_GO:0009987 cellular process,-2.3,5.9,4,30198,312,66,4,6.1,2.9,1063|4751|6722|22974,CENPF|NEK2|SRF|TPX2,-1.4
_FINAL,GO Biological Processes,19,GO:0006935,chemotaxis,19_GO:0040011 locomotion,-2.3,4.5,3.7,30198,506,66,5,7.6,3.3,1959|2920|3815|4089|51176,EGR2|CXCL2|KIT|SMAD4|LEF1,-1.4
_FINAL,GO Biological Processes,19,GO:0042330,taxis,19_GO:0040011 locomotion,-2.3,4.5,3.7,30198,508,66,5,7.6,3.3,1959|2920|3815|4089|51176,EGR2|CXCL2|KIT|SMAD4|LEF1,-1.4
_FINAL,GO Biological Processes,19,GO:0006954,inflammatory response,19_GO:0050896 response to stimulus,-2.2,4.4,3.6,30198,523,66,5,7.6,3.3,2920|3725|3815|5966|27190,CXCL2|JUN|KIT|REL|IL17B,-1.3
_FINAL,GO Biological Processes,19,GO:0140014,mitotic nuclear division,19_GO:0009987 cellular process,-2.2,8.1,4.3,30198,169,66,3,4.5,2.6,4751|22974|83540,NEK2|TPX2|NUF2,-1.3
_FINAL,GO Biological Processes,19,GO:0051493,regulation of cytoskeleton organization,19_GO:0050789 regulation of biological process,-2.2,4.3,3.6,30198,531,66,5,7.6,3.3,4089|5595|22974|54361|128239,SMAD4|MAPK3|TPX2|WNT4|IQGAP3,-1.3
_FINAL,Reactome Gene Sets,6,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),,-2.2,5.5,3.8,30198,335,66,4,6.1,2.9,148|2920|5021|5179,ADRA1A|CXCL2|OXTR|PENK,-1.3
_FINAL,GO Biological Processes,19,GO:0048285,organelle fission,19_GO:0009987 cellular process,-2.2,5.5,3.8,30198,335,66,4,6.1,2.9,699|4751|22974|83540,BUB1|NEK2|TPX2|NUF2,-1.3
_FINAL,GO Biological Processes,19,GO:0000302,response to reactive oxygen species,19_GO:0050896 response to stimulus,-2.2,8,4.3,30198,171,66,3,4.5,2.6,3043|3725|5595,HBB|JUN|MAPK3,-1.3
_FINAL,GO Biological Processes,19,GO:0030111,regulation of Wnt signaling pathway,19_GO:0023052 signaling,-2.2,5.4,3.8,30198,336,66,4,6.1,2.9,1499|3489|7480|51176,CTNNB1|IGFBP6|WNT10B|LEF1,-1.3
_FINAL,GO Biological Processes,19,GO:0007596,blood coagulation,19_GO:0032501 multicellular organismal process,-2.2,8,4.3,30198,172,66,3,4.5,2.6,1311|3043|6722,COMP|HBB|SRF,-1.3
_FINAL,GO Biological Processes,19,GO:0051052,regulation of DNA metabolic process,19_GO:0008152 metabolic process,-2.2,4.3,3.6,30198,537,66,5,7.6,3.3,1499|4436|4751|5595|6599,CTNNB1|MSH2|NEK2|MAPK3|SMARCC1,-1.3
_FINAL,GO Biological Processes,19,GO:0006259,DNA metabolic process,19_GO:0008152 metabolic process,-2.2,3.6,3.4,30198,763,66,6,9.1,3.5,571|1063|4436|10664|51176|286826,BACH1|CENPF|MSH2|CTCF|LEF1|LIN9,-1.3
_FINAL,GO Biological Processes,19,GO:0030036,actin cytoskeleton organization,19_GO:0009987 cellular process,-2.2,4.3,3.6,30198,538,66,5,7.6,3.3,3815|3845|6464|6722|7148,KIT|KRAS|SHC1|SRF|TNXB,-1.3
_FINAL,GO Biological Processes,19,GO:0010634,positive regulation of epithelial cell migration,19_GO:0040011 locomotion,-2.2,7.9,4.3,30198,174,66,3,4.5,2.6,2246|3725|8817,FGF1|JUN|FGF18,-1.3
_FINAL,GO Biological Processes,19,GO:0050817,coagulation,19_GO:0032501 multicellular organismal process,-2.2,7.9,4.3,30198,174,66,3,4.5,2.6,1311|3043|6722,COMP|HBB|SRF,-1.3
_FINAL,GO Biological Processes,19,GO:1902107,positive regulation of leukocyte differentiation,19_GO:0002376 immune system process,-2.2,7.8,4.2,30198,177,66,3,4.5,2.6,1385|6599|51176,CREB1|SMARCC1|LEF1,-1.2
_FINAL,GO Biological Processes,19,GO:0007599,hemostasis,19_GO:0065007 biological regulation,-2.2,7.8,4.2,30198,177,66,3,4.5,2.6,1311|3043|6722,COMP|HBB|SRF,-1.2
_FINAL,GO Biological Processes,19,GO:1903708,positive regulation of hemopoiesis,19_GO:0002376 immune system process,-2.2,7.8,4.2,30198,177,66,3,4.5,2.6,1385|6599|51176,CREB1|SMARCC1|LEF1,-1.2
_FINAL,GO Biological Processes,19,GO:0046890,regulation of lipid biosynthetic process,19_GO:0008152 metabolic process,-2.2,7.8,4.2,30198,177,66,3,4.5,2.6,1385|2246|54361,CREB1|FGF1|WNT4,-1.2
_FINAL,GO Biological Processes,19,GO:0062012,regulation of small molecule metabolic process,19_GO:0008152 metabolic process,-2.2,5.3,3.8,30198,345,66,4,6.1,2.9,208|2246|3815|54361,AKT2|FGF1|KIT|WNT4,-1.2
_FINAL,GO Biological Processes,19,GO:0008361,regulation of cell size,19_GO:0065007 biological regulation,-2.1,7.7,4.2,30198,179,66,3,4.5,2.6,1385|6722|128239,CREB1|SRF|IQGAP3,-1.2
_FINAL,Reactome Gene Sets,6,R-HSA-422475,Axon guidance,,-2.1,4.1,3.5,30198,552,66,5,7.6,3.3,1284|1385|3845|5595|6464,COL4A2|CREB1|KRAS|MAPK3|SHC1,-1.2
_FINAL,Reactome Gene Sets,6,R-HSA-109581,Apoptosis,,-2.1,7.6,4.2,30198,180,66,3,4.5,2.6,208|1499|5595,AKT2|CTNNB1|MAPK3,-1.2
_FINAL,GO Biological Processes,19,GO:0051249,regulation of lymphocyte activation,19_GO:0002376 immune system process,-2.1,4.1,3.5,30198,557,66,5,7.6,3.3,1499|3624|4436|6599|51176,CTNNB1|INHBA|MSH2|SMARCC1|LEF1,-1.2
_FINAL,KEGG Pathway,24,hsa04360,Axon guidance,,-2.1,7.5,4.1,30198,182,66,3,4.5,2.6,3845|5595|54361,KRAS|MAPK3|WNT4,-1.2
_FINAL,GO Biological Processes,19,GO:1904018,positive regulation of vasculature development,19_GO:0032502 developmental process,-2.1,7.5,4.1,30198,184,66,3,4.5,2.6,2246|8817|28514,FGF1|FGF18|DLL1,-1.2
_FINAL,KEGG Pathway,24,hsa04621,NOD-like receptor signaling pathway,,-2.1,7.5,4.1,30198,184,66,3,4.5,2.6,2920|3725|5595,CXCL2|JUN|MAPK3,-1.2
_FINAL,GO Biological Processes,19,GO:0045766,positive regulation of angiogenesis,19_GO:0032502 developmental process,-2.1,7.5,4.1,30198,184,66,3,4.5,2.6,2246|8817|28514,FGF1|FGF18|DLL1,-1.2
_FINAL,GO Biological Processes,19,GO:0001667,ameboidal-type cell migration,19_GO:0040011 locomotion,-2.1,7.4,4.1,30198,185,66,3,4.5,2.6,2253|3815|6722,FGF8|KIT|SRF,-1.2
_FINAL,GO Biological Processes,19,GO:0019221,cytokine-mediated signaling pathway,19_GO:0023052 signaling,-2.1,5.1,3.6,30198,360,66,4,6.1,2.9,2920|3815|4089|5595,CXCL2|KIT|SMAD4|MAPK3,-1.2
_FINAL,GO Biological Processes,19,GO:0007265,Ras protein signal transduction,19_GO:0023052 signaling,-2.1,7.3,4.1,30198,188,66,3,4.5,2.6,3725|3845|128239,JUN|KRAS|IQGAP3,-1.2
_FINAL,GO Biological Processes,19,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,19_GO:0048518 positive regulation of biological process,-2.1,7.3,4.1,30198,188,66,3,4.5,2.6,148|2253|3815,ADRA1A|FGF8|KIT,-1.2
_FINAL,KEGG Pathway,24,hsa04080,Neuroactive ligand-receptor interaction,,-2.1,5.1,3.6,30198,362,66,4,6.1,2.9,148|5021|5179|9127,ADRA1A|OXTR|PENK|P2RX6,-1.2
_FINAL,GO Biological Processes,19,GO:0031589,cell-substrate adhesion,19_GO:0009987 cellular process,-2.1,7.3,4,30198,189,66,3,4.5,2.6,1499|6722|7148,CTNNB1|SRF|TNXB,-1.2
_FINAL,GO Biological Processes,19,GO:0051302,regulation of cell division,19_GO:0050789 regulation of biological process,-2.1,7.3,4,30198,189,66,3,4.5,2.6,2246|2253|28514,FGF1|FGF8|DLL1,-1.2
_FINAL,GO Biological Processes,19,GO:0071248,cellular response to metal ion,19_GO:0050896 response to stimulus,-2.1,7.2,4,30198,190,66,3,4.5,2.6,1385|3725|5595,CREB1|JUN|MAPK3,-1.2
_FINAL,GO Biological Processes,19,GO:0048839,inner ear development,19_GO:0032502 developmental process,-2.1,7.2,4,30198,190,66,3,4.5,2.6,2253|23493|28514,FGF8|HEY2|DLL1,-1.2
_FINAL,GO Biological Processes,19,GO:0044703,multi-organism reproductive process,19_GO:0022414 reproductive process,-2.1,7.2,4,30198,190,66,3,4.5,2.6,5021|6532|54361,OXTR|SLC6A4|WNT4,-1.2
_FINAL,GO Biological Processes,19,GO:0032989,cellular component morphogenesis,19_GO:0032502 developmental process,-2.1,4,3.4,30198,574,66,5,7.6,3.3,1385|1499|1959|4089|6722,CREB1|CTNNB1|EGR2|SMAD4|SRF,-1.2
_FINAL,Reactome Gene Sets,6,R-HSA-2467813,Separation of Sister Chromatids,,-2.1,7.2,4,30198,191,66,3,4.5,2.6,699|1063|83540,BUB1|CENPF|NUF2,-1.1
_FINAL,GO Biological Processes,19,GO:0001818,negative regulation of cytokine production,19_GO:0048519 negative regulation of biological process,-2.1,5,3.6,30198,367,66,4,6.1,2.9,3624|5966|28514|51176,INHBA|REL|DLL1|LEF1,-1.1
_FINAL,GO Biological Processes,19,GO:0007204,positive regulation of cytosolic calcium ion concentration,19_GO:0065007 biological regulation,-2.1,7.1,4,30198,192,66,3,4.5,2.6,148|4040|5021,ADRA1A|LRP6|OXTR,-1.1
_FINAL,Reactome Gene Sets,6,R-HSA-9711123,Cellular response to chemical stress,,-2.1,7.1,4,30198,194,66,3,4.5,2.6,208|571|3043,AKT2|BACH1|HBB,-1.1
_FINAL,GO Biological Processes,19,GO:1901654,response to ketone,19_GO:0050896 response to stimulus,-2.1,7.1,4,30198,194,66,3,4.5,2.6,1385|2002|5021,CREB1|ELK1|OXTR,-1.1
_FINAL,GO Biological Processes,19,GO:0051656,establishment of organelle localization,19_GO:0051179 localization,-2,4.9,3.5,30198,374,66,4,6.1,2.9,1063|1499|3815|83540,CENPF|CTNNB1|KIT|NUF2,-1.1
_FINAL,GO Biological Processes,19,GO:0032940,secretion by cell,19_GO:0051179 localization,-2,4.8,3.5,30198,378,66,4,6.1,2.9,1311|3624|3815|6927,COMP|INHBA|KIT|HNF1A,-1.1
_FINAL,GO Biological Processes,19,GO:0044706,multi-multicellular organism process,19_GO:0032501 multicellular organismal process,-2,6.9,3.9,30198,199,66,3,4.5,2.6,5021|6532|54361,OXTR|SLC6A4|WNT4,-1.1
_FINAL,GO Biological Processes,19,GO:1902903,regulation of supramolecular fiber organization,19_GO:0050789 regulation of biological process,-2,4.8,3.5,30198,381,66,4,6.1,2.9,4089|7148|22974|54361,SMAD4|TNXB|TPX2|WNT4,-1.1
_FINAL,Reactome Gene Sets,6,R-HSA-375276,Peptide ligand-binding receptors,,-2,6.8,3.9,30198,201,66,3,4.5,2.6,2920|5021|5179,CXCL2|OXTR|PENK,-1.1
_FINAL,GO Biological Processes,19,GO:0061564,axon development,19_GO:0032502 developmental process,-2,4.8,3.5,30198,382,66,4,6.1,2.9,1385|1959|3725|4089,CREB1|EGR2|JUN|SMAD4,-1.1
_FINAL,GO Biological Processes,19,GO:0045619,regulation of lymphocyte differentiation,19_GO:0002376 immune system process,-2,6.8,3.9,30198,202,66,3,4.5,2.6,3624|6599|51176,INHBA|SMARCC1|LEF1,-1.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05224,Breast cancer,,-26,2.1e+02,47,30198,147,11,11,1e+02,8.7,1499|2246|2253|3725|3815|3845|4040|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|MAPK3|SHC1|FGF18|LEF1,-21
_FINAL_MCODE_ALL,WikiPathways,27,WP4262,Breast cancer pathway,,-25,1.9e+02,46,30198,157,11,11,1e+02,8.7,1499|2246|2253|3725|3815|3845|4040|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|MAPK3|SHC1|FGF18|LEF1,-21
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05226,Gastric cancer,,-19,1.7e+02,39,30198,149,11,9,82,12,1499|2246|2253|3845|4040|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|KRAS|LRP6|MAPK3|SHC1|FGF18|LEF1,-15
_FINAL_MCODE_ALL,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-17,61,25,30198,447,11,10,91,8.7,1499|2246|2253|3725|3815|4040|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|KIT|LRP6|MAPK3|SHC1|FGF18|LEF1,-14
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05200,Pathways in cancer,,-17,52,23,30198,531,11,10,91,8.7,1499|2246|2253|3725|3815|3845|4040|5595|8817|51176,CTNNB1|FGF1|FGF8|JUN|KIT|KRAS|LRP6|MAPK3|FGF18|LEF1,-13
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-15,57,22,30198,433,11,9,82,12,1499|2246|2253|3815|3845|4040|5595|6464|8817,CTNNB1|FGF1|FGF8|KIT|KRAS|LRP6|MAPK3|SHC1|FGF18,-12
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-15,4.1e+02,50,30198,40,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-12
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-15,4e+02,49,30198,41,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-12
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-14,3.3e+02,44,30198,50,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-14,3.1e+02,43,30198,54,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Canonical Pathways,11,M276,PID FGF PATHWAY,,-14,3e+02,42,30198,55,11,6,55,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-14,7.6e+02,62,30198,18,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-14,68,23,30198,325,11,8,73,13,2246|2253|3725|3815|3845|5595|6464|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-13,6.9e+02,59,30198,20,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-13,2.3e+02,37,30198,73,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-13,6e+02,55,30198,23,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-13,2.1e+02,35,30198,78,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-13,5.5e+02,52,30198,25,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-10
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-13,97,26,30198,198,11,7,64,15,1499|2246|2253|3845|5595|8817|51176,CTNNB1|FGF1|FGF8|KRAS|MAPK3|FGF18|LEF1,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-13,5.1e+02,50,30198,27,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-13,1.9e+02,34,30198,87,11,6,55,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-10
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-13,92,25,30198,210,11,7,64,15,1499|2246|2253|3815|3845|5595|8817,CTNNB1|FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-10
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-13,4.6e+02,48,30198,30,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-9.9
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-12,83,24,30198,232,11,7,64,15,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-12,47,19,30198,468,11,8,73,13,1499|2246|2253|3725|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|MAPK3|SHC1|FGF18|LEF1,-9.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-12,45,19,30198,492,11,8,73,13,1499|2246|2253|3725|3815|5595|6464|8817,CTNNB1|FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-9.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-12,44,19,30198,498,11,8,73,13,1499|2246|2253|3725|5595|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|MAPK3|SHC1|FGF18|LEF1,-9.6
_FINAL_MCODE_ALL,WikiPathways,27,WP4659,Gastrin signaling pathway,,-12,1.4e+02,29,30198,114,11,6,55,15,1499|3725|3815|3845|5595|6464,CTNNB1|JUN|KIT|KRAS|MAPK3|SHC1,-9.5
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-12,42,18,30198,521,11,8,73,13,1499|2246|2253|3815|3845|5595|6464|8817,CTNNB1|FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9.5
_FINAL_MCODE_ALL,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-12,1.4e+02,29,30198,119,11,6,55,15,1499|2246|2253|3725|4040|8817,CTNNB1|FGF1|FGF8|JUN|LRP6|FGF18,-9.4
_FINAL_MCODE_ALL,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-12,1.4e+02,29,30198,120,11,6,55,15,1499|2246|2253|4040|5595|8817,CTNNB1|FGF1|FGF8|LRP6|MAPK3|FGF18,-9.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-12,69,22,30198,280,11,7,64,15,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-12,67,21,30198,286,11,7,64,15,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-12,65,21,30198,294,11,7,64,15,2246|2253|3725|3815|3845|5595|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|FGF18,-9.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-11,36,17,30198,606,11,8,73,13,2246|2253|3725|3815|5595|6464|8817|51176,FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18|LEF1,-9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-11,59,20,30198,323,11,7,64,15,1499|2246|2253|3725|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|SHC1|FGF18|LEF1,-8.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-11,2.6e+02,36,30198,53,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-8.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-11,2.5e+02,36,30198,54,11,5,45,15,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-8.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-11,33,16,30198,663,11,8,73,13,1499|2246|2253|3725|3845|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|KRAS|SHC1|FGF18|LEF1,-8.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-11,32,16,30198,688,11,8,73,13,1499|2246|2253|3725|3815|5595|6464|8817,CTNNB1|FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-8.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-11,98,24,30198,168,11,6,55,15,1499|3845|4040|5595|6464|51176,CTNNB1|KRAS|LRP6|MAPK3|SHC1|LEF1,-8.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-11,95,24,30198,174,11,6,55,15,1499|2246|2253|3845|5595|8817,CTNNB1|FGF1|FGF8|KRAS|MAPK3|FGF18,-8.5
_FINAL_MCODE_ALL,WikiPathways,27,WP4155,Endometrial cancer,,-11,2.2e+02,33,30198,63,11,5,45,15,1499|2246|3845|5595|51176,CTNNB1|FGF1|KRAS|MAPK3|LEF1,-8.5
_FINAL_MCODE_ALL,WikiPathways,27,WP4928,MAPK pathway in congenital thyroid cancer,,-11,6.9e+02,52,30198,16,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-8.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-11,93,23,30198,178,11,6,55,15,1499|2246|2253|3845|5595|8817,CTNNB1|FGF1|FGF8|KRAS|MAPK3|FGF18,-8.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05218,Melanoma,,-11,1.9e+02,31,30198,72,11,5,45,15,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-8.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-11,46,18,30198,421,11,7,64,15,1499|2246|2253|3725|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|SHC1|FGF18|LEF1,-8.3
_FINAL_MCODE_ALL,WikiPathways,27,WP4216,Chromosomal and microsatellite instability in colorectal cancer,,-10,1.9e+02,30,30198,74,11,5,45,15,1499|3725|3845|5595|51176,CTNNB1|JUN|KRAS|MAPK3|LEF1,-8.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-10,5.5e+02,47,30198,20,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-10,5.2e+02,46,30198,21,11,4,36,15,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-8.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-10,75,21,30198,221,11,6,55,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-10,5e+02,45,30198,22,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-10,5e+02,45,30198,22,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05210,Colorectal cancer,,-10,1.6e+02,28,30198,86,11,5,45,15,1499|3725|3845|5595|51176,CTNNB1|JUN|KRAS|MAPK3|LEF1,-8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-10,38,16,30198,505,11,7,64,15,1499|2246|2253|3725|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|SHC1|FGF18|LEF1,-7.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-9.9,4.4e+02,42,30198,25,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7.8
_FINAL_MCODE_ALL,WikiPathways,27,WP382,MAPK signaling pathway,,-9.9,66,20,30198,249,11,6,55,15,2246|2253|3725|3845|5595|8817,FGF1|FGF8|JUN|KRAS|MAPK3|FGF18,-7.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-9.8,37,16,30198,526,11,7,64,15,1499|2246|2253|3725|6464|8817|51176,CTNNB1|FGF1|FGF8|JUN|SHC1|FGF18|LEF1,-7.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04916,Melanogenesis,,-9.8,1.4e+02,26,30198,101,11,5,45,15,1499|3815|3845|5595|51176,CTNNB1|KIT|KRAS|MAPK3|LEF1,-7.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-9.7,62,19,30198,267,11,6,55,15,2246|2253|3725|3815|5595|8817,FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-7.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",,-9.7,1.3e+02,25,30198,106,11,5,45,15,2246|2253|3815|5595|8817,FGF1|FGF8|KIT|MAPK3|FGF18,-7.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654732,Negative regulation of FGFR3 signaling,,-9.6,3.8e+02,39,30198,29,11,4,36,15,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-7.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654733,Negative regulation of FGFR4 signaling,,-9.5,3.5e+02,38,30198,31,11,4,36,15,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-7.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-9.5,3.5e+02,38,30198,31,11,4,36,15,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-7.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-199418,Negative regulation of the PI3K/AKT network,,-9.5,1.2e+02,24,30198,113,11,5,45,15,2246|2253|3815|5595|8817,FGF1|FGF8|KIT|MAPK3|FGF18,-7.4
_FINAL_MCODE_ALL,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-9.5,1.2e+02,24,30198,115,11,5,45,15,1499|3725|3845|6464|51176,CTNNB1|JUN|KRAS|SHC1|LEF1,-7.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2871796,FCERI mediated MAPK activation,,-9.5,3.4e+02,37,30198,32,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654727,Negative regulation of FGFR2 signaling,,-9.4,3.2e+02,36,30198,34,11,4,36,15,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-7.3
_FINAL_MCODE_ALL,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-9.3,53,18,30198,309,11,6,55,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-7.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-9.3,53,18,30198,309,11,6,55,15,2246|2253|3725|3815|5595|8817,FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-7.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-9.3,53,18,30198,312,11,6,55,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-7.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05216,Thyroid cancer,,-9.2,3e+02,34,30198,37,11,4,36,15,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-7.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-9.2,1e+02,23,30198,133,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-7.2
_FINAL_MCODE_ALL,WikiPathways,27,WP127,IL-5 signaling pathway,,-9.1,2.7e+02,33,30198,40,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7.1
_FINAL_MCODE_ALL,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-9,48,17,30198,345,11,6,55,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-7.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-9,47,16,30198,354,11,6,55,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-8.9,2.6e+02,32,30198,43,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060425,lung morphogenesis,19_GO:0032502 developmental process,-8.9,2.6e+02,32,30198,43,11,4,36,15,1499|2253|3845|5595,CTNNB1|FGF8|KRAS|MAPK3,-7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190371,FGFR3b ligand binding and activation,,-8.9,1.2e+03,59,30198,7,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-7
_FINAL_MCODE_ALL,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-8.9,92,21,30198,150,11,5,45,15,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7
_FINAL_MCODE_ALL,Canonical Pathways,11,M175,PID ERBB2 ERBB3 PATHWAY,,-8.9,2.5e+02,31,30198,44,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7
_FINAL_MCODE_ALL,Canonical Pathways,11,M70,PID PS1 PATHWAY,,-8.8,2.4e+02,31,30198,46,11,4,36,15,1499|3725|4040|5595,CTNNB1|JUN|LRP6|MAPK3,-6.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-8.7,2.3e+02,30,30198,48,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-6.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-8.7,85,20,30198,162,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-6.8
_FINAL_MCODE_ALL,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-8.7,83,20,30198,165,11,5,45,15,1499|3845|4040|5595|6464,CTNNB1|KRAS|LRP6|MAPK3|SHC1,-6.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-8.6,82,20,30198,168,11,5,45,15,1499|2253|4040|5595|51176,CTNNB1|FGF8|LRP6|MAPK3|LEF1,-6.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-8.6,80,20,30198,171,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-6.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-8.6,2.1e+02,29,30198,52,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-6.7
_FINAL_MCODE_ALL,Canonical Pathways,11,M122,PID IL2 1PATHWAY,,-8.5,2e+02,28,30198,55,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05213,Endometrial cancer,,-8.4,1.9e+02,27,30198,58,11,4,36,15,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-6.6
_FINAL_MCODE_ALL,WikiPathways,27,WP560,TGF-beta receptor signaling,,-8.4,1.9e+02,27,30198,58,11,4,36,15,1499|3725|5595|51176,CTNNB1|JUN|MAPK3|LEF1,-6.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-8.3,71,19,30198,194,11,5,45,15,1499|3725|3845|5595|51176,CTNNB1|JUN|KRAS|MAPK3|LEF1,-6.5
_FINAL_MCODE_ALL,WikiPathways,27,WP4816,TGF-beta receptor signaling in skeletal dysplasias,,-8.3,1.8e+02,26,30198,62,11,4,36,15,1499|3725|5595|51176,CTNNB1|JUN|MAPK3|LEF1,-6.5
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-8.3,1.7e+02,26,30198,63,11,4,36,15,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-6.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05221,Acute myeloid leukemia,,-8.1,1.6e+02,25,30198,67,11,4,36,15,3815|3845|5595|51176,KIT|KRAS|MAPK3|LEF1,-6.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-8.1,65,18,30198,212,11,5,45,15,2253|3725|3845|5595|8817,FGF8|JUN|KRAS|MAPK3|FGF18,-6.4
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1839130,Signaling by activated point mutants of FGFR3,,-8.1,6.9e+02,45,30198,12,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2033514,FGFR3 mutant receptor activation,,-8.1,6.9e+02,45,30198,12,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-8.1,63,18,30198,218,11,5,45,15,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-6.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190239,FGFR3 ligand binding and activation,,-8,6.3e+02,44,30198,13,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190375,FGFR2c ligand binding and activation,,-8,6.3e+02,44,30198,13,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,,-8,6.3e+02,44,30198,13,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190372,FGFR3c ligand binding and activation,,-8,6.3e+02,44,30198,13,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-8,59,17,30198,231,11,5,45,15,1499|2253|4040|5595|51176,CTNNB1|FGF8|LRP6|MAPK3|LEF1,-6.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190322,FGFR4 ligand binding and activation,,-7.9,5.9e+02,42,30198,14,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-7.9,1.4e+02,24,30198,78,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-6.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,,-7.9,1.4e+02,24,30198,78,11,4,36,15,2246|2253|3815|8817,FGF1|FGF8|KIT|FGF18,-6.2
_FINAL_MCODE_ALL,Canonical Pathways,11,M48,PID MET PATHWAY,,-7.9,1.4e+02,23,30198,79,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-6.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007423,sensory organ development,19_GO:0032502 developmental process,-7.8,30,13,30198,555,11,6,55,15,1499|2253|3725|3815|5595|51176,CTNNB1|FGF8|JUN|KIT|MAPK3|LEF1,-6.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001759,organ induction,19_GO:0032502 developmental process,-7.8,5.5e+02,41,30198,15,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-6.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,,-7.8,5.5e+02,41,30198,15,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030335,positive regulation of cell migration,19_GO:0040011 locomotion,-7.8,29,13,30198,560,11,6,55,15,2246|3725|3815|5595|8817|51176,FGF1|JUN|KIT|MAPK3|FGF18|LEF1,-6.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04012,ErbB signaling pathway,,-7.7,1.3e+02,23,30198,85,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:2000147,positive regulation of cell motility,19_GO:0040011 locomotion,-7.7,28,13,30198,584,11,6,55,15,2246|3725|3815|5595|8817|51176,FGF1|JUN|KIT|MAPK3|FGF18|LEF1,-6
_FINAL_MCODE_ALL,Canonical Pathways,11,M5493,WNT SIGNALING,,-7.6,1.2e+02,22,30198,89,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2033519,Activated point mutants of FGFR2,,-7.6,4.8e+02,38,30198,17,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051272,positive regulation of cellular component movement,19_GO:0051179 localization,-7.6,28,13,30198,597,11,6,55,15,2246|3725|3815|5595|8817|51176,FGF1|JUN|KIT|MAPK3|FGF18|LEF1,-6
_FINAL_MCODE_ALL,WikiPathways,27,WP673,ErbB signaling pathway,,-7.6,1.2e+02,22,30198,91,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6
_FINAL_MCODE_ALL,WikiPathways,27,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,,-7.6,1.2e+02,22,30198,91,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0040017,positive regulation of locomotion,19_GO:0040011 locomotion,-7.6,27,13,30198,599,11,6,55,15,2246|3725|3815|5595|8817|51176,FGF1|JUN|KIT|MAPK3|FGF18|LEF1,-5.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060438,trachea development,19_GO:0032502 developmental process,-7.5,4.6e+02,37,30198,18,11,3,27,13,1499|5595|51176,CTNNB1|MAPK3|LEF1,-5.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654710,PI-3K cascade:FGFR3,,-7.5,4.6e+02,37,30198,18,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,,-7.5,4.6e+02,37,30198,18,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.9
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05215,Prostate cancer,,-7.5,1.1e+02,21,30198,97,11,4,36,15,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-5.9
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa01522,Endocrine resistance,,-7.5,1.1e+02,21,30198,98,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043586,tongue development,19_GO:0032502 developmental process,-7.4,4.1e+02,35,30198,20,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-5.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190241,FGFR2 ligand binding and activation,,-7.4,4.1e+02,35,30198,20,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654720,PI-3K cascade:FGFR4,,-7.4,4.1e+02,35,30198,20,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.8
_FINAL_MCODE_ALL,WikiPathways,27,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,,-7.4,1.1e+02,20,30198,104,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-5.8
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2219528,PI3K/AKT Signaling in Cancer,,-7.4,1.1e+02,20,30198,104,11,4,36,15,2246|2253|3815|8817,FGF1|FGF8|KIT|FGF18,-5.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-7.3,45,15,30198,307,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-5.7
_FINAL_MCODE_ALL,WikiPathways,27,WP399,Wnt signaling pathway and pluripotency,,-7.3,1e+02,20,30198,107,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-5.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-7.2,3.6e+02,33,30198,23,11,3,27,13,2246|2253|3845,FGF1|FGF8|KRAS,-5.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654695,PI-3K cascade:FGFR2,,-7.2,3.6e+02,33,30198,23,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0002573,myeloid leukocyte differentiation,19_GO:0002376 immune system process,-7.2,95,19,30198,116,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-5.6
_FINAL_MCODE_ALL,WikiPathways,27,WP428,Wnt signaling,,-7.1,93,19,30198,118,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-5.6
_FINAL_MCODE_ALL,Canonical Pathways,11,M17200,SA B CELL RECEPTOR COMPLEXES,,-7.1,3.4e+02,32,30198,24,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-5.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04722,Neurotrophin signaling pathway,,-7.1,92,19,30198,119,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0031128,developmental induction,19_GO:0032502 developmental process,-7.1,3.3e+02,31,30198,25,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-5.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-7.1,22,11,30198,741,11,6,55,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-5.5
_FINAL_MCODE_ALL,WikiPathways,27,WP3658,Wnt/beta-catenin signaling pathway in leukemia,,-7,3.2e+02,31,30198,26,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0003156,regulation of animal organ formation,19_GO:0032502 developmental process,-7,3.2e+02,31,30198,26,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-5.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04926,Relaxin signaling pathway,,-7,85,18,30198,129,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.5
_FINAL_MCODE_ALL,Canonical Pathways,11,M186,PID PDGFRB PATHWAY,,-7,85,18,30198,129,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.5
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,,-6.9,82,18,30198,134,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-6.9,21,11,30198,789,11,6,55,15,1499|2253|3845|4040|5595|51176,CTNNB1|FGF8|KRAS|LRP6|MAPK3|LEF1,-5.4
_FINAL_MCODE_ALL,WikiPathways,27,WP3972,PDGFR-beta pathway,,-6.9,2.8e+02,29,30198,29,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-5.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04915,Estrogen signaling pathway,,-6.9,80,18,30198,138,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071542,dopaminergic neuron differentiation,19_GO:0032502 developmental process,-6.8,2.7e+02,29,30198,30,11,3,27,13,1499|2253|4040,CTNNB1|FGF8|LRP6,-5.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0110110,positive regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-6.8,2.7e+02,29,30198,30,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-5.3
_FINAL_MCODE_ALL,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-6.8,76,17,30198,144,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-5.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001569,branching involved in blood vessel morphogenesis,19_GO:0032502 developmental process,-6.8,2.7e+02,28,30198,31,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-5.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-6.8,34,13,30198,402,11,5,45,15,1499|2253|3725|5595|51176,CTNNB1|FGF8|JUN|MAPK3|LEF1,-5.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04072,Phospholipase D signaling pathway,,-6.7,74,17,30198,148,11,4,36,15,3815|3845|5595|6464,KIT|KRAS|MAPK3|SHC1,-5.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,19_GO:0023052 signaling,-6.7,34,13,30198,405,11,5,45,15,2246|2253|3815|6464|8817,FGF1|FGF8|KIT|SHC1|FGF18,-5.3
_FINAL_MCODE_ALL,WikiPathways,27,WP422,MAPK cascade,,-6.7,2.5e+02,27,30198,33,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-5.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1839126,FGFR2 mutant receptor activation,,-6.7,2.5e+02,27,30198,33,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-5.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654726,Negative regulation of FGFR1 signaling,,-6.7,2.5e+02,27,30198,33,11,3,27,13,2246|2253|5595,FGF1|FGF8|MAPK3,-5.2
_FINAL_MCODE_ALL,WikiPathways,27,WP2839,Hair follicle development: organogenesis - part 2 of 3,,-6.7,2.5e+02,27,30198,33,11,3,27,13,1499|2246|51176,CTNNB1|FGF1|LEF1,-5.2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-187687,Signalling to ERKs,,-6.7,2.4e+02,27,30198,34,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-5.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-6.6,70,16,30198,158,11,4,36,15,1499|3815|4040|5595,CTNNB1|KIT|LRP6|MAPK3,-5.2
_FINAL_MCODE_ALL,Canonical Pathways,11,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,,-6.6,2.4e+02,26,30198,35,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-5.2
_FINAL_MCODE_ALL,Canonical Pathways,11,M22,PID GMCSF PATHWAY,,-6.6,2.3e+02,26,30198,36,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-5.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010001,glial cell differentiation,19_GO:0032502 developmental process,-6.5,66,16,30198,167,11,4,36,15,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-5.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-6.5,66,16,30198,167,11,4,36,15,1499|3725|4040|51176,CTNNB1|JUN|LRP6|LEF1,-5.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048568,embryonic organ development,19_GO:0032502 developmental process,-6.5,31,12,30198,445,11,5,45,15,1499|2253|3815|5595|51176,CTNNB1|FGF8|KIT|MAPK3|LEF1,-5.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-6.5,31,12,30198,447,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-5.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-6.5,2.2e+02,25,30198,38,11,3,27,13,2246|2253|3845,FGF1|FGF8|KRAS,-5.1
_FINAL_MCODE_ALL,Canonical Pathways,11,M82,PID RET PATHWAY,,-6.5,2.1e+02,25,30198,39,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-5
_FINAL_MCODE_ALL,WikiPathways,27,WP2526,PDGF pathway,,-6.5,2.1e+02,25,30198,40,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-5
_FINAL_MCODE_ALL,Canonical Pathways,11,M62,PID EPHB FWD PATHWAY,,-6.5,2.1e+02,25,30198,40,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-5
_FINAL_MCODE_ALL,WikiPathways,27,WP2036,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,,-6.4,2e+02,24,30198,42,11,3,27,13,1499|3725|5595,CTNNB1|JUN|MAPK3,-5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001658,branching involved in ureteric bud morphogenesis,19_GO:0032502 developmental process,-6.4,2e+02,24,30198,42,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-5
_FINAL_MCODE_ALL,WikiPathways,27,WP49,IL-2 signaling pathway,,-6.4,2e+02,24,30198,42,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-5
_FINAL_MCODE_ALL,WikiPathways,27,WP4223,Ras signaling,,-6.4,59,15,30198,185,11,4,36,15,3815|3845|5595|6464,KIT|KRAS|MAPK3|SHC1,-4.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-109704,PI3K Cascade,,-6.3,1.9e+02,24,30198,44,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-4.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-6.3,28,11,30198,492,11,5,45,15,1499|2253|3815|4040|51176,CTNNB1|FGF8|KIT|LRP6|LEF1,-4.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1901861,regulation of muscle tissue development,19_GO:0032502 developmental process,-6.3,1.8e+02,23,30198,46,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-4.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001501,skeletal system development,19_GO:0032502 developmental process,-6.3,27,11,30198,505,11,5,45,15,1499|2253|3815|5595|8817,CTNNB1|FGF8|KIT|MAPK3|FGF18,-4.9
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04510,Focal adhesion,,-6.2,55,15,30198,201,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-4.8
_FINAL_MCODE_ALL,WikiPathways,27,WP2848,Pluripotent stem cell differentiation pathway,,-6.2,1.7e+02,23,30198,48,11,3,27,13,2246|2253|3815,FGF1|FGF8|KIT,-4.8
_FINAL_MCODE_ALL,WikiPathways,27,WP306,Focal adhesion,,-6.2,54,15,30198,202,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0009612,response to mechanical stimulus,19_GO:0050896 response to stimulus,-6.2,54,14,30198,203,11,4,36,15,1499|3725|3815|5595,CTNNB1|JUN|KIT|MAPK3,-4.8
_FINAL_MCODE_ALL,WikiPathways,27,WP286,IL-3 signaling pathway,,-6.2,1.7e+02,22,30198,49,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0008543,fibroblast growth factor receptor signaling pathway,19_GO:0023052 signaling,-6.2,1.7e+02,22,30198,49,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-6.2,53,14,30198,207,11,4,36,15,1499|2253|3725|3845,CTNNB1|FGF8|JUN|KRAS,-4.8
_FINAL_MCODE_ALL,WikiPathways,27,WP3646,Hepatitis C and hepatocellular carcinoma,,-6.2,1.6e+02,22,30198,50,11,3,27,13,3725|5595|51176,JUN|MAPK3|LEF1,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-6.1,53,14,30198,209,11,4,36,15,1499|2253|3725|3845,CTNNB1|FGF8|JUN|KRAS,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-6.1,52,14,30198,210,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0098609,cell-cell adhesion,19_GO:0009987 cellular process,-6.1,26,11,30198,537,11,5,45,15,1499|3815|4040|6464|51176,CTNNB1|KIT|LRP6|SHC1|LEF1,-4.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0042063,gliogenesis,19_GO:0032502 developmental process,-6.1,52,14,30198,213,11,4,36,15,1499|3845|5595|51176,CTNNB1|KRAS|MAPK3|LEF1,-4.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-6.1,25,11,30198,541,11,5,45,15,1499|2253|3725|5595|6464,CTNNB1|FGF8|JUN|MAPK3|SHC1,-4.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060675,ureteric bud morphogenesis,19_GO:0032502 developmental process,-6.1,1.6e+02,22,30198,52,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.7
_FINAL_MCODE_ALL,Canonical Pathways,11,M231,PID KIT PATHWAY,,-6.1,1.6e+02,22,30198,52,11,3,27,13,3815|5595|6464,KIT|MAPK3|SHC1,-4.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072171,mesonephric tubule morphogenesis,19_GO:0032502 developmental process,-6.1,1.6e+02,21,30198,53,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.7
_FINAL_MCODE_ALL,WikiPathways,27,WP363,Wnt signaling pathway,,-6.1,1.6e+02,21,30198,53,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-6.1,25,11,30198,557,11,5,45,15,1499|2246|2253|3845|51176,CTNNB1|FGF1|FGF8|KRAS|LEF1,-4.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-8939211,ESR-mediated signaling,,-6,49,14,30198,223,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-6,24,11,30198,575,11,5,45,15,1499|2246|3815|5595|8817,CTNNB1|FGF1|KIT|MAPK3|FGF18,-4.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0046686,response to cadmium ion,19_GO:0050896 response to stimulus,-5.9,1.4e+02,20,30198,59,11,3,27,13,3725|3815|5595,JUN|KIT|MAPK3,-4.6
_FINAL_MCODE_ALL,WikiPathways,27,WP4205,MET in type 1 papillary renal cell carcinoma,,-5.9,1.4e+02,20,30198,59,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030099,myeloid cell differentiation,19_GO:0002376 immune system process,-5.9,46,13,30198,238,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-4.6
_FINAL_MCODE_ALL,Canonical Pathways,11,M7,PID FCER1 PATHWAY,,-5.9,1.4e+02,20,30198,60,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.6
_FINAL_MCODE_ALL,WikiPathways,27,WP304,Kit receptor signaling pathway,,-5.9,1.4e+02,20,30198,60,11,3,27,13,3815|5595|6464,KIT|MAPK3|SHC1,-4.6
_FINAL_MCODE_ALL,Canonical Pathways,11,M187,PID TRKR PATHWAY,,-5.9,1.4e+02,20,30198,61,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-4086398,Ca2+ pathway,,-5.9,1.3e+02,20,30198,62,11,3,27,13,1499|3845|51176,CTNNB1|KRAS|LEF1,-4.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072078,nephron tubule morphogenesis,19_GO:0032502 developmental process,-5.9,1.3e+02,20,30198,63,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.5
_FINAL_MCODE_ALL,Canonical Pathways,11,M10,PID BCR 5PATHWAY,,-5.9,1.3e+02,20,30198,63,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05132,Salmonella infection,,-5.8,44,13,30198,249,11,4,36,15,1499|3725|5595|51176,CTNNB1|JUN|MAPK3|LEF1,-4.5
_FINAL_MCODE_ALL,Canonical Pathways,11,M272,PID CD8 TCR DOWNSTREAM PATHWAY,,-5.8,1.3e+02,19,30198,65,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072088,nephron epithelium morphogenesis,19_GO:0032502 developmental process,-5.8,1.3e+02,19,30198,65,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.5
_FINAL_MCODE_ALL,WikiPathways,27,WP2374,Oncostatin M signaling pathway,,-5.8,1.2e+02,19,30198,66,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.5
_FINAL_MCODE_ALL,WikiPathways,27,WP2324,AGE/RAGE pathway,,-5.8,1.2e+02,19,30198,66,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072028,nephron morphogenesis,19_GO:0032502 developmental process,-5.8,1.2e+02,19,30198,67,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0061333,renal tubule morphogenesis,19_GO:0032502 developmental process,-5.8,1.2e+02,19,30198,67,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.5
_FINAL_MCODE_ALL,WikiPathways,27,WP3680,Physico-chemical features and toxicity-associated pathways,,-5.7,1.2e+02,19,30198,68,11,3,27,13,1499|3725|6464,CTNNB1|JUN|SHC1,-4.4
_FINAL_MCODE_ALL,WikiPathways,27,WP4685,Melanoma,,-5.7,1.2e+02,19,30198,68,11,3,27,13,3815|3845|5595,KIT|KRAS|MAPK3,-4.4
_FINAL_MCODE_ALL,WikiPathways,27,WP3303,RAC1/PAK1/p38/MMP2 pathway,,-5.7,1.2e+02,19,30198,69,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-4.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05211,Renal cell carcinoma,,-5.7,1.2e+02,19,30198,69,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_MCODE_ALL,WikiPathways,27,WP5124,Alzheimer's disease,,-5.7,41,13,30198,267,11,4,36,15,1499|3845|4040|5595,CTNNB1|KRAS|LRP6|MAPK3,-4.4
_FINAL_MCODE_ALL,Canonical Pathways,11,M81,PID CDC42 PATHWAY,,-5.7,1.2e+02,19,30198,70,11,3,27,13,1499|3725|5595,CTNNB1|JUN|MAPK3,-4.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04917,Prolactin signaling pathway,,-5.7,1.2e+02,19,30198,70,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05230,Central carbon metabolism in cancer,,-5.7,1.2e+02,19,30198,70,11,3,27,13,3815|3845|5595,KIT|KRAS|MAPK3,-4.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048534,hematopoietic or lymphoid organ development,19_GO:0002376 immune system process,-5.7,21,9.9,30198,655,11,5,45,15,1499|3725|3815|5595|51176,CTNNB1|JUN|KIT|MAPK3|LEF1,-4.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04520,Adherens junction,,-5.7,1.2e+02,19,30198,71,11,3,27,13,1499|5595|51176,CTNNB1|MAPK3|LEF1,-4.4
_FINAL_MCODE_ALL,WikiPathways,27,WP4341,"Non-genomic actions of 1,25 dihydroxyvitamin D3",,-5.7,1.2e+02,19,30198,71,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-5.7,21,9.8,30198,660,11,5,45,15,2246|3815|4040|6464|8817,FGF1|KIT|LRP6|SHC1|FGF18,-4.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05214,Glioma,,-5.6,1.1e+02,18,30198,75,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072080,nephron tubule development,19_GO:0032502 developmental process,-5.6,1.1e+02,18,30198,76,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.3
_FINAL_MCODE_ALL,WikiPathways,27,WP2037,Prolactin signaling pathway,,-5.6,1.1e+02,18,30198,76,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05220,Chronic myeloid leukemia,,-5.6,1.1e+02,18,30198,76,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9009391,Extra-nuclear estrogen signaling,,-5.6,1.1e+02,18,30198,77,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0044344,cellular response to fibroblast growth factor stimulus,19_GO:0050896 response to stimulus,-5.6,1.1e+02,18,30198,78,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-4.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0002520,immune system development,19_GO:0002376 immune system process,-5.6,20,9.5,30198,699,11,5,45,15,1499|3725|3815|5595|51176,CTNNB1|JUN|KIT|MAPK3|LEF1,-4.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1903131,mononuclear cell differentiation,19_GO:0002376 immune system process,-5.6,37,12,30198,295,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-4.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa01521,EGFR tyrosine kinase inhibitor resistance,,-5.6,1e+02,18,30198,79,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,Canonical Pathways,11,M223,PID BETA CATENIN NUC PATHWAY,,-5.5,1e+02,17,30198,80,11,3,27,13,1499|3725|51176,CTNNB1|JUN|LEF1,-4.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0061326,renal tubule development,19_GO:0032502 developmental process,-5.5,1e+02,17,30198,80,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006931,Signaling by Nuclear Receptors,,-5.5,37,12,30198,299,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04662,B cell receptor signaling pathway,,-5.5,1e+02,17,30198,82,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001657,ureteric bud development,19_GO:0032502 developmental process,-5.5,1e+02,17,30198,82,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072164,mesonephric tubule development,19_GO:0032502 developmental process,-5.5,99,17,30198,83,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072163,mesonephric epithelium development,19_GO:0032502 developmental process,-5.5,99,17,30198,83,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.2
_FINAL_MCODE_ALL,WikiPathways,27,WP4806,EGFR tyrosine kinase inhibitor resistance,,-5.5,98,17,30198,84,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-4.2
_FINAL_MCODE_ALL,Canonical Pathways,11,M195,PID CMYB PATHWAY,,-5.5,98,17,30198,84,11,3,27,13,3815|3845|51176,KIT|KRAS|LEF1,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060070,canonical Wnt signaling pathway,19_GO:0023052 signaling,-5.5,98,17,30198,84,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071774,response to fibroblast growth factor,19_GO:0050896 response to stimulus,-5.5,98,17,30198,84,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060993,kidney morphogenesis,19_GO:0032502 developmental process,-5.5,98,17,30198,84,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-5.4,35,12,30198,314,11,4,36,15,1499|2253|3725|3845,CTNNB1|FGF8|JUN|KRAS,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-5.4,18,9.2,30198,744,11,5,45,15,1499|2253|3845|4040|51176,CTNNB1|FGF8|KRAS|LRP6|LEF1,-4.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001823,mesonephros development,19_GO:0032502 developmental process,-5.4,95,17,30198,87,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4.2
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,,-5.4,93,17,30198,89,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.2
_FINAL_MCODE_ALL,WikiPathways,27,WP2840,Hair follicle development: cytodifferentiation - part 3 of 3,,-5.4,93,17,30198,89,11,3,27,13,1499|3725|51176,CTNNB1|JUN|LEF1,-4.2
_FINAL_MCODE_ALL,WikiPathways,27,WP69,T-cell receptor signaling pathway,,-5.4,91,16,30198,91,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-4.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-195721,Signaling by WNT,,-5.4,33,11,30198,332,11,4,36,15,1499|3845|4040|51176,CTNNB1|KRAS|LRP6|LEF1,-4.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-5.3,18,9,30198,778,11,5,45,15,2246|3815|4040|6464|8817,FGF1|KIT|LRP6|SHC1|FGF18,-4.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04912,GnRH signaling pathway,,-5.3,89,16,30198,93,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-5.3,33,11,30198,335,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-4.1
_FINAL_MCODE_ALL,WikiPathways,27,WP2059,Alzheimer's disease and miRNA effects,,-5.3,33,11,30198,337,11,4,36,15,1499|3845|4040|5595,CTNNB1|KRAS|LRP6|MAPK3,-4.1
_FINAL_MCODE_ALL,WikiPathways,27,WP231,TNF-alpha signaling pathway,,-5.3,88,16,30198,94,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-8878159,Transcriptional regulation by RUNX3,,-5.3,86,16,30198,96,11,3,27,13,1499|3845|51176,CTNNB1|KRAS|LEF1,-4.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05231,Choline metabolism in cancer,,-5.3,84,16,30198,98,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072009,nephron epithelium development,19_GO:0032502 developmental process,-5.3,83,16,30198,99,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-4
_FINAL_MCODE_ALL,WikiPathways,27,WP4540,Hippo signaling regulation pathways,,-5.3,83,16,30198,99,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04933,AGE-RAGE signaling pathway in diabetic complications,,-5.2,82,16,30198,100,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4
_FINAL_MCODE_ALL,WikiPathways,27,WP1544,MicroRNAs in cardiomyocyte hypertrophy,,-5.2,82,15,30198,101,11,3,27,13,1499|4040|5595,CTNNB1|LRP6|MAPK3,-4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0002521,leukocyte differentiation,19_GO:0002376 immune system process,-5.2,31,11,30198,358,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04660,T cell receptor signaling pathway,,-5.2,79,15,30198,104,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04625,C-type lectin receptor signaling pathway,,-5.2,79,15,30198,104,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4
_FINAL_MCODE_ALL,Canonical Pathways,11,M164,PID ERBB1 DOWNSTREAM PATHWAY,,-5.2,78,15,30198,105,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051098,regulation of binding,19_GO:0065007 biological regulation,-5.2,30,11,30198,367,11,4,36,15,1499|3725|5595|51176,CTNNB1|JUN|MAPK3|LEF1,-4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030900,forebrain development,19_GO:0032502 developmental process,-5.1,29,11,30198,374,11,4,36,15,1499|2253|3845|51176,CTNNB1|FGF8|KRAS|LEF1,-3.9
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05010,Alzheimer disease,,-5.1,29,10,30198,384,11,4,36,15,1499|3845|4040|5595,CTNNB1|KRAS|LRP6|MAPK3,-3.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071900,regulation of protein serine/threonine kinase activity,19_GO:0008152 metabolic process,-5.1,28,10,30198,388,11,4,36,15,2246|3815|4040|8817,FGF1|KIT|LRP6|FGF18,-3.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-187037,Signaling by NTRK1 (TRKA),,-5.1,72,14,30198,115,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043406,positive regulation of MAP kinase activity,19_GO:0023052 signaling,-5.1,71,14,30198,116,11,3,27,13,2246|3815|8817,FGF1|KIT|FGF18,-3.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0035113,embryonic appendage morphogenesis,19_GO:0032502 developmental process,-5,69,14,30198,119,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030326,embryonic limb morphogenesis,19_GO:0032502 developmental process,-5,69,14,30198,119,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.8
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04935,"Growth hormone synthesis, secretion and action",,-5,69,14,30198,119,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051101,regulation of DNA binding,19_GO:0065007 biological regulation,-5,68,14,30198,121,11,3,27,13,1499|3725|51176,CTNNB1|JUN|LEF1,-3.8
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04919,Thyroid hormone signaling pathway,,-5,68,14,30198,121,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0042476,odontogenesis,19_GO:0032502 developmental process,-5,68,14,30198,121,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.8
_FINAL_MCODE_ALL,WikiPathways,27,WP4541,Hippo-Merlin signaling dysregulation,,-5,67,14,30198,123,11,3,27,13,1499|3815|3845,CTNNB1|KIT|KRAS,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:2000027,regulation of animal organ morphogenesis,19_GO:0032502 developmental process,-4.9,65,14,30198,126,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048608,reproductive structure development,19_GO:0022414 reproductive process,-4.9,26,9.9,30198,423,11,4,36,15,1499|2253|3815|51176,CTNNB1|FGF8|KIT|LEF1,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0061458,reproductive system development,19_GO:0032502 developmental process,-4.9,26,9.8,30198,426,11,4,36,15,1499|2253|3815|51176,CTNNB1|FGF8|KIT|LEF1,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072006,nephron development,19_GO:0032502 developmental process,-4.9,64,14,30198,128,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-3.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072073,kidney epithelium development,19_GO:0032502 developmental process,-4.9,64,14,30198,128,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-3.8
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04650,Natural killer cell mediated cytotoxicity,,-4.9,63,14,30198,131,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.7
_FINAL_MCODE_ALL,WikiPathways,27,WP3888,VEGFA-VEGFR2 signaling pathway,,-4.9,25,9.7,30198,439,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-3.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-166520,Signaling by NTRKs,,-4.9,61,13,30198,134,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04210,Apoptosis,,-4.8,61,13,30198,136,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-4.8,25,9.6,30198,447,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-3.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04910,Insulin signaling pathway,,-4.8,60,13,30198,137,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051090,regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-4.8,24,9.5,30198,452,11,4,36,15,1499|3815|4040|5595,CTNNB1|KIT|LRP6|MAPK3,-3.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0035107,appendage morphogenesis,19_GO:0032502 developmental process,-4.8,58,13,30198,142,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0035108,limb morphogenesis,19_GO:0032502 developmental process,-4.8,58,13,30198,142,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04550,Signaling pathways regulating pluripotency of stem cells,,-4.8,58,13,30198,143,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-3.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-4.8,57,13,30198,145,11,3,27,13,2253|3725|3845,FGF8|JUN|KRAS,-3.6
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-3858494,Beta-catenin independent WNT signaling,,-4.8,56,13,30198,146,11,3,27,13,1499|3845|51176,CTNNB1|KRAS|LEF1,-3.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05022,Pathways of neurodegeneration - multiple diseases,,-4.7,23,9.3,30198,476,11,4,36,15,1499|3845|4040|5595,CTNNB1|KRAS|LRP6|MAPK3,-3.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030217,T cell differentiation,19_GO:0002376 immune system process,-4.7,54,13,30198,153,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-3.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04921,Oxytocin signaling pathway,,-4.7,53,12,30198,154,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.6
_FINAL_MCODE_ALL,WikiPathways,27,WP4666,Hepatitis B infection,,-4.7,53,12,30198,154,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.6
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04934,Cushing syndrome,,-4.7,53,12,30198,155,11,3,27,13,1499|5595|51176,CTNNB1|MAPK3|LEF1,-3.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04150,mTOR signaling pathway,,-4.7,53,12,30198,156,11,3,27,13,3845|4040|5595,KRAS|LRP6|MAPK3,-3.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04390,Hippo signaling pathway,,-4.7,52,12,30198,157,11,3,27,13,1499|2246|51176,CTNNB1|FGF1|LEF1,-3.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05160,Hepatitis C,,-4.7,52,12,30198,157,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0046661,male sex differentiation,19_GO:0022414 reproductive process,-4.6,51,12,30198,160,11,3,27,13,1499|2253|3815,CTNNB1|FGF8|KIT,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007369,gastrulation,19_GO:0032502 developmental process,-4.6,51,12,30198,161,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.5
_FINAL_MCODE_ALL,WikiPathways,27,WP481,Insulin signaling,,-4.6,51,12,30198,161,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-3.5
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05161,Hepatitis B,,-4.6,51,12,30198,162,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.5
_FINAL_MCODE_ALL,WikiPathways,27,WP437,EGF/EGFR signaling pathway,,-4.6,51,12,30198,163,11,3,27,13,3725|3845|6464,JUN|KRAS|SHC1,-3.5
_FINAL_MCODE_ALL,WikiPathways,27,WP3929,Chemokine signaling pathway,,-4.6,50,12,30198,165,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051100,negative regulation of binding,19_GO:0065007 biological regulation,-4.6,50,12,30198,165,11,3,27,13,3725|5595|51176,JUN|MAPK3|LEF1,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0021543,pallium development,19_GO:0032502 developmental process,-4.6,49,12,30198,168,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0045321,leukocyte activation,19_GO:0002376 immune system process,-4.6,21,8.8,30198,526,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-3.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010634,positive regulation of epithelial cell migration,19_GO:0040011 locomotion,-4.5,47,12,30198,174,11,3,27,13,2246|3725|8817,FGF1|JUN|FGF18,-3.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060173,limb development,19_GO:0032502 developmental process,-4.5,47,12,30198,177,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048736,appendage development,19_GO:0032502 developmental process,-4.5,47,12,30198,177,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0000165,MAPK cascade,19_GO:0023052 signaling,-4.5,46,11,30198,180,11,3,27,13,2253|3845|5595,FGF8|KRAS|MAPK3,-3.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043405,regulation of MAP kinase activity,19_GO:0008152 metabolic process,-4.5,45,11,30198,183,11,3,27,13,2246|3815|8817,FGF1|KIT|FGF18,-3.4
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05034,Alcoholism,,-4.4,44,11,30198,187,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,19_GO:0023052 signaling,-4.4,44,11,30198,189,11,3,27,13,3725|5595|51176,JUN|MAPK3|LEF1,-3.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048598,embryonic morphogenesis,19_GO:0032502 developmental process,-4.4,19,8.4,30198,576,11,4,36,15,1499|2253|5595|51176,CTNNB1|FGF8|MAPK3|LEF1,-3.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-4.4,19,8.3,30198,580,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-3.3
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04062,Chemokine signaling pathway,,-4.4,43,11,30198,192,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-3.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030097,hemopoiesis,19_GO:0002376 immune system process,-4.3,18,8.1,30198,606,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-3.2
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05203,Viral carcinogenesis,,-4.3,40,11,30198,204,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.2
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05205,Proteoglycans in cancer,,-4.3,40,11,30198,205,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-3.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060348,bone development,19_GO:0032502 developmental process,-4.3,39,11,30198,209,11,3,27,13,2253|3815|8817,FGF8|KIT|FGF18,-3.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0050679,positive regulation of epithelial cell proliferation,19_GO:0048518 positive regulation of biological process,-4.3,39,11,30198,210,11,3,27,13,1499|2246|3725,CTNNB1|FGF1|JUN,-3.2
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05170,Human immunodeficiency virus 1 infection,,-4.3,39,11,30198,212,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-4.3,17,7.9,30198,632,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-3.2
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05417,Lipid and atherosclerosis,,-4.2,38,10,30198,215,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-4.2,17,7.9,30198,640,11,4,36,15,1499|3725|5595|6464,CTNNB1|JUN|MAPK3|SHC1,-3.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001775,cell activation,19_GO:0009987 cellular process,-4.2,17,7.8,30198,647,11,4,36,15,1499|3725|3815|51176,CTNNB1|JUN|KIT|LEF1,-3.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05166,Human T-cell leukemia virus 1 infection,,-4.2,37,10,30198,222,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05208,Chemical carcinogenesis - reactive oxygen species,,-4.2,37,10,30198,223,11,3,27,13,3725|3845|5595,JUN|KRAS|MAPK3,-3.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-4.2,17,7.8,30198,653,11,4,36,15,1499|2253|4040|51176,CTNNB1|FGF8|LRP6|LEF1,-3.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071902,positive regulation of protein serine/threonine kinase activity,19_GO:0048518 positive regulation of biological process,-4.2,37,10,30198,224,11,3,27,13,2246|3815|8817,FGF1|KIT|FGF18,-3.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048705,skeletal system morphogenesis,19_GO:0032502 developmental process,-4.2,37,10,30198,225,11,3,27,13,1499|2253|8817,CTNNB1|FGF8|FGF18,-3.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05163,Human cytomegalovirus infection,,-4.2,37,10,30198,225,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-3.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0050920,regulation of chemotaxis,19_GO:0040011 locomotion,-4.2,36,10,30198,226,11,3,27,13,2246|5595|8817,FGF1|MAPK3|FGF18,-3.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-201681,TCF dependent signaling in response to WNT,,-4.1,35,10,30198,233,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.1
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa04020,Calcium signaling pathway,,-4.1,34,9.9,30198,240,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0021537,telencephalon development,19_GO:0032502 developmental process,-4.1,33,9.8,30198,246,11,3,27,13,1499|2253|51176,CTNNB1|FGF8|LEF1,-3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-1280215,Cytokine Signaling in Immune system,,-4,15,7.4,30198,715,11,4,36,15,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030098,lymphocyte differentiation,19_GO:0002376 immune system process,-4,32,9.5,30198,257,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,19_GO:0008152 metabolic process,-4,32,9.5,30198,258,11,3,27,13,2253|3815|6464,FGF8|KIT|SHC1,-3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0198738,cell-cell signaling by wnt,19_GO:0023052 signaling,-4,31,9.4,30198,262,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0016055,Wnt signaling pathway,19_GO:0023052 signaling,-4,31,9.4,30198,262,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0090596,sensory organ morphogenesis,19_GO:0032502 developmental process,-4,31,9.4,30198,262,11,3,27,13,1499|2253|5595,CTNNB1|FGF8|MAPK3,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051091,positive regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-4,31,9.4,30198,265,11,3,27,13,1499|3815|4040,CTNNB1|KIT|LRP6,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0042110,T cell activation,19_GO:0002376 immune system process,-4,31,9.4,30198,265,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001503,ossification,19_GO:0032501 multicellular organismal process,-3.9,30,9.2,30198,273,11,3,27,13,1499|8817|51176,CTNNB1|FGF18|LEF1,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0007548,sex differentiation,19_GO:0022414 reproductive process,-3.9,30,9.2,30198,276,11,3,27,13,1499|2253|3815,CTNNB1|FGF8|KIT,-2.9
_FINAL_MCODE_ALL,WikiPathways,27,WP4754,IL-18 signaling pathway,,-3.9,30,9.1,30198,279,11,3,27,13,1499|3725|5595,CTNNB1|JUN|MAPK3,-2.9
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001822,kidney development,19_GO:0032502 developmental process,-3.9,29,9,30198,287,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-2.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010632,regulation of epithelial cell migration,19_GO:0040011 locomotion,-3.9,28,8.9,30198,290,11,3,27,13,2246|3725|8817,FGF1|JUN|FGF18,-2.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0048562,embryonic organ morphogenesis,19_GO:0032502 developmental process,-3.9,28,8.9,30198,292,11,3,27,13,1499|2253|5595,CTNNB1|FGF8|MAPK3,-2.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0072001,renal system development,19_GO:0032502 developmental process,-3.8,28,8.9,30198,296,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-2.8
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05206,MicroRNAs in cancer,,-3.8,27,8.6,30198,310,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-2.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,19_GO:0023052 signaling,-3.7,25,8.4,30198,326,11,3,27,13,1499|4040|51176,CTNNB1|LRP6|LEF1,-2.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0090287,regulation of cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-3.7,25,8.3,30198,331,11,3,27,13,1499|2246|8817,CTNNB1|FGF1|FGF18,-2.7
_FINAL_MCODE_ALL,KEGG Pathway,24,hsa05165,Human papillomavirus infection,,-3.7,25,8.3,30198,331,11,3,27,13,1499|3845|5595,CTNNB1|KRAS|MAPK3,-2.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0001655,urogenital system development,19_GO:0032502 developmental process,-3.7,25,8.3,30198,334,11,3,27,13,1499|2246|2253,CTNNB1|FGF1|FGF8,-2.7
_FINAL_MCODE_ALL,Canonical Pathways,11,M5883,NABA SECRETED FACTORS,,-3.6,24,8.2,30198,343,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-2.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0045765,regulation of angiogenesis,19_GO:0032502 developmental process,-3.6,24,8.1,30198,347,11,3,27,13,1499|2246|8817,CTNNB1|FGF1|FGF18,-2.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010038,response to metal ion,19_GO:0050896 response to stimulus,-3.6,23,8.1,30198,351,11,3,27,13,3725|3815|5595,JUN|KIT|MAPK3,-2.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:1901342,regulation of vasculature development,19_GO:0032502 developmental process,-3.6,23,8.1,30198,353,11,3,27,13,1499|2246|8817,CTNNB1|FGF1|FGF18,-2.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0050767,regulation of neurogenesis,19_GO:0032502 developmental process,-3.6,23,7.9,30198,364,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-2.6
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0050678,regulation of epithelial cell proliferation,19_GO:0050789 regulation of biological process,-3.5,22,7.7,30198,382,11,3,27,13,1499|2246|3725,CTNNB1|FGF1|JUN,-2.5
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0045860,positive regulation of protein kinase activity,19_GO:0048518 positive regulation of biological process,-3.4,20,7.4,30198,409,11,3,27,13,2246|3815|8817,FGF1|KIT|FGF18,-2.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0046649,lymphocyte activation,19_GO:0002376 immune system process,-3.4,20,7.4,30198,417,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-2.4
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0051960,regulation of nervous system development,19_GO:0032502 developmental process,-3.3,19,7.1,30198,443,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-2.3
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-449147,Signaling by Interleukins,,-3.3,18,7,30198,462,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-2.3
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0033674,positive regulation of kinase activity,19_GO:0048518 positive regulation of biological process,-3.2,17,6.7,30198,489,11,3,27,13,2246|3815|8817,FGF1|KIT|FGF18,-2.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0060284,regulation of cell development,19_GO:0032502 developmental process,-3.2,16,6.7,30198,501,11,3,27,13,1499|3815|51176,CTNNB1|KIT|LEF1,-2.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010638,positive regulation of organelle organization,19_GO:0048518 positive regulation of biological process,-3.2,16,6.6,30198,503,11,3,27,13,1499|2253|5595,CTNNB1|FGF8|MAPK3,-2.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071407,cellular response to organic cyclic compound,19_GO:0050896 response to stimulus,-3.2,16,6.6,30198,505,11,3,27,13,1499|4040|5595,CTNNB1|LRP6|MAPK3,-2.2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0031400,negative regulation of protein modification process,19_GO:0048519 negative regulation of biological process,-3.1,16,6.5,30198,520,11,3,27,13,1499|3725|4040,CTNNB1|JUN|LRP6,-2.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0010035,response to inorganic substance,19_GO:0050896 response to stimulus,-3.1,16,6.5,30198,521,11,3,27,13,3725|3815|5595,JUN|KIT|MAPK3,-2.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030036,actin cytoskeleton organization,19_GO:0009987 cellular process,-3.1,15,6.4,30198,538,11,3,27,13,3815|3845|6464,KIT|KRAS|SHC1,-2.1
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-422475,Axon guidance,,-3,15,6.3,30198,552,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-2.1
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030855,epithelial cell differentiation,19_GO:0032502 developmental process,-3,14,6.2,30198,576,11,3,27,13,1499|2253|3725,CTNNB1|FGF8|JUN,-2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9675108,Nervous system development,,-3,14,6.1,30198,577,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-2
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0030029,actin filament-based process,19_GO:0009987 cellular process,-2.9,14,6,30198,601,11,3,27,13,3815|3845|6464,KIT|KRAS|SHC1,-2
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-109582,Hemostasis,,-2.9,13,5.9,30198,621,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-1.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-2.9,13,5.8,30198,633,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-1.9
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-2.7,12,5.5,30198,708,11,3,27,13,3845|5595|6464,KRAS|MAPK3|SHC1,-1.8
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0071345,cellular response to cytokine stimulus,19_GO:0050896 response to stimulus,-2.7,12,5.5,30198,710,11,3,27,13,3815|5595|51176,KIT|MAPK3|LEF1,-1.8
_FINAL_MCODE_ALL,Canonical Pathways,11,M5885,NABA MATRISOME ASSOCIATED,,-2.7,11,5.3,30198,751,11,3,27,13,2246|2253|8817,FGF1|FGF8|FGF18,-1.7
_FINAL_MCODE_ALL,GO Biological Processes,19,GO:0009725,response to hormone,19_GO:0050896 response to stimulus,-2.7,11,5.3,30198,753,11,3,27,13,3815|4040|6464,KIT|LRP6|SHC1,-1.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-2262752,Cellular responses to stress,,-2.6,11,5.1,30198,784,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-1.7
_FINAL_MCODE_ALL,Reactome Gene Sets,6,R-HSA-8953897,Cellular responses to stimuli,,-2.6,10,5.1,30198,798,11,3,27,13,3725|5595|6464,JUN|MAPK3|SHC1,-1.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05224,Breast cancer,,-19,2.1e+02,40,30198,147,8,8,1e+02,12,2246|2253|3725|3815|3845|5595|6464|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SHC1|FGF18,-15
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4262,Breast cancer pathway,,-18,1.9e+02,39,30198,157,8,8,1e+02,12,2246|2253|3725|3815|3845|5595|6464|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SHC1|FGF18,-15
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-16,5.7e+02,58,30198,40,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-13
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-16,5.5e+02,58,30198,41,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-13
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-16,93,27,30198,325,8,8,1e+02,12,2246|2253|3725|3815|3845|5595|6464|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|SHC1|FGF18,-13
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-15,4.5e+02,52,30198,50,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-12
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-15,4.2e+02,50,30198,54,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-12
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M276,PID FGF PATHWAY,,-15,4.1e+02,50,30198,55,8,6,75,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-12
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654704,SHC-mediated cascade:FGFR3,,-15,1e+03,72,30198,18,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-12
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654719,SHC-mediated cascade:FGFR4,,-14,9.4e+02,69,30198,20,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-14,3.1e+02,43,30198,73,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-14,2.9e+02,42,30198,78,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654699,SHC-mediated cascade:FGFR2,,-14,8.2e+02,64,30198,23,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-14,1.1e+02,28,30198,232,8,7,88,12,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-14,2.6e+02,39,30198,87,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654708,Downstream signaling of activated FGFR3,,-14,7.5e+02,61,30198,25,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654716,Downstream signaling of activated FGFR4,,-14,7e+02,59,30198,27,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654696,Downstream signaling of activated FGFR2,,-13,6.3e+02,56,30198,30,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-13,94,26,30198,280,8,7,88,12,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-13,92,25,30198,286,8,7,88,12,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-11
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-13,90,25,30198,294,8,7,88,12,2246|2253|3725|3815|3845|5595|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|FGF18,-11
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05226,Gastric cancer,,-12,1.5e+02,30,30198,149,8,6,75,15,2246|2253|3845|5595|6464|8817,FGF1|FGF8|KRAS|MAPK3|SHC1|FGF18,-9.9
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-12,3.6e+02,42,30198,53,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-9.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-12,3.5e+02,42,30198,54,8,5,62,17,2246|2253|3845|6464|8817,FGF1|FGF8|KRAS|SHC1|FGF18,-9.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-12,61,20,30198,433,8,7,88,12,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9.5
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-12,59,20,30198,447,8,7,88,12,2246|2253|3725|3815|5595|6464|8817,FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-9.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-12,54,19,30198,492,8,7,88,12,2246|2253|3725|3815|5595|6464|8817,FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-9.2
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-12,1.1e+02,25,30198,210,8,6,75,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-9.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-11,51,19,30198,521,8,7,88,12,2246|2253|3815|3845|5595|6464|8817,FGF1|FGF8|KIT|KRAS|MAPK3|SHC1|FGF18,-9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4928,MAPK pathway in congenital thyroid cancer,,-11,9.4e+02,61,30198,16,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05218,Melanoma,,-11,2.6e+02,36,30198,72,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05200,Pathways in cancer,,-11,50,18,30198,531,8,7,88,12,2246|2253|3725|3815|3845|5595|8817,FGF1|FGF8|JUN|KIT|KRAS|MAPK3|FGF18,-9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-11,1e+02,25,30198,221,8,6,75,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP382,MAPK signaling pathway,,-11,91,23,30198,249,8,6,75,15,2246|2253|3725|3845|5595|8817,FGF1|FGF8|JUN|KRAS|MAPK3|FGF18,-8.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654706,FRS-mediated FGFR3 signaling,,-11,7.5e+02,55,30198,20,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-11,44,17,30198,606,8,7,88,12,2246|2253|3725|3815|5595|6464|8817,FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-8.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654688,SHC-mediated cascade:FGFR1,,-11,7.2e+02,54,30198,21,8,4,50,18,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-8.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-11,85,22,30198,267,8,6,75,15,2246|2253|3725|3815|5595|8817,FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-8.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655332,Signaling by FGFR3 in disease,,-11,6.9e+02,52,30198,22,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8.5
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654712,FRS-mediated FGFR4 signaling,,-11,6.9e+02,52,30198,22,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-11,38,16,30198,688,8,7,88,12,2246|2253|3725|3815|5595|6464|8817,FGF1|FGF8|JUN|KIT|MAPK3|SHC1|FGF18,-8.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654700,FRS-mediated FGFR2 signaling,,-11,6e+02,49,30198,25,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-8.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",,-11,1.8e+02,30,30198,106,8,5,62,17,2246|2253|3815|5595|8817,FGF1|FGF8|KIT|MAPK3|FGF18,-8.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-11,73,21,30198,309,8,6,75,15,2246|2253|3725|3815|5595|8817,FGF1|FGF8|JUN|KIT|MAPK3|FGF18,-8.3
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-11,73,21,30198,309,8,6,75,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-8.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-10,73,21,30198,312,8,6,75,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-8.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-199418,Negative regulation of the PI3K/AKT network,,-10,1.7e+02,29,30198,113,8,5,62,17,2246|2253|3815|5595|8817,FGF1|FGF8|KIT|MAPK3|FGF18,-8.2
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4659,Gastrin signaling pathway,,-10,1.7e+02,29,30198,114,8,5,62,17,3725|3815|3845|5595|6464,JUN|KIT|KRAS|MAPK3|SHC1,-8.2
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654732,Negative regulation of FGFR3 signaling,,-10,5.2e+02,46,30198,29,8,4,50,18,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-8.1
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-10,66,20,30198,345,8,6,75,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-8.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654733,Negative regulation of FGFR4 signaling,,-10,4.9e+02,44,30198,31,8,4,50,18,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-8
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654687,Downstream signaling of activated FGFR1,,-10,4.9e+02,44,30198,31,8,4,50,18,2246|2253|3845|6464,FGF1|FGF8|KRAS|SHC1,-8
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-10,64,19,30198,354,8,6,75,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-8
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2871796,FCERI mediated MAPK activation,,-10,4.7e+02,43,30198,32,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-8
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654727,Negative regulation of FGFR2 signaling,,-10,4.4e+02,42,30198,34,8,4,50,18,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-7.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP51,Regulation of actin cytoskeleton,,-9.8,1.3e+02,25,30198,150,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7.7
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP127,IL-5 signaling pathway,,-9.7,3.8e+02,39,30198,40,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655253,Signaling by FGFR2 in disease,,-9.6,3.5e+02,37,30198,43,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7.5
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M175,PID ERBB2 ERBB3 PATHWAY,,-9.6,3.4e+02,37,30198,44,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-9.5,1.1e+02,23,30198,174,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-9.4,48,17,30198,468,8,6,75,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-7.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-9.4,1.1e+02,23,30198,178,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-112399,IRS-mediated signalling,,-9.4,3.1e+02,35,30198,48,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190371,FGFR3b ligand binding and activation,,-9.4,1.6e+03,70,30198,7,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-7.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-9.3,45,16,30198,498,8,6,75,15,2246|2253|3725|5595|6464|8817,FGF1|FGF8|JUN|MAPK3|SHC1|FGF18,-7.2
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2428928,IRS-related events triggered by IGF1R,,-9.3,2.9e+02,34,30198,52,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7.2
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-9.2,95,22,30198,198,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7.2
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M122,PID IL2 1PATHWAY,,-9.2,2.7e+02,33,30198,55,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-7.2
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-9,89,21,30198,212,8,5,62,17,2253|3725|3845|5595|8817,FGF8|JUN|KRAS|MAPK3|FGF18,-7.1
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04810,Regulation of actin cytoskeleton,,-9,87,21,30198,218,8,5,62,17,2246|2253|3845|5595|8817,FGF1|FGF8|KRAS|MAPK3|FGF18,-7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1226099,Signaling by FGFR in disease,,-8.9,2.4e+02,31,30198,63,8,4,50,18,2246|2253|3845|8817,FGF1|FGF8|KRAS|FGF18,-7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2033514,FGFR3 mutant receptor activation,,-8.6,9.4e+02,53,30198,12,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1839130,Signaling by activated point mutants of FGFR3,,-8.6,9.4e+02,53,30198,12,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,,-8.5,1.9e+02,28,30198,78,8,4,50,18,2246|2253|3815|8817,FGF1|FGF8|KIT|FGF18,-6.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-8.5,34,14,30198,663,8,6,75,15,2246|2253|3725|3845|6464|8817,FGF1|FGF8|JUN|KRAS|SHC1|FGF18,-6.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190372,FGFR3c ligand binding and activation,,-8.5,8.7e+02,51,30198,13,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190239,FGFR3 ligand binding and activation,,-8.5,8.7e+02,51,30198,13,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190375,FGFR2c ligand binding and activation,,-8.5,8.7e+02,51,30198,13,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,,-8.5,8.7e+02,51,30198,13,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04012,ErbB signaling pathway,,-8.4,1.8e+02,27,30198,85,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190322,FGFR4 ligand binding and activation,,-8.4,8.1e+02,49,30198,14,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.6
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP673,ErbB signaling pathway,,-8.3,1.7e+02,26,30198,91,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6.5
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,,-8.3,7.5e+02,48,30198,15,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-8.2,31,13,30198,741,8,6,75,15,2246|2253|3815|3845|5595|8817,FGF1|FGF8|KIT|KRAS|MAPK3|FGF18,-6.5
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa01522,Endocrine resistance,,-8.1,1.5e+02,25,30198,98,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-8.1,58,17,30198,323,8,5,62,17,2246|2253|3725|6464|8817,FGF1|FGF8|JUN|SHC1|FGF18,-6.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2033519,Activated point mutants of FGFR2,,-8.1,6.7e+02,45,30198,17,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2219528,PI3K/AKT Signaling in Cancer,,-8,1.5e+02,24,30198,104,8,4,50,18,2246|2253|3815|8817,FGF1|FGF8|KIT|FGF18,-6.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654710,PI-3K cascade:FGFR3,,-8,6.3e+02,43,30198,18,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,,-8,6.3e+02,43,30198,18,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654720,PI-3K cascade:FGFR4,,-7.9,5.7e+02,41,30198,20,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.2
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-190241,FGFR2 ligand binding and activation,,-7.9,5.7e+02,41,30198,20,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6.2
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04722,Neurotrophin signaling pathway,,-7.8,1.3e+02,22,30198,119,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6.1
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-7.8,1.3e+02,22,30198,119,8,4,50,18,2246|2253|3725|8817,FGF1|FGF8|JUN|FGF18,-6.1
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-7.8,1.3e+02,22,30198,120,8,4,50,18,2246|2253|5595|8817,FGF1|FGF8|MAPK3|FGF18,-6.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654695,PI-3K cascade:FGFR2,,-7.7,4.9e+02,38,30198,23,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654693,FRS-mediated FGFR1 signaling,,-7.7,4.9e+02,38,30198,23,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-6
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M186,PID PDGFRB PATHWAY,,-7.7,1.2e+02,22,30198,129,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04926,Relaxin signaling pathway,,-7.7,1.2e+02,22,30198,129,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,19_GO:0023052 signaling,-7.6,47,15,30198,405,8,5,62,17,2246|2253|3815|6464|8817,FGF1|FGF8|KIT|SHC1|FGF18,-6
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M17200,SA B CELL RECEPTOR COMPLEXES,,-7.6,4.7e+02,38,30198,24,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,,-7.6,1.1e+02,21,30198,134,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-7.6,45,15,30198,421,8,5,62,17,2246|2253|3725|6464|8817,FGF1|FGF8|JUN|SHC1|FGF18,-5.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04915,Estrogen signaling pathway,,-7.5,1.1e+02,21,30198,138,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04072,Phospholipase D signaling pathway,,-7.4,1e+02,20,30198,148,8,4,50,18,3815|3845|5595|6464,KIT|KRAS|MAPK3|SHC1,-5.8
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP3972,PDGFR-beta pathway,,-7.4,3.9e+02,34,30198,29,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5.7
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP422,MAPK cascade,,-7.2,3.4e+02,32,30198,33,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-5.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1839126,FGFR2 mutant receptor activation,,-7.2,3.4e+02,32,30198,33,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-5.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5654726,Negative regulation of FGFR1 signaling,,-7.2,3.4e+02,32,30198,33,8,3,38,17,2246|2253|5595,FGF1|FGF8|MAPK3,-5.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-7.2,37,13,30198,505,8,5,62,17,2246|2253|3725|6464|8817,FGF1|FGF8|JUN|SHC1|FGF18,-5.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-187687,Signalling to ERKs,,-7.1,3.3e+02,32,30198,34,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-5.6
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M127,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,,-7.1,3.2e+02,31,30198,35,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-5.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-7.1,36,13,30198,526,8,5,62,17,2246|2253|3725|6464|8817,FGF1|FGF8|JUN|SHC1|FGF18,-5.5
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M22,PID GMCSF PATHWAY,,-7.1,3.1e+02,31,30198,36,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-5.5
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4223,Ras signaling,,-7,82,18,30198,185,8,4,50,18,3815|3845|5595|6464,KIT|KRAS|MAPK3|SHC1,-5.5
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5655302,Signaling by FGFR1 in disease,,-7,3e+02,30,30198,38,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-5.5
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M82,PID RET PATHWAY,,-7,2.9e+02,29,30198,39,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0030335,positive regulation of cell migration,19_GO:0040011 locomotion,-6.9,34,13,30198,560,8,5,62,17,2246|3725|3815|5595|8817,FGF1|JUN|KIT|MAPK3|FGF18,-5.4
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M62,PID EPHB FWD PATHWAY,,-6.9,2.8e+02,29,30198,40,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-5.4
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2526,PDGF pathway,,-6.9,2.8e+02,29,30198,40,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5.4
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP49,IL-2 signaling pathway,,-6.9,2.7e+02,28,30198,42,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:2000147,positive regulation of cell motility,19_GO:0040011 locomotion,-6.8,32,12,30198,584,8,5,62,17,2246|3725|3815|5595|8817,FGF1|JUN|KIT|MAPK3|FGF18,-5.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0060425,lung morphogenesis,19_GO:0032502 developmental process,-6.8,2.6e+02,28,30198,43,8,3,38,17,2253|3845|5595,FGF8|KRAS|MAPK3,-5.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0051272,positive regulation of cellular component movement,19_GO:0051179 localization,-6.8,32,12,30198,597,8,5,62,17,2246|3725|3815|5595|8817,FGF1|JUN|KIT|MAPK3|FGF18,-5.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-109704,PI3K Cascade,,-6.8,2.6e+02,28,30198,44,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-5.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0040017,positive regulation of locomotion,19_GO:0040011 locomotion,-6.8,32,12,30198,599,8,5,62,17,2246|3725|3815|5595|8817,FGF1|JUN|KIT|MAPK3|FGF18,-5.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-8939211,ESR-mediated signaling,,-6.7,68,16,30198,223,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-5.2
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2848,Pluripotent stem cell differentiation pathway,,-6.7,2.4e+02,27,30198,48,8,3,38,17,2246|2253|3815,FGF1|FGF8|KIT,-5.2
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP286,IL-3 signaling pathway,,-6.7,2.3e+02,26,30198,49,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5.2
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0008543,fibroblast growth factor receptor signaling pathway,19_GO:0023052 signaling,-6.7,2.3e+02,26,30198,49,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-5.2
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M231,PID KIT PATHWAY,,-6.6,2.2e+02,25,30198,52,8,3,38,17,3815|5595|6464,KIT|MAPK3|SHC1,-5.1
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4205,MET in type 1 papillary renal cell carcinoma,,-6.4,1.9e+02,24,30198,59,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0046686,response to cadmium ion,19_GO:0050896 response to stimulus,-6.4,1.9e+02,24,30198,59,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-5
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP304,Kit receptor signaling pathway,,-6.4,1.9e+02,24,30198,60,8,3,38,17,3815|5595|6464,KIT|MAPK3|SHC1,-5
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M7,PID FCER1 PATHWAY,,-6.4,1.9e+02,24,30198,60,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-5
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M187,PID TRKR PATHWAY,,-6.4,1.9e+02,23,30198,61,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.9
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M10,PID BCR 5PATHWAY,,-6.3,1.8e+02,23,30198,63,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4155,Endometrial cancer,,-6.3,1.8e+02,23,30198,63,8,3,38,17,2246|3845|5595,FGF1|KRAS|MAPK3,-4.9
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M272,PID CD8 TCR DOWNSTREAM PATHWAY,,-6.3,1.7e+02,23,30198,65,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2324,AGE/RAGE pathway,,-6.3,1.7e+02,23,30198,66,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2374,Oncostatin M signaling pathway,,-6.3,1.7e+02,23,30198,66,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05221,Acute myeloid leukemia,,-6.2,1.7e+02,22,30198,67,8,3,38,17,3815|3845|5595,KIT|KRAS|MAPK3,-4.8
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4685,Melanoma,,-6.2,1.7e+02,22,30198,68,8,3,38,17,3815|3845|5595,KIT|KRAS|MAPK3,-4.8
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05211,Renal cell carcinoma,,-6.2,1.6e+02,22,30198,69,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.8
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9006931,Signaling by Nuclear Receptors,,-6.2,50,14,30198,299,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-4.8
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05230,Central carbon metabolism in cancer,,-6.2,1.6e+02,22,30198,70,8,3,38,17,3815|3845|5595,KIT|KRAS|MAPK3,-4.8
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04917,Prolactin signaling pathway,,-6.2,1.6e+02,22,30198,70,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.8
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4341,"Non-genomic actions of 1,25 dihydroxyvitamin D3",,-6.2,1.6e+02,22,30198,71,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.8
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4216,Chromosomal and microsatellite instability in colorectal cancer,,-6.1,1.5e+02,21,30198,74,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05214,Glioma,,-6.1,1.5e+02,21,30198,75,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05220,Chronic myeloid leukemia,,-6.1,1.5e+02,21,30198,76,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2037,Prolactin signaling pathway,,-6.1,1.5e+02,21,30198,76,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9009391,Extra-nuclear estrogen signaling,,-6.1,1.5e+02,21,30198,77,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0044344,cellular response to fibroblast growth factor stimulus,19_GO:0050896 response to stimulus,-6,1.5e+02,21,30198,78,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-4.7
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M48,PID MET PATHWAY,,-6,1.4e+02,21,30198,79,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa01521,EGFR tyrosine kinase inhibitor resistance,,-6,1.4e+02,21,30198,79,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04662,B cell receptor signaling pathway,,-6,1.4e+02,20,30198,82,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0071774,response to fibroblast growth factor,19_GO:0050896 response to stimulus,-5.9,1.3e+02,20,30198,84,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-4.6
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4806,EGFR tyrosine kinase inhibitor resistance,,-5.9,1.3e+02,20,30198,84,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05210,Colorectal cancer,,-5.9,1.3e+02,20,30198,86,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,,-5.9,1.3e+02,19,30198,89,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.5
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP69,T-cell receptor signaling pathway,,-5.8,1.2e+02,19,30198,91,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4.5
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04912,GnRH signaling pathway,,-5.8,1.2e+02,19,30198,93,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.5
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP231,TNF-alpha signaling pathway,,-5.8,1.2e+02,19,30198,94,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.5
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05231,Choline metabolism in cancer,,-5.7,1.2e+02,18,30198,98,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04933,AGE-RAGE signaling pathway in diabetic complications,,-5.7,1.1e+02,18,30198,100,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04916,Melanogenesis,,-5.7,1.1e+02,18,30198,101,8,3,38,17,3815|3845|5595,KIT|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04660,T cell receptor signaling pathway,,-5.7,1.1e+02,18,30198,104,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04625,C-type lectin receptor signaling pathway,,-5.7,1.1e+02,18,30198,104,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M164,PID ERBB1 DOWNSTREAM PATHWAY,,-5.6,1.1e+02,18,30198,105,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.4
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-5.5,98,17,30198,115,8,3,38,17,3725|3845|6464,JUN|KRAS|SHC1,-4.3
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-187037,Signaling by NTRK1 (TRKA),,-5.5,98,17,30198,115,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043406,positive regulation of MAP kinase activity,19_GO:0023052 signaling,-5.5,98,17,30198,116,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-4.3
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04935,"Growth hormone synthesis, secretion and action",,-5.5,95,17,30198,119,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.2
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04650,Natural killer cell mediated cytotoxicity,,-5.4,86,16,30198,131,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.1
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048754,branching morphogenesis of an epithelial tube,19_GO:0032502 developmental process,-5.3,85,16,30198,133,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-4.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-166520,Signaling by NTRKs,,-5.3,85,16,30198,134,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.1
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04210,Apoptosis,,-5.3,83,16,30198,136,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-4.1
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04910,Insulin signaling pathway,,-5.3,83,16,30198,137,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-4.1
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001501,skeletal system development,19_GO:0032502 developmental process,-5.3,30,11,30198,505,8,4,50,18,2253|3815|5595|8817,FGF8|KIT|MAPK3|FGF18,-4.1
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-5.2,79,15,30198,144,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043524,negative regulation of neuron apoptotic process,19_GO:0048519 negative regulation of biological process,-5.2,78,15,30198,145,8,3,38,17,2253|3725|3845,FGF8|JUN|KRAS,-4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-5.2,28,10,30198,541,8,4,50,18,2253|3725|5595|6464,FGF8|JUN|MAPK3|SHC1,-4
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4666,Hepatitis B infection,,-5.1,74,15,30198,154,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04921,Oxytocin signaling pathway,,-5.1,74,15,30198,154,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0007423,sensory organ development,19_GO:0032502 developmental process,-5.1,27,10,30198,555,8,4,50,18,2253|3725|3815|5595,FGF8|JUN|KIT|MAPK3,-3.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP481,Insulin signaling,,-5.1,70,14,30198,161,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-3.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0061138,morphogenesis of a branching epithelium,19_GO:0032502 developmental process,-5.1,70,14,30198,162,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-3.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05161,Hepatitis B,,-5.1,70,14,30198,162,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP437,EGF/EGFR signaling pathway,,-5.1,69,14,30198,163,8,3,38,17,3725|3845|6464,JUN|KRAS|SHC1,-3.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-5.1,26,10,30198,575,8,4,50,18,2246|3815|5595|8817,FGF1|KIT|MAPK3|FGF18,-3.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-5.1,69,14,30198,165,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.9
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP3929,Chemokine signaling pathway,,-5.1,69,14,30198,165,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.9
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-5,67,14,30198,168,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.8
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0001763,morphogenesis of a branching structure,19_GO:0032502 developmental process,-5,66,14,30198,171,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-3.8
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0010634,positive regulation of epithelial cell migration,19_GO:0040011 locomotion,-5,65,14,30198,174,8,3,38,17,2246|3725|8817,FGF1|JUN|FGF18,-3.8
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0000165,MAPK cascade,19_GO:0023052 signaling,-4.9,63,14,30198,180,8,3,38,17,2253|3845|5595,FGF8|KRAS|MAPK3,-3.8
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043405,regulation of MAP kinase activity,19_GO:0008152 metabolic process,-4.9,62,13,30198,183,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-3.8
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05034,Alcoholism,,-4.9,61,13,30198,187,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04062,Chemokine signaling pathway,,-4.9,59,13,30198,192,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-4.8,58,13,30198,194,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-4.8,23,9.3,30198,660,8,4,50,18,2246|3815|6464|8817,FGF1|KIT|SHC1|FGF18,-3.7
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04510,Focal adhesion,,-4.8,56,13,30198,201,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-3.7
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP306,Focal adhesion,,-4.8,56,13,30198,202,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-3.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0009612,response to mechanical stimulus,19_GO:0050896 response to stimulus,-4.8,56,13,30198,203,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-3.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05203,Viral carcinogenesis,,-4.8,56,13,30198,204,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043523,regulation of neuron apoptotic process,19_GO:0050789 regulation of biological process,-4.8,55,13,30198,207,8,3,38,17,2253|3725|3845,FGF8|JUN|KRAS,-3.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:1901215,negative regulation of neuron death,19_GO:0048519 negative regulation of biological process,-4.7,54,13,30198,209,8,3,38,17,2253|3725|3845,FGF8|JUN|KRAS,-3.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0060348,bone development,19_GO:0032502 developmental process,-4.7,54,13,30198,209,8,3,38,17,2253|3815|8817,FGF8|KIT|FGF18,-3.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05170,Human immunodeficiency virus 1 infection,,-4.7,53,12,30198,212,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05417,Lipid and atherosclerosis,,-4.7,53,12,30198,215,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.6
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-1280215,Cytokine Signaling in Immune system,,-4.7,21,8.9,30198,715,8,4,50,18,3725|3845|5595|6464,JUN|KRAS|MAPK3|SHC1,-3.6
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05166,Human T-cell leukemia virus 1 infection,,-4.7,51,12,30198,222,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.5
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05208,Chemical carcinogenesis - reactive oxygen species,,-4.7,51,12,30198,223,8,3,38,17,3725|3845|5595,JUN|KRAS|MAPK3,-3.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0071902,positive regulation of protein serine/threonine kinase activity,19_GO:0048518 positive regulation of biological process,-4.7,51,12,30198,224,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-3.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0050920,regulation of chemotaxis,19_GO:0040011 locomotion,-4.6,50,12,30198,226,8,3,38,17,2246|5595|8817,FGF1|MAPK3|FGF18,-3.5
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa04020,Calcium signaling pathway,,-4.6,47,12,30198,240,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-3.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-4.6,19,8.5,30198,778,8,4,50,18,2246|3815|6464|8817,FGF1|KIT|SHC1|FGF18,-3.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,19_GO:0008152 metabolic process,-4.5,44,11,30198,258,8,3,38,17,2253|3815|6464,FGF8|KIT|SHC1,-3.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0010632,regulation of epithelial cell migration,19_GO:0040011 locomotion,-4.3,39,11,30198,290,8,3,38,17,2246|3725|8817,FGF1|JUN|FGF18,-3.2
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0060562,epithelial tube morphogenesis,19_GO:0032502 developmental process,-4.3,37,10,30198,307,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-3.2
_FINAL_SUB1_MCODE_1,KEGG Pathway,24,hsa05206,MicroRNAs in cancer,,-4.2,37,10,30198,310,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-3.2
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:1901214,regulation of neuron death,19_GO:0050789 regulation of biological process,-4.2,36,10,30198,314,8,3,38,17,2253|3725|3845,FGF8|JUN|KRAS,-3.2
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M5883,NABA SECRETED FACTORS,,-4.1,33,9.7,30198,343,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0010038,response to metal ion,19_GO:0050896 response to stimulus,-4.1,32,9.6,30198,351,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0071900,regulation of protein serine/threonine kinase activity,19_GO:0008152 metabolic process,-3.9,29,9.1,30198,388,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-2.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-3.9,28,8.9,30198,402,8,3,38,17,2253|3725|5595,FGF8|JUN|MAPK3,-2.9
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0045860,positive regulation of protein kinase activity,19_GO:0048518 positive regulation of biological process,-3.9,28,8.8,30198,409,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-2.8
_FINAL_SUB1_MCODE_1,WikiPathways,27,WP3888,VEGFA-VEGFR2 signaling pathway,,-3.8,26,8.5,30198,439,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.8
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048568,embryonic organ development,19_GO:0032502 developmental process,-3.8,25,8.5,30198,445,8,3,38,17,2253|3815|5595,FGF8|KIT|MAPK3,-2.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0002009,morphogenesis of an epithelium,19_GO:0032502 developmental process,-3.8,25,8.4,30198,447,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-2.7
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-449147,Signaling by Interleukins,,-3.7,25,8.3,30198,462,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.7
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0033674,positive regulation of kinase activity,19_GO:0048518 positive regulation of biological process,-3.7,23,8,30198,489,8,3,38,17,2246|3815|8817,FGF1|KIT|FGF18,-2.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0010035,response to inorganic substance,19_GO:0050896 response to stimulus,-3.6,22,7.8,30198,521,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-2.6
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0030036,actin cytoskeleton organization,19_GO:0009987 cellular process,-3.5,21,7.6,30198,538,8,3,38,17,3815|3845|6464,KIT|KRAS|SHC1,-2.5
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-422475,Axon guidance,,-3.5,21,7.5,30198,552,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-2.5
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048729,tissue morphogenesis,19_GO:0032502 developmental process,-3.5,20,7.5,30198,557,8,3,38,17,2246|2253|3845,FGF1|FGF8|KRAS,-2.5
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-9675108,Nervous system development,,-3.4,20,7.4,30198,577,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-2.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-3.4,20,7.3,30198,580,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.4
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0030029,actin filament-based process,19_GO:0009987 cellular process,-3.4,19,7.2,30198,601,8,3,38,17,3815|3845|6464,KIT|KRAS|SHC1,-2.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-109582,Hemostasis,,-3.3,18,7.1,30198,621,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-2.4
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-3.3,18,7,30198,633,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-2.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-3.3,18,6.9,30198,640,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0048534,hematopoietic or lymphoid organ development,19_GO:0002376 immune system process,-3.3,17,6.9,30198,655,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-2.3
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0002520,immune system development,19_GO:0002376 immune system process,-3.2,16,6.6,30198,699,8,3,38,17,3725|3815|5595,JUN|KIT|MAPK3,-2.2
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-3.2,16,6.6,30198,708,8,3,38,17,3845|5595|6464,KRAS|MAPK3|SHC1,-2.2
_FINAL_SUB1_MCODE_1,Canonical Pathways,11,M5885,NABA MATRISOME ASSOCIATED,,-3.1,15,6.4,30198,751,8,3,38,17,2246|2253|8817,FGF1|FGF8|FGF18,-2.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-2262752,Cellular responses to stress,,-3.1,14,6.2,30198,784,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.1
_FINAL_SUB1_MCODE_1,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-3,14,6.2,30198,789,8,3,38,17,2253|3845|5595,FGF8|KRAS|MAPK3,-2.1
_FINAL_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-8953897,Cellular responses to stimuli,,-3,14,6.1,30198,798,8,3,38,17,3725|5595|6464,JUN|MAPK3|SHC1,-2.1
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP3658,Wnt/beta-catenin signaling pathway in leukemia,,-9.2,1.2e+03,59,30198,26,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-7.2
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP363,Wnt signaling pathway,,-8.3,5.7e+02,41,30198,53,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-6.5
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-7.8,3.9e+02,34,30198,78,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-6.1
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0060070,canonical Wnt signaling pathway,19_GO:0023052 signaling,-7.7,3.6e+02,33,30198,84,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-6
_FINAL_SUB1_MCODE_2,Canonical Pathways,11,M5493,WNT SIGNALING,,-7.6,3.4e+02,32,30198,89,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-6
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,,-7.6,3.3e+02,32,30198,91,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.9
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,,-7.4,2.9e+02,29,30198,104,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.8
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP399,Wnt signaling pathway and pluripotency,,-7.4,2.8e+02,29,30198,107,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.8
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP428,Wnt signaling,,-7.2,2.6e+02,28,30198,118,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.7
_FINAL_SUB1_MCODE_2,KEGG Pathway,24,hsa05224,Breast cancer,,-6.9,2.1e+02,25,30198,147,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.4
_FINAL_SUB1_MCODE_2,KEGG Pathway,24,hsa05226,Gastric cancer,,-6.9,2e+02,25,30198,149,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.4
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP4262,Breast cancer pathway,,-6.9,1.9e+02,24,30198,157,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.4
_FINAL_SUB1_MCODE_2,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-6.8,1.8e+02,23,30198,167,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.3
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-6.8,1.8e+02,23,30198,168,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.3
_FINAL_SUB1_MCODE_2,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-6.8,1.8e+02,23,30198,168,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5.3
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-6.5,1.4e+02,21,30198,210,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-5
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-6.4,1.3e+02,20,30198,231,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.9
_FINAL_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-201681,TCF dependent signaling in response to WNT,,-6.3,1.3e+02,20,30198,233,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.9
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0198738,cell-cell signaling by wnt,19_GO:0023052 signaling,-6.2,1.2e+02,19,30198,262,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.8
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0016055,Wnt signaling pathway,19_GO:0023052 signaling,-6.2,1.2e+02,19,30198,262,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.8
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,19_GO:0023052 signaling,-5.9,93,17,30198,326,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.6
_FINAL_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-195721,Signaling by WNT,,-5.9,91,16,30198,332,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.6
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-5.9,90,16,30198,335,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.5
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-5.5,68,14,30198,447,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.2
_FINAL_SUB1_MCODE_2,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-5.5,68,14,30198,447,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.2
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-5.4,61,13,30198,492,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4.1
_FINAL_SUB1_MCODE_2,KEGG Pathway,24,hsa05200,Pathways in cancer,,-5.3,57,13,30198,531,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0098609,cell-cell adhesion,19_GO:0009987 cellular process,-5.3,56,13,30198,537,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-4
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-5,48,12,30198,632,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.9
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-5,46,12,30198,653,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.8
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-4.8,41,11,30198,744,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.7
_FINAL_SUB1_MCODE_2,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-4.8,38,11,30198,789,3,3,1e+02,27,1499|4040|51176,CTNNB1|LRP6|LEF1,-3.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-13,42,19,30198,433,15,9,60,13,208|1385|1499|3815|4040|4089|5595|6464|8817,AKT2|CREB1|CTNNB1|KIT|LRP6|SMAD4|MAPK3|SHC1|FGF18,-10
mRMR-SVM,KEGG Pathway,24,hsa05224,Breast cancer,,-12,96,26,30198,147,15,7,47,13,208|1499|3815|4040|5595|6464|8817,AKT2|CTNNB1|KIT|LRP6|MAPK3|SHC1|FGF18,-9.9
mRMR-SVM,KEGG Pathway,24,hsa05226,Gastric cancer,,-12,95,26,30198,149,15,7,47,13,208|1499|4040|4089|5595|6464|8817,AKT2|CTNNB1|LRP6|SMAD4|MAPK3|SHC1|FGF18,-9.9
mRMR-SVM,WikiPathways,27,WP4262,Breast cancer pathway,,-12,90,25,30198,157,15,7,47,13,208|1499|3815|4040|5595|6464|8817,AKT2|CTNNB1|KIT|LRP6|MAPK3|SHC1|FGF18,-9.7
mRMR-SVM,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-12,84,24,30198,168,15,7,47,13,208|1499|4040|4089|5595|6464|6599,AKT2|CTNNB1|LRP6|SMAD4|MAPK3|SHC1|SMARCC1,-9.6
mRMR-SVM,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-11,36,17,30198,447,15,8,53,13,208|1385|1499|3815|4040|5595|6464|8817,AKT2|CREB1|CTNNB1|KIT|LRP6|MAPK3|SHC1|FGF18,-8.6
mRMR-SVM,KEGG Pathway,24,hsa05200,Pathways in cancer,,-10,30,15,30198,531,15,8,53,13,208|1499|3815|4040|4089|4436|5595|8817,AKT2|CTNNB1|KIT|LRP6|SMAD4|MSH2|MAPK3|FGF18,-8.1
mRMR-SVM,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-9.9,73,21,30198,165,15,6,40,13,208|1499|4040|4089|5595|6464,AKT2|CTNNB1|LRP6|SMAD4|MAPK3|SHC1,-7.8
mRMR-SVM,WikiPathways,27,WP4216,Chromosomal and microsatellite instability in colorectal cancer,,-9.6,1.4e+02,26,30198,74,15,5,33,12,208|1499|4089|4436|5595,AKT2|CTNNB1|SMAD4|MSH2|MAPK3,-7.6
mRMR-SVM,KEGG Pathway,24,hsa05210,Colorectal cancer,,-9.3,1.2e+02,24,30198,86,15,5,33,12,208|1499|4089|4436|5595,AKT2|CTNNB1|SMAD4|MSH2|MAPK3,-7.3
mRMR-SVM,WikiPathways,27,WP4659,Gastrin signaling pathway,,-8.7,88,21,30198,114,15,5,33,12,1385|1499|3815|5595|6464,CREB1|CTNNB1|KIT|MAPK3|SHC1,-6.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-8.6,27,13,30198,521,15,7,47,13,208|1385|1499|3815|5595|6464|8817,AKT2|CREB1|CTNNB1|KIT|MAPK3|SHC1|FGF18,-6.7
mRMR-SVM,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-8.6,85,20,30198,119,15,5,33,12,208|1499|4040|4089|8817,AKT2|CTNNB1|LRP6|SMAD4|FGF18,-6.7
mRMR-SVM,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-8.6,84,20,30198,120,15,5,33,12,1499|4040|4089|5595|8817,CTNNB1|LRP6|SMAD4|MAPK3|FGF18,-6.7
mRMR-SVM,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-8.1,23,12,30198,606,15,7,47,13,208|3815|4089|5595|6464|6599|8817,AKT2|KIT|SMAD4|MAPK3|SHC1|SMARCC1|FGF18,-6.4
mRMR-SVM,GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-8,64,18,30198,158,15,5,33,12,1499|3815|4040|4089|5595,CTNNB1|KIT|LRP6|SMAD4|MAPK3,-6.2
mRMR-SVM,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-7.9,1.5e+02,24,30198,54,15,4,27,11,208|5595|6464|8817,AKT2|MAPK3|SHC1|FGF18,-6.2
mRMR-SVM,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-7.8,20,12,30198,688,15,7,47,13,1499|3489|3815|4089|5595|6464|8817,CTNNB1|IGFBP6|KIT|SMAD4|MAPK3|SHC1|FGF18,-6.1
mRMR-SVM,WikiPathways,27,WP4685,Melanoma,,-7.5,1.2e+02,22,30198,68,15,4,27,11,208|1385|3815|5595,AKT2|CREB1|KIT|MAPK3,-5.9
mRMR-SVM,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-7.4,48,15,30198,210,15,5,33,12,208|1499|3815|5595|8817,AKT2|CTNNB1|KIT|MAPK3|FGF18,-5.7
mRMR-SVM,KEGG Pathway,24,hsa05220,Chronic myeloid leukemia,,-7.3,1.1e+02,20,30198,76,15,4,27,11,208|4089|5595|6464,AKT2|SMAD4|MAPK3|SHC1,-5.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9009391,Extra-nuclear estrogen signaling,,-7.3,1e+02,20,30198,77,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-5.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-7.3,1e+02,20,30198,78,15,4,27,11,208|5595|6464|8817,AKT2|MAPK3|SHC1|FGF18,-5.7
mRMR-SVM,Canonical Pathways,11,M48,PID MET PATHWAY,,-7.2,1e+02,20,30198,79,15,4,27,11,208|1499|5595|6464,AKT2|CTNNB1|MAPK3|SHC1,-5.7
mRMR-SVM,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-7.2,26,12,30198,468,15,6,40,13,1385|1499|4089|5595|6464|8817,CREB1|CTNNB1|SMAD4|MAPK3|SHC1|FGF18,-5.6
mRMR-SVM,Canonical Pathways,11,M12771,SA PTEN PATHWAY,,-7.2,3.6e+02,33,30198,17,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-5.6
mRMR-SVM,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-7.1,43,14,30198,232,15,5,33,12,208|3815|5595|6464|8817,AKT2|KIT|MAPK3|SHC1|FGF18,-5.6
mRMR-SVM,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-7.1,25,12,30198,492,15,6,40,13,1499|3489|3815|5595|6464|8817,CTNNB1|IGFBP6|KIT|MAPK3|SHC1|FGF18,-5.5
mRMR-SVM,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-7.1,24,12,30198,498,15,6,40,13,1385|1499|4089|5595|6464|8817,CREB1|CTNNB1|SMAD4|MAPK3|SHC1|FGF18,-5.5
mRMR-SVM,KEGG Pathway,24,hsa05215,Prostate cancer,,-6.9,83,18,30198,97,15,4,27,11,208|1385|1499|5595,AKT2|CREB1|CTNNB1|MAPK3,-5.4
mRMR-SVM,Reactome Gene Sets,6,R-HSA-1257604,PIP3 activates AKT signaling,,-6.8,38,13,30198,267,15,5,33,12,208|1385|3815|5595|8817,AKT2|CREB1|KIT|MAPK3|FGF18,-5.3
mRMR-SVM,WikiPathways,27,WP1544,MicroRNAs in cardiomyocyte hypertrophy,,-6.8,80,18,30198,101,15,4,27,11,208|1499|4040|5595,AKT2|CTNNB1|LRP6|MAPK3,-5.3
mRMR-SVM,KEGG Pathway,24,hsa04916,Melanogenesis,,-6.8,80,18,30198,101,15,4,27,11,1385|1499|3815|5595,CREB1|CTNNB1|KIT|MAPK3,-5.3
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2219528,PI3K/AKT Signaling in Cancer,,-6.8,77,17,30198,104,15,4,27,11,208|1385|3815|8817,AKT2|CREB1|KIT|FGF18,-5.3
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,,-6.7,2.5e+02,27,30198,24,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-5.2
mRMR-SVM,Canonical Pathways,11,M274,PID LYMPH ANGIOGENESIS PATHWAY,,-6.6,2.4e+02,27,30198,25,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-5.2
mRMR-SVM,WikiPathways,27,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,,-6.6,2.4e+02,27,30198,25,15,3,20,10,4089|5595|6464,SMAD4|MAPK3|SHC1,-5.2
mRMR-SVM,Reactome Gene Sets,6,R-HSA-199418,Negative regulation of the PI3K/AKT network,,-6.6,71,17,30198,113,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-5.1
mRMR-SVM,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-6.6,70,17,30198,115,15,4,27,11,208|1499|4089|6464,AKT2|CTNNB1|SMAD4|SHC1,-5.1
mRMR-SVM,Canonical Pathways,11,M1718,SIG IL4RECEPTOR IN B LYPHOCYTES,,-6.5,2.2e+02,26,30198,27,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-5.1
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9006925,Intracellular signaling by second messengers,,-6.5,33,12,30198,309,15,5,33,12,208|1385|3815|5595|8817,AKT2|CREB1|KIT|MAPK3|FGF18,-5.1
mRMR-SVM,WikiPathways,27,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,,-6.5,33,12,30198,309,15,5,33,12,208|1385|3815|5595|8817,AKT2|CREB1|KIT|MAPK3|FGF18,-5.1
mRMR-SVM,KEGG Pathway,24,hsa04935,"Growth hormone synthesis, secretion and action",,-6.5,68,16,30198,119,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-5.1
mRMR-SVM,KEGG Pathway,24,hsa04926,Relaxin signaling pathway,,-6.4,62,16,30198,129,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,,-6.3,1.9e+02,24,30198,32,15,3,20,10,905|4089|5595,CCNT2|SMAD4|MAPK3,-4.9
mRMR-SVM,WikiPathways,27,WP4172,PI3K-Akt signaling pathway,,-6.3,29,12,30198,345,15,5,33,12,208|1385|3815|5595|8817,AKT2|CREB1|KIT|MAPK3|FGF18,-4.9
mRMR-SVM,KEGG Pathway,24,hsa04915,Estrogen signaling pathway,,-6.3,58,15,30198,138,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-4.9
mRMR-SVM,GO Biological Processes,19,GO:0043434,response to peptide hormone,19_GO:0050896 response to stimulus,-6.2,28,12,30198,354,15,5,33,12,208|1385|4040|6464|6599,AKT2|CREB1|LRP6|SHC1|SMARCC1,-4.8
mRMR-SVM,KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-6.2,28,12,30198,354,15,5,33,12,208|1385|3815|5595|8817,AKT2|CREB1|KIT|MAPK3|FGF18,-4.8
mRMR-SVM,KEGG Pathway,24,hsa04550,Signaling pathways regulating pluripotency of stem cells,,-6.2,56,15,30198,143,15,4,27,11,208|1499|4089|5595,AKT2|CTNNB1|SMAD4|MAPK3,-4.8
mRMR-SVM,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-6.2,56,15,30198,144,15,4,27,11,1385|1499|5595|6464,CREB1|CTNNB1|MAPK3|SHC1,-4.8
mRMR-SVM,KEGG Pathway,24,hsa04072,Phospholipase D signaling pathway,,-6.1,54,15,30198,148,15,4,27,11,208|3815|5595|6464,AKT2|KIT|MAPK3|SHC1,-4.8
mRMR-SVM,WikiPathways,27,WP4666,Hepatitis B infection,,-6.1,52,14,30198,154,15,4,27,11,208|1385|4089|5595,AKT2|CREB1|SMAD4|MAPK3,-4.7
mRMR-SVM,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-6.1,16,9.4,30198,741,15,6,40,13,208|905|3815|4089|5595|8817,AKT2|CCNT2|KIT|SMAD4|MAPK3|FGF18,-4.7
mRMR-SVM,Canonical Pathways,11,M82,PID RET PATHWAY,,-6,1.5e+02,21,30198,39,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-4.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-6,1.5e+02,21,30198,40,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-4.7
mRMR-SVM,GO Biological Processes,19,GO:0009725,response to hormone,19_GO:0050896 response to stimulus,-6,16,9.3,30198,753,15,6,40,13,208|1385|3815|4040|6464|6599,AKT2|CREB1|KIT|LRP6|SHC1|SMARCC1,-4.7
mRMR-SVM,GO Biological Processes,19,GO:0046661,male sex differentiation,19_GO:0022414 reproductive process,-6,50,14,30198,160,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-4.7
mRMR-SVM,KEGG Pathway,24,hsa05161,Hepatitis B,,-6,50,14,30198,162,15,4,27,11,208|1385|4089|5595,AKT2|CREB1|SMAD4|MAPK3,-4.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-6,1.5e+02,21,30198,41,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-6,25,11,30198,402,15,5,33,12,208|1385|1499|4089|5595,AKT2|CREB1|CTNNB1|SMAD4|MAPK3,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0006351,"transcription, DNA-templated",19_GO:0008152 metabolic process,-6,25,11,30198,403,15,5,33,12,905|1385|4089|4800|5595,CCNT2|CREB1|SMAD4|NFYA|MAPK3,-4.6
mRMR-SVM,WikiPathways,27,WP2036,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,,-5.9,1.4e+02,21,30198,42,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0097659,nucleic acid-templated transcription,19_GO:0008152 metabolic process,-5.9,25,11,30198,405,15,5,33,12,905|1385|4089|4800|5595,CCNT2|CREB1|SMAD4|NFYA|MAPK3,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,19_GO:0023052 signaling,-5.9,25,11,30198,405,15,5,33,12,208|3815|6464|6599|8817,AKT2|KIT|SHC1|SMARCC1|FGF18,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-5.9,48,14,30198,168,15,4,27,11,1499|4040|4089|5595,CTNNB1|LRP6|SMAD4|MAPK3,-4.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2262752,Cellular responses to stress,,-5.9,15,9.1,30198,784,15,6,40,13,208|571|1385|4800|5595|6464,AKT2|BACH1|CREB1|NFYA|MAPK3|SHC1,-4.6
mRMR-SVM,GO Biological Processes,19,GO:0032774,RNA biosynthetic process,19_GO:0008152 metabolic process,-5.9,24,11,30198,415,15,5,33,12,905|1385|4089|4800|5595,CCNT2|CREB1|SMAD4|NFYA|MAPK3,-4.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-8953897,Cellular responses to stimuli,,-5.9,15,9,30198,798,15,6,40,13,208|571|1385|4800|5595|6464,AKT2|BACH1|CREB1|NFYA|MAPK3|SHC1,-4.5
mRMR-SVM,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-5.9,46,13,30198,174,15,4,27,11,1385|1499|5595|8817,CREB1|CTNNB1|MAPK3|FGF18,-4.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,,-5.8,1.3e+02,20,30198,46,15,3,20,10,905|4089|5595,CCNT2|SMAD4|MAPK3,-4.5
mRMR-SVM,Canonical Pathways,11,M70,PID PS1 PATHWAY,,-5.8,1.3e+02,20,30198,46,15,3,20,10,1499|4040|5595,CTNNB1|LRP6|MAPK3,-4.5
mRMR-SVM,Canonical Pathways,11,M8626,SIG BCR SIGNALING PATHWAY,,-5.8,1.3e+02,20,30198,46,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-4.5
mRMR-SVM,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-5.8,45,13,30198,178,15,4,27,11,1385|1499|5595|8817,CREB1|CTNNB1|MAPK3|FGF18,-4.5
mRMR-SVM,KEGG Pathway,24,hsa05152,Tuberculosis,,-5.8,45,13,30198,180,15,4,27,11,208|1385|4800|5595,AKT2|CREB1|NFYA|MAPK3,-4.5
mRMR-SVM,GO Biological Processes,19,GO:1901652,response to peptide,19_GO:0050896 response to stimulus,-5.8,23,10,30198,441,15,5,33,12,208|1385|4040|6464|6599,AKT2|CREB1|LRP6|SHC1|SMARCC1,-4.5
mRMR-SVM,WikiPathways,27,WP4223,Ras signaling,,-5.8,44,13,30198,185,15,4,27,11,208|3815|5595|6464,AKT2|KIT|MAPK3|SHC1,-4.5
mRMR-SVM,GO Biological Processes,19,GO:0031056,regulation of histone modification,19_GO:0008152 metabolic process,-5.8,44,13,30198,185,15,4,27,11,1499|4089|4800|5595,CTNNB1|SMAD4|NFYA|MAPK3,-4.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-5.7,1.2e+02,19,30198,50,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-4.4
mRMR-SVM,Canonical Pathways,11,M7955,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,,-5.7,1.2e+02,19,30198,51,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-4.4
mRMR-SVM,KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-5.7,42,13,30198,194,15,4,27,11,208|1385|1499|5595,AKT2|CREB1|CTNNB1|MAPK3,-4.4
mRMR-SVM,Canonical Pathways,11,M231,PID KIT PATHWAY,,-5.7,1.2e+02,19,30198,52,15,3,20,10,3815|5595|6464,KIT|MAPK3|SHC1,-4.4
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2428924,IGF1R signaling cascade,,-5.6,1.1e+02,18,30198,53,15,3,20,10,208|6464|8817,AKT2|SHC1|FGF18,-4.4
mRMR-SVM,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-5.6,41,12,30198,198,15,4,27,11,1385|1499|5595|8817,CREB1|CTNNB1|MAPK3|FGF18,-4.4
mRMR-SVM,Reactome Gene Sets,6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),,-5.6,1.1e+02,18,30198,54,15,3,20,10,208|6464|8817,AKT2|SHC1|FGF18,-4.3
mRMR-SVM,Canonical Pathways,11,M286,PID TGFBR PATHWAY,,-5.6,1.1e+02,18,30198,54,15,3,20,10,1499|4089|6464,CTNNB1|SMAD4|SHC1,-4.3
mRMR-SVM,KEGG Pathway,24,hsa04510,Focal adhesion,,-5.6,40,12,30198,201,15,4,27,11,208|1499|5595|6464,AKT2|CTNNB1|MAPK3|SHC1,-4.3
mRMR-SVM,WikiPathways,27,WP306,Focal adhesion,,-5.6,40,12,30198,202,15,4,27,11,208|1499|5595|6464,AKT2|CTNNB1|MAPK3|SHC1,-4.3
mRMR-SVM,Canonical Pathways,11,M276,PID FGF PATHWAY,,-5.6,1.1e+02,18,30198,55,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-4.3
mRMR-SVM,WikiPathways,27,WP5144,NRP1-triggered signaling pathways in pancreatic cancer,,-5.6,1.1e+02,18,30198,55,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-4.3
mRMR-SVM,WikiPathways,27,WP560,TGF-beta receptor signaling,,-5.5,1e+02,18,30198,58,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.3
mRMR-SVM,KEGG Pathway,24,hsa05213,Endometrial cancer,,-5.5,1e+02,18,30198,58,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-4.3
mRMR-SVM,KEGG Pathway,24,hsa05207,Chemical carcinogenesis - receptor activation,,-5.5,38,12,30198,212,15,4,27,11,208|1385|5595|8817,AKT2|CREB1|MAPK3|FGF18,-4.3
mRMR-SVM,WikiPathways,27,WP304,Kit receptor signaling pathway,,-5.5,1e+02,17,30198,60,15,3,20,10,3815|5595|6464,KIT|MAPK3|SHC1,-4.2
mRMR-SVM,GO Biological Processes,19,GO:0008286,insulin receptor signaling pathway,19_GO:0023052 signaling,-5.5,1e+02,17,30198,60,15,3,20,10,208|6464|6599,AKT2|SHC1|SMARCC1,-4.2
mRMR-SVM,KEGG Pathway,24,hsa05166,Human T-cell leukemia virus 1 infection,,-5.4,36,12,30198,222,15,4,27,11,208|1385|4089|5595,AKT2|CREB1|SMAD4|MAPK3,-4.2
mRMR-SVM,WikiPathways,27,WP4816,TGF-beta receptor signaling in skeletal dysplasias,,-5.4,97,17,30198,62,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.2
mRMR-SVM,Reactome Gene Sets,6,R-HSA-8939211,ESR-mediated signaling,,-5.4,36,12,30198,223,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-4.2
mRMR-SVM,KEGG Pathway,24,hsa05163,Human cytomegalovirus infection,,-5.4,36,12,30198,225,15,4,27,11,208|1385|1499|5595,AKT2|CREB1|CTNNB1|MAPK3,-4.2
mRMR-SVM,Canonical Pathways,11,M254,PID MYC REPRESS PATHWAY,,-5.4,96,17,30198,63,15,3,20,10,1385|4089|4800,CREB1|SMAD4|NFYA,-4.2
mRMR-SVM,WikiPathways,27,WP4155,Endometrial cancer,,-5.4,96,17,30198,63,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-4.2
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9614085,FOXO-mediated transcription,,-5.4,93,17,30198,65,15,3,20,10,208|4089|4800,AKT2|SMAD4|NFYA,-4.1
mRMR-SVM,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-5.4,35,12,30198,231,15,4,27,11,1499|4040|4089|5595,CTNNB1|LRP6|SMAD4|MAPK3,-4.1
mRMR-SVM,WikiPathways,27,WP2374,Oncostatin M signaling pathway,,-5.4,92,16,30198,66,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-4.1
mRMR-SVM,Canonical Pathways,11,M295,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,,-5.3,90,16,30198,67,15,3,20,10,208|1385|6464,AKT2|CREB1|SHC1,-4.1
mRMR-SVM,KEGG Pathway,24,hsa05221,Acute myeloid leukemia,,-5.3,90,16,30198,67,15,3,20,10,208|3815|5595,AKT2|KIT|MAPK3,-4.1
mRMR-SVM,GO Biological Processes,19,GO:0035065,regulation of histone acetylation,19_GO:0008152 metabolic process,-5.3,89,16,30198,68,15,3,20,10,4089|4800|5595,SMAD4|NFYA|MAPK3,-4.1
mRMR-SVM,WikiPathways,27,WP3303,RAC1/PAK1/p38/MMP2 pathway,,-5.3,88,16,30198,69,15,3,20,10,1499|4436|5595,CTNNB1|MSH2|MAPK3,-4.1
mRMR-SVM,KEGG Pathway,24,hsa04917,Prolactin signaling pathway,,-5.3,86,16,30198,70,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-4.1
mRMR-SVM,KEGG Pathway,24,hsa05230,Central carbon metabolism in cancer,,-5.3,86,16,30198,70,15,3,20,10,208|3815|5595,AKT2|KIT|MAPK3,-4.1
mRMR-SVM,KEGG Pathway,24,hsa04520,Adherens junction,,-5.3,85,16,30198,71,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4
mRMR-SVM,KEGG Pathway,24,hsa05218,Melanoma,,-5.2,84,16,30198,72,15,3,20,10,208|5595|8817,AKT2|MAPK3|FGF18,-4
mRMR-SVM,KEGG Pathway,24,hsa01524,Platinum drug resistance,,-5.2,83,16,30198,73,15,3,20,10,208|4436|5595,AKT2|MSH2|MAPK3,-4
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-5.2,83,16,30198,73,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-4
mRMR-SVM,GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-5.2,18,8.9,30198,575,15,5,33,12,905|1499|3815|5595|8817,CCNT2|CTNNB1|KIT|MAPK3|FGF18,-4
mRMR-SVM,KEGG Pathway,24,hsa05214,Glioma,,-5.2,81,15,30198,75,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-4
mRMR-SVM,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-5.2,17,8.9,30198,580,15,5,33,12,208|1499|5595|6464|6599,AKT2|CTNNB1|MAPK3|SHC1|SMARCC1,-4
mRMR-SVM,WikiPathways,27,WP4674,Head and neck squamous cell carcinoma,,-5.2,79,15,30198,76,15,3,20,10,208|1499|4089,AKT2|CTNNB1|SMAD4,-4
mRMR-SVM,KEGG Pathway,24,hsa05212,Pancreatic cancer,,-5.2,79,15,30198,76,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-4
mRMR-SVM,WikiPathways,27,WP2034,Leptin signaling pathway,,-5.2,79,15,30198,76,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-4
mRMR-SVM,GO Biological Processes,19,GO:2000756,regulation of peptidyl-lysine acetylation,19_GO:0008152 metabolic process,-5.1,78,15,30198,77,15,3,20,10,4089|4800|5595,SMAD4|NFYA|MAPK3,-3.9
mRMR-SVM,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-5.1,77,15,30198,78,15,3,20,10,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.9
mRMR-SVM,WikiPathways,27,WP5124,Alzheimer's disease,,-5.1,30,11,30198,267,15,4,27,11,208|1499|4040|5595,AKT2|CTNNB1|LRP6|MAPK3,-3.9
mRMR-SVM,KEGG Pathway,24,hsa01521,EGFR tyrosine kinase inhibitor resistance,,-5.1,76,15,30198,79,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.9
mRMR-SVM,Canonical Pathways,11,M115,PID REG GR PATHWAY,,-5.1,74,15,30198,82,15,3,20,10,1385|5595|6599,CREB1|MAPK3|SMARCC1,-3.9
mRMR-SVM,GO Biological Processes,19,GO:0007548,sex differentiation,19_GO:0022414 reproductive process,-5.1,29,10,30198,276,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-3.9
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-5,29,10,30198,280,15,4,27,11,3815|5595|6464|8817,KIT|MAPK3|SHC1|FGF18,-3.9
mRMR-SVM,WikiPathways,27,WP4806,EGFR tyrosine kinase inhibitor resistance,,-5,72,15,30198,84,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.9
mRMR-SVM,KEGG Pathway,24,hsa04012,ErbB signaling pathway,,-5,71,14,30198,85,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-5,28,10,30198,286,15,4,27,11,3815|5595|6464|8817,KIT|MAPK3|SHC1|FGF18,-3.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-5,69,14,30198,87,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-3.8
mRMR-SVM,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-5,16,8.4,30198,640,15,5,33,12,208|1499|5595|6464|6599,AKT2|CTNNB1|MAPK3|SHC1|SMARCC1,-3.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-170834,Signaling by TGF-beta Receptor Complex,,-5,68,14,30198,89,15,3,20,10,905|4089|5595,CCNT2|SMAD4|MAPK3,-3.8
mRMR-SVM,WikiPathways,27,WP4263,Pancreatic adenocarcinoma pathway,,-5,68,14,30198,89,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-3.8
mRMR-SVM,KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-5,27,10,30198,294,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-3.8
mRMR-SVM,GO Biological Processes,19,GO:0051054,positive regulation of DNA metabolic process,19_GO:0048518 positive regulation of biological process,-4.9,27,10,30198,298,15,4,27,11,1499|4436|5595|6599,CTNNB1|MSH2|MAPK3|SMARCC1,-3.8
mRMR-SVM,WikiPathways,27,WP138,Androgen receptor signaling pathway,,-4.9,66,14,30198,91,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-3.8
mRMR-SVM,GO Biological Processes,19,GO:1901983,regulation of protein acetylation,19_GO:0008152 metabolic process,-4.9,66,14,30198,91,15,3,20,10,4089|4800|5595,SMAD4|NFYA|MAPK3,-3.8
mRMR-SVM,WikiPathways,27,WP673,ErbB signaling pathway,,-4.9,66,14,30198,91,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.8
mRMR-SVM,WikiPathways,27,WP69,T-cell receptor signaling pathway,,-4.9,66,14,30198,91,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-3.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9006931,Signaling by Nuclear Receptors,,-4.9,27,10,30198,299,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-3.8
mRMR-SVM,GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-4.9,15,8.3,30198,660,15,5,33,12,905|3815|4040|6464|8817,CCNT2|KIT|LRP6|SHC1|FGF18,-3.7
mRMR-SVM,GO Biological Processes,19,GO:0014033,neural crest cell differentiation,19_GO:0032502 developmental process,-4.9,65,14,30198,93,15,3,20,10,4040|4089|5595,LRP6|SMAD4|MAPK3,-3.7
mRMR-SVM,WikiPathways,27,WP2355,Corticotropin-releasing hormone signaling pathway,,-4.9,65,14,30198,93,15,3,20,10,1385|1499|5595,CREB1|CTNNB1|MAPK3,-3.7
mRMR-SVM,GO Biological Processes,19,GO:0097306,cellular response to alcohol,19_GO:0050896 response to stimulus,-4.9,64,14,30198,95,15,3,20,10,1385|1499|4040,CREB1|CTNNB1|LRP6,-3.7
mRMR-SVM,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-4.9,26,9.8,30198,312,15,4,27,11,4089|5595|6464|8817,SMAD4|MAPK3|SHC1|FGF18,-3.7
mRMR-SVM,KEGG Pathway,24,hsa01522,Endocrine resistance,,-4.8,62,13,30198,98,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.7
mRMR-SVM,KEGG Pathway,24,hsa04933,AGE-RAGE signaling pathway in diabetic complications,,-4.8,60,13,30198,100,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-3.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-4.8,25,9.6,30198,325,15,4,27,11,3815|5595|6464|8817,KIT|MAPK3|SHC1|FGF18,-3.6
mRMR-SVM,KEGG Pathway,24,hsa05165,Human papillomavirus infection,,-4.8,24,9.5,30198,331,15,4,27,11,208|1385|1499|5595,AKT2|CREB1|CTNNB1|MAPK3,-3.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",,-4.7,57,13,30198,106,15,3,20,10,3815|5595|8817,KIT|MAPK3|FGF18,-3.6
mRMR-SVM,KEGG Pathway,24,hsa04928,"Parathyroid hormone synthesis, secretion and action",,-4.7,57,13,30198,106,15,3,20,10,1385|4040|5595,CREB1|LRP6|MAPK3,-3.6
mRMR-SVM,WikiPathways,27,WP2059,Alzheimer's disease and miRNA effects,,-4.7,24,9.4,30198,337,15,4,27,11,208|1499|4040|5595,AKT2|CTNNB1|LRP6|MAPK3,-3.6
mRMR-SVM,WikiPathways,27,WP399,Wnt signaling pathway and pluripotency,,-4.7,56,13,30198,107,15,3,20,10,1499|4040|4800,CTNNB1|LRP6|NFYA,-3.6
mRMR-SVM,GO Biological Processes,19,GO:0031058,positive regulation of histone modification,19_GO:0048518 positive regulation of biological process,-4.7,55,13,30198,110,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-3.6
mRMR-SVM,KEGG Pathway,24,hsa04668,TNF signaling pathway,,-4.7,54,13,30198,112,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-3.5
mRMR-SVM,KEGG Pathway,24,hsa04725,Cholinergic synapse,,-4.6,53,12,30198,113,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-3.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-187037,Signaling by NTRK1 (TRKA),,-4.6,53,12,30198,115,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-3.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9006936,Signaling by TGFB family members,,-4.6,51,12,30198,118,15,3,20,10,905|4089|5595,CCNT2|SMAD4|MAPK3,-3.5
mRMR-SVM,KEGG Pathway,24,hsa04722,Neurotrophin signaling pathway,,-4.6,51,12,30198,119,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.5
mRMR-SVM,GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-4.6,13,7.5,30198,778,15,5,33,12,905|3815|4040|6464|8817,CCNT2|KIT|LRP6|SHC1|FGF18,-3.5
mRMR-SVM,KEGG Pathway,24,hsa04919,Thyroid hormone signaling pathway,,-4.6,50,12,30198,121,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-3.4
mRMR-SVM,Reactome Gene Sets,6,R-HSA-8878166,Transcriptional regulation by RUNX2,,-4.6,50,12,30198,121,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-3.4
mRMR-SVM,GO Biological Processes,19,GO:0034654,nucleobase-containing compound biosynthetic process,19_GO:0008152 metabolic process,-4.5,13,7.5,30198,787,15,5,33,12,905|1385|4089|4800|5595,CCNT2|CREB1|SMAD4|NFYA|MAPK3,-3.4
mRMR-SVM,GO Biological Processes,19,GO:0035270,endocrine system development,19_GO:0032502 developmental process,-4.5,49,12,30198,124,15,3,20,10,1385|4089|5595,CREB1|SMAD4|MAPK3,-3.4
mRMR-SVM,KEGG Pathway,24,hsa05010,Alzheimer disease,,-4.5,21,8.8,30198,384,15,4,27,11,208|1499|4040|5595,AKT2|CTNNB1|LRP6|MAPK3,-3.4
mRMR-SVM,KEGG Pathway,24,hsa04380,Osteoclast differentiation,,-4.5,47,12,30198,128,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-3.4
mRMR-SVM,GO Biological Processes,19,GO:0071900,regulation of protein serine/threonine kinase activity,19_GO:0008152 metabolic process,-4.5,21,8.7,30198,388,15,4,27,11,905|3815|4040|8817,CCNT2|KIT|LRP6|FGF18,-3.4
mRMR-SVM,KEGG Pathway,24,hsa04068,FoxO signaling pathway,,-4.5,46,12,30198,131,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-3.4
mRMR-SVM,WikiPathways,27,WP3915,Angiopoietin-like protein 8 regulatory pathway,,-4.4,46,11,30198,132,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.3
mRMR-SVM,Reactome Gene Sets,6,R-HSA-166520,Signaling by NTRKs,,-4.4,45,11,30198,134,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-3.3
mRMR-SVM,GO Biological Processes,19,GO:0008584,male gonad development,19_GO:0022414 reproductive process,-4.4,44,11,30198,136,15,3,20,10,3815|4089|4436,KIT|SMAD4|MSH2,-3.3
mRMR-SVM,KEGG Pathway,24,hsa04910,Insulin signaling pathway,,-4.4,44,11,30198,137,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.3
mRMR-SVM,GO Biological Processes,19,GO:0046546,development of primary male sexual characteristics,19_GO:0022414 reproductive process,-4.4,44,11,30198,137,15,3,20,10,3815|4089|4436,KIT|SMAD4|MSH2,-3.3
mRMR-SVM,KEGG Pathway,24,hsa04371,Apelin signaling pathway,,-4.4,43,11,30198,139,15,3,20,10,208|4089|5595,AKT2|SMAD4|MAPK3,-3.3
mRMR-SVM,GO Biological Processes,19,GO:0048608,reproductive structure development,19_GO:0022414 reproductive process,-4.3,19,8.3,30198,423,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-3.2
mRMR-SVM,WikiPathways,27,WP5083,Neuroinflammation and glutamatergic signaling,,-4.3,42,11,30198,144,15,3,20,10,1385|4089|5595,CREB1|SMAD4|MAPK3,-3.2
mRMR-SVM,GO Biological Processes,19,GO:0061458,reproductive system development,19_GO:0032502 developmental process,-4.3,19,8.3,30198,426,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-3.2
mRMR-SVM,GO Biological Processes,19,GO:0032869,cellular response to insulin stimulus,19_GO:0050896 response to stimulus,-4.3,41,11,30198,149,15,3,20,10,208|6464|6599,AKT2|SHC1|SMARCC1,-3.2
mRMR-SVM,KEGG Pathway,24,hsa04261,Adrenergic signaling in cardiomyocytes,,-4.3,40,11,30198,150,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-3.2
mRMR-SVM,WikiPathways,27,WP3888,VEGFA-VEGFR2 signaling pathway,,-4.3,18,8.2,30198,439,15,4,27,11,1385|1499|5595|6464,CREB1|CTNNB1|MAPK3|SHC1,-3.2
mRMR-SVM,KEGG Pathway,24,hsa04934,Cushing syndrome,,-4.2,39,11,30198,155,15,3,20,10,1385|1499|5595,CREB1|CTNNB1|MAPK3,-3.2
mRMR-SVM,GO Biological Processes,19,GO:0045834,positive regulation of lipid metabolic process,19_GO:0048518 positive regulation of biological process,-4.2,39,11,30198,156,15,3,20,10,208|1385|3815,AKT2|CREB1|KIT,-3.2
mRMR-SVM,KEGG Pathway,24,hsa04150,mTOR signaling pathway,,-4.2,39,11,30198,156,15,3,20,10,208|4040|5595,AKT2|LRP6|MAPK3,-3.2
mRMR-SVM,GO Biological Processes,19,GO:0051090,regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-4.2,18,8,30198,452,15,4,27,11,1499|3815|4040|5595,CTNNB1|KIT|LRP6|MAPK3,-3.2
mRMR-SVM,KEGG Pathway,24,hsa05160,Hepatitis C,,-4.2,38,10,30198,157,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-3.2
mRMR-SVM,WikiPathways,27,WP481,Insulin signaling,,-4.2,38,10,30198,161,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.1
mRMR-SVM,WikiPathways,27,WP706,Sudden infant death syndrome (SIDS) susceptibility pathways,,-4.2,37,10,30198,162,15,3,20,10,1385|1499|4800,CREB1|CTNNB1|NFYA,-3.1
mRMR-SVM,WikiPathways,27,WP3929,Chemokine signaling pathway,,-4.2,37,10,30198,165,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-3.1
mRMR-SVM,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-4.1,36,10,30198,167,15,3,20,10,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.1
mRMR-SVM,KEGG Pathway,24,hsa04022,cGMP-PKG signaling pathway,,-4.1,36,10,30198,167,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-3.1
mRMR-SVM,GO Biological Processes,19,GO:0010001,glial cell differentiation,19_GO:0032502 developmental process,-4.1,36,10,30198,167,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-3.1
mRMR-SVM,GO Biological Processes,19,GO:0032870,cellular response to hormone stimulus,19_GO:0050896 response to stimulus,-4.1,17,7.8,30198,481,15,4,27,11,208|3815|6464|6599,AKT2|KIT|SHC1|SMARCC1,-3.1
mRMR-SVM,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-4.1,16,7.7,30198,492,15,4,27,11,1499|3815|4040|4089,CTNNB1|KIT|LRP6|SMAD4,-3
mRMR-SVM,Reactome Gene Sets,6,R-HSA-109581,Apoptosis,,-4,34,9.8,30198,180,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-3
mRMR-SVM,GO Biological Processes,19,GO:0071407,cellular response to organic cyclic compound,19_GO:0050896 response to stimulus,-4,16,7.6,30198,505,15,4,27,11,1385|1499|4040|5595,CREB1|CTNNB1|LRP6|MAPK3,-3
mRMR-SVM,GO Biological Processes,19,GO:0001501,skeletal system development,19_GO:0032502 developmental process,-4,16,7.6,30198,505,15,4,27,11,1499|3815|5595|8817,CTNNB1|KIT|MAPK3|FGF18,-3
mRMR-SVM,KEGG Pathway,24,hsa05034,Alcoholism,,-4,32,9.6,30198,187,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-2.9
mRMR-SVM,KEGG Pathway,24,hsa04062,Chemokine signaling pathway,,-4,31,9.4,30198,192,15,3,20,10,208|5595|6464,AKT2|MAPK3|SHC1,-2.9
mRMR-SVM,GO Biological Processes,19,GO:0051052,regulation of DNA metabolic process,19_GO:0008152 metabolic process,-3.9,15,7.3,30198,537,15,4,27,11,1499|4436|5595|6599,CTNNB1|MSH2|MAPK3|SMARCC1,-2.9
mRMR-SVM,GO Biological Processes,19,GO:0098609,cell-cell adhesion,19_GO:0009987 cellular process,-3.9,15,7.3,30198,537,15,4,27,11,1499|3815|4040|6464,CTNNB1|KIT|LRP6|SHC1,-2.9
mRMR-SVM,GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-3.9,15,7.3,30198,541,15,4,27,11,1499|4089|5595|6464,CTNNB1|SMAD4|MAPK3|SHC1,-2.9
mRMR-SVM,GO Biological Processes,19,GO:0009612,response to mechanical stimulus,19_GO:0050896 response to stimulus,-3.9,30,9.2,30198,203,15,3,20,10,1499|3815|5595,CTNNB1|KIT|MAPK3,-2.8
mRMR-SVM,KEGG Pathway,24,hsa05205,Proteoglycans in cancer,,-3.9,29,9.1,30198,205,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0030335,positive regulation of cell migration,19_GO:0040011 locomotion,-3.9,14,7.1,30198,560,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0032868,response to insulin,19_GO:0050896 response to stimulus,-3.9,29,9.1,30198,207,15,3,20,10,208|6464|6599,AKT2|SHC1|SMARCC1,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-3.8,29,9,30198,210,15,3,20,10,1499|4040|4089,CTNNB1|LRP6|SMAD4,-2.8
mRMR-SVM,Reactome Gene Sets,6,R-HSA-5357801,Programmed Cell Death,,-3.8,29,9,30198,210,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0042063,gliogenesis,19_GO:0032502 developmental process,-3.8,28,8.9,30198,213,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0030855,epithelial cell differentiation,19_GO:0032502 developmental process,-3.8,14,7,30198,576,15,4,27,11,208|1385|1499|4089,AKT2|CREB1|CTNNB1|SMAD4,-2.8
mRMR-SVM,GO Biological Processes,19,GO:2000147,positive regulation of cell motility,19_GO:0040011 locomotion,-3.8,14,7,30198,584,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0008406,gonad development,19_GO:0022414 reproductive process,-3.8,27,8.8,30198,220,15,3,20,10,3815|4089|4436,KIT|SMAD4|MSH2,-2.8
mRMR-SVM,KEGG Pathway,24,hsa04024,cAMP signaling pathway,,-3.8,27,8.8,30198,221,15,3,20,10,208|1385|5595,AKT2|CREB1|MAPK3,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-3.8,27,8.8,30198,221,15,3,20,10,5595|6464|8817,MAPK3|SHC1|FGF18,-2.8
mRMR-SVM,GO Biological Processes,19,GO:0071902,positive regulation of protein serine/threonine kinase activity,19_GO:0048518 positive regulation of biological process,-3.8,27,8.7,30198,224,15,3,20,10,905|3815|8817,CCNT2|KIT|FGF18,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0051272,positive regulation of cellular component movement,19_GO:0051179 localization,-3.8,13,6.9,30198,597,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0045137,development of primary sexual characteristics,19_GO:0022414 reproductive process,-3.8,27,8.7,30198,225,15,3,20,10,3815|4089|4436,KIT|SMAD4|MSH2,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0040017,positive regulation of locomotion,19_GO:0040011 locomotion,-3.8,13,6.9,30198,599,15,4,27,11,208|3815|5595|8817,AKT2|KIT|MAPK3|FGF18,-2.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-201681,TCF dependent signaling in response to WNT,,-3.7,26,8.5,30198,233,15,3,20,10,208|1499|4040,AKT2|CTNNB1|LRP6,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0071375,cellular response to peptide hormone stimulus,19_GO:0050896 response to stimulus,-3.7,25,8.4,30198,238,15,3,20,10,208|6464|6599,AKT2|SHC1|SMARCC1,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0097305,response to alcohol,19_GO:0050896 response to stimulus,-3.7,25,8.4,30198,239,15,3,20,10,1385|1499|4040,CREB1|CTNNB1|LRP6,-2.7
mRMR-SVM,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-3.7,13,6.7,30198,632,15,4,27,11,1499|4040|4089|4436,CTNNB1|LRP6|SMAD4|MSH2,-2.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-3.7,13,6.6,30198,633,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0006366,transcription by RNA polymerase II,19_GO:0008152 metabolic process,-3.7,25,8.3,30198,244,15,3,20,10,905|1385|4800,CCNT2|CREB1|NFYA,-2.6
mRMR-SVM,WikiPathways,27,WP382,MAPK signaling pathway,,-3.6,24,8.2,30198,249,15,3,20,10,208|5595|8817,AKT2|MAPK3|FGF18,-2.6
mRMR-SVM,KEGG Pathway,24,hsa05132,Salmonella infection,,-3.6,24,8.2,30198,249,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0001775,cell activation,19_GO:0009987 cellular process,-3.6,12,6.6,30198,647,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0033044,regulation of chromosome organization,19_GO:0050789 regulation of biological process,-3.6,24,8.2,30198,250,15,3,20,10,1499|5595|6599,CTNNB1|MAPK3|SMARCC1,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-3.6,12,6.5,30198,653,15,4,27,11,1499|4040|4089|4436,CTNNB1|LRP6|SMAD4|MSH2,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0048534,hematopoietic or lymphoid organ development,19_GO:0002376 immune system process,-3.6,12,6.5,30198,655,15,4,27,11,1499|3815|4436|5595,CTNNB1|KIT|MSH2|MAPK3,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0030098,lymphocyte differentiation,19_GO:0002376 immune system process,-3.6,24,8.1,30198,257,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-3.6,12,6.5,30198,663,15,4,27,11,1499|4089|6464|8817,CTNNB1|SMAD4|SHC1|FGF18,-2.6
mRMR-SVM,GO Biological Processes,19,GO:0051091,positive regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-3.6,23,7.9,30198,265,15,3,20,10,1499|3815|4040,CTNNB1|KIT|LRP6,-2.5
mRMR-SVM,GO Biological Processes,19,GO:0001503,ossification,19_GO:0032501 multicellular organismal process,-3.5,22,7.8,30198,273,15,3,20,10,1499|4089|8817,CTNNB1|SMAD4|FGF18,-2.5
mRMR-SVM,GO Biological Processes,19,GO:0002520,immune system development,19_GO:0002376 immune system process,-3.5,12,6.3,30198,699,15,4,27,11,1499|3815|4436|5595,CTNNB1|KIT|MSH2|MAPK3,-2.5
mRMR-SVM,GO Biological Processes,19,GO:0006468,protein phosphorylation,19_GO:0008152 metabolic process,-3.5,11,6.2,30198,704,15,4,27,11,208|1385|3815|5595,AKT2|CREB1|KIT|MAPK3,-2.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-3.5,11,6.2,30198,708,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-2.5
mRMR-SVM,GO Biological Processes,19,GO:0071345,cellular response to cytokine stimulus,19_GO:0050896 response to stimulus,-3.5,11,6.2,30198,710,15,4,27,11,1385|3815|4089|5595,CREB1|KIT|SMAD4|MAPK3,-2.5
mRMR-SVM,Reactome Gene Sets,6,R-HSA-1280215,Cytokine Signaling in Immune system,,-3.5,11,6.2,30198,715,15,4,27,11,208|1385|5595|6464,AKT2|CREB1|MAPK3|SHC1,-2.5
mRMR-SVM,GO Biological Processes,19,GO:0080135,regulation of cellular response to stress,19_GO:0050896 response to stimulus,-3.4,11,6.2,30198,723,15,4,27,11,1499|3489|5595|6599,CTNNB1|IGFBP6|MAPK3|SMARCC1,-2.4
mRMR-SVM,GO Biological Processes,19,GO:1903131,mononuclear cell differentiation,19_GO:0002376 immune system process,-3.4,20,7.5,30198,295,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2.4
mRMR-SVM,GO Biological Processes,19,GO:0007281,germ cell development,19_GO:0022414 reproductive process,-3.4,20,7.5,30198,296,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2.4
mRMR-SVM,GO Biological Processes,19,GO:0007276,gamete generation,19_GO:0022414 reproductive process,-3.4,11,6.1,30198,739,15,4,27,11,1499|3815|4089|4436,CTNNB1|KIT|SMAD4|MSH2,-2.4
mRMR-SVM,GO Biological Processes,19,GO:1901653,cellular response to peptide,19_GO:0050896 response to stimulus,-3.4,20,7.4,30198,305,15,3,20,10,208|6464|6599,AKT2|SHC1|SMARCC1,-2.4
mRMR-SVM,GO Biological Processes,19,GO:1902105,regulation of leukocyte differentiation,19_GO:0002376 immune system process,-3.4,20,7.3,30198,306,15,3,20,10,1385|1499|6599,CREB1|CTNNB1|SMARCC1,-2.4
mRMR-SVM,GO Biological Processes,19,GO:0009416,response to light stimulus,19_GO:0050896 response to stimulus,-3.4,20,7.3,30198,308,15,3,20,10,208|3815|4436,AKT2|KIT|MSH2,-2.4
mRMR-SVM,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-3.3,19,7.1,30198,323,15,3,20,10,1499|6464|8817,CTNNB1|SHC1|FGF18,-2.3
mRMR-SVM,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-3.3,10,5.8,30198,789,15,4,27,11,1385|1499|4040|5595,CREB1|CTNNB1|LRP6|MAPK3,-2.3
mRMR-SVM,GO Biological Processes,19,GO:0090287,regulation of cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-3.3,18,7,30198,331,15,3,20,10,1499|4089|8817,CTNNB1|SMAD4|FGF18,-2.3
mRMR-SVM,Reactome Gene Sets,6,R-HSA-195721,Signaling by WNT,,-3.3,18,7,30198,332,15,3,20,10,208|1499|4040,AKT2|CTNNB1|LRP6,-2.3
mRMR-SVM,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-3.3,18,7,30198,335,15,3,20,10,1499|4040|4089,CTNNB1|LRP6|SMAD4,-2.3
mRMR-SVM,GO Biological Processes,19,GO:0019216,regulation of lipid metabolic process,19_GO:0008152 metabolic process,-3.2,18,6.9,30198,341,15,3,20,10,208|1385|3815,AKT2|CREB1|KIT,-2.2
mRMR-SVM,GO Biological Processes,19,GO:0010038,response to metal ion,19_GO:0050896 response to stimulus,-3.2,17,6.8,30198,351,15,3,20,10,1385|3815|5595,CREB1|KIT|MAPK3,-2.2
mRMR-SVM,GO Biological Processes,19,GO:0002521,leukocyte differentiation,19_GO:0002376 immune system process,-3.2,17,6.7,30198,358,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2.2
mRMR-SVM,GO Biological Processes,19,GO:0019221,cytokine-mediated signaling pathway,19_GO:0023052 signaling,-3.2,17,6.7,30198,360,15,3,20,10,3815|4089|5595,KIT|SMAD4|MAPK3,-2.2
mRMR-SVM,Reactome Gene Sets,6,R-HSA-3700989,Transcriptional Regulation by TP53,,-3.2,17,6.7,30198,362,15,3,20,10,208|905|4436,AKT2|CCNT2|MSH2,-2.2
mRMR-SVM,GO Biological Processes,19,GO:0051098,regulation of binding,19_GO:0065007 biological regulation,-3.1,16,6.6,30198,367,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-2.2
mRMR-SVM,GO Biological Processes,19,GO:0001701,in utero embryonic development,19_GO:0032502 developmental process,-3.1,16,6.5,30198,382,15,3,20,10,1499|4089|4436,CTNNB1|SMAD4|MSH2,-2.1
mRMR-SVM,GO Biological Processes,19,GO:1903706,regulation of hemopoiesis,19_GO:0002376 immune system process,-3,15,6.3,30198,400,15,3,20,10,1385|1499|6599,CREB1|CTNNB1|SMARCC1,-2.1
mRMR-SVM,GO Biological Processes,19,GO:0022412,cellular process involved in reproduction in multicellular organism,19_GO:0022414 reproductive process,-3,15,6.3,30198,402,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2.1
mRMR-SVM,GO Biological Processes,19,GO:0045860,positive regulation of protein kinase activity,19_GO:0048518 positive regulation of biological process,-3,15,6.2,30198,409,15,3,20,10,905|3815|8817,CCNT2|KIT|FGF18,-2
mRMR-SVM,GO Biological Processes,19,GO:0046649,lymphocyte activation,19_GO:0002376 immune system process,-3,14,6.2,30198,417,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-2
mRMR-SVM,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-3,14,6.1,30198,421,15,3,20,10,1499|6464|8817,CTNNB1|SHC1|FGF18,-2
mRMR-SVM,GO Biological Processes,19,GO:0009314,response to radiation,19_GO:0050896 response to stimulus,-2.9,14,6,30198,435,15,3,20,10,208|3815|4436,AKT2|KIT|MSH2,-2
mRMR-SVM,GO Biological Processes,19,GO:0048568,embryonic organ development,19_GO:0032502 developmental process,-2.9,14,6,30198,445,15,3,20,10,1499|3815|5595,CTNNB1|KIT|MAPK3,-1.9
mRMR-SVM,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-2.9,14,5.9,30198,447,15,3,20,10,1499|4040|4089,CTNNB1|LRP6|SMAD4,-1.9
mRMR-SVM,GO Biological Processes,19,GO:0048812,neuron projection morphogenesis,19_GO:0032502 developmental process,-2.9,13,5.9,30198,454,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.9
mRMR-SVM,GO Biological Processes,19,GO:0120039,plasma membrane bounded cell projection morphogenesis,19_GO:0032502 developmental process,-2.9,13,5.9,30198,458,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.9
mRMR-SVM,GO Biological Processes,19,GO:0048858,cell projection morphogenesis,19_GO:0032502 developmental process,-2.9,13,5.8,30198,462,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.9
mRMR-SVM,Reactome Gene Sets,6,R-HSA-449147,Signaling by Interleukins,,-2.9,13,5.8,30198,462,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-1.9
mRMR-SVM,KEGG Pathway,24,hsa05022,Pathways of neurodegeneration - multiple diseases,,-2.8,13,5.7,30198,476,15,3,20,10,1499|4040|5595,CTNNB1|LRP6|MAPK3,-1.9
mRMR-SVM,GO Biological Processes,19,GO:0032990,cell part morphogenesis,19_GO:0032502 developmental process,-2.8,13,5.7,30198,481,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0061061,muscle structure development,19_GO:0032502 developmental process,-2.8,12,5.7,30198,484,15,3,20,10,905|1499|4089,CCNT2|CTNNB1|SMAD4,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0033674,positive regulation of kinase activity,19_GO:0048518 positive regulation of biological process,-2.8,12,5.6,30198,489,15,3,20,10,905|3815|8817,CCNT2|KIT|FGF18,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0060284,regulation of cell development,19_GO:0032502 developmental process,-2.7,12,5.6,30198,501,15,3,20,10,1499|3815|4089,CTNNB1|KIT|SMAD4,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0071396,cellular response to lipid,19_GO:0050896 response to stimulus,-2.7,12,5.5,30198,503,15,3,20,10,1385|4040|5595,CREB1|LRP6|MAPK3,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0010638,positive regulation of organelle organization,19_GO:0048518 positive regulation of biological process,-2.7,12,5.5,30198,503,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-2.7,12,5.5,30198,505,15,3,20,10,1499|6464|8817,CTNNB1|SHC1|FGF18,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0007346,regulation of mitotic cell cycle,19_GO:0050789 regulation of biological process,-2.7,12,5.5,30198,517,15,3,20,10,1499|4436|6599,CTNNB1|MSH2|SMARCC1,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0010035,response to inorganic substance,19_GO:0050896 response to stimulus,-2.7,12,5.4,30198,521,15,3,20,10,1385|3815|5595,CREB1|KIT|MAPK3,-1.8
mRMR-SVM,GO Biological Processes,19,GO:0000904,cell morphogenesis involved in differentiation,19_GO:0032502 developmental process,-2.7,12,5.4,30198,522,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.7
mRMR-SVM,GO Biological Processes,19,GO:0045321,leukocyte activation,19_GO:0002376 immune system process,-2.7,11,5.4,30198,526,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-1.7
mRMR-SVM,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-2.7,11,5.4,30198,526,15,3,20,10,1499|6464|8817,CTNNB1|SHC1|FGF18,-1.7
mRMR-SVM,Reactome Gene Sets,6,R-HSA-422475,Axon guidance,,-2.6,11,5.3,30198,552,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-1.7
mRMR-SVM,GO Biological Processes,19,GO:0007423,sensory organ development,19_GO:0032502 developmental process,-2.6,11,5.2,30198,555,15,3,20,10,1499|3815|5595,CTNNB1|KIT|MAPK3,-1.7
mRMR-SVM,GO Biological Processes,19,GO:0051249,regulation of lymphocyte activation,19_GO:0002376 immune system process,-2.6,11,5.2,30198,557,15,3,20,10,1499|4436|6599,CTNNB1|MSH2|SMARCC1,-1.7
mRMR-SVM,GO Biological Processes,19,GO:0032989,cellular component morphogenesis,19_GO:0032502 developmental process,-2.6,11,5.1,30198,574,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.6
mRMR-SVM,GO Biological Processes,19,GO:0048598,embryonic morphogenesis,19_GO:0032502 developmental process,-2.6,10,5.1,30198,576,15,3,20,10,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-1.6
mRMR-SVM,Reactome Gene Sets,6,R-HSA-9675108,Nervous system development,,-2.6,10,5.1,30198,577,15,3,20,10,1385|5595|6464,CREB1|MAPK3|SHC1,-1.6
mRMR-SVM,GO Biological Processes,19,GO:0030097,hemopoiesis,19_GO:0002376 immune system process,-2.5,10,5,30198,606,15,3,20,10,1499|3815|4436,CTNNB1|KIT|MSH2,-1.6
mRMR-SVM,GO Biological Processes,19,GO:0031175,neuron projection development,19_GO:0032502 developmental process,-2.4,9.4,4.8,30198,641,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.5
mRMR-SVM,GO Biological Processes,19,GO:0002694,regulation of leukocyte activation,19_GO:0002376 immune system process,-2.4,9.2,4.7,30198,654,15,3,20,10,1499|4436|6599,CTNNB1|MSH2|SMARCC1,-1.5
mRMR-SVM,GO Biological Processes,19,GO:0040008,regulation of growth,19_GO:0040007 growth,-2.4,9.1,4.7,30198,664,15,3,20,10,1385|4089|6464,CREB1|SMAD4|SHC1,-1.5
mRMR-SVM,GO Biological Processes,19,GO:0000902,cell morphogenesis,19_GO:0032502 developmental process,-2.4,9,4.7,30198,670,15,3,20,10,1385|1499|4089,CREB1|CTNNB1|SMAD4,-1.5
mRMR-SVM,GO Biological Processes,19,GO:0045596,negative regulation of cell differentiation,19_GO:0032502 developmental process,-2.3,8.6,4.6,30198,699,15,3,20,10,1499|4089|6599,CTNNB1|SMAD4|SMARCC1,-1.4
mRMR-SVM,GO Biological Processes,19,GO:0050865,regulation of cell activation,19_GO:0050789 regulation of biological process,-2.3,8.5,4.5,30198,709,15,3,20,10,1499|4436|6599,CTNNB1|MSH2|SMARCC1,-1.4
mRMR-SVM,GO Biological Processes,19,GO:0006974,cellular response to DNA damage stimulus,19_GO:0050896 response to stimulus,-2.3,8.3,4.5,30198,725,15,3,20,10,571|4436|5595,BACH1|MSH2|MAPK3,-1.4
mRMR-SVM,GO Biological Processes,19,GO:0060341,regulation of cellular localization,19_GO:0051179 localization,-2.3,8.2,4.4,30198,733,15,3,20,10,208|1499|5595,AKT2|CTNNB1|MAPK3,-1.4
mRMR-SVM,GO Biological Processes,19,GO:0010564,regulation of cell cycle process,19_GO:0050789 regulation of biological process,-2.3,8.2,4.4,30198,734,15,3,20,10,1499|4436|6599,CTNNB1|MSH2|SMARCC1,-1.4
mRMR-SVM,GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-2.3,8.1,4.4,30198,744,15,3,20,10,1385|1499|4040,CREB1|CTNNB1|LRP6,-1.3
mRMR-SVM,GO Biological Processes,19,GO:0008285,negative regulation of cell population proliferation,19_GO:0048519 negative regulation of biological process,-2.2,7.7,4.2,30198,786,15,3,20,10,1499|3489|4089,CTNNB1|IGFBP6|SMAD4,-1.3
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05226,Gastric cancer,,-14,2e+02,35,30198,149,6,6,1e+02,15,1499|4040|4089|5595|6464|8817,CTNNB1|LRP6|SMAD4|MAPK3|SHC1|FGF18,-11
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-11,2.1e+02,32,30198,120,6,5,83,15,1499|4040|4089|5595|8817,CTNNB1|LRP6|SMAD4|MAPK3|FGF18,-8.9
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-11,70,20,30198,433,6,6,1e+02,15,1499|4040|4089|5595|6464|8817,CTNNB1|LRP6|SMAD4|MAPK3|SHC1|FGF18,-8.7
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05224,Breast cancer,,-11,1.7e+02,29,30198,147,6,5,83,15,1499|4040|5595|6464|8817,CTNNB1|LRP6|MAPK3|SHC1|FGF18,-8.5
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4262,Breast cancer pathway,,-11,1.6e+02,28,30198,157,6,5,83,15,1499|4040|5595|6464|8817,CTNNB1|LRP6|MAPK3|SHC1|FGF18,-8.4
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-11,1.5e+02,28,30198,165,6,5,83,15,1499|4040|4089|5595|6464,CTNNB1|LRP6|SMAD4|MAPK3|SHC1,-8.3
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-11,1.5e+02,27,30198,168,6,5,83,15,1499|4040|4089|5595|6464,CTNNB1|LRP6|SMAD4|MAPK3|SHC1,-8.3
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-8.5,1.7e+02,26,30198,119,6,4,67,19,1499|4040|4089|8817,CTNNB1|LRP6|SMAD4|FGF18,-6.6
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-8.4,56,17,30198,447,6,5,83,15,1499|4040|5595|6464|8817,CTNNB1|LRP6|MAPK3|SHC1|FGF18,-6.6
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-8.3,54,16,30198,468,6,5,83,15,1499|4089|5595|6464|8817,CTNNB1|SMAD4|MAPK3|SHC1|FGF18,-6.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-8.2,51,16,30198,498,6,5,83,15,1499|4089|5595|6464|8817,CTNNB1|SMAD4|MAPK3|SHC1|FGF18,-6.4
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05200,Pathways in cancer,,-8,47,15,30198,531,6,5,83,15,1499|4040|4089|5595|8817,CTNNB1|LRP6|SMAD4|MAPK3|FGF18,-6.3
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP3668,Hypothesized pathways in pathogenesis of cardiovascular disease,,-8,6e+02,43,30198,25,6,3,50,20,4089|5595|6464,SMAD4|MAPK3|SHC1,-6.3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-8,1.3e+02,22,30198,158,6,4,67,19,1499|4040|4089|5595,CTNNB1|LRP6|SMAD4|MAPK3,-6.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-7.9,1.2e+02,22,30198,168,6,4,67,19,1499|4040|4089|5595,CTNNB1|LRP6|SMAD4|MAPK3,-6.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-7.4,37,13,30198,688,6,5,83,15,1499|4089|5595|6464|8817,CTNNB1|SMAD4|MAPK3|SHC1|FGF18,-5.8
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-7.4,3.8e+02,34,30198,40,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.8
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-7.3,3.7e+02,33,30198,41,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-7.3,87,19,30198,231,6,4,67,19,1499|4040|4089|5595,CTNNB1|LRP6|SMAD4|MAPK3,-5.7
mRMR-SVM_MCODE_ALL,Canonical Pathways,11,M70,PID PS1 PATHWAY,,-7.2,3.3e+02,31,30198,46,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-5.6
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-7.1,3e+02,30,30198,50,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.5
mRMR-SVM_MCODE_ALL,Canonical Pathways,11,M286,PID TGFBR PATHWAY,,-7,2.8e+02,29,30198,54,6,3,50,20,1499|4089|6464,CTNNB1|SMAD4|SHC1,-5.4
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-7,2.8e+02,29,30198,54,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.4
mRMR-SVM_MCODE_ALL,Canonical Pathways,11,M276,PID FGF PATHWAY,,-6.9,2.7e+02,29,30198,55,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.4
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP560,TGF-beta receptor signaling,,-6.9,2.6e+02,28,30198,58,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-5.4
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4816,TGF-beta receptor signaling in skeletal dysplasias,,-6.8,2.4e+02,27,30198,62,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-5.3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-6.8,65,16,30198,312,6,4,67,19,4089|5595|6464|8817,SMAD4|MAPK3|SHC1|FGF18,-5.3
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04520,Adherens junction,,-6.6,2.1e+02,25,30198,71,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-5.1
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-6.6,2.1e+02,25,30198,73,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5.1
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4216,Chromosomal and microsatellite instability in colorectal cancer,,-6.6,2e+02,25,30198,74,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-5.1
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05220,Chronic myeloid leukemia,,-6.5,2e+02,24,30198,76,6,3,50,20,4089|5595|6464,SMAD4|MAPK3|SHC1,-5.1
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-6.5,1.9e+02,24,30198,78,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-6.5,1.9e+02,24,30198,78,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5
mRMR-SVM_MCODE_ALL,Canonical Pathways,11,M48,PID MET PATHWAY,,-6.5,1.9e+02,24,30198,79,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-5
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05210,Colorectal cancer,,-6.4,1.8e+02,23,30198,86,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.9
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-6.3,1.7e+02,23,30198,87,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-4.9
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0014033,neural crest cell differentiation,19_GO:0032502 developmental process,-6.3,1.6e+02,22,30198,93,6,3,50,20,4040|4089|5595,LRP6|SMAD4|MAPK3,-4.8
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP1544,MicroRNAs in cardiomyocyte hypertrophy,,-6.1,1.5e+02,21,30198,101,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-4.8
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0031058,positive regulation of histone modification,19_GO:0048518 positive regulation of biological process,-6,1.4e+02,20,30198,110,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-6,41,13,30198,492,6,4,67,19,1499|5595|6464|8817,CTNNB1|MAPK3|SHC1|FGF18,-4.6
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP4659,Gastrin signaling pathway,,-6,1.3e+02,20,30198,114,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-4.6
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP710,DNA damage response (only ATM dependent),,-6,1.3e+02,20,30198,115,6,3,50,20,1499|4089|6464,CTNNB1|SMAD4|SHC1,-4.6
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-5.9,39,12,30198,521,6,4,67,19,1499|5595|6464|8817,CTNNB1|MAPK3|SHC1|FGF18,-4.6
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-5.8,37,12,30198,541,6,4,67,19,1499|4089|5595|6464,CTNNB1|SMAD4|MAPK3|SHC1,-4.5
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04550,Signaling pathways regulating pluripotency of stem cells,,-5.7,1.1e+02,18,30198,143,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.4
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP2380,Brain-derived neurotrophic factor (BDNF) signaling pathway,,-5.7,1e+02,18,30198,144,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-4.4
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-5.6,33,11,30198,606,6,4,67,19,4089|5595|6464|8817,SMAD4|MAPK3|SHC1|FGF18,-4.3
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-5.5,90,16,30198,167,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-5.5,30,11,30198,663,6,4,67,19,1499|4089|6464|8817,CTNNB1|SMAD4|SHC1|FGF18,-4.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0030324,lung development,19_GO:0032502 developmental process,-5.4,87,16,30198,174,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-4.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0030323,respiratory tube development,19_GO:0032502 developmental process,-5.4,85,16,30198,178,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-4.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0031056,regulation of histone modification,19_GO:0008152 metabolic process,-5.4,82,16,30198,185,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-4.1
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0060541,respiratory system development,19_GO:0032502 developmental process,-5.3,76,15,30198,198,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-4
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04510,Focal adhesion,,-5.2,75,15,30198,201,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-4
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP306,Focal adhesion,,-5.2,75,15,30198,202,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-4
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-5.2,72,15,30198,210,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-5.2,72,15,30198,210,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-4
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-5.1,68,14,30198,221,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-3.9
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-5.1,65,14,30198,232,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-3.9
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP5124,Alzheimer's disease,,-4.9,57,13,30198,267,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001503,ossification,19_GO:0032501 multicellular organismal process,-4.8,55,13,30198,273,6,3,50,20,1499|4089|8817,CTNNB1|SMAD4|FGF18,-3.7
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-4.8,54,13,30198,280,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-3.7
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-4.8,53,12,30198,286,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-3.6
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-4.6,47,12,30198,323,6,3,50,20,1499|6464|8817,CTNNB1|SHC1|FGF18,-3.5
mRMR-SVM_MCODE_ALL,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-4.6,46,12,30198,325,6,3,50,20,5595|6464|8817,MAPK3|SHC1|FGF18,-3.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0090287,regulation of cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-4.6,46,12,30198,331,6,3,50,20,1499|4089|8817,CTNNB1|SMAD4|FGF18,-3.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-4.6,45,11,30198,335,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.5
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP2059,Alzheimer's disease and miRNA effects,,-4.6,45,11,30198,337,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051098,regulation of binding,19_GO:0065007 biological regulation,-4.5,41,11,30198,367,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-3.4
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05010,Alzheimer disease,,-4.4,39,11,30198,384,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3.3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048732,gland development,19_GO:0032502 developmental process,-4.3,38,10,30198,402,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-3.3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-4.3,36,10,30198,421,6,3,50,20,1499|6464|8817,CTNNB1|SHC1|FGF18,-3.2
mRMR-SVM_MCODE_ALL,WikiPathways,27,WP3888,VEGFA-VEGFR2 signaling pathway,,-4.2,34,9.9,30198,439,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-3.2
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-4.2,34,9.8,30198,447,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.1
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051090,regulation of DNA-binding transcription factor activity,19_GO:0008152 metabolic process,-4.2,33,9.8,30198,452,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3.1
mRMR-SVM_MCODE_ALL,KEGG Pathway,24,hsa05022,Pathways of neurodegeneration - multiple diseases,,-4.1,32,9.5,30198,476,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3.1
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-4.1,31,9.4,30198,492,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071407,cellular response to organic cyclic compound,19_GO:0050896 response to stimulus,-4,30,9.2,30198,505,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-4,30,9.2,30198,505,6,3,50,20,1499|6464|8817,CTNNB1|SHC1|FGF18,-3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001501,skeletal system development,19_GO:0032502 developmental process,-4,30,9.2,30198,505,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-3
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-4,29,9,30198,526,6,3,50,20,1499|6464|8817,CTNNB1|SHC1|FGF18,-2.9
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0098609,cell-cell adhesion,19_GO:0009987 cellular process,-4,28,8.9,30198,537,6,3,50,20,1499|4040|6464,CTNNB1|LRP6|SHC1,-2.9
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-3.9,26,8.6,30198,575,6,3,50,20,1499|5595|8817,CTNNB1|MAPK3|FGF18,-2.8
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0048598,embryonic morphogenesis,19_GO:0032502 developmental process,-3.9,26,8.6,30198,576,6,3,50,20,1499|4089|5595,CTNNB1|SMAD4|MAPK3,-2.8
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0071417,cellular response to organonitrogen compound,19_GO:0050896 response to stimulus,-3.9,26,8.6,30198,580,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-2.8
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-3.8,24,8.2,30198,632,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-2.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:1901699,cellular response to nitrogen compound,19_GO:0050896 response to stimulus,-3.7,24,8.1,30198,640,6,3,50,20,1499|5595|6464,CTNNB1|MAPK3|SHC1,-2.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-3.7,23,8.1,30198,653,6,3,50,20,1499|4040|4089,CTNNB1|LRP6|SMAD4,-2.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-3.7,23,8,30198,660,6,3,50,20,4040|6464|8817,LRP6|SHC1|FGF18,-2.7
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-3.6,20,7.5,30198,741,6,3,50,20,4089|5595|8817,SMAD4|MAPK3|FGF18,-2.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-3.5,19,7.3,30198,778,6,3,50,20,4040|6464|8817,LRP6|SHC1|FGF18,-2.5
mRMR-SVM_MCODE_ALL,GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-3.5,19,7.3,30198,789,6,3,50,20,1499|4040|5595,CTNNB1|LRP6|MAPK3,-2.5
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0001837,epithelial to mesenchymal transition,19_GO:0032502 developmental process,-7.8,3.9e+02,34,30198,78,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-6.1
mRMR-SVM_SUB1_MCODE_1,WikiPathways,27,WP3931,Embryonic stem cell pluripotency pathways,,-7.2,2.5e+02,28,30198,119,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.6
mRMR-SVM_SUB1_MCODE_1,WikiPathways,27,WP4787,Osteoblast differentiation and related diseases,,-7.2,2.5e+02,27,30198,120,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.6
mRMR-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05226,Gastric cancer,,-6.9,2e+02,25,30198,149,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.4
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-6.9,1.9e+02,24,30198,158,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.3
mRMR-SVM_SUB1_MCODE_1,WikiPathways,27,WP4239,Epithelial to mesenchymal transition in colorectal cancer,,-6.8,1.8e+02,23,30198,165,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.3
mRMR-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa04310,Wnt signaling pathway,,-6.8,1.8e+02,23,30198,167,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.3
mRMR-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05225,Hepatocellular carcinoma,,-6.8,1.8e+02,23,30198,168,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.3
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-6.8,1.8e+02,23,30198,168,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5.3
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0009952,anterior/posterior pattern specification,19_GO:0032502 developmental process,-6.5,1.4e+02,21,30198,210,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-5
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0060485,mesenchyme development,19_GO:0032502 developmental process,-6.4,1.3e+02,20,30198,231,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.9
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0003002,regionalization,19_GO:0032502 developmental process,-5.9,90,16,30198,335,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.5
mRMR-SVM_SUB1_MCODE_1,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-5.5,70,14,30198,433,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.3
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0007389,pattern specification process,19_GO:0032502 developmental process,-5.5,68,14,30198,447,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.2
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0008283,cell population proliferation,19_GO:0009987 cellular process,-5.4,61,13,30198,492,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4.1
mRMR-SVM_SUB1_MCODE_1,KEGG Pathway,24,hsa05200,Pathways in cancer,,-5.3,57,13,30198,531,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-4
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0043009,chordate embryonic development,19_GO:0032502 developmental process,-5,48,12,30198,632,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.9
mRMR-SVM_SUB1_MCODE_1,GO Biological Processes,19,GO:0009792,embryo development ending in birth or egg hatching,19_GO:0032502 developmental process,-5,46,12,30198,653,3,3,1e+02,27,1499|4040|4089,CTNNB1|LRP6|SMAD4,-3.8
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5654741,Signaling by FGFR3,,-8.7,7.5e+02,48,30198,40,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.8
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5654743,Signaling by FGFR4,,-8.6,7.4e+02,47,30198,41,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.8
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-8.4,6e+02,43,30198,50,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.6
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-74751,Insulin receptor signalling cascade,,-8.3,5.6e+02,41,30198,54,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.5
mRMR-SVM_SUB1_MCODE_2,Canonical Pathways,11,M276,PID FGF PATHWAY,,-8.2,5.5e+02,41,30198,55,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.5
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-7.9,4.1e+02,35,30198,73,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.2
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-74752,Signaling by Insulin receptor,,-7.8,3.9e+02,34,30198,78,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6.1
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-7.6,3.5e+02,32,30198,87,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-6
mRMR-SVM_SUB1_MCODE_2,KEGG Pathway,24,hsa05224,Breast cancer,,-6.9,2.1e+02,25,30198,147,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-5.4
mRMR-SVM_SUB1_MCODE_2,KEGG Pathway,24,hsa05226,Gastric cancer,,-6.9,2e+02,25,30198,149,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-5.4
mRMR-SVM_SUB1_MCODE_2,WikiPathways,27,WP4262,Breast cancer pathway,,-6.9,1.9e+02,24,30198,157,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-5.4
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-6.4,1.4e+02,20,30198,221,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-5
mRMR-SVM_SUB1_MCODE_2,KEGG Pathway,24,hsa04014,Ras signaling pathway,,-6.3,1.3e+02,20,30198,232,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.9
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-6.1,1.1e+02,18,30198,280,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.7
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-6.1,1.1e+02,18,30198,286,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.7
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0023052 signaling,-6,97,17,30198,312,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.6
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-5.9,93,17,30198,325,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.6
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-5.5,70,14,30198,433,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.3
mRMR-SVM_SUB1_MCODE_2,WikiPathways,27,WP5087,Malignant pleural mesothelioma,,-5.5,68,14,30198,447,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.2
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-5.4,65,14,30198,468,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.2
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0023052 signaling,-5.4,61,13,30198,492,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.1
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-5.4,61,13,30198,498,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.1
mRMR-SVM_SUB1_MCODE_2,Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-5.3,58,13,30198,521,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-4.1
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0023052 signaling,-5.1,50,12,30198,606,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-3.9
mRMR-SVM_SUB1_MCODE_2,GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0023052 signaling,-4.9,44,11,30198,688,3,3,1e+02,27,5595|6464|8817,MAPK3|SHC1|FGF18,-3.8
